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ABSTRACT 
INTRODUCTION 
As the global HIV epidemic enters its fourth decade, significant advances have 
been made in HIV prevention and treatment in the developing world. But, still notable 
challenge involves in the increased proportion of HIV infected children who live 
through school age and into adolescence especially prenatally infected adolescents 
due to lifelong commitment to the life-saving drug therapies. However, the 
Adolescents Living with HIVs (ALHIV) are facing  many challenges for optimal 
adherence to ART, nutritional status and QOL when compared to the children and 
adults owing to parental death, dependency on caregivers/parents, need of autonomy, 
breaking of parental bonding, attitudes of defiance/ denial, and disclosure status.  
Since, the adolescents are fulcrum of key population they are facing many 
barriers to continue the optimal adherence to ART. Subsequently it causes poor 
adherence makes to lower immunity level, reduce nutrition intake and decrease QOL 
of HIV infected adolescents. Still many research findings stated that, the 
interventional strategies help the adolescents to get better adherence improvement.  
Hence, the investigator planned to evaluate effectiveness of HIV Interventional 
Package (HIP) on HIV infected adolescents attending ART clinic: A Randomized 
Controlled Trial. The HIP includes adherence counseling, nutritional counseling and 
strategies to enhance the QOL includes selected asana and maintenance of the diary 
after the practice of asana and intake of drugs. The Objectives of the present study 
are listed below, 
1. To assess the base level of ART adherence, nutritional status and QOL on HIV 
infected adolescents in experimental and control group (pretest). 
2.  To evaluate the 3rd and 6th month level of ART adherence, nutritional status 
and QOL on HIV infected adolescents in experimental and control group (post 
test).  
3. To compare and determine the effectiveness of HIV Interventional Package 
(HIP) on HIV infected adolescents in experimental and control group 
  
4. To correlate ART adherence level with nutritional status and QOL on HIV 
Infected adolescents in experimental and control group. 
5. To associate the gain score findings of HIV Interventional package on HIV 
infected adolescents in experimental and control group with demographic 
variables of HIV infected adolescents/caregivers.  
MATERIALS AND METHODS 
The total of 388 HIV infected adolescents was divided in to experimental 
(195) and control group (193) by simple random technique. The data were collected 
from HIV infected adolescents/caregivers from four main ART centres through 
Modified Adherence Assessment Questionnaire, Nutritional assessment questionnaire 
includes anthropometric variables and Modified QOL questionnaires. The investigator 
adopted the King’s goal attainment theory and it was more suitable to interpret the 
study findings phenomenon in the conceptual frame work. The HIV interventional 
package (HIP) was given to the experimental group alone and the selected asana were 
demonstrated by the researcher. But the conservative care was given to control group. 
At the end of the 6
th
 month the cursory instructions regarding HIP and practice of 
asana were also given to the control group. Simultaneously the data were collected 
from both groups at ‘0’month, 3rd month and 6th month intervals. The collected data 
were analyzed by using of both descriptive and inferential statistics.  
RESULTS AND ANALYSIS 
Based on objectives the study results are listed below, 
Regarding level of ART adherence and CD4 count 
 However there are various methods was used in this study for to assess the 
ART adherence level, since the pill count was highly correlated with missed dose 
history in both groups. In the experimental and control group, the mean ART 
adherence score in pretest was 85.36 and 85.60 whereas in post test score was 98.74 
and 90.54 respectively. The mean difference in ART gain score with 95% confidence 
interval was 13.4% in experimental 4.9% in control group. 
 Regarding CD4 count, the baseline mean score was 664.86 in experimental 
group and 669.72 in control group. Whereas in the 6
th
 month assessment of mean 
score was 840.30 and 703.35 respectively. The paired t-test value of 7.21 was 
  
significant at p=0.001*** in experimental group. It revealed that there was significant 
changes in level of CD4 count in experimental group. 
 These findings showed that the motivational counseling and interventional 
diary has effectiveness to increase the adherence to ART among HIV infected 
adolescents in experimental group than the control group. The gain score differences 
of 8.5% showed the effectiveness of HIP in the improvement of adherence level in 
experimental group of HIV infected adolescents. 
Regarding Nutritional status 
 The repeated measures of ANOVA ‘F’ test showed the statistically 
significant improvement in all the anthropometric variables except height at 
p=0.001***. It revealed that, except height there was a marked improvement in all 
other nutritional variables of HIV infected adolescents. But in the Bonferroni t–test, 
all the variables had significance from baseline to the 6
th
 month evaluation at  
p<0.01** and the 3
rd
 to 6
th 
month evaluation also had significance at P <0.05* but 
except the variable of height. Whereas in control group all nutritional variables of 
HIV infected adolescents had no significance in ANOVA F-test and Bonferroni  
t–test. 
 Regarding the interpretation of ‘Z’ score on HIV infected adolescents in 
experimental group, 7% had severely malnourished and 22% moderately 
malnourished in baseline assessment whereas in the 6
th
 month evaluation it reduced to 
1% and 18 % respectively. The chi square value of 9.48 was significant at 
p=0.05*.However in control group there was no significant improvement from 
baseline to the 6
th 
month evaluation. The chi square value of 0.10 was not significant 
at p=0.99. 
 In consideration with nutritional gain score in experimental group, the 
baseline assessment showed that, 28% of participants had mal nourished whereas the 
in 6
th
 month evaluation it reduced to 19%. However in control group, the baseline 
assessment showed that, 29% of participants had malnourished whereas in the 
6
th
month evaluation it reduced to 28 %. It showed that the experimental group has 
gained more score i.e., 9.3% when compare to the control group (1.5%). 
 These findings revealed that the reinforcement of nutritional counseling 
including antioxidants rich diets has effectiveness to increase the nutritional level of 
HIV infected adolescents in experimental group than the control group. The gain 
  
score difference of 7.8% proved the effectiveness of HIP in the improvement in the 
nutritional status in experimental group of HIV infected adolescents. 
 Regarding  clinical  signs and symptoms the dry skin, skin rashes, oral 
problems, nausea vomiting, diarrhea  and loss  of appetite  were  reduced from 
baseline to 6
th
 month evaluation in experimental group and it was significant at 
p=0.01**.But in regard to seborric dermatitis, texture and color of hair  no marked 
improvement in study period. Whereas in the control group there was no significant 
changes seen in HIV infected adolescents. 
Regarding Quality of life 
 In regard to QOL interpretation score on HIV infected adolescents in 
experimental group 81% had poor QOL, none of them had good QOL in baseline 
assessment whereas at 6
th 
month evaluation it reduced to 23% and 14% respectively. 
The chi square value of 174.19 was significant at p=0.001***. However in control 
group there was no significant improvement from baseline to the 6
th
 month 
evaluation. The chi square value of 0.10 was not significant at p=0.99. 
 Considering with the mean QOL score in baseline assessment was 163.66 
and 162.93 whereas in the 6
th
 month score 215.64 and 166.02 respectively in both 
groups. The mean difference in QOL gain score with 95% confidence interval was 
15.1% in experimental 0.9% in control group. It revealed that there was marked 
improvement in QOL of HIV infected adolescents in experimental group than the 
control group. 
 These finding depicted that, the strategies to enhance of QOL counseling 
and yoga has effectiveness to increase the QOL of HIV infected adolescents in 
experimental group than the control group. The gain score difference of 14.2 % 
showed the effectiveness of HIP in the improvement of QOL of HIV infected 
adolescents in experimental group. 
Regarding Correlation of ART adherence with Nutritional status and QOL, 
 In regard to correlation of ART adherence and nutritional status in 
experimental group the baseline assessment showed that poor correlation between 
ART and nutritional score. But in, 3
rd 
and 6
th
 month evaluation there was fair and 
moderate correlation between ART adherence and nutritional score since r=0.31, 0.42 
  
was significant at p=0.01**. Whereas in  the control group, throughout the assessment 
period showed that, there was a poor correlation between ART adherence  and  
nutritional score because of ‘r’ value was lesser than 0.2.  
 In relevant to correlation of ART adherence and QOL score, the 
experimental group baseline assessment showed poor correlation between ART and 
QOL score. But in, 3
rd
 and 6
th
 month  evaluation there was fair and moderate 
correlation between ART adherence  and QOL score since r=0.31, 0.43 was 
significant at p=0.05** .Whereas in  the control group, throughout the assessment 
period showed that there was a poor correlation between ART and  QOL  score 
because  of ‘r’ value was lesser than 0.2.  
Regarding Association of ART Adherence, Nutritional status and QOL, 
 Regarding  association with ART adherence gain score with demographic 
variables, in Univariate analysis showed  the influencing factors of adolescents age & 
sex, age & sex of caregivers, relationship with adolescents and residence were 
significant with unadjusted OR  with 95 % CI. Whereas in multivariate analysis, the 
sex of caregivers and residence were not significant at p= 0.60 and 0.18 with adjusted 
OR 1.3 & 1.5 respectively. The rest of other variables were more significant with 
adjusted OR with 95 % CI. 
 Considering association  with nutritional gain score with demographic 
variables, in Univariate analysis showed  the influencing factors of adolescents age & 
education, age & sex of caregivers, relationship with adolescents and residence were 
significant with unadjusted OR  with 95 % CI. But in multivariate analysis, the sex of 
caregivers and residence were not significant at p=0.14 and 0.33 with adjusted OR 1.5 
& 0.5 respectively. The rest of other variables were more significant with adjusted OR 
with 95 % CI. 
 In regard to association of  QOL gain score with demographic variables, in 
Univariate analysis showed the influencing factors of adolescents age & sex, age & 
sex of caregivers, relationship with adolescent and residence were significant with 
unadjusted OR  with 95 % CI. Where in multivariate analysis, the sex of caregivers 
and residence were not significant at p= 0.60 and 0.14 with adjusted OR 1.3 & 1.5 
respectively. The rest of other variables were more significant with adjusted OR with 
95 % CI. 
  
CONCLUSION 
 The study reports revealed that, in the experimental group pretest mean score 
was 85.36 in adherence and 163.66 in QOL. But in the 6
th
 month evaluation, it was 
increased to 98.74 and 215.64 respectively. In corresponding to the improvement of 
HIP components, the mean difference score with 95 % confidence interval was 13.38 
& 51.97 and percentage of gain score was 13.4% in adherence and 15.1% in QOL. 
But in the control group, there was no significant change in mean difference score and 
the percentage of gain score increased to 4.9% in adherence and 0.9% in QOL. In 
regard to nutritional status, the both groups   baseline assessment showed 28% and 
29% of HIV infected adolescents had malnourished. But in the 6
th
 month evaluation, 
It reduced to 19% and 28% respectively. In percentage wise nutritional gain score was 
increased to 9.3 % in experimental and 1.5% in control group.   
This study finding suggests that adolescent focused interventions including 
behavior modifications are essential to improve the CD4 count, adherence rate, 
nutritional status and enhance quality of life. The global targets of zero infections, 
zero discrimination and zero deaths in the adolescent population  for HIV is within 
our reach  but  adolescents centered interventions are needed as in tailored approach  
in order to improve the overall wellbeing of adolescents. This study finding revealed 
that the motivational counseling with interventional aids of diary and yoga practice 
makes the adolescents to build a chance for a safe, happy, healthy and productive 
nation in the future. 
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CHAPTER I 
INTRODUCTION 
I am fourteen and frail 
But uncorrupt and fragrant 
Full of dreams and desires 
And, the’ ‘will to do’ like fires 
Listen to me, give me some space 
Protect my grace, brighten my face 
For I am your future, - I am  
Innocence, I am Adolescence. 
                                                 R K Baxi 
 
The word “Adolescence’ is coined from the Latin word ‘adolescere’ literally 
means, "to grow up”, “to emerge” or “to attain identity”. It’s sighted as a midway 
period between the childhood to adulthood and our enlightening purpose is the 
preparation of the children for the adult roles. It is a period of manifold transitions 
involving physical, psychological, social, economic, education, training, employment 
and unemployment, from one living circumstance to another.
1
 At the global level, 
WHO (2012) and UNICEF (2005) defines ‘adolescence’ as age straddling of 10 to  
19 years, “youth” as those in 15-24 years and these two overlapping age group of  
10-24 years covering as “young people”. According to developmental characteristic, 
the adolescence stage is further divided into early (11-14 years), middle (15-17 years) 
and late adolescence (18-21 years).
2
  
In India, the Ministry of Health and Family Welfare has recognized the WHO 
definition, but in other contentious view as per Child Rights Law and UNAIDS, up to 
18 years of age group to be considered as children.
3 
In many countries of the region, 
the Human Immuno Deficiency Virus (HIV) information is not widely available for 
adolescents (10-19 years) or young people (10-24 years) as evidenced by global 
reports. Where data are accessible for young people, principally in the context of HIV, 
they are recurrently not disaggregated by age cohort, primarily an early adolescent 
between the ages of 10 to14 years.
4 
Adolescence next to  second part of infant period, where the myriad  changes 
of physical, physiological, psychological, neurobehavioral and hormonal changes take 
place  with varying patterns of social relations and interactions. These innumerable 
changes in puberty makes to augment in height and weight, completion of skeletal 
2 
 
growth together which enhance in skeletal mass, sexual maturation and changes in 
body composition. The progression of these events during puberty is mainly reliable 
on the adolescence but often prejudiced by the age of onset, gender, duration, along 
with the individual variations.
5
   
This period is a window of opportunity that makes the stage for a healthy and 
productive adulthood and in notorious view  prone to a number of health impacting 
conditions owing to personal choices, environmental influences and lifestyle changes  
compile of  substance use disorders (tobacco, smoking, alcohol and others), Road 
Traffic Injuries (RTIs), suicides(completed and attempted),violence, teen and 
unintentional pregnancies and Sexually Transmitted Infections (STI) including 
Human Immunodeficiency Virus (HIV) infection.
5,6 
   The epidemic and non curable disease of HIV/AIDS affect the “Fulcrum” of 
population on adolescents in two ways: i.e., Perinatally Infected Adolescents (PIA) 
through vertical transmission of mother to child and Behaviorally Infected 
Adolescents (BIA) usually through the sexual transmission. It is also essential to 
remind that, adolescents can be active as a transitional phase progress to adulthood in 
which  sexual experimentation and drug use are instigated, thus growing the risk to 
invite and as well as to transmit HIV in second decade.
7
 Worldwide,  the majority of  
95% of new HIV infections were disproportionately noticed in adolescents  (10-19 
years) and mainly in Asia and the Pacific were accounted to take place in key 
population group such as adolescent males who have sex with males, adolescents who 
sell sex, and adolescents who inject drugs with contaminated injecting equipment face 
additional challenges to HIV treatment, care and support.
8
 
  Globally UNAIDS (2012) estimated that 2.2 million (2.0- 2.5 million) 
adolescents between 15 to 19 years were HIV-positive, and most of them were not 
aware of their status. The break down data was 870,000 (770,000−960,000) 
adolescent boys and 1.3 million (1.2−1.5 million) adolescent girls. Among these, the 
majority (75%) of adolescents with HIV were infected through perinatal transmission. 
In 2013, more than 1.2 billion of adolescents were in worldwide: this signifies that 
approximately one in every six persons is an adolescent.
 
The figure 1 showed the 
world population with proportion of adolescents.
9 
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Fig 1: World population with proportion of adolescents (10-19 years) 
 
Source: Progress for children, A report card on adolescents, UNICEF 
 
 The percentage of adolescents in the universal population was sharp around 
1980 and is now on the decline almost everywhere, but a tendency will increase 
slightly through 2050. Still the growth of adolescents predicted to be 1.3 billion in 
2050 the need of attention to the area is to be prioritized. About 21% of Indian 
population in adolescents (approximately 243 million) followed by 207 million in  
China , 44 million in  United States, 41 million in both Indonesia and Pakistan in 
which adolescents are newly infected with HIV for every two minutes especially in 
the age of 15 to19 years.
10  
The Human Sciences Research Council (HSRC-2012) survey estimated the 
age of 10 years, 6.2% of children born to HIV-positive women will be HIV-positive 
as a result of perinatal infection and breastfeeding. The recent survey of overall HIV 
prevalence in young people 15–19 years was 3.2%, i.e., 0.7%  for males and 5.6% for 
females; this imitates an 8 times higher prevalence in females compared to males. 
Further, the incidence rate of HIV in the 15-24 years age group was four times higher 
in females than male caused by horizontal transmission.
11
 
The figure 2 shows, the world currently holds the largest generation of young 
people in history, with 2.1 million (1.7 -2.8 million) adolescents and youth making up 
one fourth of the world’s population. Among this, females were 1.2 million; males 
930,000 and also estimated that, 7, 80,000 youth were newly infected with HIV. Even 
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in Low and Middle Income Countries (LMIC) of Africa, Asia, Caribbean and the 
Latin America accounts for 97% of the new infections .The East Asia and the pacific 
have the percentage of male and female of 49 % and 51% respectively and whereas in 
South Asia is reversible. The six countries of South Africa, Nigeria, Kenya, India, 
Mozambique and Tanzania had accounted for 26 new infections among late 
adolescents for every hour.
12
 
 Fig 2: The Estimated Number of HIV Infected Adolescents in Worldwide-2012 
 
Source: UNAIDS sixth stock taking report - Towards AIDS free generation-2013  
In 2013, as per UNAIDS reported that  globally below 15 years  were 3.4 
million and between 10 to 19 years were 2 million adolescents living with HIV. 
Among these, the mainstream of HIV positive adolescents i.e., 1.8 million an account 
of  85% was resided in Sub-Saharan Africa. In this region, the AIDS-related mortality 
among 10–19 years was more than doubled during the period of 2005 to 2012, but in 
contrast the overall level was decreased in all other age categories.
13
 AIDS among 
adolescents is not under control and the new HIV infections among adolescents are 
also not declining, evolution is also bumpy across various regions. For example, since 
2005 the number of new HIV infections have been noted moderately stable in Asia 
and the Pacific, while it has dwindled in Southern and Eastern Africa although now it 
remains unacceptably high.
14 
  
Globally, UNAIDS (2014) breakup reports estimated for the entire region 
includes, the total adolescents (10-19 years) living with HIV were 2 million: it was 
represented in figure 3. The Southern and Eastern Africa and Central & West Africa 
had maximum of 61% and 21% respectively. Next the Asia and pacific had around 
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11% of the total population. The rest of the world was minimal of 4% to 1% including 
Latin America & the Caribbean and Middle East and North America.
15
 
Fig 3: The Anticipated Percentage of Adolescents Living with HIV in 2014 
 
      Source: HIV and AIDS Estimates, UNAIDS - July 2015. 
Globally; there has been 32% declined in the estimated number of new HIV 
infections among young people (15-24 yrs) and the table 1 illustrates the data from 
2001 to 2012. Across Sub-Saharan Africa and the Caribbean, countries have achieved 
notable decline in incidence rate of 36 % and 55% respectively. In contrast, in the 
Middle East &North Africa and East Asia, there was an estimated that 50% and 24 % 
raise in the number of new HIV infections among adolescents. Moreover, there is also 
a gender divide as young women aged 15 to 24 years were 50% more possible to 
acquire HIV than their male peers. 
Table 1: The Trend of New HIV Infections Among Young people in the  
Year of 2001-12 
Region 
Number of new 
HIV infections 
(2001) 
Number of new 
HIV infections 
(2012) 
Decline/Increase in 
new HIV 
infections (%) 
Caribbean  8 300 3 700 55% decline 
East Asia  21 000 2 6000 24% increase 
Easter Europe 
Central Asia  
33 000 20 000 38% decline 
Latin America  36 000 31 000 15% decline 
Middle East and 
North Africa  
7 700 12 000 50% increase 
Oceania  1 200 <1000 53% decline 
South and South 
East Asia  
150 000 110 000 28% decline 
Sub-Saharan Africa  800 000 560 000 36% decline 
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Number of Adolescents and Youth Living with HIV and AIDS Related Mortality 
As per UNAIDS (2012) reported that, an estimated 5.4 million young people 
(10-24 years) were living with HIV. There were around 900 000 adolescents aged 10-
14 years were living with HIV, among this majority were acquired through vertical 
transmission. Unfortunately, many young people aged 10-14 years were remaining 
unaware of their HIV status. The other age groups of 15-24 years were respectively 
reduced from 2001 in 1.3million to whereas in 2012, 1.2 million in the age of 15 to 19 
years depicted in table 2.   
Table 2: The Trend of Adolescents and Youth Living with HIV in the year of 
2001-2012 
Age 
Number of adolescents 
and youth living with 
HIV (2001) 
Number of adolescents 
and youth living with 
HIV (2012) 
10-14 250 000 900 000 
15-19 1 300 000 1 200 000 
20-24 4 400 000 3 300 000 
Total (10-24) 6 000 000 5 400 0000 
 
Whereas the AIDS related deaths were increased among the same age groups 
are shown in table 3.The adolescents aged 10-14 and 15-19 years were died 21,000 
and 17,000 in 2001 but it was increased triple in amount of 61,000 and 46,000 
respectively in 2012. The total number of AIDS related death among adolescents and 
young people were 1, 10,000 in 2001 where as it had increased to1, 54,000 in 2012.
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Table 3: AIDS-Related Mortality among Adolescents and Youth living with HIV 
(2001-12) 
Age 
Number of AIDS-
related deaths (2001) 
Number of AIDS-
related deaths (2012) 
10-14 21 000 61 000 
15-19 17 000 46 000 
20-24 73 000 48 000 
Total (10-24) 110 000 154 000 
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             As per WHO report (2013), around 1.3 million adolescents pass away from 
treatable or preventable reasons and mortality is soaring in boys than in girls and also 
in late adolescents than the early adolescents. The UNAIDS also estimated that, 
growing pattern were seen in AIDS-related mortality i.e., 6 % of total AIDS-related 
mortality among young people (15-24 years). It’s mainly of inadequate prioritization 
of adolescents in national plans for scale-up of HIV testing and management services 
still the total number of young people living with HIV is mounting. The AIDS-related 
mortality among adolescents have tripled since 2000 at the same time as declining 
among all other age groups, which can be principally, attributed to PIAs without 
access to the life-saving intervention.
16,17 
   
In 2014, the "Health for the world’s adolescents" report of WHO revealed that 
depression was the major reason of illness and disability for both boys and girls aged 
10 to 19 years. Globally, the top three causes of adolescent deaths were road traffic 
injuries, HIV/AIDS, and suicide. The HIV/ AIDS is a number two cause for the death 
of the adolescents as shown in figure 4 and also number one cause for the adolescent 
death in South Africa.
18
  
 
Fig 4: The Top 10 Causes of Death Among Adolescents In World Wide 
 
Source: Health for world’s adolescents-WHO- 2014 
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The primary countries with elevated HIV prevalence in sub-Saharan Africa, 
greatly affected by HIV were young women and adolescent girls i.e., 7 in 10 new 
infections are 15-19 year girls. In worldwide, there were more than 6,300 new HIV 
infections per day was crop up in 2012 among this around 2500 of new cases were 
adolescents and youth ages of 15–24 years. While approximately, every day 712 new 
cases of HIV were diagnosed less than 15 years of age due to vertical transmission, a 
little percentage were the result of horizontal transmission, includes sexual 
transmission through sexual abuse or coercion, or early sex.
18, 19 
  In certain countries like Asia, the accessible partial facts suggested that above 
60 % of young key populations (15-19 years) instigate sexual activity earlier in their 
life. The  most regions of the world, the exposure of HIV testing and counseling was 
very poor in adolescents moreover principally in key population.
6,19
 The figure 5 
shows the age wise global HIV prevalence reveals that, nearly 21% of HIV infections 
were spread in the age of 15-24 years. The statistics from 2008 to 2012 reported that, 
the access and coverage level was fluctuate drastically even in all countries, but the 
primary country signified that the adolescents girls (15–19 years) less than 5:1 were 
not known of their disclosure status.
20 
Fig 5: Age Wise Global HIV prevalence 
 
Source: Naswa and Marfatia – Adolescent HIV/AIDS-2010  
 As per UNAIDS report (2014), after South Africa and Nigeria the third 
highest number of 2.1 million  PLHIV is India as shown in figure 6.
21
 India is 
debatably a abode for leading number of Orphans and Vulnerable Children (OVC) 
9 
 
living with HIV. It is anticipated that 13% of them acquire HIV infection through 
sexual contact and 20-30% of female sex workers in the country are less than  
18 years. In India, there are 25 million orphans from all causes of which around 2 
million may be endorsed to HIV/AIDS.
 22
   
 Fig 6: The Estimated Population of People Living With HIV.
 
   
Source: UNAIDS Gap report 2013- 2014 
   Globally the current treatment coverage data for adolescents is unavailable; as 
of May 2014, only 30 countries were reported the estimated number of adolescents on 
Anti Retroviral Therapy (ART) in the Global AIDS Response Progress Reporting 
System. In LMIC, only 34% of children were received the treatments in the age of  
0 – 14 years when compared with 64 % of adults. At present there is no precise report 
of adolescent management and care facts for some regions uniquely for ages 10-19 
years. The majority of long term survivors of PIAs endure a numerous physical, 
psychological and social transitions that increase the risk of non-adherence.
 6, 23 
 The non adherence in PIAs causes treatment resistance and failure of first line 
and in some cases second line regimens.  The imperative role of adolescent-friendly 
services are stand for the non adherence to ART in the adolescents and youth than for 
adults.  The lifelong commitment to adolescents especially PIAs, presents unique 
challenges since it may not be handled moreover by pediatric or adult HIV 
management programs. 
24
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All Adolescents Living with HIV (ALHIV) require the most constructive drug 
schedules that ease the daily pill burden and are related with lower side effects in 
order to enhance the likelihood of optimal adherence. The ALHIV have unique needs 
due to the vital transitions and individual life circumstances results in habitually face 
various challenges with adherence to ART 
25. 
In India, the National Pediatric 
HIV/AIDS project was commenced on 30
th
 Nov 2006 till September 2015, nearly the 
registered Children Living with HIV/AIDS (CLHIV) were 77, 729 for whom  the 
receiving free active services on treatment of HIV care were  49,909. The figure 7 
shows an outlook of the services provided to the CLHIVs in India, in the period of 
2005 to September 2015. 
Fig 7: The ART scale up for children living with HIV/AIDS in India, 2015-16. 
 
    Source: NACO Annual Report 2015-16 
 
Although the first line therapy was victorious, certain proportion of children 
and adolescents showed evidence of treatment failure. The sub optimal adherence was 
the main source for of many children to increase their viral load and disease 
progression to AIDS.  The WHO reported that the average switched rate for adults 
from first to second line ART is 2-3% per year. Now, prerequisite of second line ART 
for children has been accessible to all Centre of Excellences (COE) and ART plus 
Centres.
26
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Anti Retroviral Therapy (ART) and It’s Significance 
The trademark of HIV infection is progressive of CD4 + T cell reduction 
causing to an augmented risk for the evolution of Opportunistic Infections (OIs), 
AIDS and death. The HIV infected children and adolescents have prominent viral 
loads and were at risk for rapid progress of disease due to poor development of 
immune system when contrasted to the adults.  The advent of Highly Active Anti 
Retroviral Therapy (HAART) in 1996 extensively declined the mortality and 
morbidity in HIV infected children in both resource limited and rich countries. Even 
though the HAART treatment for HIV infection is a lifelong commitment to all the 
People living with HIV/AIDS (PLHIV) especially more challenge for ALHIV they 
have to take from childhood period. But the sustained intake of ART medication 
needs to reduce viral load in undetectable level and to enhance the quality of life of 
PLHIV.
27
  
   The ART is combination of at least three antiretroviral drugs markedly 
reduced the morbidity, mortality and remarkably AIDS related death rates declined by 
80% from1998 to till now. The major goal of HARRT is to repress HIV viral 
replication and renovate immune function. The booming adherence to HARRT results 
in virologic repression, boost in the CD4 count + T cells and enhancement in the 
clinical well being of the individual, evidenced the weight gain and control of OIs.
28
  
The optimal adherence (>95%) to ART is the main significant indicator to 
restrain HIV imitation and to shun the emergence of the drug resistance. The 
adherence rates exceeding 95% are vital to maximize the benefits of ARV 
medications. The optimal adherence to treatment regimen is a major requirement for 
the efficacy and stability of ART and keeping an adolescent on a first line (1 NNRTI 
+ 2 NRTI) as long as possible. Once the first line regimen had less improvements in 
therapeutic outcomes due to non adherence or  poor retention in care  or Loss of 
follow up (LFT)  causes  the  increased viral load and progress of disease turns into 
next choice  of  the second line regimen.(1 PI + 2 NRTI.)
29
  
  As per  ‘WHO’ Adherence is defined as “the extent to which a person’s 
behavior of taking medicine, following diet and or executing lifestyle changes, 
corresponding with agreed recommendations from health care providers.”30 The 
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adherence measurement is generally based on pioneer of Paterson’s study; identified 
that up to 95% adherence is essential for the efficient HIV viral suppression.
31
The 
optimal level of more than 95% drug adherence is essential and associated with 
improved Clinical, Immunological and Virological outcomes. Globally 62% of 
adolescents and young adults only were adherent to ART and comparable to adults. 
There were discrepancy between regions like poorer adherence in Europe, South and 
North America, (50-60%) and elevated levels in Africa and Asia (>70%).
32
  
  Even the adherence to the ART is worse in both categories of adolescents. The 
other litigious view of PIAs were started on ART earlier in life resulting in partial 
viral suppression, emergence of drug resistance and end in ART failure when 
compare to the adolescents infected in second decade. The adherence rates exceeding 
95% are essential to maximize the benefits of ARV medications. The non-adherence 
of less than 95% are at last associated with ART failure includes the augment of viral 
resistance, treatment failure  and increased the risk to progress the end stage of 
disease.
9,28
 
  The ALHIVs are facing the many challenges for optimal adherence to ART, 
when compared to the children and adults due to dependency on caregivers/parents, 
need of autonomy, attitudes of defiance/ denial, and delay in the disclosure status. 
 
The concomitant group of these adolescents faces many concerns related to 
disclosure, regimen fatigue, stigma within their schools, homes and communities/self 
stigma, loss of parents/caregivers support and financial burden.
33
 
 
The infected adolescents adhere to ART treatment and support has misfired 
throughout to the epidemic results in many non adherence problems. The middle and 
late adolescents are having major risk of non adherence when compared to younger 
adolescents. The high prevalence of suboptimal adherence to management during 
adolescence, boost the morbidity and OIs, ends in progress to shoddier of life and 
over use of health care system. The various causes include physical, psychological, 
medical, social and lifestyle factors were influencing the adherence rate among 
adolescents.  The common barriers are like pill burden, forgetfulness, regimen fatigue, 
busy schedule, depression, stigma and disclosure contributes to poor retention in the 
care, sub optimal and non adherence to antiretroviral therapy in this population.
25, 33, 34 
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 Antiretroviral therapy means not only for the adherence to ARV medications 
(right drug, dose, route, frequency and time) and also it includes in the complete 
treatment and care. The optimal level of (95 %) adherence to ART inhibits HIV 
reproduction which has significant in the stable decline in AIDS related to mortality 
and morbidity. The ART adherence below 95% associated with the treatment failure 
and even 80-90 % have the risk of resistance to ARV medications. The Non-
adherence to ART consequences in inadequate suppression of viral replication in the 
body and allows the disease to progress at a faster rate. It’s typically coupled with 
frequent hospital admissions, development of OIs, poor QOL and end in death.
35 
The poor adherences to ART especially of below 75% were three times more 
likely to die compared to those were above 75% of adherence levels.
36
 The Non 
adherence is prime and  the foremost reasons for the failure of first line ART and also 
reduces treatment outcomes. The perinatal HIV infected adolescents has been 
reported to correlated with malnutrition, under weight, low weight gain and delay in 
sexual maturity due to disease progression as well as the side effects of ART 
medications.
37 
 
The many adolescents who initiated treatment in early childhood have 
experienced side effects from the medications, including lipo dystrophy, anemia, 
nausea, dizziness, memory loss, inability to sleep, rashes, weakness and other 
symptoms. Such physical side effects create a complicated relationship between an 
adolescent and their body. They can result in lower self-esteem, as adolescents 
struggle to understand why they might look different from their peers or try to hide 
physical side effects like rashes that could prompt questions from other children. 
Krishnan .O from New Delhi, reported that  “The side effects are the biggest barriers 
between ALHIV and other children,” at the Lott Carey Care Home. It is because of 
the side effects that the ALHIV develop internalized stigma, and then it becomes 
difficult to address their issues. The lipodystrophy, or even the perception  
cause a risk of appearance change, can lead adolescents to discontinue their 
medication. 
24,29, 38 
  Adolescents born with HIV often experience difficult in regularly taking their 
treatment but once they become teenagers, “Adherence is particularly complex 
because of the socioeconomic pressures related to orphan-hood, neuro cognitive 
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deficits associated with chronic and severe HIV infection, and stigma and 
discrimination”. The other factor that may influence adherence is whether adolescents 
are being taken care of by their own parents or caregivers from older generations and 
in the other view, adolescents have lost either one or both of their parents and are 
cared for by their grandparents or other family members. “Those adolescents under 
their own parents custody adhere much better they will take drugs together and 
remind each other when to take them,” said Nongyao, a paediatric HIV nurse at the 
Chiang Mai University Hospital in Thailand. 
23, 39
 
After the arrival of ARV medications, progress in treatment options and 
preamble of HAART, HIV disease has changed from an acute terminal to a chronic 
disease. The HAART regimens greatly reduce the morbidity & mortality associated 
with HIV infection, but high adherence is required for an optimal response to 
HAART. Although HARRT has substantially improved the survival of the children 
infected with HIV, these remains a need to systematically evaluate and determinates 
of mortality among HIV infected children. The successful virological, immunological, 
and clinical outcomes on cART are dependent on at least 95% adherence to the 
regimen. The self-reported adherence in PIAs may be anywhere between 40 to 84% in 
resource-rich countries lower than reported for adults. In a African cohort, the 
numbers of adolescents achieving 100% adherence  estimated  by pharmacy refills 
was lower than that for adults i.e.,  at 6 , 12 ,24 months  respectively of   20.7%, 
14.3%, 6.6% compared to 100% adherence in adults.(P=0.01)
25 
   The optimal adherence to prescribed regimens is a key to ARV effectiveness 
but there is no ‘golden standard’ for the assessing and monitoring adherence. Hence, 
multiple approaches are often used and it has been dichotomized as “direct” versus 
“indirect” and now currently as “objective” versus “subjective”. The objectives 
methods of  Electronic Monitoring Device (EMD), Biological Markers monitoring 
(BMM) includes viral load and CD 4 count, and therapeutic monitoring methods 
involves measuring drug levels in blood and hair are very expensive and not possible 
to do in all health care settings.  The self report method ( 3 and 7 days recall) , missed 
dose history, visual analog scale, pill count method  and pharmacy refill records are 
generally considered as subjective measures, which mainly rely on the individual to 
caregiver’s report of his or her behavior, sometimes it may over estimate the 
adherence .
39,40
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Among all the methods the adherence is monitored by the standardized 
questionnaire developed from Adult AIDS clinical trial group (ACTG) and adapted 
by pediatric AIDS clinical trial group. The adherence can be enhanced by intervention 
strategies and modalities includes of nurse-delivered individual counseling,  
individual peer support , peer group & phone based counseling, facilitated group 
sessions, and data-driven approaches  such as using Electronic Dose Monitoring 
(EDM), text/pager messaging and incentives. Apart from  this ,  the “Remainder 
tools” like pill boxes, pill charts, medication diaries, buddy system, electronic device 
such as beepers, alarms and watches are used as to be  remainder  for taking ARV 
medications.
41
 A meta analysis report stated that, the  participants in the intervention 
arm were about 50% more likely to reach 95% adherence with OR=1.50; 95% CI  and 
25% more prone to have an untraceable HIV-1 RNA viral load with OR=1.25, 95% 
CI, than those in the control arm.
 42 
   The non-adherence is the distinct most imperative challenge to successful 
management of all HIV infected individuals, more than ever the HIV infected 
adolescents/ youth. It may be owing to any fusion of patient or provider-related, 
disease and medication related, psychological and structural barriers. The adherence is 
not stable and needs to be assessed incessantly as the factor leads to non-adherence 
may change over time, imposing different approaches to address the treatment effects 
especially PIAs.
43
 In their second decade of HIV infection in PIA with lack of 
effectiveness in cART, will generally have immunologic deterioration, with 
advancement of clinical illness, including OIs. The Indian studies have shown that 
particularly of older adolescents, encompass the majority of PHIV-infected children 
being hospitalized and have maximum rates of mortality and morbidity.
23, 44
 
Nutritional status 
  Nutrition is frequently taken as additional significant and major indicator of 
the health and general status of adolescents. The adolescence is period of fabulous 
changes made in  growth as physically, emotionally and socially, because of poor 
nutrition these changes become even more complicated for an adolescent diagnosed 
with HIV.
10 
The balanced nutrition is predominantly vital for adolescents as it is a 
principal determinant of the spurt of growth that portray of adolescence. The poor and 
malnutrition is often cited as the main reason for the low weight gain and delay in the 
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inception of puberty in Indian adolescents. In worldwide, the 47 % of underweight 
prevalence were seen among adolescent girls in India. The NFHS-3 data showed that, 
the majority of general population aged 15–19 years were had low weight (47%   girls 
and 58% boys) and anemic (56% girls and 30% boys). The in-depth data viewed that 
more than 39% were mildly anemic and other 15% and 2% had moderate to 
severe anemia respectively. The nutritional requirements are more among adolescents 
than any other stage of life. The imbalanced and inadequate diet intake at this age 
progress to stunted growth and deferred sexual maturation.
45
  
  Nutrition and HIV are interrelated; the relationship between this two is 
multifaceted and multidirectional. A vicious cycle of mal nutrition and HIV is 
represented in figure 8. 
 
Fig 8 : A Vicious Cycle : Mal nutrition and HIV 
  
   Source: Adapted from RCQHC and FANTA project -2003 
HIV can cause or deteriorate under nutrition by causing reduced food intake, 
increased energy requirements, and poor nutrient absorption. The under nutrition in 
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turns and further abate the immune system, rising vulnerability to infection and 
deteriorate the impact of disease. So the poor intake of food leads to loss of weight 
and malnutrition, which further weakens the body’s defense mechanisms, thus 
aggravating and perpetuating this cycle.  According to AIDS in Regional Center for 
Quality of Health Care (RCQHC) and Food and Nutrition Technical Assistance 
Project (FANTA) reported that, the most common and often disturbing symptoms 
were  the  loss of muscle tissue and fat, weight loss, vitamin and mineral deficiencies , 
poor nutrient absorption, metabolic changes, viral replication, reduced immune 
function  and  increased vulnerability to OIs.
46 
The one of the co-factors involvement in development of AIDS is prominent 
levels of Reactive Oxygen Species (ROS), as the deferred reaction by the immune 
system may be due to a primary reduction of antioxidants. The HIV infection 
increases the free radical production inside our body and to counter act this, our body 
increases production of own antioxidants. The HIV associated with substantial 
oxidative stress and reactive oxygen species consequently decreasing the body’s battle 
to HIV results in decline of antioxidants cause the progression of HIV to AIDS. The 
antioxidants are substances that restrain oxidation and sentinel the body from the 
detrimental effects of free radicals which play a vital role in scavenging excess ROS 
to sustain normal physiological conditions.  
 The anti oxidants are the vitamins, minerals and enzymes which protect and 
repair our cells from free radicals.  The antioxidant vitamins are A, C, E, glutathione, 
and phyto chemicals contain foods can activate the intercepting and stabilizing of the 
ROS. The cofactors of minerals like manganese, selenium, zinc, copper and iron are 
needed to enhance antioxidants enzyme activities.
47 
The combination of antioxidants 
and HAART lower the viral loads and the generation of ROS from antiretroviral 
(ARV)treatment. Hence on a global scale, it is presumed that antioxidant management 
may offer a cost effective therapeutic approach for PLHA. Anthony et al (2011) 
revealed that, the level of antioxidants inside CD4 and CD8 cells were low in PLHIV 
because of that deficit in the immune cells might impair the ability to fight HIV 
virus.
48
 
The food insecurity and malnutrition leads the adolescent to survival strategies 
that expose them to a greater risk of disease progression. The well-nourished 
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adolescents are infected with HIV virus are better able to offer some resistance to 
opportunistic infection and tolerate the side effects of  ART management but  the 
malnourished adolescents with AIDS have minimal internal resources to fight OIs. 
There are many practical and unique considerations and challenges to cART utilize in 
PIAs even in weight shunting, delayed puberty, candidiasis, poor dentition, poor 
palatability and GI intolerance (eg., nausea, vomiting and diarrhea). These adolescents 
have enhanced nutritional requirements demanding diet rich in protein, vitamins 
(includes anti oxidants) and minerals (calcium, iron, iodine and phosphorus) due to 
rapid growth spurt and better physical activity. These concerns can be declined by 
periodical screening and nutritional education for all ALHIV.
47, 49
 
  Improving and maintaining good nutrition may prolong health and delay the 
progression of HIV to AIDS. The early nutritional assessment and intervention may 
prevent severe malnutrition, decrease the incidence and severity of infection and 
provide some protection of the immune system enabling the better QOL for the 
CLHIV.  According to the stages of the disease progression, the HIV virus reduces the 
food intake, make difficulties interrelated to digestion and absorption, alternate 
metabolism of nutrients (eg., carbohydrates/ lipid metabolism may be different in 
HIV) and distorted body functions: improper utilization of fats, inability to produce 
saliva and other juices.
49,50 
 The increased Resting Energy Expenditure (REE) was sensible in HIV-
infected adults are probable to increase of 10% in order to maintain body weight in 
asymptomatic HIV-infected adults and as well as children. During symptomatic HIV 
and consequently in AIDS, the energy requirements increased to around 20–30% to 
maintain adult body weight.
51
 The data from 14 developing countries reported that 
significantly increased incidence of anemia among female (15–19 years) was 
compared to their male adolescents. Aside from India, in nine countries of Central and 
West Africa, the majority of 15–19 years girls were anemic.52  
 Chatterjee A (2007)  found that low CD4 count during pregnancy and under 
nutrition in children increased the risk of mortality.
53
The clinical trials have suggested 
the need for increasing the intake of the following  micro nutrients as supplementation 
for the prevention and treatment of AIDS: Vitamin A,C,E and Carotenoids, Selenium, 
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Zinc, Copper, Manganese, Flavonids or vitamin P and B complex vitamins.
54 
Coovadia HM et al (2002) revealed that Zinc deficiency may boost HIV replication, 
harm cellular immunity and accelerate apotosis of cells concerned in the immune 
responses.
55
 Since the nutritional counseling is necessary for all PLHIV and especially 
for the adolescents during every month of clinic visit. Moreover, nutritional 
management, counseling and education should be beneficial to reduce the nutritional 
deficiency and also increase quality and extension of life in all PLHIV.  
Quality of Life (QOL) 
    The term ‘Quality of life’ (QOL) viewed as “communicate an overall sense of 
well being and including aspects such as happiness and satisfaction with life as a 
whole”.  The WHO defined the term ‘QOL’ as, “Individuals perceptions of their 
position in life in the context of the culture and value systems in which they live and 
in relation to their goals, standards, expectations and concerns”. The QOL is the result 
of the interaction among health, environment, social and economic conditions which 
affect human and social development. It reveals the difference or gap between the 
hopes and expectations of a person and their present experience.  
The dramatic decline in morbidity and mortality among the individuals 
infected with HIV since the initiation of HAART. The recent advances in the clinical 
test and management make fatal disease of HIV/AIDS to chronic and potentially 
manageable disease. However, the constant management is required for co-morbid 
illness or iatrogenic effects from HIV related medications. But still the HIV/AIDS 
makes mounting trouble on the health of the population and furthermore makes 
socioeconomic burden for individuals, families, communities and governments in 
some countries.
56 
 
  The QOL plays an essential role in the life of an individual suffering from 
chronic disease like HIV, TB, stroke and cancer etc. The QOL is a multi dimensional 
model whose definition and evaluation remains litigious and it’s divided in to four 
major domains namely physical, psychological, social and environmental. The figure 
9 shows that, the consequence of HIV on QOL surged under four major domains. 
57
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Fig 9: Outlined the Domains of Quality of Life in HIV/AIDS 
 
Source: Basavaraj, IJSTD ; 2011. 
 The adolescents are the only a high risk and underserved group in 
international and national response to HIV epidemics. It may be due to abscond from 
formal education, enter work, commence sexual experiences and begin experimenting 
with alcohol and other substances of misuse to make their life to be more 
complicated. In the absence of a cure, HIV-infected children / adolescents will require 
adherence to ART on the lifelong basis, which is a prerequisite for their survival. The 
HIV/AIDS not only distress the physical health but also affects individual overall 
QOL. When compared to the other illness, children with HIV infection are possible to 
experience more difficulties in their daily life because of parental death from AIDS 
and social stigmatization may worsen their QOL.58  
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The HIV-Health Related Quality of Life (HRQOL) may be a primary measure 
of management and care programs for BIAs and young adults since of the unique 
stress experienced during this stage of cognitive and sexual development. Further, 
BIAs has raised concerns over stigma compared with PIAs, and challenges in coping 
with the physical and social aspects. But the stigma may impact depression and social 
support from society for both categories of adolescents. The PIAs had lower QOL 
when compared to the other age groups because of the long term management for life 
saving drugs of ART with pill burden and its side effects. 
59
 
The elevated CD4 count with optimal adherence was associated with higher 
QOL scores in the health perception domain Thai and Cambodian children.
60
 The Lee 
GM et al (2006) reported that, the  HIV infected children had significantly lowered 
QOL scores as contrasted to HIV exposed but uninfected children
61
. According to the 
Global Youth Wellbeing Index reported that, 85% of youth (10 to 24 years) had low 
levels of overall well-being in the 30 countries. The ALHIV are mostly resist with the 
profuse of socioeconomic problems   such as, poverty, substance abuse, depression, 
stigma and discrimination which can intrude their QOL not only in physical 
functioning but also in psychological distress.
62
  
The lack or delay of disclosure may prejudice treatment of accepting and 
participation in HIV care. In ALHIV and also amplify in psychosomatic and 
behavioral problems such as suicide, attempted suicide and suicidal ideations. The 
stressful events of anxiety, depression, stigma and social support were related to 
progression of HIV/ AIDS. The estimated range from 22% to 38% of prevalence of 
depression  were noticed in  HIV infected adolescents  The management of depression 
in HIV/AIDS may not extend the life but can reduce the risk of suicide and progress 
the QOL and improve the adherence  even a complex ART regimen.
63 
  A case control study was conducted in Northern India, on QOL of HIV 
infected and other chronic ailments children (40+40) at the referral hospital. A 
significantly improved QOL was observed with chronic illness than children with 
HIV.
64 
A cross-sectional study of  HIV-infected children in Thailand revealed that a 
significant correlation was found between physical functioning, symptoms, health 
care utility and social role functioning. 
65  
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The impact of HIV/AIDS among children was studied in Yunnan in the year 
2006 among 116 affected and 109 control families by measuring the HRQOL. This 
study reported that, children suffered from HIV had worse score on HRQOL than 
those from unaffected families. The significant relationships were observed between 
physical functioning, social support, time on medications and co morbid health 
problems. It showed that  co morbid health problems were less among children who 
reported a time on medications and better physical functioning was seen among those 
who had greater social support.
66 
 
  The other study from India identified the QOL of 52 boys and 45 girls in 
institutional care home in Bangalore.  The results found that, caregivers perceived 
children to have an overall increased in QOL than self-reported by children. It 
revealed that, self-reported QOL declined with age of the child, while caregiver-
reported QOL improved with age, suggesting a need to ensure better psychological 
support for older children.
67 
Garcia P (2010) found that certain modifiable factors 
like ART regimen, nutrition are strongly associated with survival and improves the 
QOL of HIV infected people. 
68
  
Assessing HRQOL is useful for to evaluate the perceived burden of chronic 
disease, effects of management and tracking changes in health over time helps to 
monitor the overall QOL of ALHIV. The strict adherence to ART promotes QOL.  
The HAART has also been shown to extend the length and improve the QOL of those 
infected with the HIV. Apart from this, in order to improve the QOL of 
children/adolescents they need good physical and mental health essential for 
enhancing the various physiological dimensions of growth and development. The 
good QOL can be maintained by sustained intake of ART, good nutrition and mild 
exercises like yoga can lead a productive life which will condense the burden on the 
society towards HIV infected people. Developing the good practices like yoga early in 
life will be benefited for future of adolescents living with HIV/AIDS.  
Yoga  
 The science of yoga is an ancient one, it is the rich heritage of our culture. It 
has now become the subject of modern scientific evaluation. The yoga is originated 
from Sanskrit word ‘Yuj’ means ‘to yoke’ or ‘to control’ and is often termed as 
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‘uniting’ or the ‘method of discipline’. In 2000 years ago, the Indian sage of Patanjali 
has intricate the practice of yoga into the Yoga Sutra and outlines the eight limbs of 
Yoga (Ashtanga Yoga). They are Yama (universal ethics), Niyama (individual ethics), 
Asana (physical postures), Pranayama (breath control), Pratyahara (strengthening 
senses), Dharana (concentration), Dyana (meditation), and Samadhi (self realization).  
      Among these eight limbs, today many people enthusiastically  followed the third 
and  the fourth limb of ashtanga yoga, together of this both limbs are called as ‘Hatha 
yoga’. The word “asana” refers to pose or posture, its helps to increase stamina, 
physical power and as well as designed to purify the body. The asanas are aided to 
open the many channels of the body especially the spine, so that energy flows in our 
body to go freely. It’s increase concentration of our breath (Prana), which helps us to 
connect the body-mind
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. In the western world, now yoga is regarded as a holistic 
approach to health. The National Institute of Health as classified yoga is a form of 
Complementary and Alternative Medicine (CAM).
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 The “Healing comes from inside” said by Jon Kaiser (1998), strongly 
recommends  that yoga makes to relieves stress, peace the mind, and regulates 
breathing and circulation. A regular practice can aid to sustain the immune system in 
concurrence with a comprehensive HIV management program.
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 Chapel Hill (2008) 
reported that stress significantly increases the hazard of HIV would progress to 
AIDS.
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 Steve Cole (2010) said that HIV was a tremendously stressful disease 
equally during the period of adjusting as well as living with it and because of the 
medications side effects. The HIV spread more rapidly in presence of nor-epinephrine 
(stress hormone) in the body, make ‘T’ cells more vulnerable to attack and can 
increase the HIV rate of the reproduction 10 fold. And also he found that, ARV 
medications were  less effective in people with high levels of nor epinephrine and 
people with HIV face treatment options that would range from uncomfortable to 
dangerous." 
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Misha Cohen (2010) reports as, “Yoga is superb tool for the stress decline 
when done appropriately.” It can help to relieve various symptoms, as well as the 
ARV medications side effects, including the digestive problems and the joints pain. 
“A regular yoga practice is a simple way to achieve the good strength, boost the 
immune system and enhance circulation always”.74 Joseph and Nair (2015) 
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evaluated the effect of naturopathy and yoga intervention on CD4 counts of 
HIV/AIDS  reported  that  an growing trend in the CD4 count was proportional to the 
participants following yoga intervention. It is signifying that the prospect of lifestyle 
changes could bring positive outcomes in PLHIV. 
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  HIV/AIDS makes a grand deal to face a disease that seems to have no heal as 
yet. The most people with HIV experience extreme feelings of despair, loneliness, 
fear, anxiety, and depression. Yoga cannot replace the professional counseling in 
connection with major grief, but yoga techniques can help to ease extreme fear and 
anxiety, gain knowledge of stress-coping skills, and fabricate the internal strength 
through the relaxation and self-awareness exercise of the meditation. Yoga helps to 
train the most of the physical capabilities; slow-paced versions that can emphasis for 
extends of flexibility and breathing techniques that helps in relaxation.
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         Pranayama increase the lung capacity and balance the system through 
physical and mental functions. The regular yoga therapy improves the flow of blood 
and oxygen in the body which helps in getting rid of toxin and other waste from the 
body. The yoga therapy restores the normal function of all endocrine glands of the 
body. The current trend makes the Yoga as complimentary medicine when it’s 
combined with allopathic, more useful for the successful health problems even in 
particular chronic ailments. The ARTs have brought rehabilitated trust for most of the 
PLHIV. Still, they do not offer cure  they can cause many side effects and other non 
adherence reasons, more than 70% of HIV-positive people have changed to 
alternative medicine for help along with HARRT regimens.
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       The regular yoga practices augments body flexibility and muscular strength, 
relieves the stress, reduces pain, anxiety and depression,  improve the cardiovascular 
and  respiratory functions, promotes sleep  patterns , increase the immune power and 
enhance overall well being and QOL. The yoga includes the selected asanas are aid to 
relax and tone up the muscles and to massage the internal organs.  The breathing 
technique of pranayama and meditation help to regulate the body’s energy levels, 
calm down the mind, reduce the stress hormone and brings down the negative effects 
of stress and it’s by products and improved QOL. In fact many researchers have 
reported that reducing stress emerged to be a key asset for supporting people with 
HIV virus.
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 Moreover the investigator as a clinical instructor observed that the 
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diagnosis of HIV creates anxiety and living with HIV makes stressful life of all 
PLHIV. But yoga has many amazing effects of PLHIV lower levels of stress, greater 
sense of peace, greater levels of physical fitness and improves immunity.  
 Now over all yoga, act both as curative and preventive therapy for the minor 
ailments in PLHIV. Today yoga has become popularity in therapeutic practice; nearly 
stress reduction in people with HIV can contributes longevity and improves health.
73 
The regular yoga practices along with adherence to HARRT regimen lead to enhance 
overall well being with less burden to the society for PLHIV. The regular practice of 
yoga will promote the health, to develop positive attitudes and health practices, 
improve self confidence of ALHIV which prevents HIV transmission in future. 
1.1. BACK GROUND OF THE STUDY 
  One of the most fascinating periods of “Adolescence” in human life, marks the 
transition from being dependent child to independently functioning with adult. But the 
adolescents in this stage discernible by emotional turmoil, risk behaviors and 
challenges. The different countries have their own understanding for an age of 
children and adolescents, the wide and overlapping age categories of data specific to 
adolescents are often subsumed in other age-ranges. As per UNAIDS (2012) report, 
globally there were approximately 4 million young people (15 to 24 years) were 
living with HIV, among these 2/3 of new HIV infections were common in youths (15 
to 24 years) and 29% were adolescents aged 15 to 19 years. The currently reported the 
global summary of AIDS epidemics 2014 was illustrated in table 4.
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In 2013, as per UNAIDS report: globally an estimated of 5 million young 
people aged 10 – 24 are living with HIV, and more than 75 were infected every hour. 
Among this, 2.1 million (1.7 – 2.8 million) adolescents (10 –19 years) were living 
with HIV. In 2014, globally the total number of PLHIV was 36.9 million; among this 
2.0 million were adolescents aged 10-19 years of age; 220, 000 million children were 
newly infected with HIV and 60,000 adolescents were died because of HIV/AIDS. 
After sub-Saharan Africa, the region with the leading number of PLHIV is Asia and 
the Pacific region. Still the global AIDS epidemic persists to affect millions of people, 
despite their age or sex. In the year of 2005 to 2012, the number of AIDS related 
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mortality was decreased by 30% for all ages apart from adolescents, though 50% 
increase in that same period.
13
  
Global Scenario of HIV/AIDS 
79
  
Table 4: The Global Summary of HIV/AIDS Epidemiological Estimates for 2014 
 Source:  Current status + Progress updated November 2016 (UNAIDS-2013) 
    
Since 2010 to 2015 the new HIV infections have fallen by 6% i.e., now the 
total number of people newly infected with HIV was 2.0 million it was reduced from 
2.2 million [2 million–2.5 million]; and new HIV infections among children have 
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decreased by 50% i.e., now 150 000 [1,10,000–1,90,000] children become newly 
infected it was down from 290 000 [2,50,000–3,50,000]. Regarding AIDS-related 
mortality, now 1.2 million [940 000–1.3 million] people died in 2015, compared to  
2 million in 2010 [1.7 million–2.3 million] i.e., reduced by 45% since in 2005. Since 
the start of HIV as epidemic, the total of 78 million [69.5 million–87.6 million] 
people has become infected and 35 million [29.6 million–40.8 million] people have 
died from AIDS-related illnesses.
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As per UNAIDS 2014 report, the new HIV infections per day among all the 
age groups were about 5,600, among this 600 were children below 15 yrs & 5,000 
were adults aged more than 15 years and about 30% are young people’s (15-24 years). 
Around 3,200 people passed away as of AIDS, since inadequate coverage to HIV 
prevention, care and management services among these age groups.
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 The figure 10 
shows the estimated number of CLHIV aged less than 15 years in 2014. Since March 
2015, approximately 17 million PLHIV (41% of the total) were accessing the ART.
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Regional Trends
79 – 83
 
 In 2014, globally the new HIV infections were estimated around 11% in 
adolescents aged 15 to 19 yrs among this more than 60% were adolescent girls. The 
regional HIV and AIDS statistics were in 2014 as shown in table 5. About two and 
half times more risk to acquiring the HIV among adolescent girls than adolescent 
boys in sub-Saharan Africa. In other view, more adolescent boys were newly infected 
with HIV every year than adolescent girls in the UNICEF regions of South Asia and 
Latin America, Middle East and North Africa and the Caribbean 
The incurable of HIV virus excessively affects persons who inject drugs, men 
who have sex with men and sex workers in nearly almost regions of the world. In 
Eastern Europe and Central Asia, HIV epidemics that were once distinguished largely 
by transmission among persons who inject drugs were now gradually more by 
significant sexual transmission. In parts of Asia, there were more and more 
distinguished by transmission among heterosexual couples. In Asia as a whole, HIV 
epidemics have long been definite in persons who inject drugs, sex workers and their 
clients and men who have sex with men. Now, they are steadily escalating into lower-
risk populations through transmission to the sexual partners of those most at risk. This 
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reflects the discrepancy in risk behavior among these regions, which means that 
interventions must be tailored to the dynamic of the epidemic and specific nature of 
adolescents.    
Fig 10: Estimated Number of Children Living with HIV (0-14 years) in 2014 

   Source: Core epidemiology Slides from UNAIDS 2014-15 report 
East and Southern Africa: (as per UNAIDS 2015 Global statistics) 
  There were more than two-thirds (70%) of all PLHIV i.e., 19 million  
(17.7 million-20.5 million)  in this region, included  88% of the world’s HIV-positive 
children. In 2015, people became newly infected in this region was around 9,60,000 
million (830000-1.1 million); it had declined from 14% from 2010 to 2015 and 
globally its accounts for 46 % of the new infection. 
In 2014, an estimated of 66% of AIDS related mortality i.e., around 470000 
(390000-560000) were adults and children and it had been declined by 38% between 
2010 to 2015, and also there were 56,000 (40,000-76,000) new HIV infections  
among children, it also fell by 66% in new HIV infections.  The Sub-Saharan Africa 
continued to be harsh in specific to HIV epidemics and accounted for around 70 % of 
PLHIV worldwide; among this both new HIV infections and AIDS-related deaths 
were accounted for 67% in this region alone. The spread of HIV is generally through 
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heterosexual, both in the circumstance of transactional and commercial sex.  In this 
region, over 80 % of ALHIV were in LMIC. The highest proportion 26 % of ALHIV 
in the world includes Swaziland, Zimbabwe and Timor-Lest. 
Table 5: Regional HIV and AIDS Statistics and Features -2015 
 
Source: Global Statistics Fact sheet - UNAIDS 2015. 
Latin America & the Caribbean 
About 2.0 million (1.7 -2.3 million) people are projected to be living with 
HIV; including 100,000 (86, 000 -1, 20,000) newly infected in 2015; among that 2100 
(1600-2900) were children. The adult HIV prevalence rate of 1.1% depicts that, the 
Caribbean was the second hardest hit region in the world next to sub-Saharan Africa. 
The six countries in Latin America and the Caribbean have universal epidemics. With 
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accessible data, Haiti had the region’s highest prevalence rate of 1.9%, and Brazil the 
maximum number of people living with the disease (around 610,000 to 1,000,000).  
Western and Central Africa 
  An estimated 6.5 million (5.3-7.8million) PLHIV in this region, including 410 
000 (310 000 -530 000) were newly infected among this 66,000(47,000-87000) 
among children and it’s declined up to 31%. Approximately AIDS related deaths were 
3,30,000 (250, 000-430000) and its fell by 10% from 2010. 
Asia and the pacific 
An estimated 5.1 million PLHIV in this region and is also home to the two 
most populous nations in the world i.e., China and India; currently low prevalence 
states were translated into large numbers of PLHIV. Nearly 300,000 people became 
newly infected among this 19,000 (16,000-22000) were children it has been declined 
to 24 and 26 % respectively. Approximately AIDS related deaths were 180,000 
(150,000 - 220000) and its fell by 5% from 2010.  
Eastern Europe & Central Asia  
An around 1.5 million PLHIV in this region, accounting of 190,000 newly 
infected and it rose by 57% among this more than 1000 were children between the 
period of 2010 to 2015. The AIDS related deaths 47,000 (39000-55000) people died 
and it was increased by 22% in the same period. The epidemic was driven mainly by 
injecting drug use and heterosexual transmission. The Russian Federation and 
Ukraine estimated that, 85% of people were living with HIV in the region. 
North Africa and the Middle East 
  In 2015, approximately 230,000 (160,000 -330,000) PLHIV in this region and 
an estimated 21,000 (12,000 - 37,000) people became newly infected. It was 4% 
reduced in between 2010-15 but even 2100 (1400-3200) new HIV infections were 
children. The AIDS related mortality of 12,000 (8700-16000) were adults and 
children and it was increased by 22% from 2010-2015.  
Western and Central Europe and North America 
  In 2015, the number of PLHIV in this region were 2.4 million (2.2-2.7 
million) and there were estimated that, 91,000 (89,000-97,000) new cases of HIV. An 
account of  22,000 people in these regions died of AIDS and it was decreased by 24% 
in 2015. 
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            Over the period of  2000 to 2013 : the global and three latest regions of new  
adolescent infections were shown in figure 11. Around 2/3 of new HIV infections in 
adolescents principally affected on girls in Saharan Africa and more than 80% of 
adolescents were in Gabon (89 %),Sierra Leone (85 %) and  South Africa (82 %); and 
In Asia and the Pacific, the new HIV infections in adolescents were reported to more 
than 95% in ‘adolescent key populations’. The selected countries in Asia, there were 
49 births per 1000 girls were aged between 15 to 19 years and  around 60% of the 
girls living with HIV were not known their status. 
Fig 11: The Number of New HIV Infections Among Adolescents aged 15-19 year 
 
Source: UNAIDS 2013 estimates 
 
In 2012, over 90 % of AIDS-related deaths among these age groups (97,000 of 
110,000) were happened in sub-Saharan Africa. According to Sixth Stocktaking 
Report on Children and AIDS (2013) published an alarming  new data  stated that,  
the only age group of  10-19 years of  AIDS-related deaths  have raised in the past 
seven years. Globally, overall AIDS-related deaths fell by 35% between 2005 and 
2013 but death among adolescents  had increased by 50% and 300 deaths for every 
day. In worldwide, the HIV/AIDS is a number two cause of mortality among 
adolescents and number one sub Africa. The figure 12 showed the estimated number 
of AIDS related mortality among children to young peoples in globally. The total 
number of AIDS related mortality among adolescents and young people were 110000 
in 2001 where as it had increased to 154000 in 2012. In South Asia, AIDS-related 
mortality had almost quadrupled among 10-19 years i.e., around 1,500 in 2001 but 
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5,300 in 2014. In East Asia and the Pacific, mortality among these cohorts elevated 
from 1,000 to 1,300 over the similar period. 
81,83 
 
Fig 12 : The Estimated Number of AIDS Related Deaths Among Children  
(0-9 years), Adolescents (10-19 years) and Young people (20-24 yrs) 
 
(Source UNAIDS  2013 Estimates, Annual report HIV/AIDS) 
Global Scenario of HAART Therapy 
  Globally, around 12.9 million people were receiving ARV management at the 
end of 2013. The PLHIV, who were not accessing ARV, had been declined from 90% 
[90–91%] in 2006 to 63% [61–65%] in 2013. The ARV access had rapidly increased 
in a few countries includes, 33% in South Africa, followed by 7% in India , 6% in 
Uganda, and 5 % in Nigeria, Mozambique, the United Republic of Tanzania and 
Zimbabwe. The figure 13 showed the percentage wise distribution of ART therapy in 
globally. Around 22 million or three of five PLHIV were still not accessing ART. The 
proportions of people who had not received to treatment are 58% [56–60%] in South 
Africa, 64% [55–72%] in India and 80% [79–82%] in Nigeria. The number of 
children receiving ART was terribly low i.e., 24% [22–26%] in contrast view the 76% 
[74–78%] were not receiving HIV treatment. Now the coverage the ART therapy has  
been increased to 17 million people as per UNAIDS report in 2015. 
A growing number of countries are developing national action plans for OVC. 
But still the orphans and children were considered as vulnerable to HIV and AIDS, 
because of higher risk of absents in schooling, residing in households with poor food 
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security, and suffering from depression and anxiety. The majority i.e., 85 % (11.0 
million) of single or double orphaned children due to AIDS were live in sub-Saharan 
Africa. The HIV has extensive social and economic consequences for children and 
their families, especially for OVC do not receive any type of support. Globally, the 
estimated 17.8 million (16.1 –21.6 million) orphaned children endure of AIDS.79,80,83 
Fig 13 : The Number of People Receiving ART in 2000-2013 
 
Source- UNAIDS gap report - 2013 
Indian scenario 
26, 84-87 
  India has the third largest number of PLHIV in the world i.e., 2.1 million (1.7 -
2.7 million) after South Africa and Nigeria and estimates for about 4 out of 10 PLHIV 
in the region. The National adult HIV prevalence (15–49 years) is estimated at 0.26% 
(0.22% –0.32%) in 2015 and almost it was estimated that males around 0.30% and 
females around 0.22%. In 2015, estimated adult HIV prevalence was highest in the 
Manipur i.e., 1.15%, followed by Mizoram (0.80%), Nagaland (0.78%), Andhra 
Pradesh & Telangana (0.66%), Karnataka (0.45%), Gujarat (0.42%) and Goa (0.40%). 
In addition to these states, national prevalence was greater than estimated i.e., 0. 26%  
in Maharashtra, Chandigarh, Tripura and Tamil Nadu. Whereas the  estimated adult 
HIV prevalence in the range of 0.21– 0.25% in Odisha, Bihar, Sikkim, Delhi, 
Rajasthan and West Bengal and  the remaining other States have below 0.20%. The 
figure 14 illustrated the epidemic regions of HIV/AIDS in India.
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The high prevalence states in India, includes the southern parts of Andhra 
Pradesh, Karnataka, Tamil Nadu and Maharashtra and the north eastern states of 
Manipur and Nagaland. At national level, it’s has continued to  steady decline an 
estimated peak of adult HIV prevalence  i.e., 0.38% in 2001-03 through 0.34% in 
2007 and 0.28% in 2012 to 0.26% in 2015 due to reduction in new HIV infections 
among adults from about 2.7 lakhs in the year 2000 to 21.17 lakhs in 2015, a drop of 
about 57%. This decline reflects impact of scaled-up HIV prevention interventions 
under the National AIDS Control Program (NACP) during this period.  
Fig 14: The Epidemic Regions of HIV/AIDS in India 
 
 Source: Dr. Y. D. Badgaiyan. Status and management of HIV/AIDS in India-2014 
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According to NACO, the estimated total number of PLHIV in India is 21.17 
lakhs (17.11 –26.49 lakhs) in 2015. The Children below 15 years were accounted for 
6.54%, and nearly two fifth i.e., 40.5% of the total new infections are females. The 
figure 15 showed the distribution of PLHIV in selected states of India in 2015.
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 The 
estimated number of PLHIV was the highest in undivided states of Andhra Pradesh 
and Telangana (3.95 lakhs) followed by Maharashtra (3.01 lakhs), Karnataka (1.99 
lakhs), Gujarat (1.66 lakhs), Bihar (1.51 lakhs) and Uttar Pradesh (1.50 lakhs). The 
other states of, Rajasthan (1.03 lakhs), Tamil Nadu (1.43 lakhs) and West Bengal 
(1.29 lakhs) are estimated with PLHIV numbers of 1 lakh or more.  
  The Government of India, NACO recently started to focus on OVC through 
Children Affected by AIDS (CABA). The low HIV prevalence state of Delhi with 
0.3% prevalence in general population in compare to national prevalence of 0.26%. 
Over the years, prevalence has steady decline in high risk groups (HRGs) and general 
population.
 
However, there is no accurate statistics available on the prevalence of 
HIV/AIDS between these age groups due to moderately lesser attention given to them 
by policymakers and program managers.
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Fig 15 : The distribution Of PLHIV in selected states of India, 2015  
           
 Source – India HIV Estimations 2015 
Annual New HIV Infection 
In 2015, the estimated new infections are around 86 (56–129) thousands in 
India, i.e., it accounted for 66% in 2000 and now it has declined to 32%. The children 
(0 to14 years) are estimated for 12% (10.4 thousand) of total new infections while the 
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remaining (75.9 thousand) new infections were among adults (>15years). In India, the 
total AIDS cases 45% aged between 5-24 years. The shocking fact is that, 6 
adolescents are infected every minute with a new HIV infections and 90% of those 
infected by horizontally are not aware of their HIV zero status and therefore there is 
risk for transmitting the virus to the partners. 
  In 2015, the range of new infections in Tamilnadu, Maharashtra, and Odisha 
are 3-4 thousands, while West Bengal and Rajasthan are 5 - 7.5 Thousands. The 
Andhra Pradesh & Telangana, Bihar, Gujarat and Uttar Pradesh currently account for 
47% among adults with each of these States contributing 7.5 thousands or more new 
infections. During 2007-15, the new infections among adults have also declined by 
50% or more in the states of Andhra Pradesh & Telangana, Karnataka, Maharashtra, 
Manipur and Odisha. 
Fig 16 : Estimated New HIV infections in India, 1998-2015 
 
Source – India HIV Estimations 2015 
A clear decline in new infections as notice at national level has been also 
observed in most of the States/UTs. The figure 16 showed the estimated new HIV 
infections in India. In 1998, adult new HIV infection rate was 2.64 and children below 
14 years was 0.21 whereas it’s was currently declined in to 0.76 and 0.10 respectively 
because of vast improvement in HIV/AIDS control and prevention management and 
PMTCT program.  
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Burden of AIDS Related Mortality 
  The number of AIDS related mortalities are started to have a waning trends 
since 2007 and also annually by 54%. The estimated of 67.6 [46.4–106.0] thousand 
people died in 2015 because of AIDS-related causes and declined by 70-81% in 
Karnataka, Maharashtra and Tamil Nadu during 2007-15.  The figure 17 showed the 
annual AIDS related deaths and ART scale up in India 2000-14. This decline is 
reliable with the rapid expansion of access to ART in the country. It is estimated that 
the scale-up of free ART since 2004 has saved cumulatively around 4.5 lakhs lives in 
India until 2014. 
The absolute numbers of deaths among children (0 to 14 years) also 
consistently started to decline, in contrast annually more than 10,000 AIDS 
mortalities among adolescents and youth that continue to occur in India. In between 
2005 and 2013, the number of AIDS related deaths fell by 27% in Asia and the 
Pacific regions. Whereas in India more than 51% of the country evidenced that, 
decline of 38% in the same period because of major scale up in access to HIV 
treatment.  
Fig 17: The AIDS related deaths and ART scale up In India - 2014. 
 
Source - HIV estimations -2015 
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 In India, there are estimated about 25 million orphans from all causes, of 
which approximately two million may be attributed to HIV/AIDS. The National AIDS 
Control Organization (NACO), Government of India, recently started to focus on 
OVC through Children Affected by AIDS (CABA). The HIV/AIDS pandemic 
brought a dramatic increase in the number of OVC due to parental illness and death. 
            Global situation of children orphaned by AIDS is a main concern, especially 
in Africa, which is estimated to have 14.2-17.5 million world orphans due to 
HIV/AIDS. India is debatably a home for largest number of OVC living with HIV. It 
is estimated that 13% of them obtain HIV infection through sexual contact and 20-
30% of female sex workers in the country are less than 18 years. Still, there is no 
accurate statistics available on the prevalence of HIV/AIDS among these cohorts due 
to relatively minimal attention given to them by policy makers and program 
managers. 
Estimated Needs for ART  
  The free ART program was launched by Government of India on 1
st
 April 
2004, in the six high-prevalence states of Andhra Pradesh, Karnataka, Maharashtra, 
Tamil Nadu, Manipur, and Nagaland. Among this the first four states account for 53% 
of all HIV infected people in the country. The estimated annual new HIV infections 
were around 1.16 lakhs in adults and around 14,500 were children. The six high 
prevalence states account for only 31% of new infections, while the ten low 
prevalence states of Odisha, Jharkhand, Bihar, Uttar Pradesh, West Bengal, Gujarat, 
Chhattisgarh, Rajasthan, Punjab & Uttarakhand together account for 57% of new 
infections. The greater vulnerabilities in these states are being given advanced focus 
in the AIDS control program. The table 6 showed list of ART centres and patients on 
ART.
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As per report on 2014, there are around 8,10,339 lakhs PLHIV registered at 
the 453 ART centers functioning all around the country in that  nearly  6.5 lakhs are 
on first line ART.  
Based on the postulation, the progression and survival of children and adults 
infected with HIV as well as current modalities, estimated that around 13.45 lakhs of 
PLHIV need ART  in  2015. It covers around 12.71 lakhs adults (aged > 15 years) and 
75 thousand children (aged<15 years). The high saddle states includes, Andhra 
Pradesh & Telangana (2.6 lakhs), Karnataka (1.4 lakhs), Maharashtra (2.3 lakhs), and 
Tamil Nadu (1.1 lakhs) require a more than half of the estimated ART support.  
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Table 6: State wise ART Centres and patients on ART (as on Sep 2014) 
 
Source: NACO Annual Report 2013-14 
40 
 
Tamilnadu 
88, 89
 
   The State AIDS project cell was formed in January 1993 in Tamilnadu. The 
Tamilnadu State AIDS Control Society (TANSACs) was first registered society in 
India for HIV/AIDS control and prevention in 1994 as mandate of NACO, New 
Delhi. The predominant mode of transmission of HIV in this state is a hetero or homo 
sexual transmission. The commercial sexual workers, truckers and intravenous drug 
users are identified targeted high risk groups in this state. The number of AIDS cases 
reported from Tamilnadu increased enormously from 1092 in 1998 and till 2014, it 
believed to have between 1.82 to 2.04 lakhs people suffering from HIV, according to 
number of various surveys. The figure 18 shows that, the geographical distribution of 
AIDS cases in Tamilnadu district in 2014.   
Fig 18:  The Geographical Distribution of AIDS Cases in Tamilnadu-2014 
 
Source: Geographical distribution of AIDS cases in TN district wise 2014 
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The map shows that the geographical distribution of AIDS in Tamilnadu in the 
year of 2014.
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 In this view, the central place of Tamilnadu concentrated high in 
HIV/AIDS affected peoples. The southern district of Tamilnadu is very low level. 
There are several districts that showed that, the high-prevalence in the general 
population and an upward trend since 2010. Erode, Salem and Trichy districts show 
over 1% prevalence in the general population. The prevalence in several other 
districts, such as Namakkal and Tiruvarur, are above the state and national average 
and it's climbing. The Kanyakumari being a new entrant in to this category. The 
following table 7 shows, the number of people in  pre ART, on ART, LTFU  in each 
district wise of Tamilnadu in 2011.
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Table 7:  Details of Pre ART and Alive on ART in district wise of  
Tamilnadu  in 2011 
S.No. District Pre ART 
Ever 
started on 
ART 
Alive and 
on ART 
Loss to Follow 
Up Rate (%) 
1.  Ariyalur  554 314 287 0.97 
2.  Chennai  45008 20321 9474 9.69 
3.  Coimbatore  8635 4301 2210 5.21 
4.  Cuddalore  3141 1666 1282 2.88 
5.  Dharmapuri  4386 1876 1481 2.13 
6.  Dindugal  4986 2636 1930 2.92 
7.  Erode  2435 1422 1143 5.84 
8.  Kanchipuram  526 272 222 2.94 
9.  Kanniyakumari  1825 920 666 0.11 
10.  Karur  3049 1509 1091 0.86 
11.  Krishnagiri  5073 2322 1815 6.16 
12.  Madurai  14604 6570 3669 1.99 
13.  Nagaipattinam  815 386 306 5.18 
14.  Namakkal  12299 6860 4120 2.81 
15.  Nilgiris  423 223 176 7.17 
16.  Perambalur  2691 1285 874 1.01 
17.  Pudukottai  1740 805 704 0.99 
18.  Ramanathapuram  966 432 355 2.08 
19.  Salem  13719 6475 3760 1.51 
20.  Sivagangai  1397 521 439 0.38 
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21.  Thanjavur  5829 3027 1824 3.24 
22.  Theni  6585 2781 2183 0.58 
23.  Thirunelveli  5361 2172 1472 1.34 
24.  Thiruvallur  1726 763 553 5.24 
25.  Thiruvannamalai  2357 1183 906 1.86 
26.  Thiruvarur  366 175 152 3.43 
27.  Thoothukudi 1888 888 678 2.14 
28.  Trichirappalli 9924 4936 3019 7.74 
29.  Tiruppur  1576 933 785 4.50 
30.  Vellore  8229 3738 2308 5.03 
31.   Villupuram  3998 2043 1390 1.81 
32.   Virudhunagar  2816 1278 911 1.72 
   
 Since, the first HIV case was identified in Tamilnadu in 1986; it has been a 
24x7 fight against the disease.  Currently the results are proven that, the number of 
new cases has plummeted of more than 60% since 2010 in the state. The Tamilnadu 
recorded 26,089 fresh cases in 2010-11, whereas in 2014, it was reduced to 9,892. In 
2014, the proportion of AIDS prevalence high in 30-49 years age group 37.82 
followed by 15-29 years age group 32.45, 10.67% AIDS prevalence in 0-14 category 
of age group. Among this many people are residing in rural areas (57%) has compared 
with urban population (43%) for the year 2014. 
ROLE OF A NURSE 
      HIV still is a chronic disease with diversified clinical manifestations need a 
lifelong commitment to ART.  The routine care of children /adolescents and 
psychological challenges with HIV demands a dedicated multidisciplinary approach 
from a variety of health care professionals including Medicals, Nurses, Psychiatrist, 
Dentist, Social worker, and Case manager. The ART care model was shown in figure 
19.
90
 The authenticity of HIV care requires that nurses to take more active and central 
role in the treatment of PLHIV. The participation of nurses in multi-disciplinary 
approach is crucial in ensuring ART to the thousands of PLHIV includes of 
adolescents living with HIV. Such participation in these new healthcare teams needs 
that nurses to acquire greater knowledge and skill in treating and managing HIV 
clients. 
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“THE NURSE IS AT THE CENTER OF PATIENT CARE 
& 
THE CENTER OF THE TEAM” 
 
Nurses take a vital role in the ART multidisciplinary team. This role includes 
triaging HIV patients, treating and assessing the patients in need of palliative or 
symptomatic care, supervising ART ancillary staff, refilling ARV medications for 
steady and adherent patients, providing enduring adherence & Nutritional assessment 
counseling and serving as an HIV/ART point person for hospital staff. The nurses 
play a vital role in the promotion of optimal adherence, nutritional Counseling; 
thereby nurse can increase the QOL of the HIV infected adolescents. The trusting of 
nurse- patient relationship makes the patient to feels safe and comfortable even while 
promoting ART adherence level, nutritional status etc., Many healthcare systems 
recognize that, adherence as the nurse holds number one responsibility while 
managing  a client who is receiving ART. The nurses play an essential role in 
generating the right environment: safe, non-judgmental, and confidential.
 
Fig 19: The ART Care Model in Multi Disciplinary Team Approach 
 
 
 
Source:  Tesfai Gabre -Kidan MD 2004 
Management of Child/adolescents with HIV/AIDS on ART: A Nursing 
Perspective: 
91,92
 
 The Nurse in partnership with the physician, Coordinates patient care and 
treatment. 
 A Multidisciplinary team - family-centered approach to care is beneficial 
to the patients. 
 The Nurse recognizes and values each team member’s contribution. 
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 The Nurse is the key resources in referring the patients to support and 
other Services. 
 The Community and other linkages are critical components of the 
successful treatment of patients in which Nurse’s role is crucial. 
Adolescence is a period, when relationships are generally shifted from family-
oriented to being peer-oriented. The proceedings such as running away, being 
homeless, or being incarcerated have the potential to disrupt social and developmental 
trajectories and bang social development. It causes a many barriers for the 
adolescents to stick on ART therapy. The adolescents require improved adherence 
support, information about their treatment schedules from health care professionals. 
So that they feel motivate to take their medication and confident to assume 
responsibility for their own health.
91 Therefore, the investigator has shown her 
interest to identify the adherence rate, nutritional status and QOL among HIV 
infected adolescents. 
1.2 NEED AND SIGNIFICANCE OF THE STUDY    
  Adolescents are the most vulnerable group to get and spread HIV/AIDS in the 
community. About 31% of   HIV prevalence in India is among the adolescents aged 
between of 10-24 years. The financial burden of preventable health problems in 
adolescence are large and include the long term costs of chronic diseases that are the 
result of behavior begun during adolescence. For adolescent infected with HIV, 
adherence to ART may be dependent upon the ability of their parents or care givers to 
administer the medication consistently according to guidelines ensure by the health 
care professionals. The HAART has given a new hope for long term survival and 
better QOL of persons with HIV disease.
38,39
  
The optimal levels of adherence are essential for clinical improvement and the 
prevention of HIV related complications and OIs. Today, the epidemic of HIV in the 
country was different from the initial scenario. Since use of ART, the large number of 
children infected by vertical transmission reaches adolescence and adulthood. 
Whereas the non adherence. to ART management  to be  foremost challenge to all 
PLHIV and especially to teenagers, even with the promise of better quality of life 
includes emotional, social and vocational rehabilitation.
25,38
. 
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   The successful treatment for PIA is complex, since they face additional 
physical challenges cause risk of co morbidity, deferred growth and development, 
often resulting in late puberty in girls, and stunting and/or wasting makes difficult to 
reach transition phase of adult.
 
Adolescents have a life time potential of transmitting 
HIV as risk behavior. So the hidden epidemic of ALHIV needs more attention and a 
tailored approach in order to reduce the risk of spreading the virus to others.  
Koech E et al (2014) conducted retrospective analysis on uniqueness and 
outcomes of HIV infected adolescents and youth enrolled in Kenya. Among 22,832 
participants, the median CD4 cell count was 332 cells/ml; 70.8% were WHO stage 
I/II. The adolescents  (10–19 years) had more advanced WHO stage and lower median 
CD4 cell count compared to youth (15–24 years) at enrollment (284 vs. 340 cells/ml; 
P<0.0001). The pre ART patients cumulative incidence of Loss of follow-up (LFTU) 
and death at 24 months was 46.1% and 2.1% (95% CI) respectively. For those on 
ART, 32.2% were LTFU and 3.9% (95% CI) died within 24 months. The LFT among 
pre-ART and ART patients was twice as high among youth and older adolescents 
compared to young adolescents. The study reports suggested that, the novel strategies 
targeting these populations are urgently needed to improve retention in ART. The 
number of youth and adolescents (10–24 years) with HIV infection has increased and 
substantially presenting unique challenges to effective health service delivery.
93 
Lwanga F et al (2015) did a study on nutritional status of HIV-infected 
adolescents    in Uganda. The nutritional status was assessed respectively by using 
BMI-for-Age (BAZ) and Height-for-age (HAZ) as indicators of thinness and stunting. 
Among 205 participants, the prevalence of stunting was 36.2% (72/199), among this 
11.1% (22/199) of adolescents were severely stunted. The eighteen percent of the 
adolescents (36/200) were thin; among this 8% (16/200) were severely thin.  The 
study findings suggested that, there is need for advanced comprehensive care and 
support system includes adequate nutritional   guidance to care and support for HIV 
infected adolescents.
94
 
 Fawzi MCS et al (2010) assessed the psycho social support intervention for 
HIV-affected youth and their caregivers in Haiti. A total of 492 HIV-affected youth 
aged 10–17 yrs, and their caregivers (n=330) were included in the study. In analysis, 
the youth reported high levels of anxiety, including constant fidget (86%), restlessness 
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(83%), and worrying a lot (56%). Their parents and caregivers also reported a high 
level of depressive symptoms, such as low energy (73%), feeling everything is an 
effort (71%), and sadness (69%). The parents’ depressive symptoms were positively 
associated with their children’s psychological symptoms and psychosocial 
functioning. (OR-1.6 to 2.4) The findings concluded that, there is a significant level of 
anxiety and depression observed among HIV-affected youth and their caregiver’s. 
The results suggested that a family-focused approach, psycho social interventions are 
needed and may be beneficial for improving overall QOL of youth and their 
caregivers.
95
  
Naoroibam R et al (2016) conducted the effects of Integrated Yoga (IY) on 
psychological status and CD4 counts of HIV-1 infected participants from Manipur 
State of India. A total of 44 participants were selected and randomized equally in to 
Yoga and control groups. The yoga group received 60 minutes/day of IY 
interventions, includes the asana, pranayama, relaxation techniques, and meditation. 
The intervention continued for 6 days a week for 1 month whereas in control group, 
followed daily routine as a conservative management. The results showed that, the 
considerable reduction in depression scores (F =4.19, P < 0.05) and non-significant 
decline in anxiety scores along with non significant increase in CD4 counts in the 
yoga group. However in the control group, there was a non-significant raise in anxiety 
and depression scores and decline in CD4 counts. In between-group comparison 
depicted a significant decline in depression scores (F =5.64, P < 0.05) and significant 
increment in CD4 counts (F=5.35, P < 0.05) in the yoga group as compared to the 
control. The study results revealed that, regular one month practice of IY can reduce 
depression and improve immunity in HIV-1 infected participants.
96  
  To address this serious gaps, the UNAIDS and UNICEF launched ‘All In’ 
movement in 2015. The objectives are, to reduce new HIV infections among 
adolescents by at least 75%, to reducing AIDS-related mortality by at least 65%, and 
eliminating stigma and discrimination by 2020.  The overall the goal of optimal level 
of adherence to ART is reduced HIV/AIDS morbidity and mortality by 60 –90%, and 
to prolong the quality and survival of life of all ALHIV. Hence, a multi disciplinary 
approach towards ALHIV is essential and specially need to focus the optimal 
adherence to ART helps to achieve global targets and also 90-90-90.
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The health professionals involved in the care of the children and adolescents 
with HIV are faced with dual challenge of understanding the effect of ART 
adherence, nutrition and QOL .The HAART regimens significantly reduce the 
morbidity & mortality associated with HIV infection among Children, maximizing the 
HRQOL has become a high priority of long term management of HIV infected 
individuals. Nutritional management during adolescent period plays a crucial role in 
maintaining the HRQOL and also to maintain the physical & mental health of the 
child. There is a strong correlation between ART& Nutrition & QOL. If a child is on 
ART and has good Nutritional status, has good impact over his QOL. The health 
professionals are involved in the care of the children and adolescents through 
counseling, knowledge will aid in effectively interpreting the factors involved in 
sustained adherence and helps to define the nutritional status and improve QOL and 
outcome of HIV infected children. 
  The effective non judgmental communication is vital in nurturing adherence to 
health promotion as well as preventive practices of treatment of chronic health 
conditions in teens. The Researcher herself is a nurse educator, administrator and 
counselor. She has come across in her clinical field, some of the adolescents were 
required counseling to correct their behavior.  These observational and professional 
experiences make the researcher to pay attention on those adolescents. The researcher 
also felt that at least nursing students have the opportunity of guiding and counseling 
to sexuality and healthy lifestyle to avert the spread and as well as contracting HIV.  
 In this present study the investigator planned to implement HIV interventional 
package of adherence counseling, Nutritional counseling, provision of educational 
strategies regarding to improve their QOL and demonstration of selected asana to HIV 
infected adolescents. The first three components of interventional package benefits 
can be enhanced by the fourth component of selected asana. The  focus of HIV 
interventional package ,  will promote the health, develop positive attitudes and health 
practices ,improve self confidence which prevents HIV transmission in future .This 
study can  helps the Tamilnadu State AIDS Control Society (TANSACS) to achieve  
the goal of  “Getting to zero”- zero new infection, zero AIDS related death, zero 
stigma and discrimination over the next five years. This study can abet to ensure that 
tomorrow’s adults will be healthy and lead productive life with fewer burdens to the 
society.  
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 Considering the facts about the prevalence of HIV among the adolescents and 
the professional experience of the researcher makes the present study to finds the 
importance. There is need for to protect the HIV infected adolescents from OI and 
counteract the HIV. The nursing professionals play a main role in making the 
adolescents group and community to aware of AIDS, its occurrence, transmission and 
its prevention. The effectiveness HIP will ensure the adolescents to improve in major 
part of adherence to ART, nutritional status and QOL in terms of improve the 
immunity, weight gain, management of symptoms and safe and healthy behaviors 
abets to reduce the new morbidity and mortality. 
Chapter - II
Aims and Objectives
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CHAPTER – II 
AIMS AND OBJECTIVES 
2.1 TITLE 
“Impact of Nurse Initiated HIV Interventional Package (HIP) on HIV Infected 
Adolescents.” 
2.2 STATEMENT OF THE PROBLEM 
Impact of Nurse Initiated HIV Interventional Package (HIP) On HIV Infected 
Adolescents Attending ART Clinic:  A Randomized Controlled Trial.     
2.3 AIMS OF THE STUDY 
2.3.1 Primary Aim 
 To improve the ART adherence level, increase nutritional status of HIV 
infected adolescents and enhance their quality of life through the HIV interventional 
package to HIV infected adolescents. 
2.3.2 Secondary Aims 
1. To improve and sustain adherence to ART among adolescents with 
HIV/AIDS. 
2. To increase and sustain normal range of CD4 count in adolescents with 
HIV/AIDS. 
3. To improve the anthropometric changes of HIV infected adolescents 
through increase the appetite and power of digestion.  
4. To reduce the minor illness and improve the quality of life among HIV 
infected adolescents through counseling of various strategies to make 
better of their life. 
5. The selected asana and pranayama of yoga   boost up the above the three 
compounds and enhance the quality of life of HIV infected adolescents. 
6. The HIV interventional package including behavior modification of yoga   
helps to prevent the HIV transmission in future generation. 
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2.4 OBJECTIVES 
1. To assess the base level of ART adherence, nutritional status and QOL on 
HIV infected adolescents in experimental and control group. (Pretest) 
2. To evaluate the 3
rd
 and 6
th
 month level of ART adherence, nutritional 
status and QOL of life on HIV infected adolescents in experimental and 
control group. (Post test) 
3. To compare and determine the effectiveness of HIV Interventional 
Package on HIV infected adolescents in experimental and control group. 
4. To correlate ART adherence level with nutritional status and QOL on 
HIV infected adolescents in experimental and control group. 
5. To associate the gain score findings of HIV Interventional package on 
HIV infected   adolescents in experimental and control group with 
demographic variables of HIV infected adolescents/caregivers. 
2.5 OPERATIONAL DEFINITIONS  
      Impact          : The effect of an HIP intervention.  
      Nurse                                          : A professionally trained person in 
nursing who is   able to look after the 
HIV clients. 
      HIV Interventional Package (HIP) : A specific interventional package 
includes adherence counseling, 
Nutritional counseling, provision of 
educational strategies to enhance the 
quality of life and demonstration of yoga 
includes selected asana. The 
interventional aid of diary to be 
maintained after the practice of yoga and 
ingestion of ART drugs. 
 Human Immunodeficiency Virus : A  retrovirus  in  humans in  which the  
 (HIV)   immune system begins to fail, leading to 
life-threatening opportunistic infections. 
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 Adolescents                          : Individuals in the age group of 10 to  
18 years. 
 Antiretroviral Therapy clinic :   One   of     the    health   centre’s   in   the 
 (ART)    hospitals providing HIV/AIDS 
prevention, treatment, care and support 
to all people living with HIV/AIDS. 
 Randomized Controlled Trial :  The gold  standards of  study design, the 
 (RCT)   subjects are selected by random to 
receive the specific interventions 
(Experimental group) and to be 
compared with standard of care. (control 
group).   
2.6 HYPOTHESIS 
  H0 -  There is significant difference in pre and post test score on adherence 
level, nutritional   status and QOL of HIV infected adolescents in both 
groups. 
 H1 -  There is significant improvement in post test score on adherence level, 
nutritional status and QOL of HIV infected adolescents in both groups 
 H2- There is significant correlation between ART adherence with 
nutritional status and QOL of HIV infected adolescents in both 
groups.                   
               H3 - There is significant association between the gain score findings of 
ART adherence, nutritional status and quality of life of HIV infected 
adolescents/caregivers with demographic variables of both groups. 
2.7 ASSUMPTIONS 
 The investigator assumes that,  
 The ART adherence can be improved by adherence counseling and daily 
maintenance of diary. 
 The optimal ART adherence can improve the nutritional status and QOL of 
HIV infected adolescents. 
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 The nutritional status of HIV infected adolescents can be improved by 
nutritional counseling and easily available, accessible and affordable foods 
of antioxidants   helps to increase the immunity and enhance their QOL. 
 The nutritional status and QOL of HIV infected adolescents can be improved 
by behavior modification of yoga.  
 The selected asana of HIV infected adolescents helps to increase the 
immunity level, improve nutritional status and enhance their QOL. 
 The ART adherence & nutritional status is influenced by demographic 
variables. 
 There will be effectiveness in all three components after HIV 
interventional package of HIV infected adolescents. 
2.8 LIMITATIONS  
 Assessment of ART Adherence based on the response from the caregivers 
and there is no objective method to confirm their claim of 100% 
adherence.  
 Regarding quality of life, most of the information on adolescents was 
obtained mainly from the caregivers as the adolescents may not come out 
with all the details.  
 The intervention strategies include adherence maintenance of diary and 
yoga practices mainly rely on the adolescents/caregiver’s subjective 
reports. 
 
Chapter - III
Review of Literatures
53 
 
CHAPTER - III 
REVIEW OF LITERATURES 
To achieve lasting literature, fictional or factual, a writer needs perceptive vision, 
absorptive capacity, and creative strength. 
                    Lawrence Clark Powell.  
The term review of literature is utilized in two ways by the research 
community. It refers to the activities involved in identifying and searching for 
information on the topic and developing a comprehensive picture of the state of 
knowledge on the topic.
98
 The purpose of review of literature for this topic will enable 
to develop a broad conceptual context into which the research problem will fit. 
     The review of literature is divided into two parts.  
          Part - I   3.1: Literature related to the study title. 
          Part- II   3.2: Conceptual frame work. 
 The Part-I consists of literatures related major areas of the study title. It 
comprises of five sections. They are, 
                      3.1.1 - General literature related to HIV/ AIDS 
                      3.1.2 -  Related  to  ART  Adherence  assessment  and  interventions     
 to improve adherence in   HIV infected adolescents. 
                      3.1.3 -    Related   to   nutritional   assessment   and   interventions  to 
 increase nutritional status  of HIV infected   adolescents. 
          3.1.4 -    Related to  QOL  of  HIV infected adolescents and   
strategies  to enhance the QOL. 
                      3.1.5 -    Related to yoga in HIV/AIDS and interventional benefits  of 
  yoga in adolescents 
 This chapter deals with selected studies that are related to the objectives of the 
study. A literature review is a compilation of scientific studies concerned to the 
present study. It was commonly found as a sub selection of a published research 
articles. The review of literature is also presented as free standing explorations of a 
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body of knowledge. A search was made by the investigator in Pubmed and Cochrane 
data base, to explore the studies pertaining to reports and publications brought out in 
medical and nursing field in India and abroad related to sub titles of thesis. The 
investigator documented the following literatures are submerged in age wise for all 
the sub themes because there is lack of studies in pertaining to specific age group of 
adolescents. In pertaining to yoga there is a lack of studies in this age group specific 
to HIV/AIDS, general studies among this age group were also included.  
PART I 
Section : 3.1.1 - General Literature Related To HIV/AIDS 
Adolescence (10-19 years) is differentiated by accelerated growth of physical, 
sexual, cognitive and emotional changes. This period is recently gained recognition as 
a distinct phase of life with its own special needs. These adolescents group face many 
difficulties and often confusing emotional and social pressures as they grow from 
children into adults. Due to changing demographic trends in a country make the 
largest number of adolescents and young people in the world including India. The 
history and milestone of HIV/AIDS are described in table number 8.  On the verge of 
fourth decade of the AIDS epidemic, the world has turned the corner to halt and 
begun to prevent the spread of HIV among these adolescents. The HIV remains a 
global issue when it comes to prevention among adolescents.   
Table 8: History and Milestone of HIV/AIDS 
26, 99, 100
 
1981 At University of California, Los Angeles a gay man was admitted to the 
medical center with severe immune deficiency  and  it is named  as" 
Gay- Related Immune Deficiency" (GRID), 
1982 Later, the CDC formally coined the term “Acquired Immuno 
Deficiency Syndrome” (AIDS). 
1983 At the National Cancer Institute in the United States, Dr. Robert Gallo 
and his colleagues acknowledged the causative organism of the disease, 
which was later named as Human Immunodeficiency Virus (HIV). 
1986 The first HIV case in Chennai was diagnosed by Dr. Suniti Solomon, in 
a female sex worker and also first report of AIDS in Mumbai. 
1989 HIV infection identified among intravenous drug users in Manipur 
state.  A medium Term plan for HIV/AIDs control with WHO support 
was started.  
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1991 Indian National AIDS control program was launched by Ministry of 
health and family welfare. 
1992-99 SACs (State AIDS Control Societies) were set up to maintain blood 
safety. 
NACP I- Launched for focused on awareness generation, setting up 
surveillance and monitoring HIV epidemic, measures to ensure access 
to safe blood and preventive services for high risk group populations. 
1999  NACP II- Launched focusing on behavior change, increased 
decentralization and NGO involvement, state AIDS Control societies 
established. 
2001 Indian pharmaceutical companies sponsored ARV drugs with 
substantial price reduction 
2002 National AIDS prevention and control policy adopted. A scale up of 
targeted interventions for high risk groups in high prevalence states. 
National blood policy adopted. 
2004  Antiretroviral  Treatment initiated 
2006  National policy on pediatrics ART formulated. 
2007- 12 NACP III- Launched to with the goal of Halting and Reversing the 
Epidemic in India by scaling up of prevention interventions among 
High Risk Groups (HRG) and General Population and integrating them 
with prevention, Care, Support & Treatment ( CST) services. 
2012-17  NACP IV launched to address the need for innovation within all key 
program strategies for integration of services, quality assurance at all 
service points and increase coverage saturation and treatment 
adherence. 
Launched of Third Line ART and scale up of first and second line 
ART. 
Demand promotion strategies specially using mass-media Campaign & 
Red Ribbon Express, Social Marketing System (SMS) and voluntary 
male circumcision. 
  
Etiology 
The HIV is a retrovirus belonging to the family of lentivirus and it usually 
transmitted through lymphocytes and monocytes. It is present in the blood, semen, 
vaginal secretion, and breast milk. It has incubation period of months to years.  There 
are two major strains of HIV includes HIV 1and 2. Among this HIV 2 is a 
predominant in West Africa, whereas HIV -1 is the dominant strain in the world wide 
and is more common.  
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Patho Physiology 
     The HIV virus principally infects a specific subset of T lymphocytes includes 
the CD4 and‘t’ cells. The virus takes more than the machinery of the CD4 + t -
lymphocytes, using it to duplicate it and rendering the CD4 cell to be dysfunctional. 
The CD4 + lymphocyte count slowly decreases over time, leading to progressive 
immune deficiency. The CD4 count ultimately reaches a decisive level of below 300 
cells/ mm
3 
which cause a considerable risk of opportunistic illnesses, followed by 
death. 
Routes of Transmission 
   The HIV/AIDS can be caused by two way of transmissions. They are 
horizontal transmission of intimate sexual contact or parental exposure to blood or 
body fluids containing visible blood and vertical transmission of parent to child. The 
following figure 20 showed the transmission of HIV/AIDS in India.
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Fig 20 : HIV/AIDS - Route of Transmission in India 
 
Source: NACO-Antiretroviral therapy for adults and adolescents May 2013 
 
Adolescents and young adults are at increased risk for HIV due to the multiple 
transitions that congregate in this stage. It also coincides with the acquisition of 
behavior patterns that potentially influence health-related risk in adult life, including 
of tobacco, drugs and alcohol misuse and unsafe sex. These important factors have 
resulted in increased global focus on meeting adolescent health needs over the last 
two decades.  
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  There are important differences between the adolescents who acquired HIV 
perinatally and those who acquired HIV non-perinatally. The PIAs will have a longer 
duration of exposure to the virus and may have been on cART for many years. This 
has implications for development, maturation, treatment side effects and clinical 
conditions.  Whereas Non-perinatal or Behavior HIV acquisition (BIAs) could include 
consensual sex, rape, sexual abuse and infection via blood (e.g. blood transfusion, 
intravenous drug users). Irrespective of their differences, both groups will share 
common experiences and challenges moving from adolescence into adulthood.  The 
following table number 9 described the differences and similarities between these two 
groups. 
Table 9: Differences and Similarities between Perinatally and Non-perinatally 
Infected Adolescents 
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S. 
No. 
Important  
Factors 
Perinatally infected 
adolescents (PIA) 
Behaviourly 
Infected 
Adolescents (BIA) 
Both share the following 
1. Awareness of  
status 
 May know their 
HIV status for 
many years or need 
to undergo 
disclosure when 
they become 
adolescents.                  
 Generally older   
and know their 
status   at time of 
diagnosis.  
 
   Challenges of 
disclosure: by others 
parents/caregivers/healthc
are providers  
to others (family 
members, friends, 
teachers, and employers)  
2. Family 
structure and 
support  
 
 Mother or other 
family members 
(father, siblings, 
etc.) may be HIV 
positive.  
 Increased chances 
of being a maternal 
and/or paternal 
orphan. 
 Acquisition can 
be associated with 
increased stigma, 
discrimination 
and decreased 
support from 
family/ 
caregivers.  
 Support and guidance 
(material and 
emotional) required 
from family and 
reliable, trustworthy 
of adults  
3. HIV disease 
severity  
 
 More likely to 
have advanced 
disease with more 
co-morbidities as a 
result of lifelong 
HIV and/or cART 
exposure.  
 The health status 
can be influenced 
by many factors 
including age at 
which cART was 
initiated, presence 
of co-morbidities, 
effective manage-
 Less likely to 
have advanced 
disease and may 
not yet meet 
criteria for 
initiation of 
cART.   
 Likely to have 
fewer HIV-
associated co-
morbidities.  
 Possibly more 
likely to use 
alcohol and 
tobacco.  
 Health status 
(includes mental, 
emotional and 
physical) influenced 
by lifestyle, including 
issues such as living 
conditions, nutrition, 
exercise, substance 
abuse.  
 Adherence and 
management of HIV 
will influence HIV 
progression.  
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ment of OI, 
achievement and 
maintenance of 
viral suppression, 
cART regimens 
exposed to, and 
length of time on 
cART.  
4. Sexual and 
reproductive 
health: 
sexuality/relati
n ships  
 May  not be 
sexually active 
 May be a time of 
sexual 
experimentation 
and sexual debut  
 May be more 
inhibited, self-
conscious and 
anxious about self-
image and entering 
romantic/sexual 
relationships.  
 If sexually active, 
more likely to 
require sexual and 
reproductive 
health services, 
including 
information, 
education, access 
to male/female 
condoms, 
hormonal 
contraception and 
screening for 
symptoms of STIs  
 Issues related to risk, 
transmission and safe 
sex. 
 Need to prevent 
unintended pregnancy 
 Need to prevent 
secondary HIV 
infection  
 Sexual orientation 
heterosexual, 
homosexual, bisexual 
and transsexual.  
5. Familiarity 
with health 
services  
 
 Most likely will 
have been 
attending pediatric 
services since 
infancy, and will 
be familiar with 
health services.  
 May be 
transitioning from 
a pediatric service.  
 Most likely will 
come to the health 
service for an 
HIV test or 
because of 
another problem, 
(e.g. illness, STI,   
contraception, 
pregnancy) and 
will have/ had 
less contact with 
the health service.  
 Require adolescent-
friendly and 
responsive services 
 
6. Antiretroviral 
treatment  
 
 Most   likely to be 
on cART and may 
be on second line 
treatment. In 
younger 
adolescents 
treatment 
adherence may be 
overseen by carer 
but likely to be 
responsible for 
own treatment if 
older.  
  Transition into 
adolescence may 
present adherence 
problem. 
 Probably not yet 
required, or only 
recently initiated 
 May be initiated 
as part of 
PMTCT.  
 Adherence may be  
 problematic in 
adolescence, 
especially as 
responsibility shifts 
from parents/ care 
givers to self-
administration 
 Need regular 
monitoring and 
management of drug 
side effects.  
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Use the 5 ‘A’s in consultations with adolescents   
Based on the WHO’s Integrated Management of Adolescent and Adult Illness 
(IMAI) for the management of chronic care and the guidelines for engaging with 
clients include the 5 ‘A’s:  Assess, Advise, Agree, Assist and Arrange. This tool 
provides a useful framework to move through a process of identifying, exploring and 
problem-solving areas of concern, together with follow-up plans or Anti retroviral 
therapy. The clinical goals of ART are,  
•  To provide maximum and robust repression of viral load and,  
•  To restore and/or preserve immune function. 
•  To reduce HIV-related morbidity and mortality. 
• To increase the lifespan and as well as enhance QOL. 
 These goals are only attained by complete repression of the viral replication 
for providing possible well tolerated and sustainable treatment. With prolonged viral 
suppression generally increases the CD4 lymphocyte count results in a remarkable 
reduction in the risk of HIV-associated morbidity and mortality. The opportunistic 
infections and related symptoms such as TB and diarrhea, affect the nutritional status 
as well as physical factors such as appetite and weight of PLHIV. The ART 
management with good nutritional support and the minimal physical exercises will 
enhance their QOL and longevity of life period of PLHA.
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  The following are the basic approaches to control the HIV/AIDS. 
1. Prevention  
 Prevention is a key component of HIV education. The most important 
areas of Information, Education and Communication (IEC) and Behavior 
Change Communication (BCC) program are needed to improve the 
knowledge  of HIV/AIDS and create awareness among ALHIV and also 
general adolescents 
 The access to health information regarding sexual and reproductive, 
education regarding safe sex and services is necessary for their well being.  
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 Also avoid use of shared razors and tooth brushes. 
 Information to Intravenous drug users - Avoid to share the needles and 
syringes involves special risk. 
 All mass media channels should be involved in educating the people on 
AIDS, its nature, transmission and prevention. 
 People on high risk groups should be urged to abstain from donating the 
blood, sperms, body organs or other tissues. 
2. Counseling and HIV testing and National level control program  
 Integrated counseling and Testing centres (ICTCs) are a key entry point 
for a range of interventions in HIV prevention. The care like prevention of 
parent to child transmission (PPTCT), Referrals STD treatment / 
Reproductive Treatment Clinics (RTC), Care and Support for treatment of 
OIs and High risk groups are essential to treat and manage the problems 
before gets complicated. 
 A common psychosocial concern includes disclosure status to the child, 
follow custody plans when the primary caregivers are infected, and 
anticipating loss of family members. 
 Provision of psycho social counseling is essential  in order to reduce the 
anger and depression towards the family members and rehabilitation and 
vocational counseling is needed to enhance their quality of life. 
 Apart from this, the government has taken initiation to create the awareness 
and control of HIV/AIDS started the programs like School AIDS Education program, 
Red Ribbon Express, Condom Promotion or Social Marketing System (SMS), Social 
mobilization, Youth Interventions and Adolescent Education Program are essential to 
control and prevent the HIV/AIDS among adolescents and youth. 
    3.   Anti Retroviral Therapy (ART) management 
 The HARRT has brought new hope for PLHA. The ART is a combination of 
drugs that are used to manage patients with HIV. The ART does not totally eliminate 
the virus or alleviate the disease but it will decline the amount of virus in the body by 
prevent from replication. According to the National guidelines each countries are 
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following the own eligible criteria to start ART. Once ART initiated for people living 
with HIV/AIDS it can’t be stopped at any level and it has to be continued as a lifelong 
commitment.   There are several types of ART drugs are used to treat for PLHIV.  
They are, 
1.  Nucleoside  ( and nucleotide)  reverse transcriptase  inhibitors ( NRTIs) 
2.  Non-Nucleoside reverse transcriptase inhibitors ( NNRTIs) 
3.  Protease inhibitors ( PIs) 
4.  Fusion inhibitors 
 These are drugs used for the combination of first line and second line ART 
regions. The following table number 10 illustrates the commonly available ARV 
drugs in the ART clinic. Patients are primarily prescribed a three drug combination as 
first line therapy (1 NNRTI and 2 NRTIs). According to the patient’s prognosis state, 
weight gain, viral load  and side effects of the drugs  the medical officers  are to  
decide  whether to continue same regimen or either one drug  in the combination  can 
be  changed or  change to the second line regimen ( 1 PI and 2 NRTIs). Currently the 
third line drugs are also available. They are, Raltegravir (RAL), Darunavir (DRV), 
Ritonavir (RTV) and Etravirine (ETV). 
Table 10:  Illustrates the Commonly available ARV drugs using  for the ART 
patients 
 
NRTIs NNRTIs PIs 
  Zidovudine (AZT) 
  Lamivudine (3TC) 
  Stavudine  (d4T) 
  Didanosine (ddI) 
  Abacavir (ABC) 
  Tenofovir (TDF) 
  Emtricitabine / Entriva (FTC) 
 Nevirapine (NVP) 
 Efavirenz (EFV) 
Lopinavir (LPV) 
Ritonavir (RTV) 
Saquinavir (SQVr) 
Nelfinavir (NFV) 
Indinavir (NFV) 
   
The fusion inhibitors disrupt the interaction between the HIV virus and the cell 
surface, averting the fusion of the HIV virus to the cell. These drugs are not widely 
available and cannot be taken by mouth. Adherence is often more complicated for 
children born with HIV, who have been on ARVs longer than adolescents who 
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acquire HIV at older ages.  The multidisciplinary team members should work together 
to create adherence support program for people living with HIV/AIDS. The nurses 
and counselors should re-address the barriers and promote the adherence for 
especially ALHIV since they are transiting to the adult care. The peer support groups 
could be particularly helpful in supporting adolescents to take their medication 
properly. The new technology or social media should also be explored as a potential 
platform for providing peer-to -peer support and counseling.       
Section : 3.1.2-  Literature Related To Adherence Assessment and Interventions 
to Improve the Adherence in HIV Infected Adolescents  
Ferrand RA et al (2016) reviewed the literatures related to the adolescents 
achieving virological suppression after initiating ART from MEDLINE, EMBASE 
and Web of Science databases from the period of January 2004 and September 
2014.Through the search result, the total of 5316 potentially relevant citations, 20 
studies were included. Among that, only 8 studies were reported the percentage of 
adolescents that were virologically suppressed at a specified time point. The 
proportion of adolescents with virological suppression at 12 months varied from  
27-89%.The study reports suggested that adolescent’s achievement of HIV virological 
suppression was greatly variable. The improved reporting of virological outcomes 
from a wider range of settings is imperative to support efforts to improve HIV care 
and management for adolescents.
105
 
Kukoyi O et al (2016) done a prospective longitudinal study on antiretroviral 
treatment outcomes and viral load monitoring in HIV infected children in Ghana. The 
total 140 children aged 5 to 17 years instigated ART were included. In analysis, 184 
hospitalizations and 102 Opportunistic infections (OI) were reviewed among that the 
pneumonia being the most common causes (22.8 %) for hospitalizations and 
tuberculosis common OI (68 %). The total of 823 outpatient sick visits was renowned, 
with upper respiratory infections (14.2 %) being the most common causes.  The 44% 
of participants had >4 log10 vireamia copy years (VCY). The sub-cohort children had 
a high frequency of sick visits compared with those with < 4 log10 VCY (P = 0.03). 
The 6.5 % of children with >4 log10 VCY had been recognized as treatment failure 
based on criteria of WHO clinical and immunological treatment failure.
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 Okatch H (2016) evaluated the significance of adherence in association with 
treatment failure of HIV infected adolescents. The 300 HIV infected cohorts were 
involved for pill counts method for calculating adherence percentages and identified 
that many patients discarding pills to hide for non-adherence. The pill counts 
percentage of > 100% can signal "pill dumping." The study reports revealed that, 
HIV-infected adolescents as having >1/3 of pill counts with > 100% adherence 
throughout the follow-up suggested that "over-adherence". The apparent over-
adherence was more frequently in virologic failure than those with suppressed viral 
loads (33% vs 13%, p=0.001). The study findings suggested that, pill count adherence 
frequently of >100% may indicate that increased risk of treatment failure in HIV-
infected adolescents.
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  Carly H & Cluver L (2015) analyzed a systemic review on factors related 
with adherence to ART among ALHIV (10-19 yrs) in LMICs. Among 15 studies and 
the total of 4363 participants, acknowledged 35 factors were significantly related with 
ART adherence in nine different LMICs. This review   highlighting   significant  
themes for  factors affecting the ART adherence include, (1) cohort factors such as 
gender and cognitive level  of zero status  (2) caregiver and family related factors (3) 
medication  related factors likes regimen  fatigue, intolerance, and attitudes about 
drugs, and (4) ecological and physical  factors, like urban  versus rural location and 
loss of follow-ups.  He concluded in this review ranged from 16% to 99% rates of 
adherence of adolescents across studies in LMICs.
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  Córdova E et al (2015) evaluated safety and efficacy of ART in PIAs  
(12-18 yrs) in Argentina at baseline (2005-2011) and after 48 weeks of ART 
initiation. Among 37 adolescents, 23 (62%) had a virologic failure, median CD4 
count 385 cells/ml (247-555) and median viral load: 3927 copies/ml (1534-6380). 
Only four patients had no history of undetectable viral load in their lives. At end of 
study, the median CD4 count was 447 cells/ml (261-1121), viral load <50 copies/ml 
was observed in 5 more (45%) patients and also observed that the most frequent HIV 
resistance associated mutations (RAM).The results findings concluded that the high 
rate of virologic failure could be attributed to the suboptimal adherence observed in 
almost all adolescents and especially in the PIAs in the study.
109
  
64 
 
Kim SH et al (2015) examined the significance of self-motivation and social 
support in medication adherence on HIV infected adolescents in United Kingdom. 
Among 138 adolescents aged 2–24 years were enrolled. Among this, 75% of 
adolescents were self reported on 7 days recall of sub optimal adherence of up to 
85%. In analysis, the self-motivation of routine work was most supportive for 33% in 
medication compliance, followed by 25 % of reminders by family and friends with 
20% recognized no specific factors were needed. Only 15% of participants chose 
interventions such as an mobile phone reminders or adherence diary as helpful 
factors, and 1% chose healthcare team input such as home visits. He concluded that 
motivation and educational strategies may decline the impact on sustained ART 
adherence among this vulnerable group.
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 Marvin BE et al (2015) conducted a study on the feasibility and acceptability 
of a cell phone support intervention for non adherence to ART among youths (15–24 
yrs). Among 19 youths, 37% discontinued the intervention due to missing over 20% 
of calls or missing 10 % consecutive calls. The 16 % participants only fulfilled exit 
interviews and only 13% reported that, after the 24-week intervention they would 
have liked to continue calls and all participants suggested they would advocate the 
intervention to friends. He concluded that, providing cell phone support to youth non 
adherent to ART was acceptable and feasible.
111
  
Orrell C et al (2015) evaluated the effects of real time electronic adherence 
monitoring with text message reminders among adolescents and adults starting first 
line ART in South Africa. Around 230 participants, aged 18 and above were 
randomized to equally (n=115) in both groups. In analysis, the median adherence was 
82.1% in the intervention arm, compared with 80.4% in control [AOR 1.08; 95% CI: 
0.77 to 1.52]. The suppressed HIV RNA (<40 copies/ ml) happened in 69.6% of 
control and 65.2% of intervention group. When compare to control the [AOR for 
virological failure 0.77; 95% CI: 0.42 to 1.40] treatment interruptions of >72 hours 
was reduced [adjusted incident rate ratio, 0.84; 95% CI: 0.75 to 0.94] in intervention 
arm. The results concluded that, text message reminders related to late doses noticed 
by real-time adherence monitoring and decreased the frequency of treatment 
interruptions, but did not significantly improve adherence or viral suppression.
112
 
65 
 
  Shet A et al (2014) assessed the impact of mobile phone reminders on 
treatment outcomes of HIV patients in south India. The HIV infected participants 
aged 18 years & above on first line ART were included. Through randomization, the 
total of 631 participants were assigned to mobile phone intervention (n=315) and 
standard care (n=316) followed for 2 years. In analysis, the rate of virological failure 
in the intervention and standard care groups was 10.52 and 10.73 respectively and it 
was found that no observed difference between the allocation groups. The suboptimal 
adherence was 81/300 in the intervention arm and 65/299 (27.0 & 21.7%) in the 
standard care arm and found that no difference in between groups. The result findings 
revealed that, no significant effect on mobile phone intervention either in virological 
failure or ART adherence at the end of study.
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Chaiyachati KH et al (2014) analyzed a systematic review on interventions 
can progress adherence to ART including individual - level interventions among 
PLHIV. The total of 124 studies were selected, among this eighty-six studies were 
RCTs and  more than 20 studies were tested  for the effectiveness of the following 
interventions, either separate or in combination with other interventions: directly 
observed therapy (DOT), education, active adherence reminder devices (such as 
mobile phone text messages), cognitive-behavioral interventions and buddy system. 
Even though there is strong facts that all five of these interventions can extensively 
enhance ART adherence in some settings and other notorious view each intervention 
has also been found not to produce momentous effects in several studies. Almost half 
(55%) of the 124 studies explored the effectiveness of combined interventions, tend to 
have same effects like single interventions.
114
 
 Intasan J et al (2014) evaluated the ART adherence through various 
assessment tools among 1-12 years of HIV-infected children (n=207) at Thai and 
Cambodia.  In analysis, 13% had Viral Failure (VF) and it’s co-related with 
announced pill count mean adherence (P = 0.03). In multivariate analysis, announced 
pill count was highly associated with sex, and education of caregivers are 
significantly influence  poor adherence  and VF  with OR 4.56; 95% CI,1.78–11.69, 
expose a  missed dose of 6 months in viral load assessment  with OR 8.64; 95%CI 
1.96–38.04 and barrier of  adherence (according to  PACTG  questionnaire) with OR 
7.08; 95% CI, 2.42–20.73. The study results recommended that, there is a strong 
association with development of VF in regard to self-report of any missed doses.
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 Maduka O and Tobin-West C.I et al (2014) done mixed method study on 
barriers of HIV treatment adherence among PLHIV aged 18 and above in ART center 
at Nigeria .The data collection was via quantitative ( n=96) and qualitative method by 
four focused group discussion were held with 27 purposively selected participants. In 
analysis, among 96 patients, the most common reason for missing medications were,  
42.7% being away from home during medication times, 36.5%  being busy with other 
things,34% forgetfulness ,26% running out of pills and difficulty taking pills,16% the 
need to avoid side effects  and 15% lack of a social support system. The barriers 
identified by the focused group discussions (FGD) were  alcohol use, poor 
understanding about the effects of drugs , fear of taking HIV drugs in front of others, 
forgetfulness, sharing drugs with infected spouse, financial challenges, poor attitude 
of health workers and  long clinic hours. The study finding suggests that, the 
adherence counseling, use of reminder systems and treatment supporters are useful in 
public health interventions for improving adherence of youth on ART.
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 Evans D et al (2013) conducted a retrospective analysis on outcome 
measures of HIV infected adolescents in South Africa. The total of 42,427 
participants on ART was participated for the outcome of one year evaluation. In 
analysis compared to adults, both older adolescents and young adults (6 & 12 months 
RR 1.75 & 1.64, 95% CI) are more likely to have viral resistance and were more 
likely to get virological failure. The young adolescents were less likely to be LFT 
during the study period when compare to older adolescents and young adults. It 
results, between the age of 15 and 24 years have poorer ART treatment outcomes in 
terms of LFT, virological resistance and failure than adults receiving ART. The study 
finding suggests that, interventions are required to improve outcomes and retention in 
ART care in this special population.
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Maduka O et al (2013 ) done a randomized control trial on reminder text 
messages and motivational counseling among adolescents in Nigeria. The total of 104 
participants aged 15 years and above were enrolled and randomized into intervention 
and control groups. Among this 45 males (43.3%) and 59 females (56.7%) were 
included. The experimental group received weekly twice of short message reminders 
for four months, monthly motivational adherence counseling and while the control 
group received only the conventional care. In pre- and post-intervention, the self-
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reported adherence and CD4+ cell counts were measured. In analysis, after 4
th
 month 
results revealed that  adherence rate was increased to  76.9% in experimental  & only  
55.8% in  control  group (χ2 = 5.211, RR = 0.75 , P = 0.022) Also, the intervention 
group  median CD4+ cell count was improved from 193 cells/ml to 575.0 cells/ml 
whereas in control group  131.0 cells/ml to 361.5 cells/ml (P = 0.007).The study 
findings depicted that, text message reminders and  motivational  adherence 
counseling improved adherence among HIV participants.
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  Donell. MK et al (2013) explored a cross sectional multisite study on 
barriers to medication adherence in behaviorally and perinatally infected adolescents 
and young adults in the age of 12-24 yrs and reported missing at least one dose of 
medication in the past 7 days. Among 484 participants, perinatally infected youth 
(M=3.68,SD = 2.62) reported significantly more barriers than behaviorally infected 
youth (M = 2.97 SD = 2.49). Forgetting (73.6 %) not want to be reminded of HIV 
infection (35.5 %) and not feeling like to take medication (39.2 %) were the most 
common barriers reported for both participants in the group. The  significant barriers 
were  missed dose  (r = .27, p ≤ .00), viral load (r = .27, p ≤ .00), and psychological 
distress (r = .38, p ≤ .00) in perinatally infected youth but where as in  behaviorally 
infected participants, missed dose   (r = .35, p ≤ .00), psychological distress (r = .25,  
p  ≤ .00), and substance use (r = .14, p ≤ .05), but not with viral load (r = .12, p = .08). 
He concluded that, multiple barriers were associated with viral load in perinatally 
infected youth, though both participants had significant associations between 
adherence and viral load.
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   Shroufi A et al (2013)  conducted retrospective cohort study on HIV-infected 
adolescents (10-19 yrs) on  management outcomes of ART in Zimbabwe. In analysis, 
1,776 adolescents were commenced on ART, 94% had no previous history of ART. 
The 97% adolescents diagnosed HIV after appearance of clinical symptoms and 
advanced HIV disease compared with adults [79.3 vs 65.2%, P< 0.001)]. Among 
those, 5.8% of adolescents were switched to a second-line regimen as a result of 
treatment failure, compared with 2.1% of adults (P<0.001) followed for 5 years or 
more. The study findings concluded that, with adolescent-focused services, are 
needed to achieve good outcomes for adolescents However, this age group has a high 
risk of treatment failure, so interventions to address poor adherence should be 
prioritized.
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  Ugwu R, Eneh A (2013) conducted a correlation study on reasons for non 
adherences by using self-report of the caregiver/child among HIV 
children/adolescents at South Nigeria. The participants aged 3 months to 18 years and 
their 213 caregivers were enrollred. In analysis, 59.2% were completely had 100% 
adherence and 76.1% had adherence rates of  ≥95%. The persistent caregiver-related 
factors for missing doses were forgetfulness (55.2%), travelled (25.3%), unavailable 
to collect the drugs (18.4%), caregiver ill (17.6%) and family problems (13.2%). 
Whereas the child-related factors were refused drugs (11.5%), slept and vomited 
(9.2%). The predictors of poor adherence includes were younger than 5years with 
95% CI (OR 2.62; 1.30-5.31) and presence of a co-morbidity (OR 3.97: 1.92-8.33). 
Whereas the predicted better adherence includes with 95 % CI, medication reminder 
strategy (OR 6.34; 3.04-13.31) and regular clinic visits (OR 8.55; 4.01-18.45). The 
study finding suggests that, adherence rate among this age groups are still suboptimal. 
Since recognizing and managing these barriers aids to improve adherence and child 
outcomes.
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  Buchanan AL et al (2012) evaluated the barriers of medication adherence in 
HIV infected children and youth based on caregiver’s report from Pediatric AIDS 
Clinical Trial Group (PACTG). The total of 120 PIAs (aged 8 to 18 years) and their 
parents/caregivers were fulfilled a questionnaire about barriers of adherence to ARV 
regimens. In analysis, the most frequently reported barrier  was “forgot reported  
either  by  the caregiver or youth” (k = 0.41, P <.001) and the other barriers are ,“ 
bitter taste” (k = 0.44, P <.001), “child refused (k = 0.26, P = .01),”  “child was away 
from home” (k = 0.38, P<001), and “child felt good (k = 0.24, P = .02)  when not 
taken medicine.” The adolescents who knew their HIV status were more likely to 
report logistical barriers like scheduling issues. The children with a biological parent 
and their caregivers were more likely to report regimen related factors or fear of 
disclosure as a barrier. The study finding suggests a need for interventions that tasks 
of remembering to take medications, sustaining adherence are essential for transition 
to adult care.
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Dowshen N et al (2012)  conducted a prospective pilot study on improving 
adherence using with personalized, interactive, daily text message remainders for 
youth (14-29 yrs) living with HIV/AIDS. The participants received personalized daily 
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SMS reminders and 1 hour later have  follow up message  for assessing the 
medication. Out of 25 participants, 21 (95%) participants were successfully completed 
the intervention. The Mean Visual Analysis Scale (VAS) scores compared with base 
line, appreciably increased at 12 and 24 weeks (week 0: 74.7, week 12: 93.3, P < 
.001; week 24: 93.1, P < .001) and ACTG questionnaire 4-day recall also improved 
(week 0: 2.33, week 12: 3.24, P = .002; week 24: 3.19, P = .005). But there was no 
considerable progress in CD4 cell count or decrease of viral load throughout the 
follow up. He concludes that, the daily SMS remainders useful to avoid missed doses 
and also it notably improved self-reported adherence.
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Kikuchi K et al (2012) done a cross sectional study on high risk of ART non 
adherence on HIV positive double orphans at Rwanda. The total of 717 HIV positive 
children aged 3 -12 years and their caregivers were participated. In analysis, among 
the 717 each orphan categories were (double orphan - 346, maternal (89), paternal 
(169) and non-orphan-(113) participated and the level of non adherence were 59.3%, 
44.9%, 46.7%, and 49.7% respectively. The multivariate analysis indicated that 
maternal, paternal and non orphans were less likely to be non-adherent contrast to 
double orphans. The non adherences were more in double orphans who had a sibling 
as a caregiver. It’s revealed that the double orphans were at highest risk of ART non-
adherence and need more attention to enhance the optimal adherence level.
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Wasti SP et al (2012) done a mixed method study on factors affecting 
adherence among ART participants (aged 18 and more) and care providers in Nepal. 
Among 330 participants only 85.5% had optimal adherence. in quantitative analysis, 
the major factors listed for adherence are: not aware of HIV status with OR = 17.99, p 
= 0.014; being female  and illiterate with OR = 6.91, 4.58 p = 0.001; ART started 
more than 24 months and side effects   with OR = 3.18 , 6.04 p = 0.009; transport time 
> 1 hour with OR = 2.84, p = 0.035 and alcohol use (OR = 12.89, p =,0.001).In 
thematic analysis, the lack of awareness and negative attitude of ART also 
significantly associated non-adherence. The other common reasons for non adherence 
include side-effects, busy schedule, transport time and costs.
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  Mellins CA et al (2011) examined behavioral health risks in perinatally HIV 
infected (PHIV +) and perinatally HIV-exposed, uninfected (PHEU) adolescents in 
the age of 10-16 yrs. Among 349 adolescents, nearly half of participants had one 
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behavioral health risks and most participants had psychological problems (28%), 
sexual activity and substance use (16%). Regarding the sexually active, 65% of PHIV 
+ and 50% of PHEU adolescents reported unprotected sex.  The 18% of PHIV and 
14% of PHEU adolescents reported substance use. The majority of adolescents were 
reported alcohol use (PHIV 58% + PHEU 69%) and marijuana (PHIV 35% + PHEU 
56%). The PHIV adolescents 34% reported history of ART non adherence of which 
45% had detectable HIV RNA levels in blood. Finally the study suggests that the 
multiple behavioral health risks causes non adherence for both PHIV + and PHEU 
adolescents.
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 Section: 3.1.3 - Literature Related to Nutritional Assessment and Interventions 
to Improve the   Nutritional Status of HIV Infected Adolescents 
 Yengopal V et al (2016) reviewed the literature on Pediatric & adolescent 
HIV with a focus on oral lesions as indicators of the efficiency of HAART and QOL. 
The  search strategy was developed form Pub Med and publications were limited from 
2009 to 2014. In analysis, the prevalence of oral lesions not has standardization in 
diagnostic criteria and the prologue of HAART had significantly reduced prevalence; 
the oral lesions remain helpful predictors for HIV infection and as indicators for the 
efficacy of HAART. The indicator suggested that caries risk was increased with HIV 
infection; management of oral lesions also incompatible with available resources. The 
oral health QOL indicators for children and adolescents are  more essential and oral 
HIV research needs to be prioritized with number of interventions available for 
management of oral lesions and as well as improve the dietary intake.
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 Ifitezue LC and Sosanya ME (2015) done a study on nutritional assessment 
of HIV infected orphan children (0-17 years) and implement food based intervention 
to improve their nutritional status in Nigeria. The total of 196 participants was chosen 
by purposive sampling method. The data was collected by using anthropometry and 
food frequency questionnaire. In analysis, the children were respectively had 
moderate (28-14.4%) and severely underweight (18 - 9.3%), whereas regarding 
moderate and severely stunted were 34 (17.6%) and 5 (2.6%) respectively. Regarding 
the food frequency, the most habitually consumed cereals were rice (92.3%) and 
maize (88.7%), whereas the most commonly consumed tuber, animal protein, 
vegetables and fruits were yam (88.1%), meat  (67%), and fish (66.5%), garden egg 
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(69.1%) and orange (75.8%) respectively.  The twenty children were consumed for 
the intervention of giving  kwash pap powder for a period of 1 month and the mean 
weight gain (0.99 ± 0.43 kg) was significantly improved after the study period 
(p<0.001).The findings recommended that, food based intervention can enhance the 
nutritional status of children orphaned by HIV/AIDS.
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 Pires P et al (2015) conducted a quantitative study to evaluate the food 
security contribution to ART non adherence in Nampula. The total of 208 
participants, aged > 15 years were participated. In analysis, 58% consider that they do 
not have enough food. The ART adherence for patients on treatment over the last 3 
months was estimated at 69%. The last 24 hours of food intake survey shows that 
21% had only one meal, 22% did not eat any vegetables, 24% did not eat any 
proteins, 56% any fruits. About economic income, 63% work in subsistence 
agriculture, 29 % have informal activity and 18% are employed. The report finding 
suggests that beans, peanuts, eggs, cabbage and fruits, locally available vegetables; as 
an ART adherence facilitator and recommend that implementing a nutritional 
education program and rural extension intervention with this group, in order to  
improve better families food security.
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 Sales-Peres SHC et al (2015) done a comparative study on oral health status 
and anthropometric condition in adolescent’s infected with and without HIV infection 
in Mozambique.  The total of 43 adolescents aged 15-19 years, were divided into two 
groups namely, in experimental group have HIV infected adolescents with AIDS; and 
in control group have adolescents without HIV infection. In analysis, the experimental 
group had a higher degree of dental caries with OR= 5.902; 95% CI=2.859 -12.188; 
p=0.000, less periodontal diseases with OR=1.318; 95% CI=0.662-2.624; p=0.540, 
higher alterations in the soft tissue with OR=0.216; 95% CI=0.057-0.811, p=0.030 
and lower  normal BMI (OR=0.498; 95% CI=0.252-0.987; p=0.066) than the control  
group. The study results depicted that HIV infected participants even on ART are at 
major risk for dental caries or alterations of soft tissue and minor risk for periodontal 
diseases.
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Shet A et al (2015) evaluated the prevalence of anemia and effect of iron on 
HIV among children in southern India. The total 240 vertically infected children   
aged 2–12 years were enrolled and followed for 1 year. In analysis, the baseline 
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assessment of the median CD4 count of 25 % to 19.2 % had advanced disease and 
45.5 % had malnutrition. Anemia was prevalent in 47.1 % children and severe anemia 
was seen in 6.7%. The majority (65.5%) of participants had iron deficiency anemia, 
26.6% in vitamin A and 8.0 % vitamin B12 deficiency. After the baseline visit, among 
113 anemic children; 77 children had peaked level of 11.3 mg/dl after 1 year. The 
prevalence of iron deficiency also declined from 66 to 49.2 % (p = 0.04). The study 
findings suggests that therapeutic iron intake for up to 6 months to be safe and are 
associated with favorable effects on anemia.
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 Swetha GK et al (2015) done a study on health and nutritional status of HIV 
infected children (1.5- 15 yrs) at two orphanages in Hyderabad. Among 77 children, 
44 children were on ART and 33 children were not on ART are included in the study. 
In analysis, 59.7% were stunted, 46.8% were underweight and 19.5% had low BMI 
for age.  The Anemia (Hb <11 g/dl) was prevalent in 45.5%  and  micronutrient 
deficiencies includes vitamin D deficiency (< 20 ng/ml) was observed in 51.9 % , 
Vitamin A deficiency in 14.3%  and  zinc deficiency was  in 16.9%  children. The 
respiratory (36.6%) and dermatological illness (18.8) were the common co-morbidity 
of the HIV infected children.
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Anyabolu H. C. et al (2014) evaluated the micronutrient status of HIV 
infected children on ART compared with HIV negative controls. The total of 140 
children aged 24 to 227 months were enrolled and 70 control children were matched 
with age and sex. In analysis, the prevalence of zinc, selenium, and vitamin C 
deficiency was 77.1%, 71.4%, and 70.0% respectively in HIV infected children as 
compared to 44.3%, 18.6%, and 15.7% in HIV negative controls.  The study findings 
depicted that 70% of the children were deficient in both Zinc and selenium with 
58.6% was deficient in the three micronutrients. This micronutrient deficiency is 
widely prevalent in HIV infected children on ART and suggests that additional 
supplementation is essential in these cohorts.
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 Hillesheim E et al (2014) evaluated the nutritional status and dietary intake 
of HIV infected adolescents in Brazil. The 49 participants were aged 7–17 years were 
included. In analysis, the mean BMI-for-age was –0.26 ± 0.86 and height-for-age was 
−0.56 ± 0.92. The majority (85.6%) of the participants had nutritional deficiency i.e., 
energy intake (50.8%) above the estimated energy requirement and inadequate 
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ingestion of polyunsaturated fat (100%), cholesterol (57.1%), fiber (40.8%), calcium 
(61.2%) and vitamin C (26.5%) These data showed that, the low BMI-for-age and 
height-for-age z-scores, high energy intake and inadequate intake of important 
nutrients were significant in poor immune function, growth and control of chronic 
diseases.
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 Modlin CE et al (2014) conducted a study on nutritional deficiencies and 
food insecurity among HIV-infected children (2-14 yrs) in Tanzania. The data was 
collected regarding anthropometric measurements and determined 24 hour macro and 
micronutrient intakes and food insecurity. Among 48 pairs  of children and their 
caregiver(s), the median weight-for-height z-score for children ≤ 5 years was 0.69 and 
BMI-for-age z-scores for children >5 was -0.84. The  macronutrient assessment  
reported that 60% children were deficient in dietary intake of energy; deficiency was 
more common in older children (p=0.004). The micronutrient evaluations showed 
that, over half of study participants were deficient in dietary intake of vitamin A, D, 
and E, thiamine, riboflavin, niacin, folate, vitamin B12, and calcium. The food 
insecurity was reported by 58% of caregivers. The study finding suggests that 
enhanced dietary counseling and provision of macro and micro-nutrient supplements 
will be necessary to achieve optimal nutrition for most of the HIV-infected 
children.
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         Brainstein P et al (2013) evaluated the effects of nutritional status among 
orphaned and separated children and adolescents (OSCA) living in western Kenya. A 
total of 2862 participants (0-18 yrs) are included and the   malnutrition measures were 
standardized with Z-scores (WHO). The findings showed that stunting was 
widespread i.e., 74% in this population and 59% of children were had abnormally low 
height and weight for-age at p=0.001. The study findings  suggested that,  the  OSCA 
living in community households were 2–3 times more and street youth are roughly 6 
times more likely to have height and weight  stunting for their age compared to 
children living in Charitable children institutions (CCI’s), suggests that, chronic under 
or malnutrition.
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Mudzinge D et al (2013) conducted a comparative cross sectional study on 
differences in serum levels of Magnesium, Phosphate and Albumin for HARRT 
experienced and Naïve female patients in Zimbabwe. The equal participants 40 HIV 
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infected women, aged 18 to 40 yrs were enrolled in both groups. The results revealed 
that, Magnesium, phosphate and albumin levels were considerably higher in the 
therapy naïve than in therapy experienced patients where as in calcium level of both 
groups no significant difference was found. The study evidence suggests that HARRT 
lowers levels of magnesium, phosphate and albumin but has no effect on serum level 
of calcium. It revealed that, the need of dietary counseling and provision of macro and 
micro nutrients supplements will be necessary to achieve the optimal nutrition for 
most of the PLHIV.
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 Schtscherbyna A et al (2012) assessed the prevalence and factors associated 
with low bone mineral density (BMD) in HIV infected adolescents in Brazil. In 
analysis, 74 adolescents aged 17.3 + 1.8 years were participated. The Low BMD was 
present in 32.4% of them. The lumbar spine (LS) and total body (TB) BMD Z-scores 
were positively correlated with weight, BMI, BMI Z-score, total body fat, and 
nutritional status. The subjects on tenofovir had lower LS, TB and BMD Z-scores. 
There is no difference was found regarding levels of calcium, parathyroid hormone, or 
25-hydroxyvitamin D according to BMD status. The study finding reveals that the 
body composition and nutritional status had a positive influence on BMD that was 
more evident in females, suggesting that nutritional intervention may have a positive 
impact on BMD.
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Barros Ramalho LC et al (2011) conducted a comparative study to identify 
abnormalities in nutritional status and body composition of HIV-infected children and 
adolescents on ART in Brazil. A group of 94 HIV-infected children and adolescents 
on ART and 364 healthy controls were participated. In analysis the HIV adolescents 
had higher risk of stunting [OR 5.33; 2.83–10.04) and thinness (OR 4.7: 2.44–9.06) 
with 95% CI, higher waist-to-hip ratios (medians 0.89 vs. 0.82 for boys and 0.90 vs. 
0.77 for girls, P= 0.001), and lower prevalence of overweight or obesity (OR 0.33, 
95% CI: 0.14–0.78). The study results revealed that the HIV-infected children on 
ART showed low in nutritional status and body composition abnormalities than the 
control group.
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     Liu E et al (2011) analyzed the nutritional status and mortality among HIV 
infected participants aged > 15 years on ART in Tanzania. The total of 18,271 HIV 
infected adults and their changes in the first 3 months of ART were included. In 
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analysis lower BMI, MUAC, and Hgb concentrations at ART initiation were strongly 
associated with a higher risk of death within 3 months. Among patients who survived 
3 months after ART initiation, those with a decrease in weight, MUAC, or 
Hemoglobin concentrations by 3 months had a higher risk of death during the first 
year. After 1 year, only a decrease in MUAC by 3 months after ART initiation was 
related with a higher risk of death. The weight loss was associated with increased risk 
of death across all levels of baseline BMI, with the highest risk observed among 
patients with BMI 17 kg/m
2
 (relative risk 7.9; 95% CI, 4.4–14.4).The study finding 
suggest the role of nutritional counseling and interventions as adjunct therapies to 
ART are aids to reduce the mortality of HIV infected adolescents.
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  Mohd Nasir MT et al (2011) conducted a cross-sectional study to determine 
the nutritional status of CLHIV in Malaysia. The total of 95 children aged one to 
eighteen years old on ART were participated. In analysis, the anthropometric 
assessment found that 32% of the children were under weight, 20.8% were stunted 
and 14.6% severely stunted. The biochemical indicators showed that 10.4% had 
deficiency in vitamin A while 12.5% had deficiency in selenium. The total cholesterol 
and HDL-C levels were found to be low in 30.5% and 10.5% of the children 
respectively. The study finding reveals that the dietary assessment showed almost all 
the participants did not achieve the recommended energy intake for their age groups 
and almost half of the children did not achieve the RDA for selenium and vitamin 
A.
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 Souza et al (2011) assessed the nutritional status of the HIV/AIDS infected 
children and adolescents receiving HAART at São Paulo city.  The 118 subjects aged 
6-19 years are attending an outpatient clinic were included in the study. The following 
anthropometric measurements of weight, height, waist circumference and triceps and 
sub scapular skin fold thickness were assessed. In analysis only one (0.9%) adolescent 
was diagnosed with abdominal obesity based on waist circumference measurement; 
three (2.5%) adolescents were obese based on sub scapular skin fold thickness. 
According to the body mass index, the population studied was mainly eutrophic. The 
findings depicted that the prevalence of fat redistribution, a nutritional status of the 
HIV/AIDS participants under HAART, was very low.
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T et al (2010) evaluated the impact of ART on endurance and 
immune response in HIV-infected children and the response to nutritional support. A 
total of 180 children were assessed, 100 (56%) of whom were on ART. The baseline 
body mass index was lower in the initial ART group (p<0.05).  During ART, a 
CD4 Z-score increase of 1 SD was associated with a 0.35 increase in body weight Z-
score (p<0.001). The increase in daily energy intake owing to nutritional 
supplementation was associated with increase in weight Z-score in both the no-
HAART and HAART group. The study concludes that increased survival rates of 
children  was correlated with an  raised CD4
+ 
T-cell count synchronized with the 
extensive  use of ART and nutrition supplementation improved the health  status in 
both the no-HAART and HAART groups.
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  Steenkamp L et al (2009) conducted a cross sectional study on nutritional, 
immune, micronutrient and health status of HIV infected children (3-12 yrs) in 
Mangaung.  Among 35 participants, 41% were underweight, 81%were stunted and 
3% was wasted. The most commonly observed clinical features were lymph 
adenopathy (84%), skin rashes (51%), hepato megaly (32%) and pallor in nails and 
conjunctiva (41%).  Regarding OIs,  8% of children had features of TB and 19% had a 
lower respiratory tract infection. The median viral load of the group was 1, 17, 000 
copies/ml and the CD4+ cell count was 477 cells/mm
3
.  It shows that, significant 
negative correlation between viral load and nutritional indicators. The children also 
had deficient serum levels relative to normal reference values for glutathione (91%), 
albumin (78%), vitamin A (63%), vitamin D (44%), zinc (38%) and vitamin E (13%). 
The 60% of the children were anemic and 30% were iron deficient. The study 
highlights needs to investigate early initiation of ART and nutrition interventions 
including supplementation in order to improve the prognosis of this children.
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  Stephenson CB et al (2006) assessed the level of vitamin D in HIV infected 
adolescents and young adults. The total of 359 participants aged 14–23 yrs were 
randomly selected and divided to 238 HIV positive and 121 HIV-negative subjects 
from Reaching for Excellence in Adolescent Care and Health study (REACH). The 
results showed that, the intake of vitamin D from food did not differ significantly by 
sex, but intake was 30% greater for HIV-positive subjects than HIV negative subjects. 
The prevalence of vitamin D supplement use was 29% and did not differ significantly 
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by HIV status (P = 0.87). The prevalence of vitamin D insufficiency [plasma 25 (OH) 
D + 37.5 nmol/L] in the study participants was 87% HIV infection did not influence 
vitamin D status. The study findings concludes that the prevalence of vitamin D 
insufficiency in both HIV-positive and HIV-negative subjects were high; perhaps 
largely urban youth have limited sun exposure.
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Kruzich LA et al (2004) evaluated the impact of nutritional supplementation 
on immune response and bioelectrical impedance in HIV-positive adolescents. The 
participants of 264 HIV-infected and 127 HIV-uninfected adolescents and young 
adults were selected from REACH study. The results revealed that half (49.0%) of the 
HIV-infected participants had CD4
+
 T cells ≥ 500 cells/μl and decreased intake of 
iron (P< .05) vitamins C and E (P<10) compared with HIV-uninfected youths. He 
concluded that HIV infected youths should focus on intake of foods rich in 
micronutrients will aids to improve growth, slow disease progression, and increase 
survival.
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Section : 3.1.4    Literature    Related   to   Quality   of   Life    of    HIV    
Infected Adolescents and  Strategies to Enhance the QOL   
 Anmol G et al (2016) analyzed the pattern of physical activity among school 
going adolescents (10-18 years) in district Ambala, Haryana. The results found that, 
sedentary activity was higher in children aged >12 yr, while intensity of Moderate-to- 
Vigorous Physical Activity (MVPA) was higher in boys than girls. The physical 
activity significantly decreased (P<0.001) with increase in age. There was also a 
significant decrease in MVPA with increase in age, metabolic equivalents (MET- 
P<0.001) with interaction effects of age group (P<0.001) and gender (P<0.001). The 
study suggests that the level of MVPA was low in school going adolescents.
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            Galanoa E et al (2016) conducted a qualitative study, on experiences of 
adolescent’s sero positive for HIV/AIDS in the age of 13-20 yrs in Brazil. The total of 
20 subjects was followed and collected data includes personal histories, experiences 
and difficulties they must face while living with HIV/AIDS. The themes derived were 
being ‘‘normal’’ and ‘‘different’’ when face the central issues. The normal life 
situation is guaranteed by being responsible with one’s health, the condition that the 
diagnosis be kept secret and concerns about HIV transmission and dissemination to a  
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sexual partner. The adolescents have plans and projects that, HIV is considered a 
stressor, positive perspectives for the future prevailed. At the end, he concludes that, 
‘‘living as an adolescent with HIV’’ involves delicate dimensions, such as silence and 
secrets, search for normality, virus transmission dilemmas and also the drug treatment 
management. Recognizing these aspects can be helped to guide the multidisciplinary 
team, especially to control of the disease, viral replication and ways to improve the 
QOL.
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Nicholas SL et al (2016) conducted a study to compare the learning and 
memory in youth with perinatally acquired HIV (PHIV). The total of 173 perinatally 
HIV exposed ( PHIV, n=173)  and uninfected (PHEU, n = 85) participants aged 9–19 
years  were completed age-standardized tests of verbal, visual learning and delayed 
memory. In analysis compared with PHEU there was a significantly lower visual 
recognition memory and verbal delayed recall for PHIV infected participants. For 
PHIV youth, current CD4% < 25 was related with poorer verbal learning, and older 
age at peak viral load was associated with poorer verbal delayed recall and design 
memory. The study finding suggests that current CD4% with poorer verbal learning 
had restrained possessions of HIV on learning and memory in youth with PHIV.
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Akpa  OM et al (2015) explored the relationship of QOL with Psycho Social 
Functioning (PSF) and other factors among adolescents in families affected with 
HIV/AIDS (FAHA) and in families not affected by HIV/AIDS (FNAHA). The total 
of 960 adolescents was assessed by using WHO QOL - BREF questionnaire. In 
analysis the 27% of adolescents in FAHA had poor QOL (OR: 2.32; 95%CI: 1.67–
4.09) and it was significantly higher than in FNAHA (p = 0.0001). The adolescents in 
FAHA have poor QOL than those in FNAHA and also face additional burden of 
psychosocial dysfunctions. The intervention focusing on economic empowerment and 
functional social support endorse adolescents in FAHA in the studied location.
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Buczynski AK et al (2015) evaluated the QOL in HIV-infected children & 
children with cancer and compared the results of children without systemic chronic 
disease. The total of 82 HIV-infected children, 31 children with cancer and 112 
children without systemic disease aged between 11 and 14 years were enrolled. The 
tool includes the, auto questionnaire Qualité de Vie Enfant Imagé (AUQEI) and the 
short version of Child Perception Questionnaire (short-CPQ11-14) was completed and 
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all children were examined for oral in presence of any oral health problems. In 
analysis the HIV-infected children and children with cancer (AUQEI= 49.93 vs 50.45; 
short-CPQ11-14= 6.29 vs 6.81) had a lower quality of life and oral-health-related 
quality of life ((p=0.011 vs 0.043) when compared to children without systemic 
disease (AUQEI=52.18; short-CPQ11-14=3.82). The QOL and the oral HRQOL of 
children are negatively affected by the HIV-infection and cancer and oral health 
problems.
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  Tanaka LF et al (2015) assessed the prevalence of physical inactivity among 
adolescents with HIV/AIDS, as well as associated factors in Brazil. The total of 
ninety-one adolescents (from 10 to 19 years old) was interviewed through the 
structured questionnaire and anthropometric data (weight, height, and waist 
circumference) were measured twice. In analysis, the prevalence was 15.4% in 
inadequate height for age (95% CI=8.0, 22.8), 9.9% in malnutrition (95% CI=3.8; 
16.0), and 12.1% in overweight/ obesity (95% CI=5.4, 18.8). The most common 
physical activities were soccer, volleyball and cycling (44.4%, 14.4% and 7.8%) 
respectively. The median times spent with physical activity and walking/bicycling to 
school were 141 min and 39 min. The 31.9% adolescents said that they did not 
practice any type of physical activity. The high prevalence of physical inactivity was 
observed among the adolescents: 71.4% (95% CI=62.1; 80.7), with a higher 
proportion of girls (girls 80.0% versus 61.0%boys; p=0.046).The study finding 
suggests that promoting physical activity among adolescents principally among girls 
with HIV/AIDS and as well as monitoring should be part of the follow-up aids to 
reduce the onset of chronic diseases.
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Bharathi et al (2014) conducted a descriptive co-relational study to find the 
relationship between QOL and social support of CLHIV (10-18yrs). The total  of  50 
participants were selected by purposive sampling method, and Horizon’s 
questionnaire was used to assess the variables. The results found that 60% of 
participants had poor QOL and 86% of the subjects were had low social support.  The 
Pearson’s correlation proved that statistically significant weak positive relationship 
(r= .293; p =.039) between QOL and social support of CLHIV. The study finding 
suggests that interventions to improve quality of life and social support could have a 
positive influence on CLHIV.
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Kumar SGP et al (2014) evaluated level of depression and its significant risk 
factors among orphaned adolescents at Hyderabad in India.  The total of four hundred 
HIV infected adolescents aged 12-16 yrs were enrolled and equally from AIDS and 
non-AIDS groups. In analysis, children orphaned by AIDS were significantly reported 
that stigma related to friends or relatives and experiencing discrimination (50.3% 
&12.6%) was higher than those orphaned due to other reasons. The overall prevalence 
of depression score was 74.1% with 95% CI and it depicted that significantly higher 
for children orphaned by AIDS (p < 0.001).  The findings could be used for planning 
the mental health interventions to meet the mental health needs of orphaned 
adolescents.
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 Qiao S et al (2014) conducted a longitudinal study to examine perceived 
social support (PSS) in loneliness and self-esteem among children affected by 
HIV/AIDS in China.  The children aged 6–18 years were assessed annually for  
3 times. In analysis, the loneliness scores significantly lowered over time. The 
children with higher PSS reported significantly lower baseline loneliness score and 
experienced a slower rate of decline in loneliness over time. The children with higher 
PSS were more likely to report higher self-esteem scores at baseline. However, the 
self-esteem scores remained stable over time controlling for baseline PSS and all the 
other variables. The study findings reported that the positive effect of PSS on 
psychological modification may imply a promising approach for future intervention 
among children affected by HIV/AIDS, in order to promote psychosocial well being 
on children and families with lower social supports.
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Wu X et al (2014) analyzed the relationship between the perceived stigma, 
social support, and QOL in PLHIV. The total of 190 participants aged more than  
15 years were enrolled in the study. The structured questionnaire of HIV-related 
Stigma Scale, Medical Outcomes Study - Social Support Survey (MOS-SSS-C), and 
the Medical Outcomes Study-HIV (MOS-HIV) were used. In analysis, the mean 
scores of the perceived stigma (104.32), social support (53.63), and QOL (61.97) 
were in moderate range. The multivariate regression analysis showed a low score of 
family stigma (R
2
 = .49, p < .01) a high score ARV management and high CD4 count 
predicted better QOL. The study finding represents that the perceived stigma and 
social support are correlated with the QOL in PLHIV. The interventions designed to 
decrease perceived stigma and strengthen social support from family are necessary to 
improve the QOL in PLHIV.
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81 
 
Gowda S et al (2013) conducted a cross sectional study on relationship 
between the CD4 counts in QOL of HIV/AIDS infected adolescents. The total of   255 
HIV/AIDS infected adolescents aged 18 and more were recruited from ART centres 
in Mysore. The WHOQOL-BREF questionnaire was used to assess the QOL. In 
analysis out of 255 adolescents, 149 had their CD4 below 350 with a mean QOL score 
50.6 and 106 adolescents had their CD4 count above 350 with mean QOL score 55.2. 
The positive correlation was seen with ‘r’ value of 0.31.  The participants with higher 
CD4 count had better QOL than those with lower CD4 count. The‘t’ test showed 
statistically significant association (P>0.05).
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. 
Rajeev K H et al (2012) assessed the QOL of PLHA and correlated with 
socio-demographic and clinical variables in Chitradurga city. The total of 395 samples 
were selected, of them 231 (58.5%) participants were on ART and 164 (41.5%) were 
not on ART between the age of 15-72 yrs. The WHOQOL 120 questionnaire was 
used. The study findings depicted that the scores for all domains were intermediate for 
the PLHAs in both group mean scores were highest for psychological domain. There 
was a significant difference in QOL of PLHA who was on ART and not on ART in 
physical, psychological and spiritual domain. The PLHAs who were literates, married, 
employed, income >1500/month, not on ART, CD4 count >200 cells/mm
3
; earlier 
stages of HIV, living with spouse had high mean scores.
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Imam MH et al (2011) conducted a cross sectional study to determine the 
level and factors associated with HRQOL among the people living with HIV. The 
total of 82 HIV infected people aged 18 and above was evaluated with "WHOQOL-
HIV BREF instrument". In analysis, a most of the respondents were had low Quality 
of Life (QOL) in all the domains. The respondents with low QOL was highest in the 
domain of social relationship (64.6%) followed by psychological domain (59.8%), 
physical domain (58.5%), level of independence domain (56.1%), environmental 
domain (52.4%) and spirituality domain (52.4%) of HRQOL.  The bivariate analysis 
revealed that the overall perception of QOL was better in the respondents living in 
urban areas, which were employed and asymptomatic of the centre for disease control 
(CDC) stage of HIV with a current CD4 count >200 cell/mm
3
. This results finding 
highlighted that need for better environment and enhanced socio-psychosocial support 
for improving the HRQOL among PLHIV.
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Zhao G et al (2011) examined the importance of functions and sources of 
Perceived Social Support (PSS) among children affected with HIV/AIDS in China. 
The total participants of 1299 children aged between 6 to 18 years were enrolled. In 
analysis, the PSS score (r = 0.527) is highly associated with children's psychosocial 
wellbeing and as well as psychosocial outcomes. This strong association predicts 
adequate social support needed to ease stressful life events and improve psychosocial 
wellbeing of children affected by HIV/AIDS. The findings of the study suggested the 
roles of specific social support functions or resources may need to be evaluated in 
relation to specific psychosocial outcomes.
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 Kumakech E et al (2009) evaluated the effects of peer-group support 
intervention improves the psychosocial well being of AIDS orphans in Uganda. The 
total of 326 AIDS orphans aged 10-15 years were assigned to either peer-group 
support intervention includes somatic healthcare (n=159) or control group (n=167) for 
follow-up assessment. The baseline and 10 week follow-up psychological assessments 
were conducted in both groups using self-administered Beck Youth Inventories. In 
analysis, the baseline scores and follow-up scores for the intervention group in 
comparison with controls showed significant improvement in depression, anxiety and 
anger but not for self-concept. This study depicted that peer-group support 
intervention decreased psychological distress, particularly symptoms of depression, 
anxiety and anger. Thus, the use of peer-group support interventions should be 
integrated into existing school health programs.
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  Lee SJ et al (2007) done a randomized trial to assess the effect of social 
support on mental and behavioral outcomes among adolescents/ parents were infected 
with HIV/AIDS. The total of 307 parents who were HIV infected ( 25-70 years) and 
their 413 adolescents (11-18 years) were assigned to a coping skills intervention or a 
standard care group and assessed for 2 years. In analysis, the adolescents’ social 
support dimensions (5.17 vs 5.27) frequency of contact (4.31 vs 3.89), satisfaction 
(0.94 vs 1.01), negative role model influence (0.76 vs 0.70) and positive support (2.42 
vs 2.45) were comparable between the standard care group and the intervention group. 
The adolescents who had more social support providers reported significantly lower 
levels of depression (p=.035) and fewer conduct problems (p=.046); adolescents who 
had more negative influence from role models reported more behavior problems 
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(p=.085).The study finding suggests that the future prevention programs must focus 
on rising social support to reduce negative outcomes among adolescents affected by 
HIV/AIDS.
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Wig N et al (2006) evaluated the impact of HIV/ AIDS on QOL on 
HIV/AIDS patients in North India. The total of sixty-eight   HIV/AIDS participants 
aged 18 and more were participated and evaluated by WHOQOL-BREF questionnaire 
by the HIV nurse coordinator. In analysis, the overall QOL mean score found to be 
25.8. Similarly, the mean scores in the four domains were 80.9 in social; 27.5 in 
psychological; physical and environmental domain was 17.7 &11.65 respectively. The 
significance of better QOL scores in the physical (p<0.040) and environmental 
domain (p<0.017) were depended on the occupation of the patients. The study finding 
reveals that QOL has significance with occupation, income, education, family support 
and clinical categories of the participants.
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3.1.5 - Literature Related To Yoga in HIV /AIDS and Interventional Benefits of 
Yoga in Adolescents  
Garg S and Chandla SS (2016) assessed the effect of Nadi shodhan 
pranayama on pulmonary functions among healthy volunteers at Rohtak, India. The 
thirty participants of both male and female in the age group of 17-21 yrs were 
practiced nadi - Shodhan pranayama twenty five minutes daily for three months. The 
Pulmonary Function Test (PFT) parameters include Vital Capacity (VC), Peak 
Expiratory Flow Rate (PEFR) and Maximum Voluntary Ventilation (MVV) is 
measured before and after pranayama practice. After 12 weeks, the results revealed 
that, there was a significant increase (p value < 0.05) in all the parameters at 6 weeks 
and as well as after 12 weeks. The study findings interpreted that nadi shodhan 
pranayama plays a significant role to increase in respiratory muscle strength and 
improving the various ventilator functions of lungs thus it helps to improve QOL.
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 Sethi JK et al (2016) done a experimental study on yoga improves attention 
and self esteem (SE) among underprivileged adolescent girls in Mysore, India. The 
total of sixty high school girls (14 to 17 yrs) were enrolled and participated in the 
Integrated Yoga Module (IJM) for 5 days includes nadi shodhan pranayama and 
asanas. The Rosenberg self esteem (RSE) scale was used to measure the self esteem 
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and d2 test was used to measure attention and concentration. The data was collected 
before and after the 5 days of IYM. The results showed that attention (10.12% P < 
0.001) and SE (9.04% P+0.001) were significantly increased in the post score when 
compared to the pre score. This study suggests that, of IYM can result in 
improvement of attention and self esteem among adolescent girls and thereby 
improving their academic achievement and enhancing their mental health.
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Felver J C et al (2015) conducted a comparative study on the acute effects of 
single yoga class versus a single standard physical education (PE) class on adolescent 
mood and affect. The forty seven high school students (14 -17 yrs) were enrolled and 
completed Brunel University Mood Scale (BRUMS) and Positive and Negative Affect 
scale for children (PANAS-C) before and after one week of session. The results 
showed that the participants reported significantly greater decrease in anger (Z = 2.48, 
P=0.013), depression (Z=2.20, P=0.028) and fatigue (T=2.20, p=0.034) from before 
and after participating in yoga compared to the physical education. The study findings 
revealed that school based yoga may provide unique benefits when compare to the 
physical education for students. The recommendation should elucidate the distinct of 
physiological and psychological effects of yoga when compare to the physical 
education activities in future research.
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  Joseph B et al (2015) evaluated the outcome of yoga interventions and 
naturopathy on CD4 count of the PLHIV (6 - 75 yrs) at Pune. The total of 96 subjects 
were grouped in to four groups ‘viz, G1, G2, G3 and G4 according to the number of 
days the treatment as received and the total duration were 180 days. The results found 
that, G2 and G4 had statistically significant improvement in CD4 counts (P = 0.052, 
and P = 0.00038) respectively. The non significance shown in the group of G1 and G3 
may be due to the baseline difference in age, stage of disease etc.  The study findings 
concludes that, naturopathy and yoga interventions when taken for 30 days or more 
can enhance CD4 counts in PLHIV.
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     Mawar N et al (2015) done a randomized control trial on Sudarshan kriya 
yoga (SKY) improves QOL of PLHIV (> 18 yrs). The total of 61 participants were 
divided equally in to, 31 in SKY intervention group (I-SKY) and 30 in standard of 
care (O-SOC) as control groups. The  I-SKY participants were taught for 6 days to 
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prepare for daily practice of 30 minutes at home.  The results were measured at 
baseline to three visits at 4 week intervals.  The outcomes are, an total of 6% 
improvement of QOL scores was observed in experimental group as compared to 
control group and  also there is a significant  improvement in  physical 
(12%,P=0.004), psychological (11%, p=0.023) and level of dependence (9%, 
p=0.001) domains. He concludes that, the low cost approach of yoga enhanced 
physical and mental status of   PLHIV. 
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   Unniraman P et al (2015) evaluated the effect of yoga on menstrual 
problems in adolescent girls in a Government vocational higher secondary school in 
kerala state. The total of 300 participants were randomly selected and equally divided 
into experimental group had yoga class  of three times a week for three months and in 
control group  no yoga section. The data was collected on 22 menstrual related 
problems from both the groups, for the period of before starting yoga and after three 
months of yoga classes using same questionnaire. After  3 months  the study results 
showed that the yoga reducing the following menstrual related  problems  in 
adolescent children namely absenting from school, bleeding, abdominal pain, leg/back 
pain, muscle cramps, nausea, anxiety , anger , fatigue , diarrhea, lack of appetite, loss 
of interest during menstruation and in maintaining proper menstrual interval. This 
study finding suggests that yoga can also be made a part of the school curriculum to 
help the students in achieving physical and mental health improvement.
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 Cramer H et al (2014) appraised a bibliometric analysis of RCT in yoga for 
the period of 1975-2014. The total of 366 papers, two hundred sixty-four randomized 
controlled trails (84.6%) were conducted with healthy volunteers remained in various 
disease conditions. Among this 335 RCTs were conducted i.e., 90.1% with youth & 
older adults and 9.9 % with children. In that 47.3% RCTs did not name the style of 
yoga used, 9.6% RCTs used Hatha yoga postures with meditations, 8.2% RCTs  used 
yoga breathing and breath control and  The remaining 34.9%  RCTs  used 46 various 
yoga styles, with a median intervention length of 9 weeks (range1 day to 1 year; IQR 
= 5 and 12).Apart from this, 21% varied control interventions were used in the 
remaining RCTs. The results shows that, yoga-based RCTs will enhance and marked 
improvement in the health aspects of individuals.
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  Gupta V et al (2014) evaluated the immediate effect of Nadi-shodhana 
pranayama on cardio respiratory and mental efficiency among healthy volunteers. The 
total of 30 participants aged 17-20 years from SMS Medical College, Jaipur were 
enrolled. The outcome measures were peak expiratory flow rate, systolic and diastolic 
blood pressure, heart rate and simple problem solving ability to explain mental 
efficiency were measured before and after 20 minutes practice of nadi- shodhana 
pranayama. The results shows  that pre and post test, there was statistically imperative 
difference (p<0.05) in heart Rate (79.47 + 1.08  vs 73.73 + 2.39), systolic blood 
pressure(78.27 + 3.473  vs 72.8 + 3.916), diastolic blood pressure (118.1 + 3.748 vs  
110.1 + 6.279), peak expiratory flow rate (3.673 + .3331 vs 3.973 + .3173) and  
reaction time (70.13 + 15.55 vs  62.63 +13.89). The study finding suggests that nadi- 
shodhana pranayama practice for 20 minutes can be advocated to improve cardio 
respiratory efficiency and also higher functions of brain of healthy individual.
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 Trivedi I (2014) assessed the impact of Manomay Kosh sadhana yoga on 
adolescent’s mental health. The thirty adolescents (13-19 years) were selected from 
quota sampling in swami satyamitrananda school from Uttarakhand. The one group of 
pre and post design was adopted and Mental Health Battery questionnaire by AK 
Singh and Alpana was used in the study. The yoga practice time was 30 minutes in 
the morning and the duration of the practice was 90 days. The posttest results revealed 
that significant effect at 0.01 levels on mental health of the adolescents. The study 
concludes that, the practice of yoga would be a significant improvement of positive 
feeling, positive attitude and self confidence which improves mental health of 
adolescents.
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 Menon A J et al (2013) evaluated the yoga based peer support group for 
human immune deficiency virus (HIV) for positive Zambian adolescents. The 
adolescents’ aged 11 to16 years (n=34) were randomized to peer group with yoga, 
peer support only group/social support group.  The outcomes were measured in pre 
intervention, post intervention and at 10 weeks follow-up. The peer only group had 
fewer emotional symptoms after the intervention (p<0.05), while combination of yoga 
and peer support group had a beneficial effect on CD4 count (p<0.05). The study 
results revealed that the peer / social support along with yoga interventions were 
associated with short term benefits for the psychological and physical well being in 
HIV positive adolescents suggesting the need for sustained support.
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   Babu N et al (2013) measured the outcomes of cyclic meditation (CM), yogic 
relaxation technique, when compared to supine rest (SR) among adolescents (10-16 
yrs) at Bangalore. The 60 high school adolescents of both genders were included and 
examined for reduction of anxiety, using Spielberger's State-Trait Anxiety Inventory 
(STAI). They were divided into SR and CM groups and tested on the STAI, 
immediately before and after 22 to 30 min of practice of CM on 1 day, and 
immediately before and after an equal period of SR on the other day. The results 
showed that, there was a significant decline on STAI scores within group of CM 
(4.27%, P = 0.016) session and no changes in SR session. Further subgroup analysis 
based on genders revealed that the female group had a significant decrease following 
both sessions, but male group had no significant decline in STAI score. The study 
finding reveals that the CM found to be a useful method to combat the state of anxiety 
in gender wise with different age groups.
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 Shaju S and Umarani J (2013) conducted a quasi experimental study to 
assess the effectiveness of pranayama on stress among adolescents (15-17 yrs) at 
Mangalore. The total of 70 participants were divided equally into experimental and 
control group. The SQ stress scale was used to evaluate the pre and post test stress 
level in both groups. In analysis there was a statistically significant variation in the 
post test stress score in study group. As the calculated ‘t’ value (t=17.016) was higher 
than the table value (t 68=1.668) at 0.05 level of significance, there was a significant 
decline in the level of stress in the experimental group after the practice of 
pranayama. But there was no significant reduction in the level of stress in the control 
group of pre and post rest.
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 Somarriba G et al (2013) analyzed the physical fitness among CLHIV an 
associations with HAART. Te total of 45 HIV-infected children and 36 uninfected 
children aged 10-16 years were participated in the study. In analysis, HIV-infected 
children had lower peak oxygen consumption (VO2 peak 25.92 vs. 30.90ml/kg/min, p 
< 0.0001), flexibility (23.71 vs. 46.09%, p = 0.0003) and lower-extremity strength-to-
weight ratio (0.79 vs. 1.10 kg lifted/kg of body weight, p = 0.002).In multivariable 
analysis among the HIV-infected children,  showed VO2 peak was 0.30ml/kg/min 
lower per unit increase in percent body fat (p < 0.0001) and VO2 peak  decreased 
29.45 (– 1.62), 28.70 (– 1.87), and 24.09 (– 0.75) ml/kg/min across HAART exposure 
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categories of no exposure, < 60, and >60 months, respectively ( p < 0.0001). The 
study findings reported that HIV-infected children had low measures of physical 
fitness compared to uninfected children.
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   Sushant S and Khyati SS (2013) overviewed the asana and Pranayama 
practice  among healthy volunteers in the age of 18-25 yrs in Gujarat. It has been 
reported that, the increase in respiratory muscle strength, improve the lung functions, 
enhance the neuro-muscular system and increase nerve conduction velocity. The 
respiratory benefits includes the prolongation of breath holding time, increase in 
PEFR (Peak Expiratory Flow Rate), FVC (Forced Vital Capacity), FEV1 (Forced 
Vital capacity in 1 second), MVV (Maximum Voluntary Ventilation) and lowered 
respiratory rate. The abdominal breathing uses the diaphragm primarily and is 
congruent with the shape of the lungs and the capacities of the breathing muscles. It 
executes respiration with the least effort and is associated with mental stability and 
calmness. The chronic lung diseases like Asthma, Bronchitis, Emphysema, COPD, 
etc. may get colossal benefits from these changes in pulmonary functions.
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   Anand U and Sharma MP (2011) examined the Mindfulness Based Stress 
Reduction (MBSR) program in reducing stress and enhancing well-being in 
adolescents in an Indian school setting. The thirty three adolescents aged 14-15 yrs 
were included in the eight week sessions approximately of 40 minutes intervention 
program. The School Situation Survey and the Personal Well-being Index for School 
Children were used at Pre, post and 3 month follow-up assessments.  In analysis, the 
results evidenced that MBSR program is significantly plummeting physiological and 
emotional manifestations of stress, anger, sadness, frustration, anxiety, fear, stress due 
to peer interactions, academic stress and enhancing academic self-concept and well-
being. The study suggests that regular practice of MBSR is essential to enhance the 
QOL of adolescents.
177
   
  Gopal A et al (2011) evaluated the outcome of integrated yoga practices on 
immune responses in examination stress among first year MBBS students. Through 
randomization the total of 60 participants were assigned to yoga and control group. 
The yoga group underwent integrated yoga practices for 35 minutes for 12 weeks 
whereas in control group did not undergo any kind of yoga practice on stress 
management. The physiological parameters like heart rate, respiratory rate and blood 
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pressure were measured. The Spielbergers state anxiety and Global Assessment of 
Recent stress score were assessed at baseline and during the examination. The results 
showed that a significant improvement was observed in experimental group whereas 
in control group no significant changes were noted. Similarly, the psychological stress 
showed highly significant difference in yoga group (P<0.001) compared with 
significant difference in control group (P< 0.05).The study concludes that yoga resists 
the autonomic changes and impairment of cellular immunity seen in examination 
stress. 
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 Mueller J et al (2011) evaluated the efficacy of the Make A Difference 
(MAD), a community ART program for children affected by HIV/ AIDS in South 
Africa. The total of 297 children aged 8–18 years (177 in study and 120 in control 
group) were participated in the study. The program runs for ART and education 
activities to build self-concept, self-esteem, and self-efficacy for 6 months. In 
analysis, the intervention program showed significantly higher self-efficacy (B=3.71 
vs 3.61, p<0.05), but it was not associated with differences in self-esteem, depression 
or emotional ⁄ behavioral problems. The double parental death remained a powerful 
effect on child psychosocial health for lower self efficacy. However, an interaction 
was found between bereavement status and self-efficacy, indicating that the 
intervention program may ameliorate some of the psychosocial vulnerabilities 
associated with becoming an orphan. The study finding suggests that this kind of 
interventions may offer opportunities to enhance the self efficacy of vulnerable 
children to protect their psychological health.
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 Cade PT et al (2010) conducted a study on yoga life style intervention 
reduces blood pressure in HIV infected adults with cardiovascular risk factors. The 
sixty HIV infected men and women (18-70 yrs) were randomly assigned to 20 wks of 
yoga practice or standard of care treatment. The results found that, the yoga group 
resting systolic and diastolic blood pressures were reduced more (-5 +/- 2 and -3 +/- 1 
mmHg) than in control group (+1 +/- 2 and+2 +/- 2 mmHg). There is no greater 
reduction in body weight, fat mass, lipid level and quality of life after yoga. The  
study  concluded that  low cost, non pharmacological , behavior intervention of yoga 
can lower blood pressure in pre hypertensive HIV infected adults with mild –
moderate Cardio vascular disease risk factors.
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Mendelson. T et al (2010) reported the preliminary and feasibility outcomes 
of a school-based mindfulness intervention to reduce the stress for urban youth in 
Baltimore city. The 97 participants were equally randomized to both groups. In 
Intervention group, received the 12 - week intervention and for each session lasted for 
45 minutes and youth were taught yoga-based physical activity, breathing techniques, 
and guided mindfulness practices whereas the control group received conservative 
management. The Stress and Short Mood & Feelings Questionnaire was used to 
assess the outcomes. The results showed that the intervention group had significant 
improvements on the overall responses to stress scale of involuntary engagement than 
the control group. In addition, significant differences were found on three of the five 
subscales– intrusive thoughts, rumination, and emotional arousal and also the 
intervention group had reduction in involuntary stress reactions. He concluds that 
mindfulness-based practices were effective in helping youth to self-regulate their 
emotions and reduce worrying thoughts.
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     Ross A and Thomas S (2010) done a comparative research literature on 
health benefits of yoga and exercise in both healthy and diseased populations. The 
results showed that, among 81 studies yoga may be as effective as or better than 
exercise in improving a variety of health related outcome measures in healthy and as 
well as diseased populations. The study concludes that future clinical trials are 
required to observe the difference between yoga and exercise and explore the physical 
and mental benefits of yoga.
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 Yarasheski E K (2010) studied the safety and efficacy of yoga life style 
intervention on fasting lipid profile / lipoprotein levels, oral glucose tolerance, body 
composition, cardiovascular function, QOL, viral load and CD4 T cell counts in HIV 
infected men and women with components of the metabolic syndrome. The sixty 
participants   aged 18-70 years were selected by randomization for a 16 week of yoga 
intervention program. The results showed that yoga life style intervention (breathing 
exercises, yoga postures / positions or Hatha / Ashtanga yoga) improved the 
metabolic, anthropometric, cardiovascular disease parameters and quality of life 
domains without adversely affecting immune or virologic status in people living with 
HIV.
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 Heather B (2009) found that the Mindfulness Based Stress Reduction 
(MBSR) program helped the people with HIV to maintain immunity. The total of 48 
HIV positive adults (43men and 5 women) with T cell in between the counts of 600 -
700 cells/mm
3
 were involved in study. One group participated in an eight week 
MBSR program that offered weekly instruction on mindfulness practices including 
the meditation techniques and the yoga postures. They were also given audio CDs 
with instructions for practicing the meditation and yoga routine everyday on their 
own. The other group received a one day MBSR seminar in which subjects were 
given cursory instruction in meditation techniques but not encouraged to practice on 
their own. After the eight weeks, the results showed that the MBSR group T cell 
counts remained high while the other groups T cells plummeted.
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PART - II 
3.2 CONCEPTUAL FRAMEWORK 
 Theoretical and conceptual frameworks play several interrelated roles in 
science and their overall rationale is to make research findings meaningful and 
generalizable. A conceptual framework or a model is made up of concepts which are 
mental images of the phenomenon. These concepts are linked together to express the 
relationship between them. The important purpose of conceptual framework is to 
communicate clearly the interrelationship of various concepts. They also help to 
stimulate research and the extension of knowledge by providing both direction and 
impetus and thus may serve as a springboard for scientific advances in nursing 
practice.
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3.2.1  Conceptual frame work based on King’s Goal Attainment Theory 184-185 
 The   Goal Attainment theory was developed by Imogene king in the early 
1960s. She described about the theory as, “dynamic, interpersonal relationship in 
which a patient grows and develop to attain certain life specific goals”. In 1971, 
King’s published a conceptual framework for nursing and structured as personal, 
interpersonal and social systems. The concepts were expanded to include of 
information, communication, interpersonal relationships, energy, social organizations, 
role and status.  
 Later, King (1981) initiated a theory of goal attainment, as middle -range 
theory derived from the conceptual system. The conceptual model contains three 
types of dynamic, interacting systems: personal systems (represented by individuals); 
interpersonal systems (characterized by such dyadic interactions as nurse – patient 
dialogue); and social systems (stand for by larger institutions, such as hospitals and 
families). The social system provides a context in which nurses work. The central 
concepts in this theory are perception, communication, interaction, transaction, self, 
role, growth and development, stressors/stress, time and space. The concepts of 
perception, interaction, and transactions are the core of a transaction process model. 
Transactions are significant antecedents to goal attainment.  
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 The Theory of Goal Attainment (1981) defines nursing as "a process of action, 
reaction and interaction by which nurse and client share information about their 
perception in a nursing situation" and "a process of human interactions between nurse 
and client whereby each perceives the other and the situation, and through 
communication, they set goals, explore means, and agree on means to achieve goals." 
For this definition, action is a sequence of behaviors involving mental and physical 
action, and reaction is included in the sequence of behaviors described in action. This 
process results in a dynamic ongoing interpersonal process in which the nurse 
client/patient are viewed as a system with each affecting the behavior of the other and 
both being affected by factors within the situation/environment. This model deals with 
interactions between nurse and patient which results in meeting the patient’s goals. At 
the end of this process of communication and perceiving, if a goal has been set, final 
transactions have occurred.  
 King states that the goal of a nurse is to help individuals to maintain their 
health so they can function in their roles. The domain of the nurse "includes 
promoting, maintaining, and restoring health, and caring for the sick, injured and 
dying." The function of a professional nurse is "to interpret information in the nursing 
process to plan, implement, and evaluate nursing care." The purpose of this study 
reflected in transaction whether the human beings achieved the goal through the 
mutual goal setting. 
Most of the people pursue a career in nursing because they want to be 
instrumental in helping patients get healthy. In order to do that, it is necessary to set 
health goals with the patient, and then take steps to achieve those goals. In hospital 
settings, as nurses, we have proved that when the nurse and client communicate and 
work together toward mutually selected goals, the goals are more likely to be attained. 
So, the investigator decided to implement King’s goal attainment theory is suitable to 
interpret the present study. 
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3.2.2: Application of the King’s Goal Attainment Theory to the Present Research 
Study 
The King’s Goal Attainment Theory originated from the elements or 
concepts in her interacting systems framework. But it focuses on the interpersonal 
system includes the interactions, communications and transactions between the nurse 
and the patient. The essence of her theory is that the nurse and the patient come 
together, communicate and make transactions to set goals and work to achieve the 
goals. They each have a purpose, they perceive, judge, act and react upon each other. 
At the end of their communication, a goal will be set and with this transactions are 
made.  The King believed that the goal of nursing is “to help individuals to maintain 
their health so they can function in their roles” (King, 1981). The transactions occur 
to set goals related to the health of the patients, and end in enhanced growth and 
development for the client. 
King’s used the following major concepts from the personal and interpersonal 
systems to support the theory of Goal Attainment. The concepts are, 
PERCEPTION- a process of organizing, interpreting, and transforming information 
from sense data and memory that gives meaning to one's experience, represents one's 
image of reality, and influences one's behavior. 
In this study, the researcher felt the need of HIV interventional package 
(Adherence counseling, Nutritional counseling, Strategies to improve the QOL 
includes the selected asana, maintenance of diary) for HIV infected adolescents 
attending ART Clinic. 
The caregivers of HIV infected adolescents perceived the need of HIP to 
increase adherence rate, nutritional status and improve quality of life of HIV infected 
adolescents. 
JUDGMENT- a dynamic and systematic process by which a goal directed choice of 
perceived alternatives is made and acted upon, by individuals or groups to answer a 
question and attain a goal. 
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In this study, the researcher sets mutual goal setting that HIV interventional 
package (HIP) improves ART Adherence rate, CD4 count, nutritional status and 
enhance the quality of life of HIV infected adolescents. 
The caregivers of HIV infected adolescents, judges that HIP improves 
immunity level, height and weight and increase quality of life HIV infected 
adolescents. 
ACTION - It’s a sequence of behavior involving mental and physical action. 
In this study, the researcher divided equally the HIV infected adolescents in to  
the control and experimental group by simple random technique and plan to 
implement HIV Interventional package for experimental group alone but for both 
groups informed consent obtained. 
REACTION - refers to the sequence of behavior described in action. 
In this study, the researcher prepared the structured questionnaires to assess 
the demographic details, and assess the baseline values (‘0’ month) of the adherence 
rates nutritional status & quality of life of HIV infected adolescents from 
caregivers/adolescents for both control and experimental group. 
INTERACTION- It’s a fact of two or more persons in mutual presence; a sequence 
of verbal and nonverbal behaviors that are goal directed.   
In the Experimental group, adolescents received a HIV interventional 
package along with standard care from ART centres. It includes adherence 
counseling, nutritional counseling and educational strategies to improve the QOL. 
After counseling session the investigator demonstrated asana to the adolescents and 
instructed to practice it every day on their own and to document the practice and drug 
intake in the diary daily and plan to evaluate the assessment at the 3
rd
  and 6
th
  month 
intervals. Whereas in the Control Group, the adolescent’s received only a standard 
care from the ART centres as a conventional management and evaluate the 
assessment at same intervals. At the end of the 6
th
 month, the cursory instructions 
were given to adolescents regarding HIV interventional package.   
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TRANSACTION - a process of interaction in which human beings communicate 
with the environment to attain goals that are valued; goal-directed human behaviors. 
In this model, humans are in constant interaction with their environment but 
adjustment to life and health are influenced by individual’s interaction with 
environment. Every human being perceives the goal as in making transactions with 
the individuals and environment. 
In this study, the adolescents in the experimental group attained in their goal 
and had significant changes in the HIP components. Whereas in the control group, the 
adolescents were not attained the goal and not had significant changes in the HIP 
components. 
FEED BACK - the outcomes of the transaction, decided to further decide to plan for 
perception. 
In this present study, the experimental group of adolescents attained the 
significant gain in the goal and there is no need for the feedback, whereas in the 
control group not attained the significant gain in goal leads to again plan for 
perception. But it’s not included in this study.        
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CHAPTER - IV 
MATERIALS AND METHODS 
Verbal and non verbal activity is a unified whole, and theory and methodology  
should be organized or created to treat it as such. 
                                                     Kenneth L. Pike 
  Research methodology is the conceptual structure which gives guidelines to 
conduct research. It constitutes the blueprint for the data collection, measurement and 
analysis of data. It is the overall plan for obtaining answers for objectives of the 
research study. The methodology of research indicates the general pattern for 
organizing the procedure to gather valid data for the problem under investigation. 
This chapter deals with the methodology that includes steps, procedures and strategies 
for gathering and analyzing the data in the research investigation. The present study 
was evaluating the effectiveness of nurse initiated HIV interventional package (HIP) 
on HIV infected adolescents attending the ART clinic in Chennai, Tamilnadu. 
 This research incorporates some of the most important methodological 
decisions that includes research approach, research design, variables under study, 
research setting, population, sample, sample size, sampling technique, criteria for 
sample selection, method of developing the questionnaire, description of developing 
tool, validity of tool, ethical considerations, pilot study, reliability of the tool, method 
of data collection and plan for data analysis procedure. 
4.1 RESEARCH APPROACH  
  In view of nature of the problem and to accomplish the objective of the 
study, Quantitative Evaluative Research approach was adopted for this study. The 
Evaluative research investigates how well a program, practice or policy is working. In 
this study, the investigator evaluates the effectiveness of nurse initiated HIV 
Interventional Package (HIP) on HIV infected adolescents. This study is intended to 
explore the effectiveness of the HIV interventional package hence the evaluative 
research approach was more appropriate to this study. 
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4.2 RESEARCH DESIGN   
The research design is the researcher’s overall plan for obtaining answers to 
all research questions for testing the hypothesis. It spells out the basic strategies that 
the research adopts to develop information that is accurate and interpretable.
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 The 
organization of a scientific investigation used for the present study was Experimental 
design - Randomized Controlled Trial as shown in table 11. The basic distinctions 
in the design are Manipulation, Control and Randomization. The effectiveness can be 
proved only if there is a comparison; hence the investigator intended to explore the 
effectiveness of the HIP among HIV infected adolescents between the study and 
control group for giving an equal opportunity to the adolescents through the simple 
random sampling allocation.  
         Table 11: The Research Design Adopted for this study is depicted below 
 
 
 
 
 
R 
Group 
Pretest 
(Baseline at ‘O’                                    
month) 
Intervention
1st post test 
at 3
rd
 month 
2
nd
 post test at 
6th   month 
E O1 X O2 O3 
C O1 -- O2 O3 
 
Key: 
   R- Randomization , E- Experimental group, C- Control group, X- HIV 
interventional package,  O1, O2, O3  - Observation points of data collection.    
4.3 VARIABLES UNDER STUDY         
4.3.1 Independent Variable   
  It is a variable that is believed to cause a change in dependent variable.
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 In 
this research study the independent variable is a HIV interventional package which 
comprises of adherence counseling, nutritional counseling, educational strategies to 
improve their QOL, practice of selected asana and maintenance of dairy every day.  
4.3.2 Dependent Variable 
  It is a variable that is hypothesized to depend or manipulate by another 
variable.
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 In this research study HIV infected adolescent is a dependent variable, 
because it can be manipulated by HIV interventional package (HIP). 
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4.3.3 Extraneous Variable 
  It is a variable factor that is not the part of the study, but it may affect the 
measurement of the study variables.
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 In this present study, the opportunistic 
infections and other Complementary Alternative Management (CAM) will influence 
the study variables. In this research study no study subjects were influenced by 
extraneous variables. 
4.4 RESEARCH SETTINGS 
 The setting is the physical location and condition in where the data collection 
takes place.
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 The study was conducted in the four ART centres in Chennai, 
Tamilnadu, India. The south India region encompass of Tamilnadu. The Chennai city 
is a capital of Tamilnadu and located in southeast coast of India and in the northeast 
corner of Tamil Nadu. The National AIDS Control Organization (NACO) directs 
Tamilnadu State AIDS Control Society (TANSAC) for rendering the services for 
PLHIV.  In 2015, the total number of ART centres in Chennai is six, among this the 
researcher was selected the maximum adolescents registered in four main ART 
centres. They are, 
   1. Institute of Child Health and Hospital For Children (ICH)Egmore, 
Chennai-8. It’s a one of the Pediatric Centre’s of Excellence (PCOE) in ART, India. 
It was started in the year of 2007 and now having the total population CLHIV is 497 
and the number of children alive on ART is 317. 
   2. Rajiv Gandhi Government General Hospital (RGGGH) Chennai-3. 
This ART centre was started in the year of 2004, and now having the total population 
of CLHIV 259 and the number of children alive on ART is 116.   
   3. Kilpauk Medical College and Hospital, (KMCH) Chennai - 10. This 
ART centre was started in the year of 2005 and now having the total population of 
CLHIV 187 and the number of children alive on ART is 102.  
   4. Government Hospital Of Thoracic Medicine (GHTM) Chennai - 47   
It’s a one and only ART Centre of Excellence (COE) in Tamilnadu, Chennai. In this 
centre the registered PLHIV were not only in Chennai, moreover it covers all the 
districts of Tamilnadu. This ART centre was started in the year of 2004 and having 
the total population of CLHIV 883 and the number of children alive on ART is 831. 
Sample - Adolescents living with HIV / AIDS
Sample Techinique - Simple Random Techinique 
Sample Size - 400, Informed Consent Obtained  
Structured Questionnaire - Modified Adolescent Adherence 
Questionnaire (ACTG), Nutritional Assessment
Questionnaire and Modified QOL - Questionnaire (ACTG)
 
Control Group - 200 Experimental Group - 200 
Routine care + assessment 
th
at 6  month
HIV Interventional Package 
th
+ assessment at 6  month   
Descriptive and Inferential Statistics / 
Interpretation of Results 
Routine care + assessment 
rd
at 3  month
HIV Interventional Package 
rd
+ assessment at 3  month   
Routine care + assessment 
at ‘0’ month
HIV Interventional Package 
+ assessment at ‘0’ month   
Research Approach - Quantitative Research 
Discussion / Recommendations
Dissemination of findings 
Schematic Representation of Research Design 
Design - Randomized Controlled Trial 
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4.5 POPULATION 
 The term population refers to the aggregate or totality of all subjects or 
members that conform to set specification.
98
 In this study, a heterogeneous group of 
HIV/AIDS infected individuals attending ART centres in Chennai, Tamilnadu has 
been considered as population. 
4.5.1 Target Population 
 It is the aggregate of subjects about the investigation would like to generalize 
the findings. In this present study, the target population consists of all Adolescents 
Living with HIV (ALHIV) and attending ART centres in Chennai, Tamilnadu 
4.5.2 Accessible Population   
 It is the aggregate of subjects that confirm to designate criteria that are 
accessible as subjects of the study. In this present study, the accessible populations are 
ALHIV in selected main four ART centres in Chennai. 
4.6 SAMPLE  
 A sample is a subject of the units that compare the population.
98
 In this study, 
the both genders of HIV / AIDS infected adolescents who fit in to the criteria for 
sample selection were selected.  
4.6.1. Criteria for Sample Selection 
4.6.1 (a) Inclusion criteria  
The subjects who are all, 
1. in the age group of 10 to 18 years. 
2. on ART for more than 3 months attending the ART clinic. 
3. know Tamil and English and also including the caregivers. 
4. willing to participate in the interventional package. 
4.6.1(b) Exclusion Criteria  
The subjects who are all, 
1. not on ART attending ART clinic. 
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2. in IV clinical stage of HIV/AIDS and hospitalized HIV infected 
adolescents 
3. in transgender group. 
4. got married and teenage pregnancy.  
5. physical and mentally  challenged. 
4.7 SAMPLESIZE  
  The sample size was calculated by using power analysis method. 
Sample Size Estimation   
Anticipated common SD          =  
Level of Significance     = 100 (1-) %  
Power of the Test      = 100 (1-) % 
Medically Meaningful Difference    = d 
 
n    = 2 2  (Z + Z)
2
  
  d
2
 
    =   7.6 
    =   2.58 
    =   1.28 
d    = 3 
 n    = 2  X  7.6
2
  (2.58 + 1.28)
 2 
      3
2 
                         = 191 per group    
 With 10% dropout rates final required sample size is 191+19 =210 per group 
(minimum). For statistical significance, the investigator fixed sample size as 200 per 
group. i.e., 200 for experimental and 200 for control group, so the total sample size 
were 400. 
 
4.8 SAMPLING TECHNIQUE  
 It’s a process of selecting the sample from the population to represent the 
entire population. The sampling technique employed in this study was simple random 
method.  
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4.9 DEVELOPMENT OF INSTRUMENTS 
The investigator adopted following steps was carried out in preparing the 
questionnaires. 
1. Literature review 
2. Experts opinion 
4.9.1  Literature review 
Literature from books, journals and newspaper articles were received and used 
to develop the assessment tools. The assessment of adherence and quality of life 
questionnaires were standardized tools.  
4.9.2 Experts opinion 
The investigator discussed with the experts and incorporated their valuable 
suggestions in the format of the assessment tool. 
4.10 DESCRIPTION OF DATACOLLECTION INSTRUMENTS 
The instruments has consists of IV parts. They are, 
PART I : It consists of three sections. They are, 
 Section A:  Its deals with Socio Demographic Data. The structured interview 
schedule was used to collect the data from HIV infected adolescents/care givers from 
experimental and control group. The socio demographic variables were age, gender, 
education, religion of adolescents and   caregiver’s age, sex, caregiver’s relational 
ship of adolescents, education, occupation, income and residence were considered as 
demographic variables 
 Section B: It consists of structured questionnaire for clinical information of 
adolescents includes diagnosis of HIV in years, probable route of transmission, HIV 
stage, On ART, History of ATT drugs, and level of CD4 count.  
 Section C: It comprises of structured questionnaire for back ground 
information of adolescents, social and financial support and knowledge about basic 
information about HIV/AIDS.  
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PART II: The modified Adolescent Adherence Questionnaire which was designed by 
AIDS Clinical Trial Group (ACTG) was used in this study. According to the expert’s 
view and based on our regional back ground some modifications was done in this 
study. It includes self appraisal, assessment of adherence in various methods (Five 
point response scale, visual analog method ‘3’ days recall method and Pill count 
method) reason for non adherence and aids used to improve the adherence. 
PART III: The nutritional assessment questionnaire consist of two sections, 
 Section A: It includes anthropometric assessments of Height, Weight, Body 
Mass Index, Mid Upper Arm Circumference, Waist Circumference, Skin Fold 
Thickness (Triceps) and ‘Z’ score. All the anthropometric measurements were taken 
according to standard procedures of National Institute of Health (NIH). 
 The stadiometer was used to determine the height of the subjects. 
 An ISO certified digital weighing machine was used to measure the weight of 
subjects.   
 The BMI is a ratio of weight relative to height and calculated by the standard 
formula of weight in kilograms divided by the square of height in meters.  
 The waist circumference, mid upper arm circumference was measured by 
measuring tape. 
 The skin fold thickness was measured with Harpenden caliper. 
 The ‘Z’ score was calculated by the formula of observed value subtracted by 
median of the reference population divided by SD of the reference population.    
 Section B: It covers the structured questionnaire of clinical assessments to rule 
out the nutritional deficiency disorders. 
PART IV - The modified QOL assessment questionnaire which was designed by the 
AIDS Clinical Trial Group (ACTG) was used in this study with some modifications 
suggested by experts. The questionnaire includes 2 categories viz., 5 to 11 years and 
12 to 20 years related to the following areas of General Health Ratings, Physical 
Functioning, Psychological Well Being, Social Role Functioning, Health Care 
Services and Symptom Distress Management. 
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4.10 (a) SCORING KEY  
The scoring key format was based on the type of questionnaires used in the 
HIP.  
Regarding basic information of HIV 
 In Part I, section III had 30th question of basic information about HIV/AIDS, 
consist of five multiple choice questions (30 a to e). For each question the exact 
correct answer has score of ‘1’ and wrong answer has score of ‘0’.The overall 
maximum score was ‘5’ and minimum score was ‘0’. It was interpreted as good, 
moderate and poor knowledge in the respective score of > 75, 50-75 and < 50. 
Regarding Assessment of Adherence level, 
 Item 1 to 10 was used to assess the subjective information regarding 
adherence questionnaire. For each question a positive score has ‘1’ and 
negative score has ‘0’ 
 Item 11, 12, 13 and 14 was used to assess the adherence to HIV 
medication. In that item 11 questionnaires have 5 Point rating scale.  The 
responses are  scored as follows, Never - 0, Rarely -1, Sometimes -2, 
Often-3, Always-4.The score ranges from 0-16.  
 Item 12 is the exact percentage mentioned as adherence from the Visual 
analogue instrument. 
 Item 13 used to assess the adherence by ’3’days recall method and exact 
percentage has given respectively. 
 Item 14 represents the adherence by Pill count method and exact 
percentage to be mentioned as adherence level.  For all these assessments, 
the optimal adherence was considered as > 95%, 80-95 % as sub optimal 
adherence and < 80 % as poor adherence.                    
Regarding Assessment of Nutritional Status      
 The anthropometric measurements of Height, Weight, and BMI were 
compared with National Centre of Health Statistics (NCHS, 1970s)  
 The reference value for Waist Circumference, Mid Arm Circumference 
(MAC) and Skin Fold Thickness for adolescents are still in  controversial 
view, the investigator  taken ‘0’  month  assessment as a baseline value 
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and further assessment of at 3
rd
 and 6
th
 month  was  considered as 
improvement value  in order  to assess the nutritional level of  HIV 
infected adolescents in both groups.  
 The ‘Z’ - scores were generated by using NCHS (1970) growth standards 
as indicator of nutritional status of adolescents. The Z score was 
interpretation mentioned as,  
                    Normal                                   -  2.0 < Z score,  
                  Moderately malnourished   -  3.0 < Z score <  - 2.0  
                  Severely malnourished    -   Z score < -3.0 
Regarding Quality of Life assessment 
The following table 12 shows the QOL domain score in both age group of  
5 -10 and 12-20 years. 
Table 12: Quality of Life Domain Score 
S.No. QOL Domain Minimum score Maximum score 
1. General Health Rating 11 61 
2. Physical Functioning 6 30 
3. Psychological Wellbeing 28 84 
4. Social Role Functioning 2 19 
5. Health Care Services 4 24 
6. Symptoms Distress 20 120 
 Total 71 338 
 
 As usual normal scoring was calculated in general health ratings and 
psychological wellbeing domain. Whereas remaining domains of physical 
functioning, Healthcare services, symptoms distress and social role 
functioning part - A are scored reversely in order to indicate the increased 
score in better QOL. 
  In psychological domain aspect item no 24 to 27 has different questions in 
these two categories and Social Role Functioning part B item no 3 has 
different options because of age difference but scores are same.  
 In social role functioning  part B item no 3 to 6 and health care services item 
no 5 are   calculated  for each  positive outcome the score as  ‘1’ and negative 
outcome  as ‘0’ 
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 The QOL maximum score was 338 and minimum score was 71. Each domain 
is scored separately, summed and then transformed to a scale ranging from 0 
to100 with higher scores indicating better QOL. The total scoring was 
interpreted as   
0 - 50%         Poor QOL,  
51 - 75 %      Moderate QOL and  
76 - 100 %    Good QOL. 
4.11 ETHICAL CONSIDERATIONS 
  The investigator considered and followed the ethical principles throughout the 
study investigation. The investigator adhered to the following actions in order to 
protect the ethical rights of the study participants. 
4.11.1 Human Rights 
1. Ethical committee approval was obtained from Madras Medical College 
and Hospital, Chennai. 
2. Permission also obtained from National AIDS Control Organization 
(NACO) and Tamilnadu State AIDS Control Society. (TANSAC) 
3.  The trial has been registered in Clinical Trial Registry of India (CTRI), 
New Delhi. The trial registration number is CTRI/2015/02/005521.    
           4. To execute the study, the research protocol with research instruments and a 
sample of informed consent, assent form, with all necessary administrative 
letters were submitted to all the four research centres and obtained all head 
of the department permission. 
4.11.2 Beneficence and Non- Maleficence 
5. Explained about the importance of adherence and nutritional counseling and 
strategies to enhance QOL of HIV infected adolescents/caregivers. 
6. Potential benefits and risks were explained to the HIV infected 
adolescents/caregivers. 
 The counseling and the behavior modification of yoga improve the 
immunity, decrease the viral load, reduce the opportunistic infections, 
increase appetite, promote the digestion and enhance the QOL. 
107 
 
 There may chance to get pain in the muscles due to strain in doing the 
asana in the initial stage (3 to 5 days) and it will be subsided 
automatically  by doing the regular practice of yoga.  
4.11.3 Dignity 
7. Informed consent was obtained from all subject caregivers related to study 
purpose, type of data, and willingness to participate in counseling, yoga & 
maintenance of diary  
8. Assent form obtained only if the subject know their disclosure status. 
9.  Anonymity of each individual and the privacy was maintained. 
10. The subjects have been informed about the freedom of withdrawal from 
the study at any time. 
11.  The investigator contact information was disseminated to all participants. 
4.11.4 Confidentiality 
12. Confidentiality pledge was maintained throughout the data collection 
process. 
4.11.5 Justice  
 13. The HIV interventional package cursory instructions were informed to all 
participants in the control group after 2
nd 
 post test and those shown their 
willingness to  learn yoga the investigator also thought  to the control 
group subjects. The adolescents with low adherence, poor nutritional status 
were motivated to come for routine checkup. 
4.12 CONTENT VALIDITY  
  Content Validity is the degree to which the items in the instrument adequately 
represent the content for the concept being measured.
98
 The tool was validated for its 
content by panel of 15 experts from various fields from Nursing, Medicine, Nutrition 
and Alternative Medicine Department.  In nursing, a total of 4 professors working in 
academic side have given their consent, whereas in medicine 3 ART medical officers 
and 3 eminent professors from department of medicine, head of academic and 
research  and  2 pediatric pulmonologist have given their valuable suggestions. Apart 
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from these, 1 person from department of clinical nutrition and 2 more medical officers 
from alternative medicine department have given their informative suggestions. The 
various suggestions from experts were incorporated and with minor modifications of 
the tool have been approved by the doctoral advisory committee members were 
finalized to execute in the main study. 
4.13 PILOT STUDY REPORT 
 It’s is preliminary trial to the actual study. The pilot study was conducted in 
Institute of Child Health and Hospital For Children, Egmore. By simple random 
technique the 10 % of samples i.e., 40 subjects were selected and divided equally into 
experimental and control group. The data were collected from both groups and it was 
interpreted in the improvement range of experimental vs. control group for the 
following components of adherence rate were 6.4 % vs. 2.2 % and for QOL 7.2 % vs. 
0.4%, it’s was significant at 95 % confidence interval. The other component of 
nutritional gain score was increased to 4.5% vs. 0.8%. This study reports revealed that 
the setting and tools used in the study was found to be feasible to conduct the main 
study. There was no modification done in the tool after the pilot study. 
4.14 RELIABILITY 
    Reliability is the degree of consistency with which an instrument measures 
the target attributes for what it is designed to measure.
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 After pilot study, the 
reliability of the tool was assessed by using Cron bach alpha method and inter rater 
method. In the present study,  correlation coefficient ‘r ’values for the following tools  
were, ART adherence  was 0.87, nutritional status was 0.90 and QOL was 0.88. It 
shows that the correlation of coefficient value is very high and the internal 
consistency of the tool was reliable to execute the main study.  
4.15 SAMPLE SELECTION PROCEDURE 
     The data collection was obtained from the four ART clinics in the period of 
Feb 2015 to May 2016 by two phases. In phase I, the ICH, RGGGH and KMCH ART 
clinics were included .The investigator collected the data in all working days from 8 
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am to 3 pm. The subjects who were come on even days are taken as experimental 
group and odd days were in control group. The first 2 weeks the data were collected 
in ICH, since more subjects were registered and it’s one of the PCOE in India and the 
other next two weeks for RGGGH & KMCH and followed for the first six months 
period of evaluation. In  phase II, the data was collected in all the four centres 
respectively for each week one ART centre and followed for the another six months 
period of evaluation. Approximately the total adolescents selected per day were 8-10 
and the average time taken for the each subject is 30-45 minutes. The samples 
selected from ART centres were shown in the table 13 and the drops out reasons were 
analyzed. The samples were selected for pilot study was excluded from the main 
study. 
Table 13:  The selected study sample size and dropout rates in research settings 
S. 
No. 
Places 
Total number of      
samples 
Dropout samples Final sample size 
Exp Control Total Exp Control Total Exp Control Total 
1. ICH&HC 75 78 153 3 2 5 72 76 148 
2. RGGGH 39 36  75 1 1 2 38 35   73 
3. KMCH 34 31  65 - 2 2 34 29   63 
4. GHTM 52 55 107 1 2 3 51 53 104 
 Total 200 200 400 5 7 12 195 193 388 
 
4.15 (a) Drop out Analysis 
The total dropout sample size was 12. The main reasons are, transfer to other 
ART centres, busy daily schedule and not practiced the yoga daily. Once the child 
reached the age of 16 years they were prefer to continue the treatment with biological 
parents who are all taking drugs in their nearest ART centres. The adolescents in the 
age group of 16-18 years were not able to continue the HIP instructions since this age 
group was busy in their school scheduled when compare to the other age groups. In 
gender wise the male adolescents were had more dropouts when compare to the 
females since they don’t have patience to do the asana and practice the diary every 
day.   
PROCEDURE ADOPTED FOR SAMPLE SELECTION 
ICH, KMC, MMC, GHTM
ART Centres 
Odd
days
Yes
Control 
group
No Experimental
group
Select the
adolescents
for routine care and
assess the existing  
routine Care 
No Is sample
enough 
Yes
Data Collection  
Yes
Select the 
adolescents from
due list based on 
inclusion criteria
Select the
adolescents
for routine care + given 
consent to follow 
HIV interventional 
package (HIP) and asses 
the effect of HIP  
Is sample
enough 
No
Used Simple
Random Method
of Lottery Method
to Select 8-10 
Adolescents / day
Used Simple
Random Method
of Lottery Method
to Select 8-10 
Adolescents / day
Compare & Conclude
Select the
adolescents from
due list based on 
inclusion criteria
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4.16 DATA COLLECTION PROCEDURE 
   After getting the informed consent and assent form the pertinent data was 
collected from the care givers / adolescents through in depth structured interview 
method and observation of hospital records. The adherence assessment and QOL 
assessment was collected with necessary questionnaire and the assessment of 
nutritional status were taken by anthropometric measurements. The initial assessment 
score was taken as pretest or baseline value at ‘0’ month. The HIV interventional 
package (HIP) was given on same day to experimental group includes the counseling 
sections of adherence improvement, increase nutritional status and strategies to 
enhance the QOL. The selected asanas of Padmasana, Vajrasana, Trikonsana, 
Ardhamatsyendrasana, Ushtrasana, Bhujangasana, Shavasana  & Pranayama were 
demonstrated by the researcher and instructed to do re demonstration by study 
subjects. They were also given brochures for practicing the selected asana every day 
for minimum 15-20 minutes on their own at home. The investigator had been given a 
diary for an interventional aid to improve adherence and instructed to maintain daily 
after the drug intake and yoga practice.  
The investigator had given special attention to few adolescents those who had 
learning difficulties in practicing the asana.  For these adolescents, the investigator 
had given extra time for 15 minutes for maximum to learn the asana on the same day 
itself i.e., total time taken for each sample was 45 minutes to1 hour. Every month 
when the subjects were come for the pharmacy refill, the investigator monitored the 
dairy and continuing the HIV interventional package interventions as reinforcement 
counseling and redemonstration of the asana. The HIV interventional package was 
given to the study group for up to 6 months, however in control group subjects were 
in routine care as conventional management. The effect of the HIV 
interventional package was assessed at 3
rd
 & 6
th
 month intervals by collecting 
required data from the care givers and adolescents in the study group. Simultaneously 
the data also collected from control group at the same intervals. The cursory 
instructions were given to the control group at the end 6
th
 month.  
4.17 DATA ANALYSIS PROCEDURE  
 The data analysis is the systematic organization and synthesis of research data 
by testing with null hypothesis. 
98
 Here the investigator used the Statistical Package 
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for the Social Sciences (SPSS) version16 for analyzing the present study data.  The 
collected data were analyzed by using of both descriptive and inferential statistics.  
4.17.1 Descriptive Statistics  
1. Number and percentage distribution was used to analyze the 
demographic, clinical and background information of HIV infected 
adolescents/caregivers in both groups. 
2. Mean and standard deviation was used to compute level of pre and post 
test score of HIP components of HIV infected adolescents in both groups. 
4.17.2. Inferential Statistics  
3. Chi square test was used to identify the similarities of demographic 
variables of HIV infected adolescents / caregivers in both groups. 
4. Repeated measure of  nutritional variables  were analyzed by ANOVA  
‘F’ test and bonferroni ‘t’ test was used to  find out the  significant 
difference between the baseline to 6
th
  month  and 3
rd
  vs. 6
th
 month of 
nutritional variables. 
5. Student Independent t-test was used to evaluate the effectiveness of HIV 
interventional package of HIV infected adolescents.  
6. Differences between pretest and post test score was given in mean 
difference with 95 % Confidence interval (CI) and percentage distribution 
with 95 % CI.    
7. Karl Pearson correlation coefficient was used to correlate the ART 
adherence with nutritional status and QOL of HIV infected adolescents in 
both groups. 
8. One way ANOVA / student independent t- test/ chi square test was used 
to associate the gain score of HIP components with demographic 
variables of HIV infected adolescents and their caregivers in both groups. 
9. Uni & Multivariate logistic regression method was used to identify the 
influencing factors gain score in experimental group of HIV infected 
adolescents and it was given in unadjusted and adjusted odds ratio with 
95 % CI. 
10.  Simple bar diagram, multiple bar diagram, subdivided bar diagram and 
box plot   was used to represent the study data. 
Chapter - V
Data Analysis and
Results
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CHAPTER – V 
         DATA ANALYSIS AND RESULTS 
  The goal is to turn data into information, and information into insight. 
-  Carly Fiorina 
This chapter deals with analysis and interpretation of collected data from 
adolescents/caregivers in order to identify the effectiveness of HIP includes adherence 
rate, nutritional status and QOL. Analysis is a method for rendering quantitative, 
meaningful and providing intelligible information, so that the research problem can be 
studied and tested including the relationship between the variables.  
Data analysis usually begins with descriptive statistics. The descriptive 
statistics are used to describe and synthesis data. Whereas, inferential statistics which 
are based on the laws of probability aids to draw meaningful conclusion or inferences 
about the population and to determine relationship between two variables in order to 
interprets the data.
98
 In this study, both descriptive and inferential statistics were used 
to analyze the data. Based on the objectives, the findings of the present study were 
organized and presented under the following sections were outlined below, 
Section-I: 5.1 
 This section deals with, demographic variables HIV infected 
adolescents/caregivers, clinical and background information related to HIV infected 
adolescents in both groups. 
5.1.1 Demographic variables of HIV infected adolescents/caregivers in both 
groups. 
5.1.2 Clinical information related to HIV infected adolescents in both groups. 
5.1.3 Back ground information of HIV infected adolescents in both groups.  
Section-II: 5.2 
  This section assess and evaluate the pre (baseline) and post test (3
rd
 & 6
th
 
month) level of ART adherence, nutritional status and QOL in both groups of HIV 
infected adolescents.  
 5.2.1 Assessment of information related to the ART adherence in both 
groups of HIV infected adolescents.   
113 
 
 5.2.2 Assess and evaluate the  pre and post test level of ART adherence in 
both groups of  HIV infected adolescents  by ‘5’ point response scale, 
visual  analog, ‘3’ days recall and pill count methods in both groups. 
 5.2.3 Assess and evaluate the pre and post test level of nutritional status in 
both groups of HIV infected adolescents by anthropometric variables. 
 5.2.4 Assessment of clinical histories and presence of clinical signs and 
symptoms related to nutrition in both groups of HIV infected 
adolescents. 
 5.2.5 Assess and evaluate pre and post test level of QOL in both groups of 
HIV infected adolescents. 
Section III : 5.3 
  This section compares and determines the effectiveness of HIV interventional 
package on HIV infected adolescents in experimental and control group. 
5.3.1 Compares the number and percentage distribution of overall level of 
CD4 count in both groups of HIV infected adolescents. 
5.3.2  Determine the effectiveness of HIP in mean and SD level of CD4 
count in both groups of HIV infected adolescents. 
5.3.3  Compares the number and percentage distribution of overall level of 
ART adherence in both groups of HIV infected adolescents used by 
various methods 
5.3.4  Determine the effectiveness of HIP in the level of mean ART 
adherence score in both groups of HIV infected adolescents. 
5.3.5  Compares the number and percentage distribution on Interpretation of 
‘Z’ score in both groups of HIV infected adolescents. 
5.3.6  Determine the effectiveness of HIP in the level of nutritional gain 
score in both groups of HIV infected adolescents. 
5.3.7  Compares the number and percentage distribution of level of mean 
QOL score in both groups of HIV infected adolescents. 
5.3.8.  Determine the effectiveness of HIP in mean QOL score in both groups 
of HIV infected adolescents   
5.3.9 Evaluate the overall effectiveness of HIP components in both groups of 
HIV infected adolescents. 
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Section IV: 5.4 
 This section correlates the HIP components of ART adherence with nutritional 
status and QOL in both groups of HIV infected adolescents. 
5.4.1  Assess the correlation between ART adherence with nutritional status in 
both groups of HIV infected adolescents 
5.4.2  Assess the correlation between ART adherence with QOL in both 
groups of HIV infected adolescents   
Section V: 5.5 
 This section associates the relationship between the HIP components of ART 
adherence; nutritional status and QOL score with demographic variables of HIV 
infected adolescents/caregivers in both groups. 
 5.5.1 Associates ART adherence gain score with demographic variables of 
HIV infected   adolescents/caregivers   in both groups. 
 5.5.2 Associates the nutritional status gain score with demographic variables 
of HIV infected adolescents/ caregivers   in both groups. 
           5.5.3 Associates QOL gain score with demographic variables of HIV 
infected adolescents/caregivers in both groups.  
Section VI: 5.6  
 This section identifies the influencing factors for HIP components by using 
Uni and Multi variate logistic regression in experimental group of HIV infected 
adolescents/care givers. 
  5.6.1 Identification of the influencing factors for ART adherence by using 
Uni and Multivariate analysis in experimental group of HIV infected 
adolescents/care givers. 
           5.6.2 Identification of   the influencing factors for nutritional status by using 
Uni and Multivariate analysis in experimental group of HIV infected 
adolescents/care givers. 
           5.6.3  Identification of the influencing factors for QOL by using Uni and 
Multivariate analysis in experimental group of HIV infected 
adolescents/care givers. 
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SECTION – I 
 
5.1: This section deals with, demographic variables of HIV infected    
Adolescents/Caregivers, Clinical and Background information related to 
HIV Infected Adolescents in both groups. 
5.1.1:Demographic Variables of HIV Infected Adolescents / Caregivers in 
Experimental and Control group. 
Table 5.1.1 (a): Number and Percentage distribution in the demographic 
variables of HIV infected adolescents in both groups. 
S. 
No. 
Demographic variables 
of  Adolescents 
Group 
Chi square 
test 
Experimental Control 
No. % No. % 
2. Age 10 -12 years 60 30.8% 68 35.2% 2=1.58 p=0.45 
   13 -15 years 91 46.7% 78 40.4% DF=2 
   16 -18 years 44 22.6% 47 24.4% NS 
3. Sex Male 97 49.7% 109 56.5% 2=1.76 p=0.18  
   Female 98 50.3% 84 43.5% DF=1 NS 
4. Education Primary 44 22.6% 43 22.3% 2=1.13 
   Middle 77 39.5% 85 44.0% p=0.76 
   Secondary 59 30.3% 50 25.9% DF=3 
   Higher 
secondary 
15 7.7% 15 7.8% 
NS 
5. Religion Hindu 165 84.6% 148 76.7% 2=4.44 p=0.10 
   Muslim 26 13.3% 36 18.6% DF=2 
   Christian 4 2.1% 9 4.7% NS 
   Not significant P >0.05 
 
 Table 5.1.1(a) shows the number and percentage distribution in the 
demographic variables of HIV infected adolescents in both groups. In experimental 
group, out of 195  samples, the majority of 91(47%) are in the age group of 13-15 yrs, 
60 participants (31%) are in the age group of 10-12 yrs and  44 samples (23%)  are in 
the age group of 16-18 yrs. In gender wise nearly 50% are equally distributed in both 
categories. Regarding educational status, the majority 77 and 59 (40% and 30%) 
samples are in the middle and in the secondary level of education, 23% are in primary 
level education, and only 8% are in higher secondary level education. Considering the 
religion aspect, the majority 165 (85%) are belong to Hindu, 13% Muslim and 2% 
Christian. 
Whereas in control group, out of 193 samples the majority of 78(40%) are in 
the age group of 13-15 yrs, 68 samples (35%) are in the age group of 10-12 yrs and 47 
Fig 5.1.1(a -i): Percentage wise distribution in Age of HIV infected adolescents in
both groups
Fig 5.1.1(a-ii): Percentage wise distribution in gender of HIV infected adolescents
in both groups
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Fig 5.1.1(a-iii): Percentage wise distribution in educational status of HIV infected
adolescents in both groups
Fig 5.1.1 (a-iv): Percentage wise distribution in religion of   HIV infected
adolescents in both groups
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samples (24%) are in the age group of 16-18 yrs. In gender wise, the majority of 109 
(57%) are in male and 44 % are females. Regarding educational status, the majority 
85 and 50 (44% and 26%) participants are in middle and secondary level of education, 
22% are in primary level education, and only 8% are in higher secondary level 
education. Considering the religion aspect, the majority 148 (76%) are belongs to 
Hindu, 19% are Muslim and 5 % are in Christian.  In all the demographic variables 
showed the ‘p’ value is less than the calculated 2 value and it’s not significant at the 
level of 5%. It revealed that both groups are similar.  
 
Table 5.1.1(b):Number and Percentage distribution in the demographic variables 
of caregivers of HIV infected adolescents in both groups 
 
S. 
No. 
Demographic variables of 
caregivers 
Group 
Chi square 
test 
Experimental Control 
No. % No. % 
7. Age of 
caregivers 
  
  
20 -35 years 
49 25.1% 49 25.4% 
2=3.24 
p=0.19 
 36 -50 years 136 69.8% 125 64.8% DF=2 
 > 50 years 10 5.1% 19 9.8% NS 
8. Sex 
  
Male 
59 30.3% 65 33.7% 
2=0.52 
p=0.47 
 Female 136 69.7% 128 66.3% DF=2 NS 
9. Relationship 
with  
Adolescents 
Father 24 12.3% 22 11.4% 2=1.25  
 Mother 52 26.7% 43 22.3% p=0.53  
 Caregivers 119 61.0% 128 66.3% DF=2,NS 
10 Education 
 
No formal 
education 
38 19.5% 53 27.5% 
2=4.35  
  Up to school 
level 
97 49.7% 94 48.7% 
p=0.11 
   Up to college  
level 
60 30.8% 46 23.8% 
DF=2NS 
11. Occupation  Employed 85 43.6% 94 48.7% 2=1.54  
   Not Employed 28 14.4% 21 10.9% p=0.46 
   Not applicable 82 42.1% 78 40.4% DF=2NS 
12. Annual 
income 
  
  
  
Up to Rs.12000 31 15.9% 25 13.0% 2=4.35 
  Rs.12000 -
24000 
70 35.9% 83 43.0% 
p=0.11 
  > Rs.24000 12 6.2% 7 3.6% DF=2 
 Not applicable 82 42.1% 78 40.4% NS 
13. Residence Rural 88 45.1% 90 46.6% 2=2.63 
   Urban 
107 54.9% 103 53.4`% 
p=0.10 
DF=2 NS 
Not significant P >0.05 
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The table 5.1.1 (b) shows number and percentage distribution in the 
demographic variables of caregivers of HIV infected adolescents in both groups. In 
experimental group, the majorities (70%) of the caregivers are in the age group of  
36-50 yrs, 25% are in 20-35 yrs and only 5% are more than 50 yrs. In gender wise, the 
majorities (70%) of the caregivers are females and 30% are males. Regarding 
relationship with adolescents, the majority of 61% are caregivers, 27% are mothers 
and only 12% are fathers.  
Considering about educational status, nearly half of participants (49%) were 
completed school level education, 31% were completed the college level and 20% 
were not gone to formal education. Regarding occupational status and annual income 
the majority of 42% lives in nongovernmental organization and annual income is not 
applicable in this category, apart from this 47% of caregivers are employed and 14% 
are not employed. In regard to annual income, the 36% are in Rs 12,000-24,000, 16 % 
are  Rs 12,000 and only 6%  are getting more than Rs 24,000/-. The nearly equal 
percent of participants i.e., 55% are residing in urban areas and 45% in rural areas. 
  In control group, the majorities (65%) of the caregivers are in the age group of 
36-50 yrs, 25 % are in 20-35 yrs and only 9% are more than 50 yrs. In gender wise, 
the majorities (66%) of the caregivers are females and only 34% are males. Regarding 
relationship with adolescents, the majority of 66% are in caregivers, 22% are mothers 
and only 11% are fathers. Considering about educational status, nearly half of the 
participants (49%) were completed school level education, 24% completed the college 
level and 28 % were not gone to formal education. Regarding occupational status and 
annual income the majority 40 % lives in nongovernmental organization and annual 
income is not applicable in this category, apart from this 49% of caregivers are 
employed and 11% are not employed. In regard to annual income, the 43 % are in   
Rs.12,000-24,000, 13%  Rs.12,000 and only 4 % were getting more than  Rs.24,000/-.  
The near equal percent of participants i.e., 53% are residing in urban and 47% in rural 
areas. 
   In all the demographic variables of the caregivers, the ‘p’ value is less than the 
calculated 2 value and it’s not significant at the level of 5%. It denotes that both 
groups are similar. 
Fig 5.1.1(b-i) : Percentage wise  distribution  in caregiver’s age of HIV infected
adolescents in both groups.
Fig 5.1.1(b-ii): Percentage wise distribution of caregiver’s gender in both groups
of HIV infected adolescents.
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Fig 5.1.1(b-iii): Percentage wise distribution in caregiver’s relationship of HIV
infected adolescents in both groups
Fig 5.1.1(b-iv): Percentage wise distribution in caregiver’s educational status of
HIV infected adolescents in both groups.
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Fig 5.1.1(b-vi): Percentage wise distribution in place of residence of HIV infected
adolescents in both groups.
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5.1.2: Clinical information related to HIV infected adolescents in both groups.     
Table 5.1.2 (a): Number and Percentage distribution in the clinical information 
of HIV infected adolescents in both groups 
 
S. 
No. 
Clinical Information of HIV 
Infected Adolescents 
Group 
Chi square 
test 
Experimental Control 
No. % No. % 
14. Diagnosed as 
HIV positive 
  
< 5 years 
32 16.4% 42 21.8% 
2
=4.13  
   p=0.13 
 DF=2 NS  5 -10 years 108 55.4% 112 58.0% 
 >10 years 55 28.2% 39 20.2% 
15. Route of 
Transmission 
  
  
Mother to child 
transmission 
190 97.4% 192 97.9% 
2=2.80  
p=0.24 
DF=2  
NS 
 Blood transfusion 4 2.1% 1 2.1% 
 Sexual 
transmission 
1 0.5% 0  0.0%  
16. Stage of  
Adolescents 
Stage I 138 70.8% 125 65.8% 2=1.80  
p=0.17 
DF=1  
NS 
 
Stage II     56 29.2% 68 35.2% 
17. On ART 3 months - 1 year 14 7.2% 11 5.7% 
2
=0.91 
p=0.63 
DF=2 NS 
   1 - 5 years 131 67.2% 138 71.5% 
   > 5 years 50 25.6% 44 22.8% 
18. History of TB Yes 108 55.4% 107 55.4% 2=0.01 
p=0.97 
DF=1 NS 
   
No 87 44.6% 86 44.6% 
18.a  If yes, History 
of ATT drugs Completed 108 100.0% 107 100.0% 
2=0.00 
p=1.00 
DF=1 NS 
19. Disclosed 
information 
Yes 
133 68.2% 124 64.2% 
2=0.67 
p=0.41  
DF=1 NS    No 62 31.8% 69 35.8% 
 Not significant P >0.05 
 
  The table 5.1.2 (a) shows the number and percentage distribution in the 
clinical information of HIV infected adolescents in experimental and control group. In 
experimental group, the majority (55%) of the adolescents is diagnosed 5-10 years 
before, 28 % are less than10 yrs and only 16% are less than 5 yrs. In route of 
transmission, the majority (97%) of adolescents had the infection through mother to 
child transmission, 2 % through blood transfusion and only 0.5% through sexual 
transmission. Regarding HIV stages of adolescents, the majority of 71% are in stage I 
and the remaining 29 % in stage II and none of them in stage III. Considering about 
consumption of ART, the majority of participants (67%) are taking in 1-5 years, 26 % 
are in more than 5 years and only 7%  are in 3months to 1 year. Regarding the history 
of tuberculosis, nearly half of the participants (55%) had history of tuberculosis and 
completed their treatment successfully. In regard to disclosure status, the majority 
(68%) of participants do not know their status. 
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In control group, the majority (58%) of the adolescents was diagnosed 5-10 
years before, 22 % were less than 5 years and 20% were diagnosed more than 10 
years. In route of transmission, the majority (98%) of adolescents had the infection 
through mother to child transmission and remaining 2 % had through blood 
transfusion. Regarding HIV stages of adolescents, the majority of 65% are in stage I 
and the remaining 35 % are in stage II and none of them are in stage III. Considering 
about consumption of ART, the majority of 138 participants (72%) are taking drugs in 
1-5 years, 23% are in more than 5 years and 6% are in taking for 3months to 1 year. 
Regarding the history of tuberculosis, nearly half of the participants (55%) had history 
of tuberculosis and completed their treatment successfully. In regard to disclosure 
status, the majority of 124 (65%) participants do not know their status. 
The chi square test in the all variables of the ‘p’ value is lower than the 
tabulated value and it’s not significant at the level of P >0.05. It shows that the 
distributions of the clinical histories of HIV infected adolescents in both groups are 
similar. 
Table5.1.2 (a -i) : Percentage  of age wise distribution in disclosure information 
of HIV infected adolescents in both groups 
 
S. 
No. 
 
19. 
Age 
Disclosure information 
Chi 
square 
test 
Experimental group Control group 
      Yes No Yes No 
No % No % No % No % 
1. 10-12  yrs 28 21.1%  32 51.6% 29 23.4% 39 56.5% 2=3.16  
  p=0.20 
NS 
2. 13-15 Yrs 71 53.4%  20 32.3% 53 42.7% 25 36.2% 
3. 16-18 Yrs 34 25.6%  10  16.1% 42 33.9%   5  7.3% 
Not significant P >0.05 
   
  Table5.1.2 (a -i) shows percentage of age wise distribution in disclosure 
information of HIV infected adolescents in both groups. In experimental group,  the 
total of  105 (71+34) adolescents in the age of 13-15 yrs and 16-18 yrs are known  for 
their status and 32 participants (52%) in the age group of 10-12 yrs not known their 
status. But in control group, the total of 95 adolescents in the age of 13-15 yrs and 16-
18 yrs are known their status and 39 participants (56 %) in the age group of 10-12 yrs 
not known their status. The chi square value of 3.16 is not significant in the level 
p>0.05. It depicts that the distribution of HIV infected adolescents in both groups are 
similar. 
Fig 5.1.2 (a-i): Percentage wise distribution of diagnosed as HIV positive in both
groups of HIV infected adolescents
Fig 5.1.2 (a-ii): Percentage wise distribution of route of transmission of HIV
infected adolescents in both groups.
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Fig 5.1.2(a-iii): Percentage wise distribution in stage of   HIV infected adolescents
in both groups
Fig 5.1.2 (a-iv): Percentage wise distribution on ART treatment in both groups of
HIV infected adolescents.
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5.1.2 (b): Level of CD4  count of HIV infected  adolescents in both groups 
Table 5.1.2 (b-i) : Number and percentage distribution in the level of CD4 count 
before initiating ART in HIV infected adolescents in both groups 
S. 
No 
20. 
Level of CD4 
Count before 
initiating ART 
Group 
Chi square 
Value 
 Experimental          Control 
No % No % 
1. < 300cells 133 68.2% 137 71.0% 2=0.36 
p=0.83,DF=2 
NS 
2. 301-600 cells 60 30.8% 54 28.0% 
3. 601-900 cells 2   1.0% 2   1.0% 
    Not significant P >0.05  
    
  The table 5.1.2 (b-i) shows the number and percentage distribution in the level 
of CD4 count before initiating ART in HIV infected adolescents in experimental and 
control groups. In both groups, the majority (68 & 71%) were in < 300 cells/mm
3
, 
31% and 28% were in the level of 301-600 cells/mm
3
, and only 1% in level of  
601-900 cell/mm
3
 in both groups. The chi square value is 0.36 at the ‘p’ level of 0.83 
shows that it’s not significant. 
 
Table 5.1.2 (b-ii): Mean difference level of CD4 count before initiating ART in 
HIV infected adolescents in both groups. 
S. 
No. 
 
 
 
 
Level of CD4 count Before 
Start of ART Mean 
difference 
Student 
Independent 
‘t’ test Experimental Control 
1.  Mean 272.15         267.79      
     4.37 
t=0.54 
p=0.58 
 NS 2.  SD        78.635         79.336 
    Not significant P >0.05 
 
  The table 5.1.2 (b-ii) shows the mean difference level of CD4 count before 
initiating ART in HIV infected adolescents in both groups. In experimental group, the 
mean value is 272.15 with SD of 78.635 and in control group the mean value is 
267.79 with SD of 79.336. The mean difference is 4.37.The student independent  ‘t’ 
test is 0.54 at ‘p’ value of 0.58. It shows that it’s not significant at P >0.05. 
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Table 5.1.2(b-iii): Number and Percentage distribution in the level of CD 4 count 
at baseline assessment in both groups of HIV infected adolescents 
S. 
No. 
21(a) 
Level of CD4 
Count 
Group Chi square value 
 Experimental          Control  
 
2=4.17 
p=0.24 
DF=3 
NS     
No. % No. % 
1. 300-600 cells 92 47.2% 95 49.2% 
2. 601-900 cells 77 39.5% 80 41.5% 
3. 901-1200 cells 19  9.7% 13   6.7% 
4. > 1200 cells 7   3.6% 5   2.6% 
     Not significant P >0.05 
 
 The table 5.1.2 (b-iii) shows the number and percentage distribution in the 
level of CD4 count at baseline assessment in both groups of HIV infected adolescents. 
In experimental group, 47 % participants are in 300-600 cells/mm
3
, 40%  in  601-900 
cells/mm
3
, 10%  in 901-1200 cells/mm
3
 and only 3.6%  in >1200 cells/mm
3
.  Whereas 
in control group, the nearly 50 % participants are in 300-600 cells/mm
3
, 42% in 601-
900 cells/mm
3
, 7 % in  901-1200cells/mm
3
 and only 3% are in  > 1200 cells/mm
3
. 
The chi square value of 4.17 is not the significant at P>0.05. It shows that there is no 
statistical variation in the level of CD4 count of HIV infected adolescents in both 
groups. 
 
Table 5.1.2 (b-iv):  Baseline mean difference level of CD4 count in both groups of 
HIV infected adolescents 
S. 
No. 
 
 
 
 
Level of CD4 count baseline 
level at ‘0’ month Mean 
difference 
Student 
Independent 
t-test 
Experimental   Control  
1. Mean 664.86 669.72 
4.86 
t=0.24, P=0.81 
NS 2.  SD 221.688 174.703 
   Not significant P >0.05 
   
The table 5.1.2 (b-iv) shows the baseline mean difference level of CD4 count 
in both groups of HIV infected adolescents. In experimental group, the mean value is 
664.86 with standard deviation of 221.688, whereas in control group the mean value 
is 669.72 with standard deviation of 174.703. The mean difference is 4.86. The 
Student Independent t- test is 0.24 and its is not significant at p > 0.05. It reveals that 
the distribution for baseline level of CD4 count of HIV infected adolescents in both 
groups are similar. 
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Table 5.1.2 (b-v) : Number  and Percentage distribution in  the level of CD4 
count after  HIP at 6
th
 month in both groups of HIV infected adolescents. 
S. 
No. 
21(b) 
Level of CD4 
Count 
Group 
Chi square 
value 
Experimental Control  
2=44.56 
p=0.001*** 
DF=3 
S 
No. % No. % 
1. 300-600 cells  18   9.2 %  58 30.1% 
2. 601-900 cells 119 61.0% 109 56.5% 
3. 901-1200 cells   46 23.6%   23 11.9% 
4. > 1200 cells   12  6.2%    3 1.5% 
   *** very high significant at P≤0.001 
 
The table 5.1.2 (b-v) shows the number and percentage distribution in the level 
of CD4 count after HIP at 6
th
 month in both groups of HIV infected adolescents. In 
experimental group, the majority (61%) participants are in 601-900 cells/mm
3
, 24% in 
901-1200 cells/mm
3
, 9% in 300- 600 cells/mm
3
 and 6 % in >1200 cells/mm
3
. 
Whereas in control group, the 57% of participants are in 601-900 cells/mm
3
, 30 % in 
300-600cells/mm
3
, 12% in 901-1200cells/mm
3
and 2%in >1200 cells/mm
3
. The chi 
square value of 44.56 shows the significant at P= 0.001***.  It reveals that there is a 
marked improvement in the level of CD4 count of HIV infected adolescents in 
experimental group than the control group. 
 
Table 5.1.2 (b-vi): Mean difference level of CD4 count at 6
th
 month in both 
groups of HIV infected adolescents 
S. 
No. 
 
 
Level of CD4 count baseline 
level at 6
th
 month 
Mean 
difference 
Student 
Independent test 
  Experimental         Control  
1.  Mean 840.30 703.35      
    136.96 
t=6.67 
 p=0.001*** 
S 
2.  SD 232.671 165.724 
   *** very high   significant at   P≤0.001 
 
  The table 5.1.2 (b-vi) shows the mean difference level of CD4 count at ‘6th’ 
month in both groups. In experimental   group, the mean value is 840.30 with standard 
deviation of 232.671, but in control group the mean value is 703.35 with Standard 
deviation of 165.724. The mean difference is 136.96. The Student Independent test 
score is 6.67 it’s significant at p=0.001***. It’s depicts that there is statistical 
improvement in the level of CD4 count of HIV infected adolescents in experimental 
group than the control group.   
Fig 5.1.2 (b): Percentage wise distribution in level of CD4 count of HIV infected adolescents in before ART, in baseline and after 6th
months in both groups of HIV infected adolescents.
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  5.1.3: Background information of HIV infected adolescents in both groups 
Table 5.1.3(a): Number and percentage distribution of family members living 
status in   both groups of HIV infected adolescents 
 
S. 
No. 
Family members 
Living status 
Group 
Chi square 
test 
Experimental Control 
  No.    % No.     % 
22.  a. Father Alive 78 40.0% 94 48.7% 2=3.84p=0.15 
DF=2  
NS 
   Dead 112 57.4% 97 50.3% 
   Unknown 5 2.6% 2 1.0% 
 b. Mother Alive 100 51.3% 122 63.2% 2=5.7 p=0.06 
DF=2 
NS 
   Dead 90 46.2% 68 35.2% 
   Unknown       5 2.6% 3 1.6% 
 c. Siblings Alive 66 69.5% 60 69.8% 2=1.86p=0.39 
DF=2 
NS 
   Dead 27 28.4% 26 30.2% 
   Unknown       2 2.1% 0 0.0% 
             Not significant P >0.05 
 
 Table 5.1.3 (a) shows number and percentage distribution of family members 
living status in both groups of HIV infected adolescents. In experimental group, 
regarding living status of fathers the most of them (57%) were died, 40% are only 
alive and remaining 3% are unknown for their status. Whereas, in control group, the 
half of percentage (50%) were died 48% are only alive and remaining 1% are 
unknown for their status. Regarding the living status of mothers in experimental 
group, nearly half of percentage (51%) are alive, 46% were died and remaining 3% of 
unknown for their status. But in control group, the majority of 63% are alive, 35% 
died and remaining 2% unknown of their status. Considering about the living status of 
siblings in experimental group, the majority (70%) are alive, 28% were died and 
remaining 2% did not know their living status. while in control group, the majority 
(70%) of are alive and remaining 30% died. The chi square value of the all the 
variables shows that the distribution are similar in both groups. 
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Table 5.1.3 (b): Number and percentage distribution of family members HIV 
status, residing information in both groups of HIV infected adolescents 
S. 
No. 
Family members  
HIV status 
Group 
Chi square test Experimental Control 
No. % No. % 
23. a. Father Positive 191 97.9% 190 98.4% 2=0.13 p=0.71  
   Negative 4 2.1% 3 1.6% DF=1 NS 
 b. Mother Positive 190 97.4% 190 98.4% 2=0.49 p=0.48  
   Negative 5 2.6% 3 1.6% DF=1 NS 
 c. Siblings Positive 71 80.0% 71 82.5% 2=2.06 p=0.15  
   Negative 25 20.0% 12 17.5% DF=1 NS 
24. Residing 
with  
biological 
parents 
Yes 76 39.0% 71 37.8% 
2
=2.06 p=0.15  
  
No 119 61.0% 122 62.2% 
 
DF=1 NS 
24.a If No, Family 
members 
32 26.9% 43 35.2% 
2=4.34 p=0.11  
   NGO 82 68.9% 78 63.9% DF=2  
   Adopted 5 4.2% 1 0.8% NS 
            Not significant P >0.05 
 
  Table 5.1.3 (b) shows the number and percentage distribution of family 
members HIV status, residing information in both groups of HIV infected 
adolescents. Regarding father and mother HIV status, the majority (98%) was positive 
and nearly 2-3% was negative in both groups. Considering with siblings HIV status, 
majority of 80% were positive and 20% & 18% were negative in both groups.  
Considering with the residing information of HIV infected adolescents in 
experimental group, the majority of 119 participants (61%) are not residing with 
biological parents and remaining 39% are only residing with parents. Among 119 
participants, the majority of 69% got accommodation through NGOs, 27% are along 
with family members and remaining 4 % living with adopted parents. While in control 
group, only 71(38%) are residing with biological parents, and remaining 122 (62%) 
participants are residing respectively in 35%, 63% and 0.8% in family members, 
NGO and adopted parent. The chi-square value of all the variables shows that, the 
distributions are similar in both groups. 
 
 
 
 
Fig 5.1.3 (a-i): Percentage wise distribution of family members living status in
both groups of HIV infected adolescents.
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Table 5.1.3 (c): Number and Percentage distribution of the Health Care Facilities 
and Financial and Social Support in both groups of HIV infected adolescents 
S. 
No. 
Back Ground 
Information 
Group 
Chi square 
test 
Experimental Control 
No. % No. % 
25. Healthcare facilities 
  
Yes 191 97.9% 186 96.4% 2=0.87 p=0.34 
 No 4 2.1% 7 3.6% DF=1 NS 
26. Financial support Yes 102 52.3% 107 55.4% 2=0.38 p=0.53 
   No 93 47.7% 86 44.6% DF=1 NS 
27. Satisfied social      Yes 103 52.8% 108 56.0% 2=0.38 p=0.53 
 Support No 92 47.2% 85 44.0% DF=1 NS 
a. If yes,  Relatives &      Yes 59 57.3% 65 60.2% 2=0.87 p=0.34 
 Neighbor No 44 42.7%  43 39.8% DF=1 NS 
b. Governmental  Yes   97 94.2% 85 88.0% 
2
=2.55 p=0.11 
 Support No 6 5.8% 23 12.0% DF=1 NS 
c. NGO support Yes 83 80.6% 76 70.4% 2=2.96 p=0.09 
   No 20 19.4% 32 29.6% DF=1 NS 
d. Discriminated by Yes 38 36.9% 47 43.5% 2=0.96 p=0.32 
   No 65 63.1% 61 56.5% DF=1 NS 
e Satisfied social 
support 
Yes 87 84.5% 84 77.8% 2=1.53 p=0.21 
   No 16 15.5% 24 22.2% DF=1 NS 
       Not significant P >0.05 
   
  Table 5.1.3 (c) shows number and percentage distribution of the health care 
facilities and financial and social support in both groups of HIV infected adolescents. 
In experimental group, the majority of 191 participants (98%) are utilizing health care 
facilities and remaining 2% not getting proper health care facilities. Considering with 
financial support, 52% are receiving financial sources from government and NGOs 
and the remaining 48% are not receiving any help. But in control group the majority 
of participants (96%) are utilizing and remaining 4% not received proper health care 
facilities. Considering with financial support, 55% are receiving financial sources 
from government and NGOs and the remaining 45% are not receiving any help from 
any other private and public sources. 
  Regarding social support, nearly half of percentage (53%) participants are 
receiving social support and the remaining 47% are not received in the experimental 
group.  Among 103 participants, 57% are receiving social support from relatives and 
neighbors, 94 % are from the way of government and 81 % are from NGOs.  In regard 
to discrimination, the majorities (63%) of participants were not discriminated and the 
Fig 5.1.3(b-ii): Number and Percentage wise distribution of residing
information in both groups of HIV infected adolescents.
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majorities (85%) are satisfied with social support.  Whereas in control group, the 56% 
participants are receiving social support and the remaining 44% have not received.  
Among 108 participants, 60% are receiving social support from relatives and 
neighbors, 88 % are from the way of government and 70% are through NGOs.  
Consider about discrimination, the 57% participants were not discriminated and 78% 
participants are satisfied with available social support. The chi square value of all the 
variables are not significant at P>0.05. It depicts that the distribution of these 
variables are similar in both groups.  
Table 5.1.3 (d): Number and percentage distribution of the information 
regarding  HIV / ART in both groups of HIV infected adolescents/caregivers 
S. 
No. 
Background information 
Group 
Chi square 
test 
Experimental Control 
 No. % No. % 
28. Information on  Newspaper 24 12.3% 28 14.5% 2=2.31 
 HIV/ART TV/cinema 20 10.3% 28 14.5% p=0.31DF=2 
   HCP 151 77.4% 137 71.0% NS 
29. Information and  Doctors 24 12.3% 32 16.6% 2=4.22 
 benefits on ART Nurse 49 25.1% 51 26.4% p=0.12DF=2 
   Counselors 122 62.6% 110 57.0% NS 
     Not significant P >0.05 
   
  Table 5.1.3 (d) shows number and percentage distribution of the information 
regarding HIV/ART in both groups of HIV infected adolescents / caregivers. 
Considering with basic information on HIV/ART are known through, 77 % from 
health care professionals, 12% from news paper and remaining 10% from public 
medias of TV/cinema in experimental group. But, in control group the majority (71%) 
are through health care professionals and equal percentage (15%) from newspaper and 
as well as TV/cinema. 
 In regard to the dissemination of information and benefits of ART, the 
majority (63% and 57%) are through counselors, 25% and 26 % by nurses and 
remaining 12 % and 16% from doctors respectively in both groups. The chi square 
value of these variables is not significant at p < 0.05.It shows that both variables are 
similar. 
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Table 5.1.3. (e): Number and percentage distribution in the level of Knowledge 
regarding basic information of HIV/AIDS in both groups of HIV infected 
adolescents/caregivers. 
 
S. 
No. 
Basic Information 
on HIV/ART 
Group 
Chi square 
test 
Experimental Control 
No. % No. % 
30. Basic 
Information on 
HIV/ART 
Yes 195 100.0% 193 100.0% 
2=0.00 p=1.00  
DF=1 NS 
a. Caused by HIV virus 195 100.0% 193 100.0% 
2=0.00 p=1.00 
DF=1 NS 
b. 
Transmitted 
through 
Sexual 
Intercourse 
195 100.0% 193 100.0% 
2=0.00 p=1.00 
DF=1 NS 
c. Prevention by Condom 195 100.0% 193 100.0% 
2=0.00 p=1.00 
DF=1 NS 
d. Diagnosed by  Yes 148 75.9% 144 74.6% 2=0.08 p=0.76 
DF=1 NS    No   47 24.1%   49 25.4% 
e. Controlled Yes 180 92.3% 175 90.7% 2=0.33 p=0.56 
DF=1 NS    No   15 7.7%   18 9.3% 
  Not significant P >0.05 
  
 Table 5.1.3 (e) shows number and percentage distribution in the level of   
knowledge regarding basic information of HIV/AIDS in both groups of HIV infected 
adolescents/caregivers. All the participants (100%) knew the basic information of 
HIV/AIDS in both groups. In split of view, the cause, transmission and prevention 
part, all the participants in both groups where answered correctly. Whereas regarding 
diagnosis, the majorities (75%) of the participants have answered correctly, but 
remaining 25% have confusion in both groups. Considering with management of ART 
in both groups, still 8-9 % believe that it can be cured. The chi square value is not 
significant at P >0.05.  It reveals that the distributions of knowledge of HIV infected 
adolescents in both groups are similar. 
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Table 5.1.3 (f) : Number and Percentage distribution in overall level of 
Knowledge regarding the basic information of HIV/AIDS among 
HIV Infected adolescents/caregivers in both groups 
 
S. 
No. 
Level of 
Knowledge 
Experimental group Control group Chi square 
test No. % No. % 
  1. Poor       - - - - 2=0.44 
p=0.50 DF=1 
NS 2. Moderate  40 20.5%  45 23.3% 
3. Good 155 79.5% 148 76.7% 
  Not significant P >0.05 
  Table 5.1.3 (f) shows number and percentage distribution in overall level of 
knowledge regarding the basic information of HIV/AIDS among HIV infected 
adolescents/ caregivers in both groups. In experimental group, the majority (80%) of 
participants had adequate knowledge and 20% in moderate knowledge and none of 
them in poor knowledge. Whereas in control group, the majority (77%) of participants 
had adequate knowledge and 23% in moderate knowledge and none of them in  poor 
knowledge. The chi square value of 0.44 it’s not significant at p<0.05. It reveals that 
the distribution of knowledge regarding the basic information of HIV/AIDS infected 
adolescents/ caregivers in both groups are similar.  
   
 
 
 
 
 
 
 
 
 
 
 
Fig 5.1.3(d-i): Percentage wise distribution in source of information of HIV/ART
among   HIV infected adolescents/caregivers in both groups
Fig 5.1.3(f-i): Percentage wise distribution in overall level of knowledge of
HIV/AIDS among   HIV infected adolescents/caregivers in both
groups
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SECTION II  
5.2: This section assess and evaluate the pre (baseline) and post test (3
rd
 & 6
th
 
month) level of ART adherence, nutritional status and QOL of HIV infected 
adolescents in both groups.  
5.2.1:Information related to assessment of the ART adherence level in both 
groups of HIV infected adolescents. 
 
Table 5.2.1(a): Number and percentage distribution of the information  
related to the assessment of the ART adherence level in both groups of  
HIV infected adolescents. 
S. 
No. 
Information of ART Adherence 
Group 
Chi square 
test 
Experimental     Control 
No.  % No.  % 
1. Line of ART 
treatment  
 
I line treatment 169 86.7% 163 84.5% 
2=0.74 p=0.68 
DF=2 NS 
 Alternative  
treatment 
20 10.3% 25 13.0% 
 II line treatment 6 3.1% 5 2.6% 
2. Responsible  
Person 
Self 53 27.2% 45 23.3% 
2=0.74 p=0.68 
DF=2 NS 
 Caregivers 
142 72.8% 148 76.7% 
3. Exposure to 
Adherence 
tools 
No 
195 100.0% 193 100.0% 
2=0.00p=1.00 
DF=1 NS 
4. Previous  Yes 86 44.1% 92 47.7% 2=0.49p=0.48 
DF=1 NS  Hospitalization No 109 55.9% 101 52.3% 
4.a If yes 
  
  
  
Typhoid 11 12.8% 19 20.7% 
2=0.62p=0.30 
DF=3 NS 
 Fever (PUO) 29 33.7% 21 22.7% 
 Diarrhea 24 27.9% 26 28.3% 
 Others 22 25.6% 26 28.3% 
    Not significant P >0.05  
 
  Table 5.2.1(a) shows number and percentage distribution of the information 
related to assessment of the ART adherence level in both groups of HIV infected 
adolescents. In experimental group, regarding the line of treatment the majority  
(87%) of the participants are in I line treatment, 10% are in alternative I line treatment 
and 3% are in II line treatment. The majorities (73%) of the adolescents are taking the 
medications under the control of caregivers, and the remaining 27% are taking self 
medications. All the participants (100%) are not exposure to adherence tools. In 
considering with hospitalizations, 44% participants were hospitalized, in split of view 
47% fever (includes typhoid), 28% diarrhea and 26% were admitted for injuries or 
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accidents. In control group, regarding the line of treatment, the majority (85%) of the 
participants are in I line treatment, 13 % are in alternative treatment and remaining 
3% are in II line treatment. The majorities (77%) of the adolescents are taking   the 
medications under the control of caregivers, and the remaining 23% were taking self 
medications. All the participants (100%) are not exposure to adherence tools. In 
considering with hospitalizations, 40% participants were hospitalized for fever and 
typhoid, equal percentage of 28% admitted for diarrhea and injuries or accidents. The 
chi square values for all the variables are shows that the distribution of the 
information related to the level of ART adherence of HIV infected adolescents in both 
groups are similar.  
 
Table 5.2.1 (a-i): Line of treatment according to the name of drugs of HIV 
infected adolescents in both groups 
Name  
of the 
drug 
I line Name of 
the drug 
Alternative I 
line 
Name of 
the drug 
II line 
Exp Con Exp Con Exp Con 
ZLN  129 129  ALN 14 21 AL/LR 6 5 
ZLE   13   21  ALE     4         4    
SLN   19     7  ZL/LR     1     
SLE     0     1  TL/LR     1     
TLE     8     5        
Total 169 163  20 25  6 5 
 2  test 2=9.00 
p=0.66NS 
2=3.99 p=0.21 
NS 
2=0.00 p=1.00 
NS 
   Not significant P>0.05 
 Table 5.2.1 (a-i) shows the line of treatment of HIV infected adolescents in 
both groups. Regarding the  I line of treatment  among 169 and 163  participants in 
both groups, the majority (129) of the adolescents are taking  ZLN,  where as  
respectively 13 & 21 participants are taking  ZLE and 19 and 7  participants are taking 
SLN. Considering with SLE, none of the participants in the experimental group and 
only one participant in control group. The newer drugs of one pill of TLE are 
consumed by 8 participants in experimental and 5 in control group. Among 20 and  
25 participants in alternative I line treatment for both groups, 14 and 21 adolescents 
are in ALN and equal of 4 participants are in ALE. Regarding ZL/LR, and TL/LR 
only in one participant in experimental group. With regard to II line treatment 6 and 5 
subjects are taking AL/LR. The above all chi square values reveal that the 
distributions of line of treatment are similar in both groups.  
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Table 5.2.1(b) : Number and percentage distribution in exact dose and frequency 
of pills in both groups of HIV infected adolescents 
S. 
No. 
Dose and frequency       
Questionnaire 
Group Chi square 
test 
Experimental Control 
No.  % No.  % 
5. Exact dose of 
medication 
 
Yes 
 
135 
 
69.2% 
 
135 
 
  69.9% 
2=0.02 
p=0.87 
DF=1 NS  ‘0’ month No 60 30.8% 58 30.1% 
 3
rd
  month Yes 192 98.5% 144 74.6% 2=47.5 
p=0.001*** 
DF=1 S 
  
No 3 1.5% 49 25.4% 
 6
th
  month Yes 195 100.0% 157 81.3% 2=58.2 
p=0.001*** 
DF=1 S 
  
No 0  0.0%  36 18.7% 
6. Exact dosage 
frequency 
 ‘0’ month 
Yes 195 100.0% 193 100.0% 
2=0.00 
p=1.00 
DF=1NS 
  3
rd
 month 
Yes 195 100.0% 193 100.0% 
2=0.00p=1.00 
DF=1NS 
  6
th
 month 
Yes 195 100.0% 193 100.0% 
2=0.00p=1.00 
DF=1NS 
7. Changes in ART 
No 195 100.0% 193 100.0% 
2=0.00p=1.00 
DF=1NS 
  Not significant P >0.05, *** very high   significant at  P≤0.001 
   
  Table 5.2.1(b) shows number and percentage distribution in exact dose and 
frequency of pills in both groups of HIV infected adolescents. Regarding the exact 
dose of medications, in ‘0’ month  69 % of participants only knew correctly but in 3rd  
& 6
th
 month it was increased to  98% and 100 %. Whereas in control group, 70% were 
known correctly in ‘0’ month but in 3rd  & 6th month it was increased only up to 74% 
and 81% respectively. The chi square value is significant in 3
rd
 and 6
th
 month at  
p<0.001***. It shows that, there is a statistical improvement in exact dose of 
medication in experimental group of HIV infected adolescents. Regarding the exact 
dosage frequency, all the participants in both groups were known correctly. There are 
no changes in ART during study period in both groups.  
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Table 5.2.1(c) :  Number and percentage distribution in medication burden, 
difficulty to take drugs and depression of HIV infected adolescents  
in both groups. 
S. 
No. 
Adherence 
Assessment 
Questionnaire 
Group 
Chi square 
test Experimental Control 
No. % No. % 
8. Medication 
burden 
Yes 
188 96.4% 184 95.3% 
2
=0.28p=0.59 
 ‘0’ month No 7 3.6% 9 4.7% DF=1 NS 
  3
rd
 month 
  
Yes 99 50.8% 169 87.6% 
2
=61.47 p=0.001*** 
No 96 49.2% 24 12.4% DF=1 S 
  6
th
 month Yes 71 36.4% 148 76.7% 
2
=63.04 p=0.001***  
No 124 63.6% 45 23.3% DF=1 S 
9.  Difficulty to 
take 
 ‘0’ month 
Yes 138 70.8% 137 71.0% 
2
=0.02 p=0.96  
No 57 29.2% 56 29.0% DF=1 NS 
  3
rd
 month 
  
Yes   89 45.6% 125 64.8% 
2
=14.33 p=0.001***  
No 106 54.4% 68 35.2%              DF=1  S 
  6
th
 month 
  
Yes 54 27.7% 121 62.7% 2= 47.99p=0.001***  
No 141 24.6% 72 37.3% DF=1 S 
10. Depression  Yes 147 75.4% 154 79.8% 
2
= 1.08 p=0.29 
 ‘0’ month No 48 24.6% 39 20.2% DF=1 NS 
  3
rd
 month Yes 103 52.8% 144 74.6% 
2
= 19.90p=0.001*** 
  No 92 47.2% 49 25.4% DF=1 S 
  6
th
 month Yes 62 31.8% 139 72.0% 
2
= 62.86p=0.001*** 
  No 133 68.2% 54 28.0% DF=1 S 
  Not significant P >0.05, ***very high significant at P ≤ 0.001                                     
 
  Table 5.2.1(c) shows the number and percentage distribution in medication 
burden, difficulty to take drugs and depression of HIV infected adolescents in both 
groups. In baseline assessment, the majority of 95% & 96 % participants had medication 
burden respectively in both groups. At the 3rd and 6th month it was reduced to 51% and 
36% respectively in experimental group whereas it reduced to 88% and 77% only in the 
control group. Consider with difficulty in taking the drugs, the majority (71%) of 
participants from both groups had difficulties in baseline assessment, but at the 3rd and 6th 
month it is reduced to 46% and 25% respectively in experimental group whereas in 
control group it only reduced to 64 % and 62%. 
Regarding the subjective assessment of depression, the majority of 70% & 80% of 
participants was in ‘0’ month assessment in both groups, but at the 3rd and 6th month it is 
reduced to 53% and 32 % gradually in experimental group whereas it reduced to 75 % and 
72% only in control group. It shows that significant improvement in the experimental group 
than the control group of HIV infected adolescents. The chi-square value of all these variables 
at 3
rd
 and 6
th
 month is significant at p=0.001***. It depicts that significant improvement in 
reducing medication burden, feeling difficulty and depression of HIV infected adolescents in 
experimental group. 
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5.2.2 :  Assess and evaluate the pre and post test level of ART adherence in both 
groups of HIV infected adolescents by ‘5’ point response scale, visual 
analog scale, ‘3’ day recall method and pill count methods  
Table 5.2.2 (a): Number and percentage distribution in the level of ART 
adherence in both groups of HIV infected adolescents by ‘5’point response scale 
S. 
No. 
5 Point Response Scale 
Group 
Chi-square 
test 
Experimental Control 
No.  % No.  % 
11. a. Forgot Never 102 52.3% 107 55.4% 2=3.63  
 ‘0’month Rarely 61 31.3% 45 23.3% p=0.16 
  Sometimes 32 16.4% 41 21.2% DF=2 NS 
‘3’month Never 149 76.4% 109 56.5% 2=22.63  
  Rarely 35 17.9% 46 23.8% p=0.001***   
  Sometimes 21 5.6% 38 19.7% DF=2  S 
‘6’ month Never 168 86.2% 112 58.0% 2=39.67   
  Rarely 19 9.7% 45 23.3% p=0.001*** 
  Sometimes 8 4.1% 36 18.7% DF=2  S 
b. Careless 
    in time 
Never 101 51.8% 107 55.4% 2=1.34 
‘0’month Rarely 55 28.2% 56 29.0% p=0.51 
  Sometimes 39 20.0% 30 15.5% DF=2 NS 
‘3’month Never 162 83.1% 108 56.0% 2=5.99  
  Rarely 22 11.3% 63 32.6% p=0.05 
  Sometimes 11 5.6% 22 11.4% DF=2 S 
‘6’ month Never 183 93.8% 110 57.0% 2=34.23  
  Rarely 12 6.2% 64 33.2% p=0.001*** 
  Sometimes 0 0.0% 19 9.8% DF=2 S 
c. Feel better Never 112 57.4% 110 57.0% 2=0.08  
 ‘0’month Rarely 76 39.0% 75 38.9% p=0.96 
  Sometimes 7 3.6% 8 4.1% DF=2 NS 
‘3’month Never 172 88.2% 113 58.5% 2=85.73  
  Rarely 23 11.8% 71 37.3% p=0.001*** 
  Sometimes 0 0.0% 9 4.1% DF=2 S 
‘6’ month Never 195 100% 119 61.7% 2=92.38  
  Rarely 0 0.0% 69 35.7% p=0.001*** 
  Sometimes 0 0.0% 5 2.6% DF=2 S 
d. Feel worse Never 142 72.8% 144 74.6% 2=4.13  
 ‘0’month Rarely 42 21.5% 30 15.5% p=0.12 
  Sometimes 11 5.6% 19 9.8% DF=2  NS 
‘3’month Never 186 95.4% 149 77.2% 2=29.83  
  Rarely 9 4.6% 28 14.5% p=0.001*** 
  Sometimes 0 0.0% 16 8.3% DF=2 S 
‘6’ month Never 195 100% 154 79.8% 2=63.40  
 Rarely 0 0.0% 28 14.5% p=0.001*** 
  Sometimes 0 0.0% 11 5.7% DF=2 S 
 Not significant P >0.05, *** very high  significant at   P≤0.001 
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 Table 5.2.2(a) shows the number and percentage distribution in the level of 
ART adherence in both groups of HIV infected adolescents by ‘5’point response 
scale. Regarding the response to forgot, 52-55% of participants are in never category 
but in subsequent evaluation it is increased to 76 % and 86 % in experimental group 
but it is increased 57-58 % only in the control group. The chi square value of 22.63 
and 39.67 is significant at the level of 0.001***. It shows the marked improvement in 
the experimental group. In consideration of careless in time, 52-55 % of participants 
are in never category but in subsequent evaluation it is increased to 83% and 94% in 
experimental group but it is increased to 56 &57 % only in the control group. The chi 
square value of 5.99 is significant at the level of 0.05** at 3
rd
 month and 34.23 
significant at the level of 0.001*** at 6
th
 month. It shows the significant improvement 
in the experimental group. 
  Regarding the response to feel better, 57% of participants are in never 
category in both groups. But in subsequent evaluation in experimental group it is 
increased to 88% in 3
rd
 month and achieved 100% at 6
th
 month but it is increased to 
58% and 61% only in the control group. The chi square value of 85.73 and 92.38 is 
significant at the level of 0.001***. It shows the remarkable improvement in the 
experimental group. In regard to feel worse, 72-75% of participants are in never 
category but in subsequent evaluation in the experimental group it is increased to 95% 
in 3
rd
 month and 100% in 6
th
 month and subsequently it is increased to 77% and 79% 
in the control group. The chi square value of 29.83 and 63.40 is significant at the level 
of 0.001***. It shows the significant improvement in ART adherence level of HIV 
infected adolescents in experimental group than the control group.  
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Table 5.2.2(a-i): Number and Percentage distribution in overall level of  
ART adherence in both groups of HIV infected adolescents  
by ‘5’ point response scale. 
 
S. 
No. 
Overall ‘5’ Point Response 
Scale  Adherence  Level 
Group 
Chi square 
test 
Experimental Control 
No. % No. % 
10.a Baseline Poor adherence 30 15.4% 28 14.4% 
2
=0.23 
  Sub optimal 135 69.2% 132 67.7% p=0.88 
  Optimal 
adherence 
30 15.4% 33 16.9% DF=2  NS 
3
rd  
month 
Poor adherence 
0 0.0% 28 14.4% 2=207.87 
  Sub optimal 18 9.2% 130 66.7% p=0.001*** 
  Optimal 
adherence 
177 90.8% 35 17.9% DF=2 S 
6
th
 month Poor adherence 0 0.0% 26 13.5% 2=269.39 
  Sub optimal 0 0.0% 132 68.4% p=0.001*** 
  Optimal 
adherence 
195 100 % 35 18.1% DF=2 S 
  Not significant P >0.05, *** Very high   significant at   P≤0.001 
 
 Table 5.2.4 (a-i) shows number and percentage distribution in overall level of 
ART adherence in both groups of HIV infected adolescents by ‘5’ point response 
scale. In baseline assessment, the   majority of participants from both groups had sub 
optimal level of adherence (69% & 67%). In experimental group, there is an equal 
percentage of participants (15%) are in optimal and as well as poor adherence. But in 
subsequent evaluation of 3
rd
 and 6
th
 month, optimal adherence is increased to 91%   
and 100 %. In subsequent evaluation of  the control group, the optimal adherence 
level is increased from 16.9 %, 17.9% & 18.1% respectively The chi square value  
of 207.87 and 269.39 is significant at P ≤ 0.001***. It shows the significant 
improvement in experimental group than the control group.  
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Table 5.2.2(b) : Number and percentage distribution in the level of ART 
adherence in both groups of HIV infected adolescents by Visual analog method 
 
S. 
No. 
Visual analog method 
Group 
Chi square 
test 
Experimental Control 
No. % No. % 
12. ‘0’month 
  
  
  
  
  
  
  
  
60.0% 7 3.6% 3 1.6% 
2=13.85 
p=0.09 
DF=8 NS 
65.0% 4 2.1% 4 2.1% 
70.0% 10 5.1% 17 8.8% 
75.0% 11 5.6% 10 5.2% 
80.0% 48 24.6% 33 17.1% 
85.0% 24 12.3% 43 22.3% 
90.0% 46 23.6% 35 18.1% 
95.0% 16 8.2% 21 10.9% 
100.0% 29 14.9% 27 14.0% 
 ‘3’month  
  
  
  
  
65.0%   5   2.6% 
2=81.74 
p=0.001*** 
DF=7 S 
70.0%   11 5.7% 
75.0%   15 7.8% 
80.0% 10 5.1% 32 16.6% 
85.0% 14 7.2% 26 13.5% 
90.0% 49 25.1% 51 26.4% 
95.0% 23 11.8% 22 11.4% 
100.0% 99 50.8% 31 16.1% 
 ‘6’month 
  
  
  
75      12 6.2% 
2=177.23 
p=0.001*** 
DF=5 S 
80     8 4.1% 
85%     35 18.1% 
90% 6 3.1% 65 33.7% 
95% 37 19.0% 38 19.7% 
100% 152 77.9% 35 18.1% 
      Not significant P >0.05, *** very high   significant at   P≤0.001 
   
  Table 5.2.2 (b) shows number and percentage distribution in the level of ART 
adherence in both groups of HIV infected adolescents by visual analog method.  In ’0’ 
month assessment, nearly 15% had optimal level adherence in both groups. But at 3
rd
 
and 6
th
 month evaluation it is increased to 50% and 80% in experimental group but 
there is no marked improvement in control group. The chi square value of 81.74 and 
177.23 is significant p=0.001*** in 3
rd
 & 6
th
 month evaluation. It shows the marked 
improvement in the experimental group of HIV infected adolescents.  
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Table 5.2.2 (b-i): Number and percentage distribution in overall level ART 
adherence in both groups of HIV infected adolescents by visual analog method 
S. 
No. 
Visual Analog Method 
Group 
Chi square 
test 
Experimental Control 
No.  % No. % 
12. Baseline Poor adherence 32 16.4% 34 17.6% 2=0.13 
  Sub optimal 134 68.7% 132 68.4% p=0.93 
  Optimal adherence 29 14.9% 27 14.0% DF=2 NS 
3
rd
  month Poor adherence 0  0.0%  31 16.1% 2=71.9 
  Sub optimal 96 49.2% 131 67.9% p=0.001*** 
  Optimal adherence 99 50.8% 31 16.1% DF=2 S 
6
th
 month Poor adherence 0  0.0%  12 6.2% 2=141.3 
  Sub optimal 43 22.1% 146 75.6% p=0.001*** 
  Optimal adherence 152 77.9% 35 18.1% DF=2 S 
    Not significant P >0.05, *** very high   significant at   P≤0.001 
 
 Table 5.2.2 (b-i) shows the number and percentage distribution in overall level 
ART adherence in both groups of HIV infected adolescents by visual analog method. 
In experimental group, only 15 % of participants had optimal level of adherence, 69% 
in sub optimal level of adherence and 16% in poor adherence in the baseline 
assessment of HIV infected adolescents. Whereas the optimal level of adherence  
increased to 51% in 3
rd
 month and 78% in 6
th
 month and subsequently reduced the 
suboptimal level from 49% to 22%.While in control group, only 14% of participants 
had optimal level of adherence, 68 % in sub optimal level of adherence and 18% had  
poor adherence in the baseline assessment.  There is slight improvement in the 
subsequent evaluation of 3
rd
 and 6
th
 month but it’s not statistically improved. The chi 
square value in 3
rd 
 & 6
th
 month evaluation of 71.9 and 142.3 is significant in the level 
of p=0.001***. It shows the marked improvement in the experimental group of HIV 
infected adolescents. 
 
 
Fig5.2.2 (a-i) : Percentage wise distribution in level of  ART adherence in both
groups of HIV infected adolescents by ‘5’ point response scale
‘5’ Point Response Scale
Fig 5.2.2 (b-i): Percentagewise distribution in level of ART adherence in both
groups of HIV infected adolescents by visual analog method.
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Table 5.2.2 (c): Number and percentage distribution in the level of ART 
adherence in both groups of HIV Infected Adolescents by ‘3’ days recall method. 
S. 
No. 
‘3’ days Recall 
method 
Group 
Chi square 
test 
Experimental Control 
No. % No. % 
13. 
 
‘0’ month 
  
  
  
  
80% 12 6.2% 23 11.9% 
2=4.94 
p=0.29 
DF=4 
NS 
85% 32 16.4% 24 12.4% 
90% 13 6.7% 13 6.7% 
95% 15 7.7% 12 6.2% 
100% 123 63.1% 121 62.7% 
3
rd
  month 
  
  
  
80% 0  0.0%  17 8.8% 
2=34.31 
p=0.001*** 
DF=4 
S 
85% 5 2.6% 24 12.4% 
90% 14 7.2% 13 6.7% 
95% 16 8.2% 16 8.3% 
100% 160 82.1% 123 63.7% 
6
th
 month 
  
  
  
  
80% 0  0.0%  15 7.8% 
2=62.20 
p=0.001*** 
DF=4 
S 
85% 0  0.0%  24 12.4% 
90% 0  0.0%  13 6.7% 
95% 11 5.6% 13 6.7% 
100% 184 94.4% 128 66.3% 
             Not significant P >0.05, *** very high   significant at   P≤0.001 
 
 Table 5.2.2(c) shows number and percentage distribution in the level of ART 
adherence in both groups of HIV infected adolescents by ‘3’ days recall method. In 
‘0’ month assessment, nearly 63 % had optimal level adherence in both groups. But in 
3
rd
 and 6
th
 month evaluation it increased to 82% and 94% in experimental group but 
there is no marked improvement in the control group i.e., it’s increased to 64% and 
66% respectively.  
 The chi square value of 34.31 and 62.20 is significant in the level of  
p=0.001*** at 3
rd
 & 6
th
 month evaluation. It shows the marked improvement in the 
experimental group of HIV infected adolescents than the control group.  
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Table 5.2.2 (c-i) :  Number and percentage distribution in overall level of ART 
adherence in  both groups of HIV infected  adolescents by  ‘3’ days recall method 
 
S. 
No. 
‘3’ days recall method 
Group 
Chi square 
test 
Experimental Control 
No.      % No.  % 
13.a Baseline Poor adherence 0  0.0%  0  0.0%  2=0.01 
  Sub optimal 72 36.9% 72 37.3% p=0.93 
  Optimal adherence 123 63.1% 121 62.7% DF=2 NS 
3
rd
  month Poor adherence 0  0.0%  0  0.0%  2=16.5 
  Sub optimal 35 17.9% 70 36.3% p=0.001*** 
  Optimal adherence 160 82.1% 123 63.7% DF=2  S 
6
th
 month Poor adherence 0  0.0%  0  0.0%  2=48.4 
  Sub optimal 11 5.6% 65 33.7% p=0.001*** 
  Optimal adherence 184 94.4% 128 66.3% DF=2  S 
         Not significant P >0.05, *** very high   significant at   P≤0.001 
 
 
  Table 5.2.2 (c-i) shows number and percentage distribution in overall level of 
adherence in both groups of HIV infected adolescents by ‘3’ days recall method. In 
‘0’ month assessment, only 63 % of participants had optimal level of adherence and 
remaining 37% in sub optimal level of adherence in both groups. Whereas the optimal 
level of adherence is increased to 82% in 3
rd
 month and 94% in 6
th
 month. 
Subsequently, reduced the suboptimal level of adherence from 18% to 6% in 
experimental group.  But in the control group, there is a minimum improvement in the 
subsequent evaluation of 3
rd
 and 6
th
 month. The chi square value of 16.5 and 48.4 is 
significant at p=0.001*** in the subsequent evaluation. It shows the marked 
improvement in experimental group than the control group. 
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Table 5.2.2(d):  Number and percentage distribution in level of ART adherence 
in both groups of HIV infected adolescents by pill count method. 
S. 
No 
Pill count 
Method 
Group 
Chi square 
test 
Experimental Control 
No. % No. % 
14. Base line 
  
  
  
  
80.00% 4 2.1% 7 3.6% 
2=3.66 
p=0.45 
DF=4 
NS 
85.00% 8 4.1% 13 6.7% 
90.00% 63 32.3% 70 36.3% 
95.00% 35 17.9% 30 15.5% 
100.00% 85 43.6% 73 37.8% 
3
rd
 month 
  
  
  
80% 0 0.0% 5 2.6% 
2=90.15 
p=0.001*** 
DF=4 
S 
85% 3 1.5% 17 8.8% 
90% 7 3.6% 50 25.9% 
95% 15 7.7% 40 20.7% 
100% 170 87.2% 81 42.0% 
6
th
 month 
  
  
  
80% 0 0.0% 3 1.6% 
2=66.7 
p=0.001*** 
DF=4 
S 
85% 0  0.0% 21 10.9% 
90% 5 2.6% 27 14.0% 
95% 9 4.6% 30 15.5% 
100% 181 92.8% 112 58.0% 
         Not significant P >0.05, *** very high   significant at   P≤0.001 
 
 Table 5.2.2(d) shows number and percentage distribution in the level of ART 
adherence in both groups of HIV infected adolescents by pill count method. In ’0’ 
month assessment, nearly 44% in experimental group and 38 % in control group had 
optimal level adherence. But in 3
rd
 month evaluation it is increased to 87% and in 6
th
 
month 92% in experimental group. But there is no marked improvement in control 
group it is increased to 42 % and 58% respectively. The chi square value of 27.8 and 
45.1 is significant in the level of p= 0.001*** at 3
rd
 & 6
th
 month evaluation. It shows 
there is a marked improvement in the experimental group of HIV infected 
adolescents. 
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Table 5.2.2 (d-i): Number and percentage distribution in overall level of ART 
adherence in both groups of HIV infected adolescents by pill count method 
S. 
No. 
Overall level of 
Adherence 
Group 
Chi square 
Test 
Experimental Control 
No. % No. % 
14. Baseline 
  
  
Poor adherence 0 0.0% 0 0.0% 2=1.33 
p=0.44 
DF=1  
NS 
Sub optimal 110 56.4% 120 62.2% 
Optimal 
adherence 
85 43.6% 73 37.8% 
3
rd
 month 
  
  
Poor adherence 0 0.0% 0 0.0% 
2=91.95 
p=0.001*** 
DF=2   S 
Sub optimal 25 12.8% 112 58.0% 
Optimal 
adherence 
170 87.2% 81 42.0% 
6
th
 month 
  
  
Poor adherence 0  0.0% 0  0.0% 2=93.13 
p=0.001*** 
DF=2  
S 
Sub optimal 14 7.2% 100 57.8% 
Optimal 
adherence 
181 92.8% 93 48.2% 
         Not significant P >0.05, *** very high   significant at   P≤0.001 
 
 Table 5.2.2 (d-i) shows number and percentage distribution in overall level of 
ART adherence in both groups of HIV infected adolescents by pill count method. In 
experimental group, only 44% of participants had optimal level of adherence, 56% in 
sub optimal level of adherence and no one in poor adherence in the baseline 
assessment. But in the optimal level is increased to 87% and 93% in 3
rd
 and 6
th
 month 
subsequently reduced the suboptimal level from 13% and 7% .While in control group, 
only 38% of participants had optimal level of adherence and remaining 68 % in sub 
optimal level of adherence in the baseline assessment and there is slight improvement 
in the subsequent evaluation but it is not statistically improved. The chi square value 
at 3
rd
 & 6
th
 evaluation of 91.95 and 93.13 is significant in the level of p=0.001***. It 
shows the significant improvement in the experimental group of HIV infected 
adolescents than the control group. 
 
 
 
Fig 5.2.2(c-i):  Percentage wise distribution in level of ART adherence in both
groups of HIV infected adolescents by ‘3’ days recall method
Fig 5.2.2(d-i) : Percentage wise distribution in level of  ART adherencein both
groups of HIV infected adolescents by pill count method.
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Table 5.2.2(e):  Reasons for the non adherence to ART in both groups of HIV 
infected adolescents 
S. 
No. 
Reasons for non adherence 
Group 
Chi square 
test 
Experimental Control 
No. % No. % 
15. Baseline 
  
  
  
  
  
  
Not applicable 80 41.0% 70 36.3% 
2=3.90 
p=0.68 
DF=6 
NS 
Forgot 65 33.3% 77 39.9% 
Boring 12 6.2% 10 5.2% 
Busy scheduled 20 10.3% 15 7.8% 
Travelling 13 6.7% 18 9.3% 
Not having finance to 
come and collect the 
drug  
3 1.5% 2 1.0% 
Side effects of drugs 2 1.0% 1 .5%  
 3
rd
 
month 
  
  
  
  
Not applicable 174 89.2% 88 45.6% 
2=88.98 
p=0.001*** 
DF=4 
S 
Forgot 21 10.8% 73 37.8% 
Boring   11 5.7% 
Busy scheduled   15 7.8% 
Travelling 
  6 3.1% 
 6
th
 
month 
  
  
  
  
Not applicable 183 93.8% 119 61.7% 
2=60.69 
p=0.001*** 
DF=4 
S 
Forgot 12 6.2% 51 26.4% 
Boring   6 3.1% 
Busy scheduled   14 7.3% 
Travelling 
  3 1.6% 
 Not significant P >0.05, *** very high   significant at   P≤0.001 
 
  Table 5.2.2(e) shows the reasons for the non adherence to ART in both groups 
of HIV infected adolescents. In baseline assessment, respectively there were 41% and 
36% of adolescents only in the not applicable category and remaining adolescent’s  
had many reasons for the non adherence in both groups. But after HIP, in 
experimental group it is increased to 89 % and 94% respectively in subsequent 
evaluation but still 6% of adolescents were had non adherence problems because of 
forgot. Whereas in control group it’s increased up to 46% and 62% only in further 
evaluation period. The chi square value of 88.98 and 60.69 is significant in 
p=0.001***. This table finding depicts the counseling and interventional diary has 
effectiveness to increase the adherence to ART among HIV infected adolescents in 
experimental group. 
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Table 5.2.2(f): Aids for improving adherence to ART in both groups of HIV 
infected adolescents 
S. 
No. 
Aids for improve adherence 
 
Group Chi 
square 
test 
Experimental Control 
No. % No.  % 
16. Baseline 
  
  
Pill box 92 47.2% 97 50.3% 2=4.50 
p=0.21 
DF=3 
NS 
Reminders in mobile 9 4.6% 3 1.6% 
Buddy system 8 4.1% 4 2.1% 
Nothing 86 44.1% 89 46.1% 
3
rd
 
month 
Pill box   97 50.3% 
2=189.50 
p=0.001 
DF=3 
S 
Reminders in mobile   3 1.5% 
Buddy system   5 2.6% 
Diary 86 44.1%   
Nothing   88 45.6% 
Pill box+ Diary 92 47.2%   
Reminders in mobile+ 
Diary 
9 4.6%   
Buddy system+ Diary 8 4.1%   
6
th
 
month 
Pill box   97 50.3% 
2=182.45 
p=0.001 
DF=3 
S 
Reminders in mobile   3 1.5% 
Buddy system   7 3.6% 
Diary 86 44.1%   
Nothing   86 44.6% 
Pill box+ Diary 94 48.2%   
Reminders in mobile+ 
Diary 
7 3.6%   
Buddy system+ Diary 8 4.1%   
     Not significant P >0.05, *** very high   significant at   P≤0.001 
 
  Table 5.2.2 (f) shows the aids for improving adherence to ART in both groups 
of HIV infected adolescents. In baseline assessment, the half of percentage (47% and 
50%) of adolescents was using pillboxes and nearly 44% and 46 % of adolescents 
were not using any aids to improve the adherence in both groups. Whereas, in 3
rd
 and 
6
th 
month evaluation
   
along with investigator counseling and the diary also used as a 
remainder cue along with previous aids in order to improve the adherence for 
experimental group. But in control group there is no special aids used to improve the 
adherence and also there is no marked changes in the aids from the baseline to 6
th
 
month evaluation. The chi square value of 189.50 and 182.45 is significant at 
p=0.001*** in subsequent evaluation. It depicts that, the interventional diary has 
effectiveness to improve the adherence among HIV infected adolescents in 
experimental group. 
Fig 5.2.2 (e): Percentage wise distribution of reasons for the non adherence to
ART in experimental group of HIV infected adolescents
Fig 5.2.2 (f) :Percentage wise distribution of Aids for improving adherence to
ART in  experimental group of  HIV infected adolescents.
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5.2.3: Assess and evaluate the pre and post test level of nutritional status in both 
groups of HIV infected adolescents by anthropometric variables. 
Table 5.2.3 (a): Mean and Standard deviation level of   Height in both groups of 
HIV infected adolescents. 
S. 
No. 
Assessment of 
Height 
Group Mean 
Std. 
Deviation 
Student 
Independent 
t-test 
1. Base line Experimental 141.36 12.648 t=1.21 
P=0.22 NS   Control 139.84 11.816 
3
rd
 month Experimental 142.26 14.625 t=1.73 
P=0.08 NS   Control 139.92 11.797 
6
th
 month Experimental 142.57 12.356 t=1.92 
P=0.06  NS   Control 140.21 11.713 
             Not significant P >0.05 
 
Table 5.2.3 (a) shows mean and standard deviation level of height in both 
groups of HIV infected adolescents. There is no marked improvement in mean and 
standard deviation of both groups of adolescents from baseline to 6
th
 month 
evaluation. The student independent t-test is also not significant at p >0.05. It shows 
that there is no marked change in the height during the study period in both groups. 
 
Table 5.2.3 (b): Mean and Standard deviation level of weight in both groups of 
HIV infected adolescents. 
S. 
No. 
Assessment of 
Weight 
Group Mean 
Std. 
Deviation 
 
Student 
independent 
t-test 
2. Base line Experimental 34.39 8.91 
0.77 
t=0.83 
P=0.41 NS   Control 33.62 9.28 
3
rd
 month Experimental 35.00 8.86 
1.30 
t=1.41 
P=0.16 NS   Control 33.70 9.30 
6
th
 month Experimental 37.01 17.47 
2.85 
t=2.01 
P=0.05* S   Control 34.16 9.20 
            Not significant P >0.05, * Significant at P≤0.05,  
   
 Table 5.2.3 (b) shows mean and standard deviation level of weight in both 
groups of HIV infected adolescents. In experimental group, the mean value is 
gradually increased from 34.39 to 37.01 during the study period. It depicts that there 
is gradual improvement in weight of HIV infected adolescents. But in control group, 
there is no gradual improvement in the mean value, denotes no improvement in 
weight during the study period. At 6
th
 month ‘t’ value of 2.01 is significant at 
p=0.05*. It reveals that there is significant improvement in weight of HIV infected 
adolescents in experimental group. 
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Table 5.2.3(c) : Mean and standard deviation level of BMI in both groups of HIV 
infected adolescents 
 
S. 
No. 
Assessment of 
BMI 
Group N Mean 
Std. 
Deviation 
 
Student 
Independent 
t-test 
3. Base line Experimental 195 16.82 2.314 0.02 t=0.07 
P=0.94 NS   Control 193 16.80 2.368 
3
rd
 month Experimental 195 17.08 2.292 0.25 t=1.06 
P=0.28 NS   Control 193 16.83 2.369 
6
th
 month Experimental 195 17.43 2.278 1.81 t=1.96 
P=0.05* S   Control 193 16.98 2.328 
          Not significant P >0.05, * Significant at P≤0.05  
 
  Table 5.2.3 (c) shows mean and standard deviation level of BMI in both 
groups of HIV infected adolescents. In experimental group, the mean value is 
gradually increased from 16.82 to 17.43 during the study period depicts that there is 
gradual improvement in BMI of HIV infected adolescents. But in control group, there 
is no gradual improvement in the mean value, which denotes that there is no 
improvement in BMI during the study period.  At 6
th
 month ‘t’ value of 1.96 is 
significant at p=0.05*. It denotes that there is a significant improvement in BMI of 
HIV infected adolescents in experimental group than the control group. 
 
Table 5.2.3(d): Mean and Standard deviation of waist circumference in both 
groups of HIV infected adolescents. 
 
S. 
No. 
Assessment of 
Waist 
circumference 
Group N Mean 
Std. 
Deviation 
 
Student 
independent 
t-test 
4. Base line Experimental 195 52.31 7.546  
0.05 
t=0.07 
P=0.94 NS   Control 193 52.36 5.771 
3
rd
 month Experimental 195 52.90 7.625  
0.48 
t=0.69 
P=0.49 NS   Control 193 52.42 5.792 
6
th
 month Experimental 195 54.02 7.572  
1.34 
t=1.96 
P=0.05* S   Control 193 52.68 5.753 
     Not significant P >0.05, * significant at P≤0.05 
 
 Table 5.2.3 (d) shows mean and standard deviation of waist circumference in 
both groups of HIV infected adolescents. In experimental group, the mean value is 
gradually increased from 52.31, 52.90 and 54.02 respectively throughout the study 
period reveals that there is gradual improvement in waist circumference of HIV 
infected adolescents. But in control group, there is no gradual improvement in the 
mean value, which shows that there is no marked improvement in waist 
circumference of HIV infected adolescents. At 6
th
 month ‘t’ value of 1.96 is  
significant at p=0.05*. 
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Table 5.2.3 (e) :Mean and Standard deviation of Mid arm circumference in both 
groups of HIV infected adolescents. 
 
S. 
No. 
Assessment of 
mid arm 
circumference 
Group N Mean 
Std. 
Deviation 
 
Student 
independent 
t-test 
5. Base line Experimental 195 17.852 1.8263 
0.23 
t=1.49 
P=0.13 NS   Control 193 17.618 1.1850 
3
rd
 month Experimental 195 17.982 1.8692 
0.26 
t=1.61 
P=0.11 NS   Control 193 17.726 1.1807 
6
th
 month Experimental 195 18.148 1.8486 
0.40 
t=2.56 
P=0.01** S   Control 193 17.745 1.1822 
     Not significant P >0.05,** highly significant at P≤ 0.01  
   
 Table 5.2.3 (e) shows mean and standard deviation of mid arm circumference 
in both groups on HIV infected adolescents. In experimental group, the mean value is 
gradually increased from 17.85 to 18.14 and the mean difference is 0.23 to 0.40 
during the study period depicts that there is gradual improvement in mid arm 
circumference of HIV infected adolescents. But in control group, there is no gradual 
improvement in the mean value or there is no improvement in mid arm circumference 
during the study period. At 6
th
 month ‘t’ value of 2.56 is significant at p=0.01*.  
 
Table 5.2.3 (f) :  Mean and Standard deviation of skin fold thickness (Triceps) in 
both groups of HIV infected adolescents. 
 
S. 
No 
Assessment of 
Skin fold 
thickness 
Group N Mean 
Std. 
Deviation 
 
Student 
independent 
t-test 
6. Base line Experimental 195 3.753 .8642 
0.08 
t=1.08 
P=0.28 NS   Control 193 3.668 .6456 
3
rd
 month Experimental 195 3.8841 .86894 
0.12 
t=1.49 
P=0.14 NS   Control 193 3.7684 .64557 
6
th
 month Experimental 195 4.199 .7566 
0.33 
t=4.66 
P=0.01** S   Control 193 3.867 .6436 
    Not significant P >0.05,   ** highly significant at P≤ 0.01  
 
 Table 5.2.3 (f) shows mean and standard deviation of skin fold thickness in 
both groups of   HIV infected adolescents. In experimental group, the mean value is 
gradually increased from 3.753, 3.8884 and 4.199 respectively throughout the study 
period reveals that there is gradual improvement in skin fold thickness (triceps) of 
HIV infected adolescents. But in control group,  there is no gradual improvement in 
the mean value or there is no marked improvement in skin fold thickness of HIV 
infected adolescents. At 6
th
 month   ‘t’ value of 4.66  is significant at p=0.01*.  
Fig 5.2.3(g): Mean score distribution of anthropometric variables in experimental group of HIV infected adolescents
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Table 5.2.3 (g): Mean and SD level of pre and post test score in nutritional 
variables of HIV infected adolescents in experimental group with ANOVA F- test   
and Bonferroni t–test  
S. 
No. 
Nutritional 
Variables 
Experimental Repeated 
Measure 
ANOVA  
F-test 
Bonferrni        
t-test 
‘0’ month 3rd month 6th month 
Mean SD Mean SD Mean SD 
1. Height 141.36 12.65 142.26 14.63 142.57 12.36 
F=4.40 
P=0.04 
Base Vs 
6
th
month 
(p<0.01) 
2. Weight 34.39 8.91 35.00 8.86 37.01 17.47 
F=15.32 
P=0.001 
Base Vs 
6
th
month 
(p<0.01) 
3
rd
 vs 6
th
 
month 
(p<0.05) 
3. BMI 16.82 2.31 17.08 2.29 17.43 2.28 
F=28.22 
P=0.001 
Base Vs 
6
th
month 
(p<0.01) 
3
rd
 vs 6
th
 
month 
(p<0.05) 
4. 
Waist 
circumference 
52.31 7.55 52.90 7.62 54.02 7.57 
F=63.88 
P=0.001 
Base Vs 
6
th
month 
(p<0.01) 
3
rd
 vs 6
th
 
month 
(p<0.05) 
5. 
Mid Arm 
circumference 
17.85 1.83 17.98 1.87 18.15 1.85 
F=35.13 
P=0.001 
Base Vs 
6
th
month 
(p<0.01) 
3
rd
 vs 6
th
 
month 
(p<0.05) 
6. 
Skin fold 
thickness 
   3.75 .86 3.88 .87 4.20 .76 
F=33.44 
P=0.001 
Base Vs 
6
th
month 
(p<0.01) 
3
rd
 vs 6
th
 
month 
(p<0.05) 
*significant at P≤0.05, **highly significant at P≤0.01, ***very high significant at   P≤0.001 
 
 Table 5.2.3 (g) shows the ANOVA F-test and Bonferroni t–test values for 
nutritional variables of HIV infected adolescents in experimental group.  All the 
variables except height had significance in repeated measure of ANOVA ‘F’ test at 
p=0.001***. It shows that except height there is a marked improvement in all other 
nutritional variables of HIV infected adolescents. But the Bonferroni t–test revealed 
that all the variables had significance from baseline to the 6
th
 month evaluation at 
p<0.01** and  3
rd
  to  6
th
 month evaluation also had significance at P<0.05* except 
the height. It denotes that there is a significant improvement in all the variables of 
HIV infected adolescents, but only the height had minimal improvement of HIV 
infected adolescents.  
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Table 5.2.3 (h) : Mean and Standard deviation level of pre and post test score in 
nutritional variables of HIV infected adolescents in control group with ANOVA 
F- test  and Bonferroni t–test 
 
S. 
No. 
Nutritional 
variables 
Control group Repeated 
Measure 
ANOVA  
F-test 
Bonfer-
roni  
t-test 
‘0’ month 3rd month 6th month 
Mean SD Mean SD Mean SD 
1 Height 
139.84 11.82 139.92 11.80 140.21 11.71 
F=0.95 
P=0.33 
- 
2 Weight 
33.62 9.28 33.70 9.30 34.16 9.20 
F=1.02 
P=0.30 
- 
3 BMI 
16.80 2.37 16.83 2.37 16.98 2.33 
F=1.11 
P=0.27 
- 
4 Waist 
Circumference 52.36 5.77 52.42 5.79 52.68 5.75 
F=0.88 
P=0.34 
- 
5 Mid Arm 
Circumference 17.62 1.19 17.73 1.18 17.74 1.18 
F=0.86 
P=0.35 
- 
6 Skin fold 
thickness 3.67 .65 3.77 .65 3.87 .64 
F=1.40 
P=0.24 
- 
Not significant P >0.05 
 
  Table 5.2.3 (h) shows ANOVA F-test and Bonferroni t–test values for 
nutritional variables of HIV infected adolescents in control group. The all nutritional 
variables of HIV infected adolescents in control group did not have significance in 
ANOVA F-test and Bonferroni t–test. It reveals that there is no marked improvement 
in the all nutritional variables of HIV infected adolescents in control group.   
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Table 5.2.3 (i): Pre and post test ‘Z’ score of HIV infected adolescents in both 
groups 
 
 
Z-score 
  
Experimental Control  
Baseline 3
rd
 month 6
th
 month Baseline 3
rd
 month 6
th
month 
No.  % No. % No. % No. % No. % No % 
-4.00 to -3.00 13 6.7% 9 4.6% 2 1.0% 11 5.6% 10 5.1% 9 4.7% 
-3.00 to -2.00 42 21.5% 38 19.5% 35 17.9% 45 23.1% 44 22.6% 44 22.8% 
-2.00 to -1.00 37 19.0% 32 16.4% 29 14.9% 27 13.8% 24 12.3% 25 12.8% 
-1.00 to  0.00 22 11.3% 25 12.8% 29 14.9% 30 15.4% 29 14.9% 29 14.9% 
0.00  to  1.00 23 11.8% 25 12.8% 30 15.4% 28 14.4% 35 17.9% 32 16.4% 
1.00  to  2.00 58 29.7% 58 29.7% 60 30.8% 52 26.7% 53 27.2% 54 27.7% 
2.00  to  3.00 0 0.0% 8 4.1% 10 5.1% 0 0.0% 0 0.0% 0 0.0% 
Total 195 100 195 100 195 100 193 100  193 100 193 100 
Chi square 
test 
2=20.74p=0.05 
Significant 
2=1.22p=0.97 
Not significant 
Not significant P > 0.05, * significant at P ≤ 0.05 
 
Table 5.2.3 (i) shows, pre and post test ‘Z’ score of HIV infected adolescents 
in experimental and control group.  The chi square value of 20.7 is significant at the 
p= 0.05* in experimental group. But in control group, there won’t be any progress in 
nutritional status and chi square value of 1.22 is not significant at p>0.05. It depicts 
that there is gradual increase in nutritional status of HIV infected adolescents in the 
experimental group than the control group.   
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5.2.4: Assessment of clinical histories and presence of clinical signs and 
symptoms related to nutrition in both groups of HIV infected adolescents 
 
Table 5.2.4 (a): Information related to clinical histories in both groups of HIV 
infected adolescents. 
S. 
No. 
Clinical  History 
Assessment 
Group Chi 
square 
test 
Experimental Control 
No. % No. % 
1. Previous history 
Nutritional  
Deficiency 
Yes 9 4.6% 11 5.7% 2=0.23 
 P=0.63  
NS 
 
No 186 95.4% 182 94.3% 
1.a  If yes 1 years 2  22.2%  3 27.2% 2=0.84  
P=0.84 
NS 
   2 years 3 33.3% 5  45.5% 
   3 years 2 22.2% 1  9.1% 
   4 years 2 22.2% 2  18.2% 
2 De wormed of  Yes  105 53.8% 91 47.2% 
2
=1.73 
P=0.19 NS   subject regularly No 90 46.2% 102 52.8% 
3. Presence of  Iron  Yes     3                1.5% 2 1.0% 2=0.20  
P=0.90.NS   deficiency No 192 98.5% 191 99.0% 
4. Weight loss Yes  13 6.7% 10 5.2% 2=0.38  
P=0.53 NS    No 182 93.3% 183 94.8% 
  If yes, Present 
body weight 
(0-5%) 
13 100.0% 10 100.0% 
2=0.00 
P=1.00 NS 
 
      Not significant P >0.05 
 
  Table 5.2.4 (a) shows the information related to clinical histories in both 
groups of HIV infected adolescents. Among this both groups, 5% and 6% had 
nutritional deficiency and nearly 46% in experimental and 53% in control group of 
adolescents had not followed de worming regularly. Nearly 3% in experimental group 
and 2% in control group of adolescents having iron deficiency anemia. In 
consideration with loss of weight, nearly 5-7% lost their present weight from  
0-5 % within 3 months. In all the clinical variables shows the ‘p’ value is less than the 
calculated chi square value and it’s not significant at P>0.05. It reveals that, the 
distribution variables in both the groups are similar. 
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Table 5.2.4 (b): Presence of Clinical signs and symptoms in both groups of HIV 
infected adolescents 
Table 5.2.4 (b-i): Dry skin, Nail, Head and Eyes in both groups of HIV infected 
adolescents 
S. 
No. 
Clinical signs and 
symptoms 
Group 
Chi square 
test   Experimental       Control 
No. % No. % 
1. Dry Skin Yes 8 4.1% 12 6.2% 
2
=0.88 
P=0.34 NS ‘0’ month No 187 95.9% 181 93.8% 
3
rd
  month Yes 5 2.6% 10 5.2% 
2
=1.78 
P=0.18 NS No 190 97.4% 183 94.8% 
6
th 
 month Yes 2 1.0% 13 6.7% 
2
=8.50 
P=0.01** S No 193 99.0% 180 93.3% 
2. 
Nails No 195 100.0% 193 100.0% 
2=0.00 
P=1.00 NS 
3. Head-  
Color / texture 
Yes 14 7.2% 11 5.6% 
2
=0.36 
P=0.54 NS 
‘0’ month No 180 92.3% 182 93.3% 
3
rd
  month Yes 11 5.6% 15 7.7% 
2
=0.70 
P=0.40 NS No 184 94.4% 178 92.3% 
6
th 
 month Yes 7 3.6% 13 6.7% 
2
=1.96 
P=0.14 NS No 188 96.4% 180 93.3% 
3.a Infection  
S.dermatitis 
Yes 8 4.1% 10 5.1% 
2
=0.25 
P=0.61 NS 
‘0’ month No 187 95.9% 183 93.8% 
3
rd
  month Yes 6 3.1% 10 5.1% 
2
=1.08 
P=0.29 NS No 189 96.9% 183 93.8% 
6
th 
 month Yes 5 2.6% 10 5.1% 
2
=1.78 
P=0.18 NS No 190 97.4% 183 93.8% 
4. Eyes Yes 7 3.6% 7 3.6% 
2
=0.0 
P=0.99 NS ‘0’ month No 188 96.4% 186 95.4% 
3
rd
  month Yes 5 2.6% 7 3.6% 
2
=1.68 
P=0.19 NS No 190 97.4% 186 95.4% 
6
th 
 month Yes 3 1.5% 6 3.1% 
2
=0.36 
P=0.54 NS No 192 98.5% 187 95.9% 
    Not significant P >0.05, ** highly significant at P≤ 0.01  
   
  Table 5.2.4 (b-i) shows clinical signs and symptoms of dry skin, nail, head and 
eyes in both groups of   HIV infected adolescents. In regard to presence of dry skin 
4% and 6 % were respectively seen in both group adolescents in baseline assessment, 
but in subsequent evaluation it was reduced to 1% in experimental group and 
remaining same in control group. The chi square value of 8.50 was significant at 
p=0.01** denoted that, there is gradual decrease in dryness of skin among HIV 
infected adolescents in experimental group.  In consideration of nails, there is no 
change noticed in nails in both groups of HIV infected adolescents throughout the 
assessment period. With regard to the head and eyes there is no significant changes 
are found throughout study period in both the groups. 
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Table 5.2.4 (b-ii) : Clinical  signs and symptoms of mouth, Gastro intestinal 
system and extremities in both groups of HIV infected adolescents. 
 
S. 
No. 
Clinical signs and symptoms 
Group 
Chi square 
test Experimental Control 
No.  % No.  % 
5. Oral Yes 17  8.7% 13 6.7% 2=0.53 
P=0.46 NS ‘0’ month No 178 91.3% 180 92.3% 
3
rd
  month 
  
Yes 9  4.6% 11 5.6% 2=0.23 
P=0.62 NS No 186  95.4% 182 93.3% 
6
th 
 month Yes 
No 
0 
195 
100.0% 
10 
183 
5.1% 
94.9% 
2=15.39 
P=0.01** S 
6. G.I. System  Yes 
 No 
     56    
139 
28.7% 
71.3% 
49 
144 
25.3% 
74.7% 
2=0.54 
P=0.46 NS 
If yes  ‘0’ month  Appetite 38        67.9% 32 65.3% 
2=1.58 
P=0.66 
NS 
 Nausea 14 25.0% 10 20.4% 
Vomiting 2 3.6% 4 8.2% 
Diarrhea 2 3.5% 3 6.1% 
3
rd
 month 
  
  
  
Appetite 21 72.4% 28 51.9% 
2=5.89 
P=0.05* 
S 
Nausea 8 27.6% 18 33.3% 
Vomiting 0  0.0% 8 14.8% 
Diarrhea 0 0.0% 0 0.0% 
6
th
   month 
  
  
  
Appetite 7  87.5% 25 55,5% 
2=6.00 
P=0.05* 
S 
Nausea 1  12.5% 15 33.3% 
Vomiting 0 0.0% 3 6.7% 
Diarrhea 0 0.0% 2 4.5% 
7. Extremities Yes  25  2.8% 19 9.8% 2=0.85 
P=0.35 NS a. Muscle wasting No 170 87.2% 174 90.2% 
b. Edema No 195      100.0% 193 100.0% 2=0.00 
P=1.00 NS 
c. Lipo dystrophy Yes 22 11.2% 13 6.7% 2=2.44 
P=0.11 NS   No 173 88.8% 180 93.3% 
Not significant P >0.05, * significant at P≤0.05, ** highly significant at P≤ 0.01  
 
 
 
Table 5.2.4 (b-ii) shows the clinical signs and symptoms for oral, gastro 
intestinal system and extremities in both groups of HIV infected adolescents. In 
relevant to oral, 6-8 % had problems in the baseline assessment. At 6
th
 month 
evaluation, there is marked improvement in experimental group and no one is found 
with dryness of lips, bleeding gums and apthus ulcers but still 5 % in control group. 
The chi square value of 15.39 is significant at p=0.01**. In regard to the gastro 
intestinal system, in baseline assessment shows that 25-28 % of adolescents had 
various GI problems in both the groups. But at the 6
th
 month evaluation, it is reduced 
in the experimental group and it’s proved with chi square values whereas in the 
control group there is no significant changes found at 6
th
 month evaluation. In regard 
to extremities, the presence of muscle wasting and lipo dystrophy were seen in 13% 
Fig  5.2.4  (b-i)  -  Percentage  wise  distribution  in  dry  skin  of  HIV  infected
adolescents in both groups.
Fig 5.2.4 (b-ii): Percentage wise distribution in Oral Problems of HIV infected
adolescents in both groups
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and 11% in experimental group whereas in control group10% and 7% respectively in 
both the groups. There is no participants had edema during study period in both 
groups. 
 
5.2.5:  Assess and evaluate pre and post test level of QOL in both groups of HIV 
infected adolescents. 
Table 5.2.5 (a): Pre and post test mean score of quality of life mean in 
experimental group of the HIV infected adolescents. 
S. 
No. 
QOL 
Domains 
Assessment 
Baseline % 
3
rd
 
month 
% 
6
th
 
month 
% 
1. General Health 
Ratings 
   34.83 57.1% 39.11 64.1% 40.01 65.6% 
2. Physical Functioning 17.10 57.0% 19.43 64.8% 23.63 78.8% 
3. Psychological 
Wellbeing 
54.82 65.3% 58.04 69.1% 60.97 72.6% 
4. Social Role 
Functioning 
4.25 22.4% 6.30 33.2% 9.94 52.3% 
5. Health care Services 3.75 15.6% 6.86 28.6% 13.36 55.7% 
6. Symptoms 48.92 40.8% 58.02 48.4% 67.74 56.5% 
 TOTAL 163.66 48.4% 187.75 55.5% 215.64 63.8% 
 
Table 5.2.5 (a) shows pre and post test score of quality of life in baseline, the 
3
rd
 month and the 6
th
 month evaluation in experimental group of the HIV infected 
adolescents. In general health ratings domains, 57% are in baseline assessment and it 
is increased to 64% in 3
rd
 month and 66% in 6
th
 month evaluation. With regard to 
physical functioning there is a marked improvement i.e., 57 % to 79 % respectively. 
In consideration with psychological well being it is increased from baseline value of 
65 % to 73%.  In regards to social role functioning and health care services its marked 
improvement from baseline value from 22% and 16 % to 52% and 58% respectively. 
Regarding symptoms of the HIV infected adolescents; it is increased from 41% to 
57%. The overall percentage of baseline assessment is 48% but at 6
th
 month 
evaluation it is increased to 64 %. 
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Table 5.2.5 (b) Pre and post test mean score of quality of life in control group of 
the HIV infected adolescents 
 
S. 
No. 
QOL 
Domains 
Assessment and QOL score 
Baseline % 
3
rd
 
month 
% 
6
th
 
month 
% 
1 General Health 
Ratings 
34.32  56.3% 32.95 56.3% 34.47 56.5% 
2 Physical 
Functioning 
17.31 57.7% 18.15 57.9% 17.54 58.5% 
3 Psychological 
Wellbeing 
54.17 64.5% 53.25 64.8% 54.81 65.3% 
4 Social Role 
Functioning 
4.19 22.1% 4.25 22.5% 4.42 23.3% 
5 Health care Services 3.66 15.3% 3.50 15.8% 3.97 16.5% 
6 Symptoms 49.28 41.1% 43.30 41.8% 50.80 42.3% 
 TOTAL 162.93 48.2% 155.40 48.6% 166.02 49.1% 
   
  
 Table 5.2.5 (b) shows pre and post test  quality of life score in baseline, 3
rd
 and 
6
th
 month evaluation in control group of the HIV infected adolescents. In all the 
domains, there is no marked improvement from baseline to 6
th
 month evaluation in 
the control group of HIV infected adolescents. The total percentage is increased only 
from 48% to 49% respectively throughout the evaluation period. 
 
Fig 5.2.5(a): Percentage wise distribution in domain wise QOL score in experimental group of HIV infected adolescents.
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Table 5.2.5 (c):  Number and percentage distribution in overall quality of life 
score in experimental group of the HIV infected adolescents 
 
QOL 
Interpretation 
Base line 3
rd
  month 6
th
 month 
Chi square test 
No. % No. % No. % 
Poor 157 80.5%   93 47.7%   45 23.1% 2=174.19 
P=0.001*** 
DF=4  S 
Moderate    38 19.5% 102 52.3% 122 62.6% 
Good      0 0.0%     0 0.0%    28 14.3% 
        *** very high   significant at   P≤0.001 
 
Table 5.2.5 (c) shows  number and percentage distribution in overall  quality 
of life score in experimental group of the HIV infected adolescents. In baseline 
assessment, the majority of 81% of the participants had poor QOL and 20% had 
moderate QOL.  The next assessment of the 3
rd
 month, 48 % of participants had poor 
QOL and 52% had moderate QOL and none of them had good QOL .At the 6
th
 month 
evaluation, only 23% in poor QOL, 63 % had moderate QOL and 18 % of adolescents 
achieved good QOL. The chi square value of 174.19 is significant at p =0.001***. It 
depicts that there is significant improvement in quality of life of HIV infected 
adolescents in experimental group.  
 
Table 5.2.5(d ):  Number and percentage distribution in overall  quality of life 
score in control group of the HIV infected adolescents 
 
QOL 
Interpretation 
Base line 3
rd
  month 6
th
 month Chi square 
test No. % No. % No. % 
Poor 160 82.9% 155 80.3% 151 78.2% 2=1.34  
P=0.51 
DF=2 
NS 
Moderate 33 17.1% 38 19.7% 42 21.8% 
Good    0     0.0%     0     0.0%     0     0.0% 
 193 100.0% 193 100.0% 193 100.0% 
         Not significant P >0.05 
 
  Table 5.2.5 (d) shows number and percentage distribution in overall quality of 
life score in control group of the HIV infected adolescents. In the baseline assessment, 
the majority 83% of the HIV infected adolescents had poor QOL and 17% had 
moderate QOL. In subsequent evaluation, it is increased to 19% and 23% respectively 
in moderate QOL. There is no participants had good QOL throughout study period. 
The chi square value of 1.34 is not significant at p>0.05. 
Fig 5.2.5(c):  Percentage wise distribution of overall QOL scores in experimental
group of HIV infected adolescents
Fig 5.2.5(d) :Percentagewise distribution of  overall QOL scores in control group
of HIV infected adolescents.
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SECTION III 
 
5.3:   Compares and determines the effectiveness of HIV interventional package 
in both groups of HIV infected adolescents. 
 
5.3.1: Compares the overall level of CD4 count in both groups of HIV infected 
adolescents. 
 
5.3.1(a): Compares the number and percentage distribution in overall level of 
CD4 count in both groups of HIV infected adolescents. 
S. 
No. 
CD4 Count 
Experimental Control 
‘0’ month 6th month ‘0’ month 6th month 
No. % No. % No. % No. % 
1 301-600 Cells   92 47.2% 18 9.2%   95 49.2%  58 30.1% 
2 601-900 Cells 77 39.5% 119 61.0%   80 41.5% 109 56.5% 
3 901-1200 
Cells 
19   9.7%  46 23.6%   13   6.7 %   23 11.9% 
4 >1200 Cells   7   3.6% 12 6.2%    5  2.6%     3   1.5% 
    Chi square value 2=71.47 P=0.001***  
DF=3  S 
2=3.89 P=0.14 
 DF=2   NS 
 Not significant P >0.05, *** very high   significant at   P≤0.001 
 
Table 5.3.1(a) shows the number and percentage distribution in overall level 
of CD4 count in both groups of HIV infected adolescents. In experimental group, 
40% are in 601-900 cells/mm
3
, 10% are in 901-1200 cells/mm
3
 and only 4 % are 
>1200 cells/mm
3
 of CD4 count in baseline assessment. But on 6
th
 month evaluation it 
is increased to 61 % , 23 % and 6 % in respective of the CD4 counts and only 9% are 
in  the CD4 count of 301-600 cells/mm
3
. The chi square value of 71.47 is significant 
at P=0.001***. While in control group, there is no marked improvement in CD4 
count from baseline to 6
th
 month evaluation. The chi square value 3.89 is not 
significant at P=0.14. It reveals that there is significant improvement in the level of 
CD4 count in the experimental group than the control group of HIV infected 
adolescents.   
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Table 5.3.1(b): Effectiveness of HIP in mean and SD level of CD4 count in both 
groups of HIV infected adolescents. 
 
Group 
Baseline 6
th
 month 
Paired 
t-test Mean SD 
Mean 
difference 
Mean SD 
Mean 
difference 
Experiment 
664.86 221.688 
4.86 
840.30 231.671 
136.96 
t=7.21  
P=0.001*** 
S 
Control  
669.72 174.703 703.35 165.724 
t=1.62 
p=0.12  NS 
    Not significant P >0.05, *** very high significant at  P≤0.001 
 
 
Table 5.3.1 (b) shows the effectiveness of HIP in mean and SD level of CD4 
count in both groups of HIV infected adolescents.  In baseline assessment, the mean 
score is 664.86 in experimental group and 669.72 in control group. The mean 
difference is 4.86. Whereas in the 6
th
 month assessment of mean score in experimental 
and control group is 840.30 and 703.35 respectively. The mean difference is 136.96. 
The paired t-test value of 7.21 is significant at p=0.001*** in experimental group. It 
depicts that the CD4 count is increased in experimental group than the control group. 
Fig 5.3.1: Comparison of percentagewise of distribution in overall level of
CD4 count of HIV infected adolescents in both groups.
Overall Level of CD4 Count
Fig 5.3.1(a):  Effectiveness of HIP in mean level of CD4 count of HIV infected
adolescents in both groups
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
0 Month 6 Month 0 Month 6 Month
47%
9%
49%
30%
39.5%
61%
42%
56%
9.7%
24%
7%
12%
3.6% 6% 3% 2%
301-600cells
601-900cells
901-1200cell
more than
1200cells
0
100
200
300
400
500
600
700
800
900
Baseline 6th month
664.86
840.3
669.72
703.35
M
ea
n 
sc
or
e
Mean Level of CD4 Count
Experimental
Control
Experiment Control
Pe
rc
en
ta
ge
158 
 
Table 5.3.2: Compares the overall level  of ART adherence in  both groups of 
  HIV infected adolescents by various methods 
Table 5.3.2(a): Compares the number and percentage distribution in overall level 
of ART adherence in experimental group of HIV infected adolescents by various 
methods 
S. 
No. 
Methods 
Experimental Group Chi 
Square 
value 
‘0’ Month 3rd Month 6th Month 
No. % No. % No. % 
1. ‘5’point response 
Optimal  
30 15.4% 177 90.8% 195 100.0% 
2=392.99 
p=0.001** 
DF=2 
S 
Sub optimal  135 69.2% 18 9.2% 0 0.0% 
Poor  30 15.4%       0 0.0% 0 0.0% 
2. Visual analog 
Optimal 
29 14.9% 99 50.8% 152 77.9% 
2=191.4 
p=0.001*** 
DF=4 
S 
Sub optimal  134 68.7% 96 49.2% 43 22.1% 
Poor  32 16.4% 0 0.0% 0 0.0% 
3. ‘3’ days recall  
Optimal 
123 63.1% 160 82.1% 184 94.4% 
2=60.1 
p=0.001*** 
DF=2 
S 
Sub optimal  72 36.9% 35 17.9% 11 5.6% 
Poor  0 0.0% 0 0.0% 0 0.0% 
4. Pill count method 
Optimal 
85 43.6% 170 87.2% 181 92.8% 
2=149.14 
p=0.001*** 
DF=2 
S 
Sub optimal  110 56.4% 25 12.8% 14 7.2% 
Poor        0 0.0%        0 0.0% 0 0.0% 
       *** very high   significant at   P≤0.001 
 
  Table 5.3.2(a) compares the overall level of ART adherence in experimental 
group of HIV infected adolescents by various methods .With regard to ‘5’ point 
response scale, only 15 % had  optimal level adherence in baseline assessment but its  
reached 100% in 6
th
 month evaluation. The chi square value of 392.99 is significant at 
the p=0.001***. Regarding the visual analog method, the baseline assessment 
only15% had optimal level adherence, whereas in the 6
th
 month it’s increased to 78%. 
The chi square value of 191.4 is significant at the p=0.001***. Consider with ‘3’ days 
recall method, 63% had optimal level adherence in baseline method, but it’s increased 
to 94%. The chi square value of 60.1 is significant at the p=0.001***. In consideration 
of pill count method, 44% had optimal level adherence in baseline method, but it’s 
increased to 93%. The chi square value of 149.14 is significant at the p=0.001***. It 
denotes that there is significant improvement in the adherence level among HIV 
infected adolescents in the experimental group.  
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Table 5.3.2 (b) : Compares overall level of ART adherence in control group of 
HIV infected adolescents by various methods. 
S. 
No. 
Methods 
Control Group Chi 
Square 
value 
‘0’ Month 3rd Month 6th Month 
No. % No. % No. % 
1. ‘5’point response 
Optimal 
33 17.1% 35 18.1% 35 18.1% 
2
=0.19 
p=099 
DF=2 
NS 
Sub optimal  132 68.4% 130 67.4% 132 68.4% 
Poor  28 14.5% 28 14.5% 26 13.5% 
2. Visual analog method 
Optimal 
27 14.0% 31 16.1% 35 18.1% 
2
=13.1 
p=0.01** 
DF=4 
S 
Sub optimal  132 68.4% 131 67.9% 146 75.6% 
Poor  34 17.6% 31 16.1% 12 6.2% 
3. ‘3’ days recall method 
Optimal 
121 62.7% 123 63.7% 128 66.3% 
2=0.58 
p=0.74 
DF=2 
NS 
Sub optimal  72 37.3% 70 36.3% 65 33.7% 
Poor  0 0.0% 0 0.0% 0 0.0% 
4. Pill count method 
Optimal 
73 37.8% 81 42.0% 93 48.2% 
2
=4.29 
p=0.11 
DF=2 
NS 
Sub optimal  120 62.2% 112 58.0% 100 57.8% 
Poor  0 0.0% 0 0.0% 0 0.0% 
  ** highly significant at P≤ 0.01  
 
  Table 5.3.2(b) compares overall level of ART adherence in control group of 
HIV infected adolescents by various methods. In regard to ‘5’ point response scale, 
there is no marked improvement in adherence rate from baseline to 6
th
 month 
evaluation. The chi square value of 0.19 is not significant at the p=0.99. In relevant to 
drug color method, the baseline assessment only14% had optimal level adherence, 
whereas in 6
th
 month it’s increased to 18%. The chi square value of 13.1 is significant 
at the p=0.01**. Consider with ‘3’ days recall method, 63% had optimal level 
adherence in baseline method, but it’s slightly increased to 66%. The chi square value 
of 0.58 is not significant at the p=0.74. 
 In consideration of pill count method, 38% had optimal level adherence in 
baseline method, but it’s markedly increased to 48%. Still the chi square value of 4.29 
is not significant at the p=0.11.  It depicts that there is no significant changes in 
control group of HIV infected adolescents. Even though there were many different 
adherence rates were estimated in various methods, the missed dose history was 
correlated with pill count method only. So the investigator has taken the mean 
adherence score of pill count method in order to evaluate the effectiveness of 
adherence improvement in both groups. 
Fig. 5.3.2: Compares  overall level of ART adherence by pill count method in both groups of HIV infected adolescents.
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Table 5.3.2 (c): Effectiveness of HIP in mean level of ART adherence score in 
both groups of HIV infected adolescents. 
Groups  
Mean   
ART 
Adherence 
Mean Difference in 
ART score  with 
95% Confidence 
interval 
Percentage  of  
ART  adherence 
gain  score with 
95% Confidence 
interval 
Experimental Pretest 85.36               13.38 
    (11.91 – 14.84) 
             13.4% 
    (11.9% –14.8%) Posttest 98.74 
Control Pretest 85.60                4.94 
        (3.26 – 6.61) 
              4.9% 
      (3.3% –6.6%) Posttest 90.54 
 
  Table 5.3.2(c) shows effectiveness of HIP in mean level of ART adherence 
score in both groups of the HIV infected adolescents. In experimental group, the mean 
ART adherence score in pretest is 85.36 and post test score is 98.74. The mean 
difference in ART score with 95% confidence interval is 13.38 and percentage of 
adherence gain score is 13.4%. However, in control group, the mean ART adherence 
score in pretest is 85.60 and post test score is 90.54. The mean difference in ART 
score with 95% confidence interval is 4.94   and percentage of adherence gain score is 
only 4.9%. It denotes that there is marked improvement in adherence level of HIV 
infected adolescents in experimental group than the control group. 
5.3.3: Comparison of overall level of nutritional score of HIV infected 
adolescents in both groups 
Table 5.3.3(a) : Comparison on interpretation of ‘Z’ score of HIV infected 
adolescents in    both groups 
Z-score 
Experimental Control  
Baseline 3
rd
 month 6
th
 month Baseline 3
rd
 month 6
th
month 
No.  % No. % No. % No. % No. % No. % 
Severely 
malnourished 
13 6.7 9 4.6% 2 1.0% 11 5.7% 10 5.2% 9 4.7% 
Moderately 
malnourished 
42 21.5 38 19.5% 35 17.9% 45 23.3% 44 22.8% 44 22.8% 
 
Normal 140 71.8 148 75.9% 158 81.1% 137 71.0% 139 72.0% 140 72.5% 
Chi square 
test 
2=9.48p=0.05* 
Significant 
2=0.10p=0.99 
Not significant 
Not significant P >0.05, * significant at P≤0.05 
 
Table 5.3.3(a) compares the interpretation of ‘Z’ score on HIV infected 
adolescents in experimental and control group. In experimental group of HIV infected 
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adolescents, 7% were severely mal nourished, 22 % were moderately malnourished  
and 72 % were normal in their nutritional status in baseline assessment. Whereas in 
subsequent evaluation, the severely and moderate malnourished adolescents were 
reduced to 4.6% &19.5% at 3
rd
 month and 1% & 18% at 6
th
 month respectively. The 
normal adolescent’s percentage is increased to 76 % and 81 % for further respective 
evaluation periods. The chi square value of 9.48 is significant at level of p=0.05. 
Whereas in control group there is no marked improvement in throughout the study 
period. The chi square value of 0.10 is not significant at level of   p=0.99. 
Table 5.3.3 (b): Effectiveness of HIP on nutritional gain score in both groups of 
the HIV infected adolescents. 
 
Groups  
Nutritional status 
Baseline 6
th
 month 
% of 
Nutritional 
Gain score 
Experimental Normal 140(71.8%) 158(81.1%) 
9.3% 
Malnourished 55(28.2%) 37(18.9%) 
Control Normal 137(71.0% 140(72.5%) 
1.5% 
Malnourished 56(29.0%) 53(27.5%) 
 
  Table 5.3.3 (b) shows effectiveness of HIP on nutritional gain score in both 
groups of the HIV infected adolescents. In experimental group, 72 % were only in 
normal level and 28% were malnourished. However in the 6
th
 month the normal level 
is increased to 82% and malnourished adolescents are reduced to 19%. The 
percentage wise nutritional gain score is 9.3%. Whereas in control group, 71 % were 
only in normal level and 29% were malnourished. But in the 6
th
 month the normal 
level is increased to only 72% and malnourished adolescents are reduced to 28%. The 
percentage wise nutritional gain score is only 1.5 %. It depicts that the experimental 
group has gained more score than the control group.  
 
 
 
 
 
Fig 5.3.3: Comparison of ‘Z’ score distribution in both groups of HIV Infected
adolescents.
Fig 5.3.3(a): Effectiveness of HIP on Nutritional gain score in both groups of
HIV infected adolescents
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Table 5.3.4:       Compares the mean and standard deviation in quality of life 
    score in both groups of the HIV infected adolescents. 
 
Table 5.3.4 (a) : Comparison of baseline level of the mean & S.D of quality of life 
       score in both groups of the HIV infected adolescents. 
S. 
No. 
Quality of life 
Domains 
 
Group 
QOL 
mean 
difference 
Student 
independent 
t-test 
Experimental Control 
Mean SD Mean SD 
1 General Health Ratings 34.83 4.31 34.32 2.17 0.51 t=1.45 P=0.15 NS 
2 Physical Functioning 17.10 1.35 17.31 1.42 0.20 t=1.44 P=0.15 NS 
3 Psychological 
Wellbeing 
54.82 4.24 54.17 3.30 0.64 t=1.67 P=0.10 NS 
4 Social Role Functioning   4.25   .43 4.19   .39 0.06 t=1.42 P=0.16 NS 
5 Healthcare Services   3.75  .54 3.66   .81 0.09 t=1.30 P=0.19 NS 
6 Symptoms 48.92 2.48 49.28 5.17 0.36 t=0.88 P=0.37 NS 
 Total 163.66 6.22 162.93 4.85 0.73 t =1.30 P=0.19 NS 
Not significant P >0.05 
 
  Table 5.3.4(a) shows comparison of baseline level of the mean & S.D of 
quality of life score in both groups of the HIV infected adolescents. In all the QOL 
domain in both groups had more as less equal mean value. i.e., the total mean value is 
163.7 and 162.9 respectively and the mean difference score is 0.73. It is tested with 
student independent t-test and proved that all variables are not significant. It denotes 
that there is no difference in the quality of life score of HIV infected adolescents in 
both groups. 
 
Table 5.3.4 (b) : Comparison of 3
rd
 month level of the mean & S.D of quality of 
life score in both groups of the HIV infected adolescents 
S. 
No. 
Quality of life 
Domains 
Group QOL 
mean 
difference 
Student independent 
t-test 
Experimental Control 
Mean SD Mean SD 
1 General Health 
Ratings 
39.11 4.47 34.34 2.17 4.77 t=13.32 P=0.001*** S 
2 Physical Functioning 19.43 1.40 17.37 1.49 2.06 t=13.99 P=0.001*** S 
3 Psychological 
wellbeing 
58.04 4.35 54.46 3.27 3.58 t=  9.16 P=0.001*** S 
4 Social Role 
functioning 
6.30 .56 4.27 .45 2.02 t=39.30 P=0.001*** S 
5 Health care services 6.86 .73 3.78 .86 3.07 t=38.03 P=0.001*** S 
6 Symptoms 58.02 2.72 50.10 5.16 7.92 t=18.94 P=0.001*** S 
 Total 187.75 6.84 164.32 5.22 23.43 t=37.89 P=0.001*** S 
    ***Very high   significant at   P≤0.001  
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Table 5.3.4 (b) shows comparison of the 3
rd
 month level of the mean & S.D of 
quality of life score in both groups of the HIV infected adolescents. In experimental 
group, there is slight improvement in all QOL domains i.e., the total mean value is 
increased from 163.6 to 187.8 Where as in control group, its  increased from  162.9 to 
164.3 only and  the total mean difference score is 23.43.  The t-test is used to prove 
the significance in all QOL domains at p≤0.001***. 
 
 
Table 5.3.4(c): Comparison of 6
th
 month level of the mean & S.D of quality of life 
score in both groups of the HIV infected adolescents 
 
S. 
No 
Quality of life 
Domains 
Group 
QOL mean 
difference 
Student independent 
t-test 
Experimental Control 
Mean SD Mean SD 
1 General health 
ratings 
40.01 12.27 34.47 2.18 5.53 t=6.17 P=0.001*** S 
2 Physical 
functioning 
23.63 2.12 17.54 1.67 6.08 t=31.34 P=0.001*** S 
3 Psychological 
wellbeing 
60.97 5.15 54.81 3.28 6.16 t=14.05 P=0.001*** S 
4 Social Role 
functioning 
9.94 1.73 4.42 .60 5.51 t=41.89 P=0.001*** S 
5 Health care 
Services 
13.36 1.82 3.97 .98 9.38 t=63.19P=0.001*** S 
6 Symptoms 67.74 6.16 50.80 4.79 16.94 t=30.22 P=0.001*** S 
 Total 215.64 16.10 166.02 5.33 49.61 t=40.66 P=0.001*** S 
       *** very high significant at   P≤0.001 
 
 
  Table 5.3.4 (c) shows comparison of the 6
th
 month level of the mean & S.D of 
quality of life score in both groups of the HIV infected adolescents. In experimental 
group, there is marked  improvement in all QOL domains i.e., the total mean value is 
increased from 163.6 to 215.6 Whereas in control group, its increased from  162.9 to 
166.02 only  and the total mean difference score is 49.61.  The t-test is used to prove 
the significance in all QOL domains at p≤0.001***. 
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Table 5.3.4 (d): Effectiveness of HIP on quality of life score in both groups of the 
HIV infected adolescents 
Groups Assessment 
Mean 
QOL 
score 
Mean Difference 
in QOL score  
with 95% 
Confidence 
interval 
Percentage  of   
QOL gain score 
with 95% 
Confidence 
interval 
Experimental Baseline  163.66             51.97 
   (49.97 – 53.97) 
         15.1% 
(14.8% –16.0%) 6th  month 215.64 
Control Baseline  162.93              3.09 
      (2.48 – 3.70) 
          0.9% 
     (0.7% –1.1%) 6th  month 166.02 
 
  Table 5.3.4 (d) shows effectiveness of HIP on quality of life score in both 
groups of the HIV infected adolescents.  In experimental group, the mean QOL score 
in pretest is 163.66 and post test score is 215.64. The mean difference in QOL score 
with 95% confidence interval is 51.97 and percentage of QOL gain score is 15.1%. 
However, in control group, the mean QOL score in pretest is 162.93 and post test 
score is 166.02. The mean difference in QOL score with 95% confidence interval is 
3.09 and percentage of QOL gain score is only 0.9%. It denotes that there is marked 
improvement in QOL level of HIV infected adolescents in experimental group than 
the control group. 
 
Table 5.3.5: Overall effectiveness of HIP components in both groups of the HIV 
infected adolescents 
S.No. HIP Components 
Percentage wise gain score 
Experimental Control Difference 
1. Adherence rate 13.4% 4.9%   8.5% 
2. Nutritional status   9.3% 1.5%          7.8% 
3. QOL score  15.1% 0.9% 14.2% 
  
  Table 5.3.5 shows overall effectiveness of HIP on various components in both 
groups of the HIV infected adolescents. In adherence rate, the experimental group has 
gained 13.4% and control group 4.9%.The difference is 8.5%.Considering with   
nutritional status, the gain score is 9.3% in experimental group and 1.5% in control 
group. The difference is 7.8%. In regard to QOL the gain score is 15.1% in 
experimental group and 0.9% in control group where the difference is 14.2%.It 
reveals that, the experimental group has gained more score than the control group.   
Fig 5.3.4:   Box  plot  diagram  shows  the  pre  and   post test   level  of overall
  mean QOL score of HIV infected adolescents in both groups
Fig 5.3.5: Overall effectiveness of HIP components in both groups of the
HIV infected adolescents.
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SECTION- IV 
 
Section 5.4: This section correlates the HIP components of ART adherence, 
nutritional status and QOL of HIV infected adolescents in both 
groups 
Table 5.4.1: Correlation between ART adherence  and nutritional status of HIV 
infected adolescents in both groups 
Groups Assessment 
Karl Pearson 
correlation 
coefficient 
Interpretation 
Experimental Baseline       r = 0.17 
p = 0.26 
There is a poor correlation between 
ART and Nutritional score 
3
rd
 month r = 0.31 
p = 0.01** 
There is a Fair correlation 
between  ART and Nutritional score 
6
th
 month r = 0.42  
p = 0.001*** 
There is a Moderate correlation 
between ART and Nutritional score 
Control Baseline r = 0.16 
p = 0.28 
There is a poor correlation between 
ART and Nutritional score 
3
rd
 month r = 0.17 
p = 0.25 
There is a poor correlation between  
ART and Nutritional score 
6
th
 month r =  0.19 
p = 0.22 
There is a poor correlation between 
ART and Nutritional score 
 
  Table 5.4.1 shows correlation between the ART adherence and nutritional 
status of HIV infected adolescents in both groups by Karl Pearson correlation 
coefficient. In experimental group, the baseline assessment shows that there is a poor 
correlation between ART adherence and nutritional score. But in, the 3
rd
 month there 
is fair correlation between ART adherence and nutritional score since r=0.31 
significant at p=0.01** and in the 6
th
 month there is moderate correlation between 
ART adherence and nutritional score since r=0.42 significant at p=0.001***. Whereas 
in control group, throughout the assessment period shows that there is a poor 
correlation between ART adherence and nutritional score because of ‘r’ value is lesser 
than 0.2. This table depicts that the adherence and nutrition are directly propositional 
it reveals that there is a positive correlation between the ART adherence and 
nutritional status of the HIV infected adolescents in experimental group. 
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Table 5.4.2: Correlation between ART adherence and QOL score of HIV 
infected adolescents in both groups 
Groups Assessment 
Karl Pearson 
correlation 
coefficient 
Interpretation 
Experimental Baseline r = 0.17 
p = 0.26 
There is a Poor correlation 
between ART and QOL score 
3
rd
 month r = 0.31 
p = 0.05* 
There is a Fair correlation 
between ART and QOL score 
6
th
 month r = 0.43  
p = 0.001*** 
There is a Moderate correlation 
between ART and QOL score 
Control Baseline r =  0.16 
p = 0.28 
There is a Poor correlation 
between ART and QOL score 
3
rd
 month r = 0.18 
p = 0.25 
There is a Poor correlation 
between ART and QOL score 
6
th
 month r = 0.20 
p = 0.22 
There is a Poor correlation 
between ART and QOL score 
 
  Table 5.4.2 shows correlation between ART adherence and QOL of HIV 
infected adolescents in both groups by Karl Pearson correlation coefficient. In 
experimental group, the baseline assessment shows that there is a poor correlation 
between ART and QOL score. But in, 3
rd
 month there is fair correlation between ART 
and QOL score since r=0.31 significant at p=0.05** and in 6
th
 month there is 
moderate correlation between ART and QOL score since r=0.43 significant at 
p=0.001***. Whereas in control group, throughout the assessment period shows that 
there is a poor correlation between ART and QOL score because of ‘r’ value is lesser 
than 0.2. This table denotes that the ART adherence and QOL are directly 
propositional and it reveals that there is a positive correlation between the ART 
adherence and QOL of the HIV infected adolescents in experimental group. 
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SECTION-V 
 
5.5: This section associates the relationship between the HIP components of ART 
adherence; Nutritional status and QOL of HIV infected adolescents in both 
groups.  
5.5.1: Associates the ART adherence gain score with demographic variables of 
HIV infected adolescents with their caregivers in both groups 
   5.5.1(a): Association between the ART adherence gain  score with demographic 
variables of HIV infected adolescents/ caregivers in experimental group. 
S. 
No. 
Demographic variables No. 
ART Adherence Gain Score 
One way 
ANOVA/ 
t-test 
Pretest Posttest 
Gain score 
Post - Pre test 
score 
Mean SD Mean SD Mean SD 
1. Age of  10 -12 years 60 82.84 10.75 97.73 2.74 15.89 9.09 F=3.02 
 P=0.05*  
S 
  adolescents 13 -15 years 91 86.42 9.26 99.67 1.26 13.25 9.15 
   16 -18 years 44 85.88 10.21 98.63 2.80 11.45 9.95 
2. Sex Male 97 84.31 10.48 99.02 2.24 14.71 9.77 t=2.13  
 P=0.03* 
S 
   Female 98 85.41 9.76 97.47 2.73 12.06 9.35 
3. Education Primary 44 86.93 9.95 99.55 1.81 12.61 8.99 F=0.24  
P=0.87 
 NS 
   Middle 77 84.94 10.24 98.83 2.68 13.90 9.75 
   Secondary 59 85.17 10.17 98.22 2.59 13.05 9.83 
   Higher 
secondary 
15 83.67 9.90 98.00 2.54 14.33 9.61 
4. Religion Hindu 165 84.73 10.20 98.52 2.66 13.79 9.63 F=1.33  
P=0.26 
 NS 
   Muslim 26 89.42 8.29 100.00 .00 10.58 8.29 
   Christian 4 85.00 12.91 100.00 .00 15.00 12.91 
5. Age of  20 -35 years 49 84.11 10.71 100.10 2.79 15.99 9.35 F=3.06  
P=0.05*  
S  
 caregivers 36 -50 years 136 85.11 10.71 98.35 2.79 13.24 9.17 
   > 50 years 10 88.50 13.34 98.50 2.42 10.00 10.30 
6. Sex Male 59 85.11 10.28 97.15 2.73 12.04 9.84 t=1.98 
P=0.05* S    Female 136 85.93 9.71 100.76 1.57 14.83 8.89 
7. Relationship  Father 24 85.00 10.62 98.15 2.83 13.15 9.98 F=2.04 
P=0.04*   
S 
 with Mother 52 82.75 8.88 100.23 2.04 17.48 7.89 
 adolescents Caregiver 119 86.92 9.35 98.01 1.18 11.09 9.20 
8. Education No formal 
education 
38 87.37 10.95 99.47 1.94 12.11 10.11 
F=0.81 
 P=0.44 
NS    School level 97 84.74 10.22 98.97 2.16 14.23 9.69 
   College level 60 85.08 9.32 97.92 3.09 12.83 8.94 
9 Occupation Employed 85 87.24 9.90 99.65 1.50 12.41 9.37 F=1.09  
P=0.33 
NS  
   Not Employed 28 82.14 10.67 97.50 3.47 15.36 10.80 
   Not applicable 82 84.51 9.83 98.23 2.65 13.72 9.26 
10. Annual  < Rs.12000 31 83.87 11.95 97.42 3.62 13.55 11.12 F=0.17  
p=0.91 
NS 
  income  Rs.12000 -
24000 
70 86.50 9.94 99.71 1.17 13.21 9.67 
    > Rs.24000 12 88.33 6.85 100.00 .00 11.67 6.85 
   Not applicable 82 84.51 9.83 98.23 2.65 13.72 9.26 
11. Residence Rural 88 86.14 9.67 101.06 1.56 14.92 9.05 t=1.97 
P=0.05* S    Urban 107 85.82 10.43 98.04 2.89 12.22 9.98 
Not significant P >0.05, * significant at P ≤ 0.05 
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5.5.1(b) Association between  the ART adherence gain score with demographic 
variables of HIV infected adolescents/caregivers in control group 
S. 
No. 
Demographic variables No. 
ART adherence gain score 
One 
way 
ANOVA
/t-test 
Pretest Posttest 
Gain score Post 
test-Pre test 
score 
Mean SD Mean SD Mean SD 
1. Age of  
adolescent 
10 -12 years 68 86.03 9.87 89.56 7.21 3.53 11.94 F=0.70 
P=0.49  
NS 
 13 -15 years 78 84.62 9.07 90.26 6.97 5.64 11.99 
 16 -18 years 47 86.60 10.53 92.45 5.30 5.85 13.20 
2. Sex 
  
Male 109 84.68 9.98 89.40 6.93 4.72 13.09 t=0.28 
 P=0.77  
NS  
 
Female 84 86.79 9.27 92.02 6.26 5.24 11.16 
3. Education Primary 43 86.86 9.20 88.84 6.71 1.98 11.24 F=1.43  
P=0.28  
NS 
 Middle 85 84.71 9.74 90.47 7.26 5.76 12.64 
 Secondary 50 86.80 8.85 91.80 5.60 5.00 10.35 
 H.Secondary 15 83.00 13.20 91.67 6.99 8.67 17.37 
4. Religion Hindu 148 86.42 9.49 90.44 6.70 4.02 12.03 F=1.08 
 P=0.33  
NS 
 Muslim 36 82.92 10.65 88.36 5.79 5.44 13.30 
 Christian 9 82.78 7.55 85.00 8.66 2.22 9.55 
5. Age of  
caregiver 
20 -35 years 49 86.33 11.12 88.37 7.53 2.04 13.88 F=1.81  
P=0.15 
NS 
 36 -50 years 125 86.12 9.00 91.40 6.37 5.28 11.31 
 > 50 years 19 84.26 9.20 90.53 6.21 6.26 12.41 
6. Sex 
 
Male 65 84.46 10.39 91.00 5.94 6.54 12.68 t=1.28 
P=0.20 
NS 
 Female 128 86.17 9.34 90.31 7.15 4.14 12.01 
7. Relationship  
with 
adolescents 
Father 22 87.27 9.73 92.05 6.48 4.77 10.96 F=0.96 
P=0.38  
NS 
 Mother 43 85.47 11.69 92.67 6.93 7.21 13.02 
 Caregiver 128 85.35 9.01 89.57 6.58 4.22 12.21 
8. Education No formal 
education 
53 86.79 10.15 89.81 6.86 3.02 13.10 
F=1.10 
 P=0.33  
NS  School level 94 85.53 9.05 91.17 7.20 5.64 11.48 
 College level 46 84.35 10.52 90.11 5.63 5.76 12.82 
9. Occupation Employed 94 86.91 9.01 89.31 7.17 2.39 11.59 F=0.90 
P=0.41  
NS 
 Not 
Employed 
21 87.86 10.44 93.10 6.80 5.24 9.15 
 Not 
applicable 
78 84.40 10.02 91.35 5.96 6.95 13.18 
10. Annual 
income 
< Rs.12000 25 87.20 8.67 87.20 5.02 .00 10.99 F=1.99  
P=0.11  
NS  
  Rs.12000 -
24000 
83 85.54 9.78 90.18 7.55 4.64 12.68 
  > Rs.24000 7 90.00 11.55 97.14 3.93 7.14 10.75 
 Not 
applicable 
78 84.74 9.80 91.41 5.97 6.67 12.05 
11. Residence Rural 90 86.89 8.20 90.44 6.16 3.56 10.97 t=1.48 
P=0.14 
NS 
 Urban 103 84.47 10.78 90.63 7.27 6.17 13.21 
Not significant P > 0.05 
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   Table 5.5.1(a) shows association between the ART adherence gain score with 
demographic variables of HIV infected adolescents / caregivers in experimental 
group. In that, the age and sex of adolescent, caregiver’s age, sex, relationship with 
adolescents and residence variables are shows significant association with adherence 
gain score. Regarding age and sex of adolescents, the younger age of 10-12 years and 
males are gained high gain score of 15.89 and 14.71 and it is significant at the  
p≤0.05* and 0.03*. In consideration with caregivers age and sex, the younger age of  
20-35 years and females gained high gain score of 15.99 and 14.83 are significant at  
p≤0.05*.  
In regard to relationship with adolescents and residential area, the high gain 
score of 17.48 and 14.99 is seen with mothers and adolescents residing in rural areas. 
It is significant at p≤0.04* and 0.05* respectively. The rest of other demographic 
variables are not associated with adherence gain score. This table reveals that, there is   
a significant association between the adherence levels of HIV infected adolescents 
with specific demographic variables of HIV infected adolescents/caregivers. 
Table 5.5.1(b) shows association between the ART adherence gain score with 
demographic variables of HIV infected adolescent/ caregivers in control group. The 
gain score difference is not significant in one way analysis of variance F-test and 
student independent test. Here none of the variables are significant with adherence 
gain score. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5.5.1(a): Association of ART adherence gain score with demographic variables of HIV Infected adolescents/care givers in
experimental group
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5.5.2: Associates the nutritional status with demographic variables of HIV  
infected adolescents /caregivers in both groups 
5.5.2(a):   Association between the nutritional status with demographic variables 
of HIV infected adolescents/ caregivers in experimental  group. 
 
S. 
No. 
Demographic variables 
Normal Malnourished 
Total 
Chi square 
test No. % No. % 
1. Age of  
adolescents 
  
10 -12years 55 91.7% 5 8.3% 60 2=15.85 
P=0.001*** 
S 
 13 -15years 76 83.5% 15 16.5% 91 
 16 -18years 27 61.4% 17 38.6% 44 
2. Sex Male 78 80.4% 19 19.6% 97 2=0.05 
P=0.82 
NS 
   Female 
80 81.6% 18 18.4% 98 
3 Education Primary 41 93.2% 3 6.8% 44 
2=15.44 
P=0.001*** 
S 
   Middle 67 87.0% 10 13.0% 77 
   Secondary 41 69.5% 18 30.5% 59 
   H.secondary 9 60.0% 6 40.0% 15 
4. Religion Hindu 129 78.2% 36 21.8% 165 2=5.68 
P=0.06 
NS 
   Muslim 25 96.2% 1 3.8% 26 
   Christian 4 100.0%   4 
5. Age of  20 -35years 46 93.9% 3 6.1% 49 2=7.10 
P=0.03* 
S 
  caregivers 36 -50years 105 77.2% 32 22.8% 136 
   > 50 years 8 80.0% 2 20.0% 10 
6. Sex  Male 41 69.4% 18 30.6% 59 2=7. 32 
P=0.01** 
S 
   Female 
117 86.0% 19 14.0% 136 
7. Relationship 
with 
adolescents 
Father 20 83.3% 4 16.7% 24 2=6.64 
P=0.04* 
S 
 Mother 48 92.3% 4 7.7% 52 
 Caregivers 90 75.6% 29 24.4%  119 
8. Education No formal 
education 
30 78.9% 8 21.1% 38 
2=0.33 
P=0.84 
NS 
   Scholl level 78 80.4% 19 19.6% 97 
   college  
level 
50 83.3% 10 16.7% 60 
9. Occupation Employed 70 82.4% 15 17.6% 85 
2=3.43 
P=0.17 
NS 
   Not 
Employed 
20 71.4% 8 28.6% 28 
   Not 
applicable 
72 87.8% 11 12.2% 82 
10. Annual 
income 
< Rs.12000 
24 77.4% 7 22.6% 31 
2=0.54 
P=0.90 
NS 
   Rs.12000 -
24000 
56 80.0% 14 20.0% 70 
   > Rs.24000 10 83.3% 2 16.7% 12 
   Not 
applicable 
68 82.9% 14 17.1% 82 
11. Residence Rural 77 87.5% 11 12.5% 88 2=4.37 
P=0.05* 
 S 
   
Urban 81 75.7% 26 24.3% 107 
 
Not significant P >0.05, * significant at P≤0.05, *** very high significant at  P≤0.001 
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5.5.2( b) : Association between the nutritional status with demographic variables 
of HIV infected adolescents / caregivers in control  group 
S. 
No. 
Demographic  variables 
Normal Malnourished 
Total 
Chisquare 
test No.  % No.  % 
1. Age of  10 -12 years 54 79.4% 14 20.6% 68 2=3.42 
P=0.18 
NS 
adolescents 13 -15 years 56 71.8% 22 28.2% 78 
  16 -18 years 30 63.8% 17 36.2% 47 
2. Sex Male 85 78.0% 24 22.0% 109 2=3.72 
P=0.6 NS   Female 55 65.5% 29 34.5% 84 
3. Education Primary 35 81.4% 8 18.6% 43 
2=6.55 
P=0.08 
NS 
  Middle 65 76.5% 20 23.5% 85 
  Secondary 30 60.0% 20 40.0% 50 
  H.secondary 10 66.7% 5 33.3% 15 
4. Religion Hindu 108 73.0% 40 27.0% 148 2=4.77 
P=0.09 
NS 
  Muslim 23 63.9% 13 36.1% 36 
  Christian   9 100.0%   9 
5. Age of  20 -35 years 39 79.6% 10 20.4% 49 2=3.81 
P=0.15 
NS 
caregivers 36 -50 years 85 68.0% 40 32.0% 125 
  > 50 years 16 84.2% 3 15.8% 19 
6. Sex  Male 45 69.2% 20 30.8% 65 2=0. 53 
P=0.46 
NS 
  
Female 95 74.2% 33 25.8% 128 
7. Relationship  
with 
adolescents 
Father 18 81.8% 4 18.2% 22 2=3.98 
P=0.13 
NS 
Mother 35 81.4% 8 18.6% 43 
Caregivers 87 67.9% 41 32.1% 128 
8. Education No formal 
education 
45 84.9% 8 15.1% 53 
2=0.33 
P=0.84 
NS 
  School level 69 73.4% 25 26.6% 94 
  College  
level 
26 56.5% 20 43.5% 46 
9. Occupation Employed 69 73.4% 25 26.6% 94 
2=5.07 
P=0.08 
NS 
  Not 
Employed 
11 52.4% 10 47.6% 21 
  Not 
applicable 
60 76.9% 18 23.1% 78 
10. Annual 
income 
< Rs.12000 
19 76.0% 6 24.0% 25 
2=7.36 
P=0.06 
NS 
   Rs.12000 -
24000 
67 80.7% 16 19.3% 83 
   > Rs.24000   4 57.1%   3 42.9%   7 
  Not 
applicable 
49 62.8% 29 37.2% 78 
11. Residence Rural 68 75.6% 22 24.4% 90 2=0.77 
P=0.38 NS   Urban 72 69.9% 31 30.1% 103 
 
Not significant P >0.05 
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Table 5.5.2(a) shows association between the nutritional status with 
demographic variables of HIV infected adolescents/ caregivers in experimental group. 
In that, the age and education of adolescent, caregiver’s age, sex, relationship with 
adolescents and residence variables are shows significant association with 
improvement in nutritional status. Regarding adolescents age, the majority of 92% are 
normal in the younger age of 10-12 years  and  only 8 % are in malnourished  when 
compare to other age categories and it is  significant at p=0.001***. In consideration 
with education, the highest  percentage of 93% and 87 % are normal in primary and 
middle level educated adolescents and it is significant at p=0.001***.  
In regard to caregiver’s age, the majority of 94 % are normal in younger age of 
20-35 years and it is significant at p=0.03*. In relationship with adolescents, the 
highest percentage of 92 % were associated with mothers when compare to the other 
categories and it is significant at 0.04*.  In regard to residence, the majority of 88% 
are associated with rural and it is significant at p=0.05*. The remaining other 
demographic variables are not associated with nutritional status of HIV infected 
adolescents. This table finding depicts that there is a significant association between 
the nutritional status of HIV infected adolescents with specific demographic variables.  
Table 5.5.2(b) shows association between the nutritional status with 
demographic variables of HIV infected adolescents/caregivers in control group. Here 
none of the variables are significant with nutritional status and it is proved by chi 
square test. 
 
 
 
 
 
 
 
 
 
 
 
Fig 5.5.2 (a): Association of nutritional gain score with demographic variables of HIV Infected adolescents/care givers in experimental
group.
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5.5.3 :  Associates   the  QOL  gain  score   with  demographic  variables  of   HIV  
   infected adolescents in both groups. 
5.5.3(a): Association between   the  QOL  gain  score  with  specific  demographic 
variables of HIV infected adolescents  in experimental group. 
 
S. 
No. 
Demographic variables No. 
QOL gain score 
One way 
ANOVA/ 
t-test 
Pretest Posttest 
Gain score: 
Post-pre test 
score 
Mean SD Mean SD Mean SD 
1. Age of  10 -12 years 60 163.84 6.25 218.80 19.13 54.96 15.90 F=3.27 
P=0.04* 
S 
 adolescents 13 -15 years 91 164.02 5.95 216.51 14.15 52.49 12.06 
   16 -18 years 44 163.00 6.63 211.00 16.07 48.00 13.78 
2. Sex Male 97 164.03 5.89 218.38 11.99 54.35 10.37 t=2.35 
P=0.02* 
S 
  
Female 98 163.30 6.53 212.92 19.01 49.62 16.87 
3. Education Primary 44 164.20 6.34 221.80 14.06 57.60 13.13 
F=1.51 
P=0.21 
NS 
   Middle 77 164.62 5.64 215.70 14.47 51.08 12.85 
   Secondary 59 163.34 6.52 216.80 19.48 53.46 17.26 
   H. secondary 15 162.23 6.61 211.86 13.91 49.64 11.69 
4. Religion Hindu 165 164.07 5.99 216.30 15.56 52.23 13.98 F=0.20 
P=0.81 
NS 
   Muslim 26 160.92 6.94 211.23 19.77 50.31 16.57 
   Christian 4 164.50 7.68 216.75 8.18 52.25 1.89 
5. Age of  20 -35 years 49 163.31 6.41 221.11 19.12 57.80 15.20 F=3.50 
P=0.03* 
S 
 caregiver 36 -50 years 136 163.66 6.21 215.38 15.22 51.72 14.14 
   > 50 years 10 165.40 5.64 216.10 8.80 50.70 4.94 
6. Sex Male 59 163.25 6.33 213.30 20.03 50.05 11.89 t=1.97 
P=0.05*  
S 
   Female 136 163.84 6.18 217.82 14.14 53.98 13.41 
7. Relationship  Father 24 163.81 6.18 215.79 15.59 51.98 14.87 F=3.53 
P=0.05 
*S 
 with  Mother 52 164.00 5.99 222.25 18.65 58.25 15.42 
 adolescents Caregiver 119 163.17 6.49 212.23 15.31 49.06 10.91 
8. Education No formal 
education 
38 164.08 5.80 215.00 10.32 50.92 6.68 
F=0.27 
P=0.76 
NS 
   School level 97 164.03 6.19 216.73 12.98 52.70 10.00 
   College  
level 
60 162.80 6.53 214.27 22.52 51.47 21.65 
9. Occupation Employed 85 164.47 5.83 215.11 11.40 50.64 7.58 F=2.02 
P=0.13 
NS 
   N.Employed 28 162.25 6.81 219.04 10.19 56.79 9.35 
   N.applicable 82 163.30 6.36 215.02 21.14 51.72 19.57 
10. Annual  <  Rs.12000 31 162.65 6.64 218.71 9.64 56.06 9.08 
F=1.12 
P=0.33 
NS 
  income  Rs.12000 -
24000 
70 164.66 5.67 215.14 12.22 50.49 8.36 
    > Rs.24000 12 162.92 7.17 214.75 7.78 51.83 1.40 
   N.applicable 82 163.30 6.36 215.02 21.14 51.72 19.57 
11. Residence Rural 88 163.32 6.45 219.51 19.01 56.19 14.75 t=1.99 
P=0.05* 
S 
   Urban 107 164.08 5.93 216.11 11.70 52.03 14.41 
Not significant P >0.05, * significant at P≤0.05 
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5.5.3(b)  Association between the QOL gain  score with specific demographic  
 variables of HIV infected adolescents  in control  group. 
S. 
No. 
Demographic variables No. 
QOL gain score 
One way 
ANOVA/ 
t-test 
Pretest Post test 
Gain score: 
Post test-Pre 
test score 
Mean SD Mean SD Mean SD 
1. Age of  
adolescents 
10 -12 years 68 163.34 4.87 167.03 5.40 3.69 4.86 
F=1.35 
P=0.26 NS 
 13 -15 years 78 163.00 5.15 166.01 5.49 3.01 4.22 
 16 -18 years 47 162.21 4.30 164.57 4.68 2.36 3.44 
2. Sex Male 109 162.44 4.36 165.57 5.01 3.13 4.32 t=0.12 
P=0.89NS    Female 84 163.56 5.39 166.61 5.69 3.05 4.30 
3. Education Primary 43 162.51 4.32 166.09 5.49 3.58 4.67 
F=1.11 
P=0.34 NS 
   Middle 85 163.45 5.13 166.88 5.42 3.44 4.69 
   Secondary 50 162.60 4.77 164.82 4.90 2.22 3.26 
   H.Secondary 15 162.27 5.18 164.93 5.24 2.67 3.85 
4. Religion Hindu 148 163.01 4.80 166.34 5.33 3.33 4.43 F=0.98 
P=0.37 
NS 
   Muslim 36 162.42 5.28 164.67 5.44 2.25 3.45 
   Christian 9 163.56 4.36 166.11 4.48 2.56 5.13 
5. Age of  20 -35 years 49 161.37 3.23 165.06 5.01 3.69 5.01 F=1.79 
P=0.16 
NS 
 caregivers 36 -50 years 125 163.49 5.34 166.11 5.54 2.62 3.93 
   > 50 years 19 163.26 4.24 165.32 4.88 2.05 3.75 
6. Sex Male 65 162.08 4.61 164.98 5.14 2.91 4.25 t=0.42 
P=0.67 
NS 
   Female 
128 163.36 4.93 166.55 5.36 3.19 4.34 
7. Relationship  Father 22 161.36 4.40 165.36 5.09 4.00 3.77 F=0.63 
P=0.53 
NS 
 with  Mother 43 162.28 4.60 165.49 5.62 3.21 3.17 
 adolescents Caregiver 128 163.41 4.96 166.31 5.29 2.90 4.70 
8 Education No formal 
education 
53 162.96 4.64 165.75 5.06 2.79 4.10 
F=1.10 
P=0.33 NS    School level 94 163.81 5.37 166.67 5.31 2.86 4.08 
   College level 46 161.09 3.31 165.00 5.58 3.91 4.92 
9. Occupation Employed 94 162.20 4.26 165.87 5.41 3.67 4.52 F=1.68 
P=0.18 
NS 
   N.Employed 21 165.62 4.59 168.00 4.66 2.38 3.29 
   N.Applicable 78 163.08 5.35 165.67 5.34 2.59 4.22 
10. Annual  Rs.12000 25 161.96 2.99 166.80 5.37 4.84 5.47 
F=1.17 
P=0.32 
NS 
  Income  Rs.12000 -
24000 
83 162.45 4.47 165.45 5.09 3.00 4.09 
    > Rs.24000 7 159.86 3.39 163.00 4.16 3.14 4.49 
   N. applicable 78 164.03 5.58 166.33 5.53 2.31 3.78 
11. Residence Rural 90 164.24 5.32 167.18 5.35 2.93 4.80 t=0.48 
P=0.63 NS    Urban 103 161.78 4.09 165.01 5.12 3.23 3.83 
Not significant P >0.05 
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  Table 5.5.3(a) shows association between the QOL gain score with 
demographic variables of HIV infected adolescents/ caregivers in experimental group. 
In that, the age and sex of adolescent, caregiver’s age, sex, relationship with 
adolescents and residence variables shows significant association with QOL gain 
score. Regarding age and sex of adolescents, the younger age of 10-12 years and 
males are gained high gain score of 54.96 and 54.35 when compare to the other 
categories and it is significant at the p value of 0.04 * and 0.02*.  
In consideration with caregivers age and sex , the younger age of 20-35 years 
are gained high gain score of 57.80 and  it is significant at p=0.03* and in caregivers 
sex  females are gained  little more than males i.e., 53.98 and it is significant at 
p=0.05*. In regard to relationship with adolescents and residential area, the high gain 
score of 58.25 and 56.19 are seen with mothers and rural areas and it is significant at 
p=0.05*. The rest of the other demographic variables are not associated with QOL 
gain score. This table reveals that there is a significant association between the QOL 
of HIV infected adolescents with specific demographic variables of HIV infected 
adolescents /caregivers. 
Table 5.5.3(b) shows association between the QOL gain score with 
demographic variables of HIV infected adolescents/ caregivers in control group. The 
gain score difference is not significant in one way analysis of variance F-test and 
student independent test. Here none of the variables are significant with QOL gain 
score.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5.5.3 (a): Association of QOL gain score with demographic variables of HIV Infected adolescents/care givers in experimental group.
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SECTION VI 
5.6:  This section identifies the influencing factors for HIP components by using  
Uni and multivariate logistic regression in experimental group of HIV 
infected adolescents/caregivers 
5.6.1: Identification the influencing factors for ART adherence by using Uni and 
multivariate analysis in experimental group of HIV infected 
adolescents/caregivers 
 
5.6.1(a): Influencing factors for ART adherence gain score by using univariate 
analysis  in experimental group of HIV infected adolescents/caregivers 
 
S. 
No. 
Influencing 
variables 
ART Adherence  Gain Score 
Total 
Chi 
square 
test 
Odds 
Ratio 
(95%CI) 
Below     
average 
( ≤13.38) 
Above average 
( >13.38) 
No. % No. % 
1. Age 
  
< 15years 68 45.0% 83 55.0% 151 
2
=5.94 
p=0.01** 
2.4 
(1.1 -5.1)  >15 years 29 65.9% 15 34.1% 44 
2. Sex 
  
Male 40 15.5% 57 84.5% 97 
2
=5.59 
p=0.02* 
2.0 
 Female 57 56.2% 41 43.8% 98 (1.1 -3.6) 
3. Age of 
caregivers 
< 35years 20 15.5% 39 84.5% 49 
2
=9.58 
p=0.01** 
2.9 
 > 35years 77 56.2% 59 43.8% 146 (1.4 -6.2) 
4. Sex of 
caregivers 
  
Female 20 33.8% 39 66.2% 59 

2
=8.50 
p=0.01** 
2.5 
(1.3 -5.1)  Male 77 56.7% 59 43.3% 136 
5. Relationship 
with  
adolescents 
Parents 29 38.2% 47 61.8% 76 

2
=6.69 
p=0.01** 
2.2 
 Caregivers 
68 57.1% 51 42.9% 119 (1.2- 4.1) 
6. Residence 
  
Rural 31 35.2% 57 64.8% 88 
2
=14.49 
p=0.001*
** 
3.1 
 Urban 67 62.6% 40 37.4% 107 (1.6 -5.8) 
 
** significant at P≤0.01, *** very high significant at P≤0.001 
 
  Table 5.6.1(a) shows the influencing factors for ART adherence gain score by 
using Uni variate analysis in experimental group. In regard to the  adolescents age 
with gain score, the majority of 83 participants  (55%) of below 15 years are gained 
the above the average  and majority of 66 % of above 15 years are gained below the  
average of gain score. It is significant at p=0.01** with OR 2.4 with 95% CI.  In 
relevant to adolescents gender with gain score, the majority 85 % of males gained 
above the average and 56 % of females are gained the below level and it is significant 
at p=0.02* with OR 2.0 with 95% CI. Considering with caregivers age & sex with 
gain score, the majority   85 %  and 66% adolescents who were taken care by  below 
35 years with  females are gained above the average of gain score and it is significant 
at p=0.01* with OR  2.9 & 2.5 respectively with 95 % CI. In concern of relationship 
with adolescents, 62% adolescents who are residing with parents are gained the above 
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the average gain score and it is significant at p=0.01** with OR 2.2 with 95% CI. In 
pertain to residence, the majority 65 % of adolescents from rural areas is gained above 
the average of gain score and it is highly significant at p=0.001*** with OR 3.1  
(1.6-5.8).  
 
5.6.1(b):  Influencing factors for ART adherence gain score by using Uni and 
Multi variate logistic regression analysis  in experimental group of HIV 
infected adolescents/caregivers 
 
S. 
No. 
Influencing  variables 
Uni-variate analysis Multivariate analysis 
p-value 
Unadjusted 
OR 
(95%CI) 
p-value 
Adjusted 
OR 
(95%CI) 
1. Age 
(<15 years  Vs > 15 years) 
0.01** 
2.4 
(1.1 -5.1) 
0.02* 
2.2 
(1.1 - 4.6) 
2. Sex 
(Male Vs Female) 
0.02* 
2.0 
(1.1 -3.6) 
0.01** 
1.7 
(1.1 - 5.9) 
3. Age of caregiver 
(<35 years Vs > 35years) 
0.01** 
2.9 
(1.4 -6.2) 
0.03* 
2.2 
(1.3 - 4.8) 
4. Sex of caregiver 
 (Female Vs  Male) 
0.01* 
2.5 
(1.3 -5.1) 
0.60 
1.3 
(0.4 - 8.2) 
5. Relationship with 
adolescents 
(Parents  Vs  caregivers) 
0.01** 
2.2 
(1.2- 4.1) 
0.02* 
1.8 
(1.3 - 5.2) 
6. Residence 
(Rural  Vs Urban) 
0.001*** 
3.1 
(1.6 -5.8) 
0.18 
1.5 
(0.3 - 5.7) 
        ** significant at P≤0.05, *** very high  significant at P≤0.001 
 
 
  Table 5.6.1(b) shows the influencing factors for ART adherence gain score by 
using uni and multivariate logistic regression analysis in experimental group. In 
univariate analysis, the influencing factors of adolescents age & sex, age & sex of 
caregivers, relationship with adolescents and residence are significant with unadjusted 
OR  with 95 % CI. Whereas in multivariate analysis, the sex of caregivers and 
residence are not significant at p= 0.60 and 0.18 with adjusted OR 1.3 & 1.5 
respectively. The rest of other variables are more significant with adjusted OR with 95 
% CI.  
 
Fig5.6.1 (a): Influencing factors for ART adherence gain score by Uni and Multi variate analysis of HIV infected adolescents/care givers
in experimental group.
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5.6.2: Identification of the influencing factors for nutritional gain score by using 
  Uni and multivariate analysis in experimental group of HIV infected 
  adolescents/caregivers. 
 
5.6.2(a) : Influencing factors for nutritional  gain  score  by  using  Univariate 
     analysis in experimental group of HIV infected adolescents/caregivers. 
 
S. 
No. 
Influencing 
variables 
Nutrition  gain score  
Chi square 
test 
Odds 
Ratio 
(95%CI) 
Normal Malnutrition Total 
No. % No. %  
1. Age 
  
< 15 
years 
131 65.0% 20 35.0% 151 
2=14.29 
p=0.001*** 
4.1 
(1.8-9.5)  >15 
years 
27 47.1% 17 52.9% 34 
2. Education 
  
Up to 
middle  
108 56.8% 13 43.2% 121 
2=14.05 
p=0.001*** 
3.9 
(1.8-9.1)  Above 
middle 
50 41.4% 24 58.6% 74 
3. Age of  
caregivers 
< 35 
years 
46 57.0% 3 43.0% 49 
2=6.94 
p=0.01** 
4.6 
(1.3-19.8)  > 35 
years 
113 39.6% 34 60.4% 147 
4. Sex of  
caregivers 
  
Female 117 60.7% 19 39.3% 136 2=7.32 
p=0.01** 
2.7 
(1.1-6.0)  Male 41 43.0% 18 57.0% 59 
5. Relationship 
with  
Parents 68 56.9% 8 43.1% 76 2=5.78 
p=0.02* 
2.7 
(1.1-6.9) 
 adolescent Others 90 42.5% 29 57.5% 119 
6. Residence 
  
Rural 77 52.1% 11 47.9% 88 2=4.37 
p=0.04* 
2.2 
(1.0-5.2)  Urban 81 22.2% 26 77.8% 107 
   ** significant at P≤0.01, *** very high  significant at  P≤0.001 
 
 Table 5.6.2(a) shows the influencing factors for nutrition gain score by using 
uni variate analysis in experimental group. In regard to the adolescent’s age with gain 
score, the majority of 131 participants (65%) of below 15 years are in normal and 
53% of above 15 years are in malnourished level. It is highly significant at 
p=0.001*** with OR 4.1 with 95% CI.  In relevant to adolescents education with gain 
score, the majority of 108 participants (56.8 %) are normal in middle level of 
education and it is highly significant at p=0.001*** with OR 3.9 with 95% CI. 
 Considering with caregivers age & sex with gain score, the  57%  adolescents 
who were taken care by  below 35 years  of  females are in normal state  and it is 
significant at p=0.01* with OR 2.9 & 2.5 respectively with 95 % CI. In concern of 
relationship with adolescents, 60 % adolescents residing with parents are in normal 
state and it is significant at p=0.02* with OR 2.7 with 95% CI. In pertain to residence, 
the majority 52% of adolescents from rural areas are in normal status and 78% of 
adolescents from urban areas are malnourished and it is significant at p=0.04*** with 
OR 2.2 (1.6- 5.8).  
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5.6.2(b) :  Influencing factors for  nutrition  gain  score  by  using Uni and 
  Multivariate logistic regression analysis in experimental group of 
  HIV infected adolescents/caregivers 
 
 
S. 
No. 
Influencing variables 
Uni variate analysis Multivariate analysis 
p-value 
Unadjusted 
OR 
(95%CI) 
p-value 
Adjusted 
OR 
(95%CI) 
1. Age 
(<15 years  Vs > 15 years) 
0.001*** 
4.1 
(1.8 - 9.5) 
0.01** 
2.2 
(1.1 – 6.2) 
2. Education 
(Up to  middle Vs Above 
middle) 
0.001*** 
3.9 
(1.8 - 9.1) 0.01** 
2.1 
(1.1 - 5.9) 
3. Age of caregiver 
(<35 years Vs > 35years) 
0.01** 
4.6 
(1.3 -19.8) 
0.05* 
1.3 
(1.2 -3.8) 
4. Sex of caregiver 
 (Female Vs  Male) 
0.01** 
2.7 
(1.1 - 6.0) 
0.14 
1.5 
(0.7 – 8.2) 
5. Relationship with 
adolescent 
 (Parents  Vs others) 
0.02* 
2.7 
(1.1- 6.9) 
0.05* 
1.2 
(1.1– 3.2) 
6. Residence 
(Rural  Vs Urban) 
0.04* 
2.2 
(1.0 - 5.2) 
0.33 
0.5 
(0.9-6.2) 
 
  Table 5.6.2 (b) shows the influencing factors for nutrition gain score by using 
uni and multivariate logistic regression analysis in experimental group. In univariate 
analysis, the influencing factors of adolescents age & sex, age & sex of caregivers, 
relationship with adolescents and residence are significant with unadjusted OR  with 
95 % CI. Whereas in multivariate analysis, the sex of caregiver and residence are not 
significant at p= 0.14 and 0.33 with adjusted OR 1.5 & 0.5 respectively. The rest of 
other variables are more significant with adjusted OR with 95 % CI.   
 
 
 
 
 
Fig5.6.2 (a) : Influencing factors for Nutritional gain score by Uni and Multi variate analysis of HIV infected adolescents/care givers in
experimental group.
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5.6.3 : Identification of the influencing factors for QOL gain score by using Uni 
 and Multivariate analysis in experimental group of HIV infected 
 adolescents/caregivers. 
 
5.6.3(a): Identification of the influencing factors for QOL gain score by using Uni 
 variate analysis in experimental group of HIV infected 
 adolescents/caregivers. 
 
S. 
No. 
Influencing 
variables 
QOL  gain score 
Total 
Chi square 
test 
Odds 
Ratio 
(95%CI) 
Below 
average 
(≤51.97) 
Above 
average 
(>51.97) 
No. % No. % 
1. Age < 15 years 67 44.4% 84 55.6% 151 2=7.73 
p=0.01** 
2.7 
(1.3 -5.8) >15 years 30 68.2% 14 31.8% 44 
2. Sex 
  
Male 37 38.2% 60 61.8% 97 2=10.39 
p=0.001*** 
2.6 
Female 60 61.2% 38 38.8% 98 (1.4 -5.0) 
3. Age of  
caregivers 
< 35 years 16 32.7% 33 67.3% 49 2=7.65 
p=0.01** 
2.6 
> 35 years 81 55.4% 65 44.2% 146 (1.2 -5.4) 
4. Sex of  
caregiver 
  
Female 22 37.3% 37 52.7% 59 
2=5.25 
p=0.02* 
2.1 
(1.1 -4.1) Male   75 55.1% 61 44.9% 136 
5. Relationship  
with 
adolescents 
Parents 29 38.2% 47 61.8% 76 
2=6.69 
p=0.01** 
2.2 
Others 68 58.0% 51 42.0% 119 (1.2- 4.1) 
6. Residence 
  
Rural 34 38.6% 54 61.4% 88 2=7.91 
p=0.01** 
2.3 
Urban 63 58.9% 44 51.1% 107 (1.1 -4.2) 
 
  Table 5.6.3 (a)   shows the influencing factors for QOL gain score by using 
univariate analysis in experimental group. In regard to the QOL gain score, the 
majority 84 participants (56%) of below 15 years are gained the above the average  
and majority 68 % of above 15 years are gained below the  average of gain score. It is 
significant at p=0.01** with OR 2.7 with 95% CI.  In relevant to adolescents gender 
with gain score, the majority 62 % of males are gained above the average and 61% of 
females are gained the below level and it is significant at p=0.001* with OR 2.6 with 
95% CI. 
Considering with caregivers age & sex with gain score, the majority 67% and 
45% of adolescents who are taken care by below 35 years with females are gained 
above the average of gain score. It is significant at p=0.01* and 0.02* with OR 2.9 & 
2.5 respectively with 95% CI. In concern of relationship with adolescents, 62% of 
adolescents who are residing with parents are gained the above the average gain score 
and it is significant at p=0.01** with OR 2.2 with 95% CI. In pertain to residence, the 
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majority 62% of adolescents from rural areas is gained above the average of gain 
score and it is highly significant at p=0.01** with OR 2.3 (1.6-5.8). 
 
5.6.3(b): Identification of the influencing factors for QOL gain score by using 
Uni and Multi variate logistic regression analysis in study group 
 
S. 
No. 
Influencing variables 
Uni variate analysis Multivariate analysis 
p-value 
Unadjusted 
OR 
(95% CI) 
p-value 
Adjusted 
OR 
(95% CI) 
1. Age 
(<15 years  Vs > 15 years) 
0.01** 
2.7 
(1.3 - 5.8) 
0.03* 
2.2 
(1.2 - 4.9) 
2. Sex 
(Male Vs Female) 
0.001*** 
2.6 
(1.4 - 5.0) 
0.01** 
2.0 
(1.1 - 4.9) 
3. Age of caregiver 
(<35 years Vs > 35years) 
0.01** 
2.6 
(1.2 - 5.4) 
0.02* 
2.1 
(1.2 - 5.1) 
4. Sex of caregiver 
 (Female Vs  Male) 
0.02* 
2.1 
(1.1 - 4.1) 
0.60 
1.3 
(0.7 - 6.9) 
5. Relationship with adolescent  
(Parents  Vs others) 
0.01** 
2.2 
(1.2 - 4.1) 
0.02* 
1.8 
(1.2 - 5.9) 
6. Residence 
(Rural  Vs Urban) 
0.01** 
2.3 
(1.1 - 4.2) 
0.14 
1.5 
(0.4 - 5.2) 
 
 
5.6.3 (b) table shows the influencing factors for QOL gain score by using uni 
and multivariate logistic regression analysis in experimental group. In uni variate 
analysis, the influencing factors of adolescents age & sex, age & sex of caregivers, 
relationship with adolescent and residence are significant with unadjusted OR  with 
95% CI. Whereas in multivariate analysis, the sex of caregivers and residence are not 
significant at p=0.60 and 0.3 with adjusted OR 1.3 & 1.5 respectively. The rest of 
other variables are more significant with adjusted OR with 95 % CI.  
 
 
 
 
 
 
 
   
 
Fig 5.6.3 (a): Influencing factors for QOL gain score by Uni and Multi variate analysis of HIV infected adolescents/care givers in
experimental group.
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CHAPTER – VI 
 
DISCUSSION 
The aim of argument or discussion should not be victory, but progress.                                                                                       
   Joseph Joubert 
  As the global HIV epidemic cross the threshold of its fourth decade, in the 
developing world have been made a major advances in HIV prevention and 
management. One remarkable challenge involves, the increased proportion of HIV 
infected children who live through school age into adolescence owed to increase with 
the access of life saving HARRT therapies. But still physical health and activity are 
very low in HIV infected children/adolescents when compared with non-infected 
children/adolescents due to non adherence to ART therapy, low immunity, growth 
stunting and poor QOL.  
In this study, the investigator planned to implement the HIV interventional 
package of counseling related to significance of optimal adherence, importance of 
nutrition, strategies to enhance their QOL and along with yoga practice in order to 
improve their physical health and activity of the HIV infected adolescents. However, 
it has been proved with comparison of groups, the investigator conducted a 
experimental study to, evaluate the effectiveness of nurse initiated HIV interventional 
package (HIP) on HIV infected adolescents attending ART clinic in Chennai. The 
study was conducted in the four ART centres namely, Institute of Child Health and 
Hospital For Children (ICH) Egmore, Rajiv Gandhi Government General Hospital 
(RGGGH), Kilpauk Medical College and Hospital, (KMCH) and Government 
Hospital of Thoracic Medicine (GHTM). 
 The total of 388 participants was selected by using simple random technique 
and the samples were divided into experimental (195) and control (193) group. The 
data was collected from both groups of caregivers / adolescents through in depth 
interview, observation of hospital records, structured questionnaires and assessments 
of nutritional status by means of anthropometric measurements. The HIV 
interventional package (HIP) was given only to experimental group and the selected 
asana were demonstrated by the researcher whereas in control group received only 
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conservative care. The data was collected from both groups at ‘0’month, the 3rd month 
and the 6
th
 month intervals. At the end of the 6
th
 month the cursory instructions 
regarding HIP and practice of asana were also given to control group. The investigator 
adopted the King’s goal attainment theory and it was more suitable to interpret the 
study findings phenomenon in the conceptual framework. The collected data was 
analyzed by SPSS version 16 by using the descriptive and inferential statistics 
methods.   
 The demographic variables of HIV infected adolescents in experimental and 
control group,  
Table 5.1.1(a) showed that, the majority of 91 and 78 (47% and 40%) were in 
the age group of 13-15years. The mean age of the study group adolescents was 13.6 + 
2.2 years and the mean age of the control group was 13.8 + 2.4 years. In gender wise 
the majority 97 and 109 (50% and 57%) were males. Regarding the educational 
status, the majority of 77 and 85 (40% & 44%) were in middle level of education and 
considering the religion aspect, the majority of 85% and 77% belonged to Hindu 
respectively in both the groups. The chi square value showed that, all demographic 
variables distribution of HIV infected adolescents was similar in both groups. 
  The demographic variables of caregiver’s in experimental and control 
group,   
 Table 5.1.1 (b) showed that, the majority 136 and 125 (70% and 69%) were in 
the age group of 36-50 years. The mean age of the caregivers was 44.3 + 13.5 years 
and the control group was 45.5 + 12.2 years. In gender wise, the majority 136 and 128 
(70% and 66%) were females. In regard to, the relationship of adolescents 61% and 
66% of children were taken care by the caregivers and 27% and 22% by the mothers 
and nearly 12% by fathers in both the groups. Regarding the educational status, nearly 
50% of their completed the school level of education and 30% and 24% were 
completed college level education respectively in both the groups. In consider with 
occupational status, the majority of 44% and 49% respectively in both groups were 
employed. The most of the participants i.e., 42% and 40% were living in 
nongovernmental organization since the annual income was not applicable category. 
In regard to Residence, nearly half of the participants of and 55% & 53% resided in 
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urban areas corresponding to both groups. The chi square test proved that, the 
caregiver’s demographic variables distribution of both the groups were similar. 
The clinical information of HIV infected adolescents in experimental and 
control groups includes,  
Table 5.1.2(a) showed that, the majority of 55% and 58% were diagnosed as 
HIV status before 5-10 years and 97% and 98% got the HIV infection through the 
mother to child transmission respectively in both groups. Cardoso C.A. (2012) found 
the majority (80%) of adolescents had HIV through vertically than behaviorally 
infected adolescents aged 0-19 years old. This study also observed that significant 
improvement in patients survival times and a reduction in the number of deaths 
among patients using HAART.
186
 In another Brazilian study, a reduction of 87.8% in 
the death rate of vertically HIV-infected children was observed from 1994-2002 after 
the arrival of HARRT.
187 
Considering with stage of adolescents, most of the 
participants (71% & 65%) were in stage I and majority of 67% and 72% were on ART 
in between 1-5 years. In regard to the history of tuberculosis, nearly half of the 
participants (55%) had tuberculosis and completed their treatment successfully. This 
finding was similar in other study, found that TB is being the most common OI for 
HIV/AIDS and only prompt and appropriate care is essential to treat and cure the 
infections.
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Regarding the disclosure of the status, the majority of the 68 % and 64% of 
participants respectively didn’t know their status in both groups and table 5.1.2 (a-i) 
showed that, more than 50% of in the age group 10-12 years didn’t know their status 
in both groups. Rick Lorenz et al (2016) stated that study, majority (65%) of children 
were informed of their disclosure status with the mean age of 7 and between the ages 
of 5 to 9 years. Once known of their disclosure status, guiding principles 
recommended that the child and caregivers continue to discuss the child’s HIV status 
and its effect on their life in growing complexity till the child matures 
intellectually.
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The South African study reported that, the higher adherence was associated 
with the early age (<12 years) of disclosure (OR -2.65; 95% CI). The finding 
suggested that, early and full disclosure was significantly associated with improved 
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adherence among adolescents on ART, and also it was an essential tool for reducing 
mortality and transmission.
34 
The other review article stated that, 13 to 60% of 
children between 5 to 17 years from Asia and Southern-Eastern Africa known their 
disclosure status and the prevalence of disclosure vary in all countries.189 
  Butler AM et al (2009) in their prospective study evaluated the effects of HIV 
disclosure on HRQOL among children and adolescents (5-21 yrs). In analysis, the 
mean QOL scores were not significantly different at the last undisclosed visit contrast 
with the first disclosed visit, with the exception of general health domain. It depicted 
that, age at disclosure was reducing QOL significantly over time; therefore, disclosure 
should be encouraged at an appropriate time.
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 In regard to CD4 count before start of ART, the majority of the adolescents in 
both groups were in below 300cells/mm
3
 of all the age groups due to prognosis of 
diseases for HIV to AIDS as shown in the table 5.1.2(b). Once they started the ART it 
was increased but sustained up to 900 cells/mm
3
 for majority (81-86%) of adolescents 
and only 10 % in above 900 cells/mm
3
 even after 5 years of ART in both groups i.e., 
showed in the table 5.1.2 (c). The similar finding was seen in retrospective analysis of 
young adolescents in Kenya, i.e., the median CD4 count was 332 cells/mm
3 
and 
majority were in WHO stage of I/II.
93
 The other study also reported with similar 
results i.e., the median CD4 count was 385 cells/mm
3
 (247-555) and the high rate of 
sub optimal adherence was observed in all the prenatally infected adolescents.
109
 But 
the present study, after HIP there was marked improvement in experimental group  
i.e., nearly 15% was increased above 900 cells/mm
3
 and majority (61%) were in 600-
900 cells/mm
3
 where as in control group there was no significant improvement as 
shown in table 5.1.2(d).  
 In the present study, the increased CD4 count mean difference was 4.86 in 
baseline assessment as shown in table 5.1.3 (c-i), it increased to 136.96  in  6
th
 month 
as shown in table 5.3.1(d-i)  and proved with  student independent test score of 6.67 
was significant at p=0.001***. The review article of Botros D et al (2012) also stated 
that, the reinforcement counseling regarding adherence improvement, nutritional 
intervention trial and exercise program can be successful in promoting the health 
outcomes of PLHIV especially to increase CD4 count, improve the body 
compositions and reduce the risk of cardiovascular diseases and diabetes.
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 The RCT on HIV infected participants, one hour of three times weekly aerobic 
exercises with monthly nutritional counseling compared with workshop on discuss the 
importance of physical activity and nutrition. The exercise group had significant 
improvements in CD4 count (P=0.002), resting heart rate (P=0.001), metabolic 
equivalents (P=0.014) and QOL than the control group. The domains of QOL, general 
health, vitality and mental health improved in the exercise group (P<0.05) compared 
with the control group. The study findings suggested that the practice of regular 
exercises, coupled with nutritional guidance, for the individuals with HIV/AIDS 
significantly improves the QOL.
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The background information of experimental and control group,  
Table 5.1.3(a) showed the living status of family members, among this 
mothers (50-60 %) were alive more when compare to fathers (40-49%) in respective 
of both groups because fathers had the additional behaviors of alcohol, smoking and 
continue to acquiring repeated infection of HIV makes to decline their  life span . 
Regarding of family members HIV status, table 5.1.3 (b) showed that the majority of 
parents nearly 97- 98 % were positive and only 2-3 % were negative. Only 39% and 
38 % participants living with their biological parents and majority of  69% & 64% 
respectively in both groups were living in NGOs.  
In relevant to health, financial and social support as shown in table 5.1.3 (c). 
The majority of 98% and 96% of corresponding group of adolescents were receiving 
helps from nearer health care facilities. The half of (52% & 55%) participants only 
had adequate financial support and remaining 47% & 45% of respective group 
subject’s are in need of financial supports still to meet their daily requirements. In 
regard to social support, nearly (53% & 56 %) half of participants were receiving 
helps from relatives & neighbor, NGOs and government support. Among these 85% 
& 79% of the participants from both groups were satisfied. But nearly 37% & 44% of 
participants respectively in both groups were discriminated by relatives, friends in 
their schools and communities.  
It was similar to findings conducted in India by Bharathi (2014)  86%  
ALHIV (mean 83.16 , SD 9.717) had low social support and all the participants had 
low level of (mean 92.84, SD 2.510) stigma and discrimination score. The study 
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reports suggested that need of counseling regarding available social support from 
government and non government organization in order to improve their QOL.
193
 The 
other study also found, the perceived social support was highly correlated with (r= 
0.527) structural measures (family /relatives, teachers& friends) and psychosocial 
well being of adolescents among AIDS orphans
.160
 According to  Gupta AK et al 
(2013) portrayed  in their study, the NACO and DSACS planned a special financial 
assistance scheme for PLHIV in order to retain children affected by AIDS (CABA) in 
home based care, recently started to  focus on orphan and vulnerable children (OVC) 
affected by AIDS in order to strengthen social service providers.
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 The background and basic information of HIV/ART,  
 Table 5.1.3 (d) showed that, the majority of 77% and 71% of respective 
participants received the information from health care professionals. Among this 
majority of 63% and 62% from respective groups received the information’s were 
disseminated through counselors and nearly 25% and 26% from nurses. Regarding the 
adolescents and their caregiver’s knowledge of HIV/AIDS were shown in 5.1.3 (e & 
f). In that, the majority (80%) of participants had good knowledge and remaining 20% 
in moderate knowledge and zero percent in poor knowledge. But nearly 25% of the 
both group participants had confusion in the diagnosis part of view and 8-9% had 
dilemma regarding AIDS is a curable/manageable disease.  
The findings was supported by another  study, revealed  that  14% of the 
children only know the mode of transmission of HIV/ AIDS and still they need 
knowledge in all the aspects especially prevention and management for HIV/AIDS.
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The UNICEF (2003–2008) also stated that, only 36% of adolescent males in India 
have comprehensive knowledge of HIV.
20
 The another US based study depicted that, 
adolescents (18% at mean age 16.6 years) and young adults (28% at 18.3 years) had  
low knowledge in HIV transmission, safer sex suggested that formal education needed 
in preventive aspects of HIV/AIDS among adolescents groups.
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Based on the objectives of present study the results were discussed below 
They are, 
The pre (base level) and the post test (3
rd
 and 6
th
 month) level of ART 
adherence, nutritional status and QOL of HIV infected adolescents in experimental 
and control group are discussed in section 5.2, 
Regarding the adherence assessment questionnaire dealt with section 5.2.1 
showed that, the majority (85 & 86 %) of participants were in I line treatment, 10% 
and 13 % were in alternative I line treatment and only 3 % in II line treatment in 
respective of both groups. Barenness et al (2014) found in their study that many of 
the children/ adolescents (75.4%) were in first line regimen than second line ART 
(24.6%).
197 
In this present study, majority of 129 participants from both groups were 
receiving ZLN regimen as shown in table 5.2.1(a-i). No changes were made in ART 
during the study period. The chi square value showed that, there was no significant 
changes were found among this variable. Hence further evaluation was not 
progressed. The majority of participants (73% and 77%) were taking the medications 
under the supervision of caregivers and the remaining 27 % and 23 % of adolescents 
from both groups were taking self medications. Considering with hospitalizations in 
both group participants, 47% and 43 % were hospitalized for fever, 28 % for diarrhea 
and 25-28% were admitted for injuries or accidents, management for anemia and 
stomach pain for evaluation respectively in both groups.  
Considering with exact dose and dosage of medications as shown table  
5.2.1(b), stated that all the participants in both groups had good knowledge about the 
dosage frequency but in exact dose part, 69% of participants only knew in both 
groups, but at the 6
th
 month assessment all the participants in experimental group 
knew their exact dose whereas in control group, 18% in confused state. Biressaw S  
et al (2013) also stated in their study that all the caregivers of the HIV/AIDS children 
knew the right dose and frequency of pills.
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The table 5.2.1(c) showed that, 95 % of the participants had medications 
burden in both groups, whereas in the 6
th
 month it was reduced to 36% in 
experimental group but there was no changes in control group as a subjective 
assessment. Regarding difficulty in taking drugs in both groups, the majority of (71%) 
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adolescents refused to take drugs due to swallowing, oral problems and also boring to 
take drugs. However in the 6
th
 month it was reduced to 28% in experimental group 
but there was no changes in control group. It was supported by the review article 
stated that, there are many reasons for the non adherence i.e., ranged from 16% to 
99% not interest to take the medications, refused to take medications, felt medication 
has burden, not aware of the benefits of ART and adverse effects of drugs.
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In this present study baseline assessment revealed that, the majority (75% & 
80%) of adolescents had depression in both the groups due to parental death, financial 
problems, physical health and known their status. But it reduced to 31% in the 6
th
 
month evaluation in experimental group whereas no marked changes in the control 
group.  It was supported by the following review articles Lata S and Verma S (2013) 
stated that, the majority of HIV/AIDS orphan children/adolescents were in depression 
state. This findings recommended the need of psychosocial counseling and relaxation 
therapy in order to reduce the depression and improve their psychosocial health of 
adolescents.
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 The other RCT study from Cade PT (2010) found that; yoga is effective in 
reducing systolic and diastolic blood pressure. The participation of one hour yoga 
session 2-3 times per week aimed to encourage adherence, reduce depression, and 
promote mental focus, self control, self awareness and physical resilience.
180
 Jong E 
and Colleagues (2010) identified that, granted exercise therapy is an effective way to 
reduce HIV related fatigue, depression, anxiety and improve the QOL.
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  The evolution of ART has altered the perception of HIV/AIDS from a fatal to 
a chronic and potentially manageable disease. The ART is hope to increase survival, 
reducing the episode of HIV-related OIs, and humanizing patients QOL. The clinical 
development of HIV-infected clients under ART has been measured in every visit of 
pharmacy refill. Among many approaches, to assessing medication adherence is the 
subjective measures of patient self-report and it’s remained the most common method 
when compare to the objective measures. In the present study the investigator 
assessed the adherence by subjective measures of  five point response, visual analog, 
‘3’ days recall method and pill count methods in section 5.2.2. 
190 
 
  Table 5.2.2 (a-i) showed number and percentage distribution of overall level 
of ART adherence in both groups of HIV infected adolescents by ‘5’ point response 
scale. In baseline assessment, the   majority of participants from both groups had sub 
optimal level of adherence (69% & 67%). In experimental group, the equal percentage 
of participants (15%) had optimal and as well as poor adherence. But in subsequent 
evaluation of the 3
rd
 and the 6
th
 month, optimal adherence increased to 91% and 
100%. While in control group, it increased from 16.9% to 17.9% & 18.1% in 
subsequent evaluation. The chi square value of 207.87 and 269.39 was significant at  
P ≤ 0.001***. It showed that, there was a significant improvement in study group than 
the control group.  
  Table 5.2.2 (b-i) showed the overall level ART adherence in both groups of 
HIV infected adolescents by visual analog method. In experimental group of HIV 
infected adolescents, only 15% of participants had optimal level of adherence, 69% in 
sub optimal and 16% in poor adherence in the baseline assessment. Whereas it was 
increased to 51% in the 3
rd
 month and 78% the in 6
th
 month of optimal level and 
subsequently reduced the sub optimal level from 49% to 22%.While in control group, 
only 14% of participants had optimal level of adherence, 68% in sub optimal and 18% 
in poor adherence in the baseline assessment and there was slight improvement in the 
subsequent evaluation of the 3
rd
 and 6
th
 month but it was not in statistically improved. 
The chi square value in 3
rd
 & 6
th
 month evaluation of 71.9 and 142.3 was significant 
in the level of p=0.001***. It showed that, there was a marked improvement in the 
experimental group of HIV infected adolescents. 
 Table 5.2.2 (c-i) showed overall level of adherence in both groups of HIV 
infected adolescents by ‘3’ days recall method. In ‘0’ month assessment, only 63% of 
participants had optimal level of adherence and remaining 37% in sub optimal level of 
adherence in both groups. Whereas it was increased to 82% in the 3
rd
 month and 94% 
in the 6
th
 month of optimal level and subsequently reduced the suboptimal level from 
18% to 6% in experimental group. But in control group, there was only slight 
improvement in the subsequent evaluation of the 3
rd
 and 6
th
 month. The chi square 
value of 16.5 and 48.4 was significant at the p = 0.001*** in subsequent evaluation. It 
showed that there was a marked improvement in study group than the control group. 
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Table 5.2.2 (d-i) shows overall level of ART adherence in both groups of HIV 
infected adolescents by pill count method. In experimental group, only 44% of 
participants had optimal level of adherence, 56% in sub optimal level and no one in 
poor adherence in the baseline assessment. Whereas in subsequent evaluation it was 
increased to 87% in the 3
rd
 month and 93% in the 6
th
 month of optimal level and 
subsequently reduced the suboptimal level from 13% to 7% .While in control group, 
only 38% had optimal level of adherence and remaining 68 % in sub optimal level of 
adherence in the baseline assessment and there was slight improvement in the 
subsequent evaluation of 3
rd
 and 6
th
 month but it was not in statistically significant. 
The chisquare value in the 3
rd
 & 6
th
 month evaluation of 91.95 and 93.13 was 
significant in the level of p=0.001***. It showed that, there was a significant 
improvement in the experimental group of HIV infected adolescents than the control 
group. 
 The above findings were supported by Tran BX et al (2013) identified the 
prevalence of optimal ART adherence using visual analog method. The mean 
difference range was 40 to 100% and the rate of suboptimal adherence was 25.9% and 
the missed doses were 25.2%. 
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 The other cross sectional survey on caregiver’s 
reported adherence to ART in HIV infected children at Mekelle. Among 193 
participants, caregivers reported ‘7’ days recall adherence was 83.4%.The major 
cause of missed dose by caregiver’s report includes: depression (24.4%), side effects 
of the drug (16.3%), pill burden (15.5%) and difficulty in swallowing pills (13.3%).Its 
depicted that the prevalence of sub optimal adherence to ART among children was 
found to be high and impart the knowledge to caregivers on essential of optimal 
adherence and their fundamental role in maintaining adherence.
202
 This findings was 
supported by the other similar studies reports.
115,123,149
 
 Ernesto AS et al (2012)  evaluated the prevalence of non-adherence to 
HAART among the HIV infected children / adolescents aged 7 to 19 years in Brazil. 
The overall prevalence of non-adherence was 11.1%, in split of view 15.8% in  
24 hour self-report, 27.8% in seven-day self report and 45.4% in pharmacy dispensing 
record (PDR). When compared to PDR, 24 hour and seven-day self-reports, showed 
low sensitivity (29% & 43% respectively) but high specificity (95% & 85% 
respectively).
203 
The other cross sectional study identified that among 262 adolescents 
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only 101 adolescents (39%) reported “excellent” adherence and the remaining 
161(61%) reported suboptimal adherence.
204
 
 In the present study, the investigator used subjective assessments of four 
methods along with caregiver’s report, still the adolescent’s poses unique and 
formidable challenges in measuring antiretroviral adherence suggests that need to 
correlate with biological markers. The numeral articles are pointing out the different 
rates and predictors of pediatric adherence to ART. The review of the pediatric HIV 
literature portrayed 13 studies found that, the mean adherence rates as compared with  
adults are suboptimal typically ranging from <50% to >95% depending on the method 
of assessment
205
. In the other view, objective measure of adherence such as MEMS 
caps or pharmacy refill data was included in the adherence assessment, mean 
adherence range was only from <50% to 75% in adolescents.
206
  
  To improve adherence in these age groups requires, identifying the causes for 
the non adherence and an intervention strategies to address the needs. In regard to 
reasons for the non adherence of HIV infected adolescents as shown in table 5.2.2 (e). 
In the baseline assessment showed that, only 41% and 36 % were in not applicable 
categories for both groups. The remaining adolescents had the following reasons, i.e., 
the most of the participants had forgot (33% & 40%), boring (6% & 5%) busy 
scheduled (10% & 8%), travelling (7 % & 9%)  and not having finance to  come and 
collect the drug (2% & 1%) and less than 1%  had non adherence because of side 
effects of drug respectively in both groups. In 3
rd 
and 6
th 
month assessment, the non 
applicable categories were gradually increased to 89% and 93% in experimental 
group whereas in control group, there was no significant improvement.  
In both groups the foremost reason of forgot is major reason for the non 
adherence, even in 6
th
 month evaluation the experimental group had 6% in forgot 
showed the computer assisted interventions are needed in this age groups. The study 
from Koole O et al found that 29% reported at least one reason for missed ART 
(1278/4425) The most frequent reason was simply forgetting (681/1278 or 53%), 
followed by food insecurity (30%) travelling and migration (18%) and lack of money 
to come and collect the drugs (12%).
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 The other  study also found that the primary 
cause for non-adherence was, forgot to take the pills, financial constraints, side effects 
& lack of access to drug and low knowledge in the benefit of the drugs.
208
 In African 
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study also noted that, forgetting to take the medication and not having finance to visit 
the ART centre were the major reasons for non-adherence.
209
 
The study from Hansana V et al (2013) also reported that, nearly 40% of the 
participants had non adherence. The major reasons were being busy (97.0%), forgot 
(62.2%) side effects (52.3%) and lack of money to travel to the health centre (32.6%). 
The common side effects of the drugs were skin rash (42%), headache or dizziness 
(34.3%) and numbness (32.6%).
210
 These similar findings were reported in another 
study the caregivers’ forgetfulness (36.4%) and child refusal to take medication 
(27.3%) were reported as the main causes for missing doses. The above findings 
suggested that longitudinal study evaluating adherence combined with objective 
assessments (viral load, CD4 count and drug level in plasma) are essential to 
recognize the reliable measure of adherence.
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To address the needs of this adolescents the investigator assessed, aids for 
improving adherence for ART to HIV infected adolescents in both groups as shown in  
table 5.2.2(f). In baseline assessment nearly 47% & 50% of participants were using 
pill boxes, 44% & 46% were not using any thing and remaining only 2-4% were only 
using remainders in mobile and buddy system in both groups. In this study, the 
investigator has given a diary as remainder device in order to improve their adherence 
and maintenance of diary after the yoga practice for the experimental group alone. In 
3
rd
 and 6
th 
month assessment, along with remainder cues the diary also used for 
adolescents and also in non applicable categories used dairy alone in the experimental 
group. The chi square value of 189.50 and 182.45 was significant at p=0.001***. 
It was supported by Randomized trial involved with 170 Spanish participants 
on stable ART found a positive effect. The interventions focused to the participants 
were individual education and supportive counseling session at baseline with follow-
up telephone sessions regarding on medication scheduling to the patient's lifestyle. 
After 24 weeks, 76% of intervention group vs. 52.5% in the control group had >90% 
of self-reported adherence (RR=1.45; 95% CI: 1.35-2.62).
 211 
Lyon M.E. et al (2004) 
found multiple alarm watch as the best aid for improving adherence to medication and 
family/treatment buddies rated as highly helpful to progress adherence.
212
 The other 
view of study suggested that apart from device, the motivational counseling and 
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educational strategies may bestow the sustained ART adherence among this risk 
groups.
110
 
 
Regarding the nutritional variables of HIV infected adolescents; table 5.2.3 (g) 
showed the ANOVA F- test and Bonferroni t–test values in experimental group. The 
all variables except height had significance in repeated measure of ANOVA ‘F’ test at 
p=0.001***. It showed that, except height there was a marked improvement in all 
other nutritional variables of HIV infected adolescents. But the Bonferroni t–test 
revealed that, all the variables had significance from baseline to 6
th
 month evaluation 
at p<0.01 and 3
rd
 to 6
th
 evaluation also had significance at P<0.05* except the height. 
It denoted that there was a marked improvement in all the nutritional variables, but 
only the height had minimum improvement of HIV infected adolescents in 
experimental group. Whereas in table 5.2.3 (h) showed the all nutritional variables in 
control group did not have significance in ANOVA F-test and Bonferroni t-test. It 
revealed that there was no marked improvement in the all nutritional variables of HIV 
infected adolescents in control group.  
The similar findings were seen in Jeanine U et al (2015) in longitudinal study 
at Rwanda depicted that the mean (SD) Z-score of stunting, wasting and underweight 
was -2.01 (1.59), 0.15 (1.46),-1.19 (1.29) for boys; for girls they were  
-1.46 (1.56), 0.22 (1.29), -0.63 (1.19); all sex differences in all three indicators were 
statistically significant (P < 0.001).
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 Tang AM et al (2015) done systematic review 
on 21 studies suggested that nutritional assessment and counseling are needed to 
improve good clinical outcomes.
214 
The similar findings also supported by other 
studies included in review of literatures.
131,132
   
Table 5.2.3 (i) showed that comparison of pre and post test ‘Z’ score of HIV 
infected adolescents in both groups. The chi square value of 20.74 was significant at 
the p>0.05* in experimental group. It depicts that there was gradual increase in 
nutritional status of HIV infected adolescents.  But in control group, there was no be 
any progress in nutritional status and chi square value of 1.22 proved that not 
significant at p=0.97. This findings also supported by retrospective aspects includes 
the burden of anemia and nutritional status of HIV-positive children (1-1 years) in 
Ethiopa. The results revealed that around 54.4% of the children had anemia at 
baseline level, among this 7.8% had severely anemic and 44.7% had moderately 
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anemic. At baseline, 51.6% of the study subjects were underweight (weight-for-age Z 
score less than -2 SD); 49.1% were stunted (height-for-age Z score less than -2 SD); 
and 31.5% were wasted (BMI less than -2 SD), but after a year on ART declined to 
8.9%, 15.9%, and 9.8%, respectively. The study finding suggests that, after initiation 
of ART there was decline in high prevalence of anemia and growth failure. Therefore, 
adherence and nutritional counseling are needed to strengthen overall health status of 
PLHA.
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 The clinical histories related to nutrition were dealt with section 5.2.4. The 
table 5.2.4  (a) showed the previous history of nutritional deficiency  nearly 95 & 94% 
of HIV infected adolescents were in normal state and only 5-6% had nutritional 
deficiency states namely,  iron deficiency anemia (< 8-10 gm /dL) and vitamin D  
deficiency for past 2-4 years. In the present study, nearly 46% and 53% did not 
deworm their adolescents regularly in respective of both groups. At present, 2% in 
experimental and 1 % in control group participants having iron deficiency anemia and 
7% and 5% from participants in both groups loosed their weight in 0-5 %.  
It’s supported by review article findings  stated the overall prevalence of 
anemia (defined as hemoglobin < 11 gm/dL) was 66%, and 8% had severe anemia 
(Hb < 7 gm/dL) with the proportion of underweight and stunted children in the 
population was 55% and 46% respectively.
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 The similar findings were  reported 
that, 25 % of 12-20 years perinatally infected adolescents were also had vitamin D 
and iron deficiency.
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 The other study from Souza et al (2011) found that the 
anthropometric variables of weight, height, waist circumference, triceps and sub 
scapular skin fold thickness was very low in participant aged of 6-19 yrs in sao Paulo 
city.
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Table 5.2.4 (b-i) showed the clinical signs and symptoms of dry skin nail, head 
and eyes of HIV infected adolescents in experimental and control groups. In regard to 
presence of dry skin 4% and 6 % were seen in both group adolescents in baseline 
assessment, but in subsequent evaluation it was reduced to 1% in experimental group 
and remaining same percentage in control group. The chi square value of 8.50 was 
significant at p=0.01**. It denoted that, there was gradual decrease in dryness of skin 
of HIV infected adolescents in experimental group.  In consideration of nails, there 
are no changes noticed in nails in both groups of HIV infected adolescents throughout 
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the assessment period. But the controversial view on Cribier B et al (1998) stated 
that, discoloration and brittle nails reflect various conditions observed in HIV 
217
 and 
other study of  Sehgal VN et al (2011)  noted that decreased rate of nail growth has 
been observed in patients treated with Zidovudine 
218
. With regard to the head and 
eyes there was no significant changes were found throughout study period in both 
groups. The other study also suggested that paleness in conjunctiva helps to rule out 
the anemia 
219
.  
Table 5.2.4 (b-ii) shows the clinical signs and symptoms for oral, gastro 
intestinal system and extremities of HIV infected adolescents in both groups. In 
relevant to oral 8% and 6% were had problems respectively in the baseline 
assessment. At 6
th
 month evaluation, there was marked improvement in experimental 
group and no one was found with dryness of lips, bleeding gums and apthus ulcers but 
still 5% present in control group. The chi square value of 15.39 was significant at 
p=0.01**. In regard to the gastro intestinal system, in baseline assessment 25-28% of 
adolescents had various GI problems of loss of appetite, nausea, vomiting and 
diarrhea in both groups. But at 6
th
 month evaluation, the signs and symptoms  was 
reduced in the experimental group and it’s proved with chi square value of 5.89 and 
6.00 was significant at p=0.05* In the control group there was no significant changes  
found at 6
th
 month evaluation. In regard to extremities, the presence of muscle 
wasting and lipo dystrophy were seen in 13% and 11% in experimental group whereas 
in control group10% and 7% respectively. There was no participants had edema 
during study period in both groups.  
It was supported by  Tukei VJ et al (2012) determined the frequency and 
outcomes of ART related adverse events among 6 weeks to 18 years of 378 HIV 
infected children/adolescents with Zidovudine and stavudine plus lamivudine and 
Efavirenz or nevirapine. Among these participants 126 adverse events reported among 
107 (28.3%) patients, dizziness (17.5%), diarrhea (13.5 %) and nausea and vomiting 
(14.3%) were most frequent. Anxiety/night mares, skin rashes, nail discoloration, and 
lipo dystrophy each contributed between 5% and 10%; whereas anorexia, abdominal 
pain, hepatitis, and somnolence contributed to 1 -5%.
220 
           The other studies from review articles also reported that, fatigue or loss of 
energy was the most cited symptom (37%), followed by headache (34%) feeling sad 
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or depressed was reported by 30% of participants. Other symptoms that were not as 
common but more frequently attributed to ART by at least 30% of participants with 
the symptoms included trouble in remembering (37%), hair loss or changes in hair 
(35%), loss of appetite, (34%) nausea or vomiting (32%) and skin problems 
(30%).
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  The results of the present study and other supportive studies  have shown that 
PLHIV face various psychosocial problems such as poverty, depression, substance 
abuse, stigma and discrimination, which can influence their QOL not only from the 
view of physical but also from psychological and social health, which may interrupt in 
essential activities and managements of ART. In this view, the present study was 
assessed QOL among adolescents through the Modified AIDS Clinical Trial Group 
(ACTG) questionnaire. 
 Table 5.2.5 (a) shows pre and post test score of QOL in the experimental 
group of the HIV infected adolescents. In general health ratings domains, 57% were 
in baseline assessment and it was increased to 64% in the 3
rd
 month and 66% in the 6
th
 
month evaluation. With regard to physical functioning there was a marked 
improvement i.e., from 57% to 65% and 79% respectively. In consideration with 
psychological wellbeing it increased from baseline value of 65% to 73%.  With 
regards to social role functioning and health care services had marked improvement 
from baseline value from 22% and 16% to 52% and 56% respectively. Regarding 
symptoms distress of the HIV infected adolescents, it was increased from 41% to 
57%. The overall percentage of baseline assessment was 48% but at the 6
th
 month 
evaluation it was increased to 64 %.  
Whereas in control group, there was no marked improvement from baseline to 
the 6
th
 month evaluation i.e., total percentage increased only from 48% to 49% 
respectively throughout the evaluation period as shown in table 5.2.5(b).  
Oberdorfer P et al (2008) stated in their study, general health, physical functioning, 
symptoms, psychological well being and social role functioning domains score was 
similar to the present study. The poor physical functioning, more symptoms and low 
social functioning were significantly related to higher use of health care 
services(p<0.05).
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  Bunupuradah et al (2013) found the early group had higher QOL score 
changes in five domains, including health perception (p = 0.04), physical resilience  
(p = 0.02), psychosocial well-being (p = 0.04), social and role functioning (p < 0.01), 
and symptoms (p = 0.01) compared to the deferred group.
60
 The study from Gupta R 
et al (2015) also revealed the need to provide appropriate counseling, education and 
creative ways to decrease the psychological impact of HIV/AIDS with a view to 
improve their quality of life.
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  Table 5.2.5 (c & d) showed that, the overall interpretation of quality of life 
score in experimental and control group of the HIV infected adolescents. In 
experimental group, 81% had poor QOL, none of them in good QOL at baseline 
assessment whereas in 6
th
 month evaluation it reduced to 23% had poor QOL and 
14% in good QOL. The chi square value of 174.19 was significant at p=0.001*. 
However in control group, there was no significant improvement from baseline to the 
6
th
 month evaluation. The chi square value of 0.10 was not significant at p=0.99. The 
above findings proved that, the overall QOL was increased in experimental group 
than the control group.  It’s supported by Swindells et al (1999) findings revealed that 
the association between HIV infection and the QOL of   PLHIV showed that QOL 
was influenced by social support and coping style strategies.
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  The above findings suggested that, there is significant difference in post test 
score on adherence rate, nutritional status and QOL of HIV infected adolescents in 
experimental group alone. Since the first hypothesis Ho is rejected here. 
  The effectiveness of HIV interventional package on HIV infected 
adolescents in experimental and control group are discussed in section 5.3.  
  Table 5.3.1(a) showed the comparison of overall level of CD4 count of HIV 
infected adolescents in both groups. In experimental group, 40% were in 601-900 
cells/mm
3
, 10% were in 901-1200 cells/mm
3
 and only 4% were in >1200 cells/mm
3
 of 
CD4 count in baseline assessment. At the 6
th
 month evaluation it increased to 61%, 
23% and 6% in respective of the CD4 counts and only 9% had the CD4 count of 301-
600 cells/mm
3
. The chi square value of 71.47 was significant at P=0.001***. While in 
control group, there was no marked improvement in CD4 count from baseline to 6
th
 
month evaluation. The chi square value of 3.89 was not significant at P=0.14. Its 
revealed that, there was significant improvement in the level of CD4 count in the 
experimental group of HIV infected adolescents. Diniz LO and Pinto JA (2009) 
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revealed that increased CD4 cell percentage, low viral load was associated with 
increased QOL especially in social and role functioning.
222
  
 Table 5.3.2 (b) showed the effectiveness of HIP in mean and SD in the level of 
CD4 count of HIV infected adolescents in both groups.  In baseline assessment, the 
mean score was 664.86 in experimental group and 669.72 in control group. The mean 
difference was 4.86. Where as in the 6
th
 month assessment of mean score in 
experimental and control group was 840.30 and 703.35 respectively. The mean 
difference was 136.96. The paired t-test value was 7.21 was significant at p=0.001*** 
in experimental group. It’s depicted that the CD4 count was increased in experimental 
group than the control group. 
The findings was supported from  Caroline F
 
et al (2014) conducted pilot trial 
on adherence intervention combining with Financial Incentives (FI) with motivational 
counseling (MI) among adolescents in 16-25 yrs. The total of eleven young people 
outcomes values were compared with CD4 gain with post test. The results showed 
that, baseline to 1 year 9 out of 11 were achieved VL < 50, median CD4 140; mean 
CD4 gain 90cells/μL. Whereas after twelve months post cessation of MI/FI; six 
adolescents achieved VL < 50, median CD4 175, mean CD4 gain 122 cells/μL. The 
finding concludes that to prevent death and improve the adherence of adolescents, 
require novel interventions like FI/MI in order to improve virological and 
immunological outcomes with minimal expenditure.
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 The other review articles also 
supported the present study results.
191, 192 
  Table 5.3.2 (a) compared the overall level of ART adherence in experimental 
group of HIV infected adolescents by various methods. With regard to ‘5’ point 
response scale, only 15 % had optimal level adherence in baseline assessment but it 
was reached 100% in 6
th
 month evaluation. The chi square value of 392.99 was 
significant at the p=0.001***. Regarding the visual analog method, the baseline 
assessment only15% had optimal level adherence, whereas in the 6
th
 month it was 
increased to 78%. The chi square value of 191.4 was significant at the p=0.001***. 
With ‘3’ days recall method, 63% had optimal level adherence in baseline method, 
but it was increased to 94%. The chi square value of 60.1 was significant at the 
p=0.001***. In consideration of pill count method, 44% had optimal level adherence 
in baseline method, but it was increased to 93%. The chi square value of 149.14 was 
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significant at the p=0.001***. It’s denoted that there was significant improvement in 
the adherence rate among HIV infected adolescents in the experimental group.  
Table 5.3.2(b) compared the overall level of ART adherence in control group 
of HIV infected adolescents by various methods used. In regard to ‘5’ point response 
scale, there was no marked improvement in adherence rate from baseline to the 6
th
 
month evaluation. The chi square value of 0.19 was not significant at the p=0.99. In 
relevant to visual analog method, the baseline assessment only14% had optimal level 
adherence, whereas in the 6
th
 month it increased to 18%. The chi square value of 13.1 
was significant at the p=0.01**.  
With ‘3’ days recall method, 63% had optimal level adherence in baseline 
method, but it was slightly increased to 66%. The chi square value of 0.58 was not 
significant at the p=0.74. In consideration of pill count method, 38% had optimal level 
adherence in baseline method, but it was markedly increased to 48%. Still the chi 
square value of 4.29 was not significant at the p=0.11. It’s depicted that there was no 
significant changes in control group of HIV infected adolescents. Even though there 
were many different adherence rates were estimated in various methods, the missed 
dose history was highly correlated with pill count method only. So the investigator 
has taken the mean adherence score of pill count method in order to evaluate the 
effectiveness of adherence improvement in both groups. 
Nyogea D et al (2015) reported that only 70% of study participants had 
optimal level of adherence through pill count method. The study findings suggested 
that biological parent remains a key determinant of adherence among children and 
teenagers.
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 Kang E et al (2014) assessed the factors associated with high rates of 
antiretroviral medication adherence among perinatal HIV youth (13-21 years) in 
Thailand. Among the various methods of 24 hrs, ‘7’ days, visual analog method and 
pill count method, the reliable measure of pill count mean adherence range was 83.5 
to 99.8%.The optimal adherence was significantly associated (P<0.05) with treatment 
outcomes, psychological status, social support, and positive attitude of medications.
225
 
The other study objectively measured and positively associated with rising Nevirapine 
(NVP) concentration in hair but the associations were not statistically significant. 
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It was also supported by other study results included in the review of literature.
115,116, 
202
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  Table 5.3.2 (c) showed effectiveness of HIV interventional package on level 
of ART adherence score in both groups of the HIV infected adolescents. In 
experimental group, the mean ART adherence score in pretest was 85.36 and post test 
score was 98.74. The mean difference in ART score with 95% confidence interval 
was 13.38 and percentage of adherence gain score was 13.4%. However, in control 
group, the mean ART adherence score in pretest was 85.60 and post test score was 
90.54. The mean difference in ART score with 95% confidence interval was 4.94 and 
percentage of adherence gain score was only 4.9%. Its denoted that there was marked 
improvement in adherence level of HIV infected adolescents in experimental group 
than the control group.  
  It was supported by RCT on 116 participants initiating their first or second 
regimen of ART in the Netherlands. The intervention group received an 
individualized educational counseling session for improving QOL at baseline and at 
each follow-up visit (0, 4, 24, and 48 weeks). The control group received standard-of-
care and clinical follow-up. At week 48, 94% in the intervention group vs. 69% of 
those in the control group achieved >95% self-reported adherence (p = 0.008); 89% of 
the intervention group vs. 66% of the control had HIV viral loads <400 copies/mL (p 
= 0.026). He concludes that specific and maintained psycho educative interventions 
based on excellence on clinical practice are useful to keep high levels of adherence as 
well as high levels of viral suppression.
227
  
  Table 5.3.3(a) compared the interpretation of ‘Z’ score on HIV infected 
adolescents in both groups. In experimental group, 7% were severely malnourished, 
22% moderately malnourished in baseline assessment whereas in the 6
th
 month 
evaluation it was reduced to 1% and 18 % respectively. The chi square value of 9.48 
was significant at p=0.05*. However in control group, there was no significant 
improvement from baseline to the 6
th
 month evaluation. The chi square value of 0.10 
was not significant at p=0.99. The other cross sectional study also found that, higher 
risk of stunting (OR 5.33, 95%  CI: 2.83–10.04) and thinness (OR 4.7, 95% CI: 2.44–
9.06) and lower prevalence of overweight or obesity (OR 0.33, 95% CI: 0.14–0.78) 
was seen in  with the severity of vertical HIV infection and the consequences of 
prolonged ART.
139
 The  similar study results  revealed that, increased in fat mass is 
associated with better QOL.
215
 The similar findings also found in higher alterations in 
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the soft tissue (OR=0.216; 95% CI=0.057-0.811; p=0.030) and higher normal BMI 
(OR=0.498;  95% CI=0.252-0.987; p=0.066) in the intervention group than the 
control group.
13
 The study in Tanzania also suggested that better dietary counseling 
and prerequisite of macro and micro-nutrient supplements will be necessary to attain 
optimal nutrition for most of HIV-infected children in resource-limited regions.
228  
 Table 5.3.3(b) showed effectiveness of HIV interventional package on 
nutritional gain score in both groups of the HIV infected adolescents. In experimental 
group, the baseline assessment showed that 28% of participants were malnourished 
whereas in  the 6
th 
month evaluation it reduced to 19%. The percentage wise gain 
score was 9.3%. However in control group, the baseline assessment showed that, 29% 
of participants malnourished whereas in 6
th
 month evaluation it was reduced to 28%. 
The percentage wise gain score was 1.5% only. It’s depicted that the experimental 
group has gained more nutritional score when compare to the control group. Anitha V 
et al (2014) found that, after 12 week of yoga training program enhanced 
micronutrient adsorption and increased physical fitness among rural school children 
and adolescents than  the control group.
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  Table 5.3.4 (a, b, c) showed comparison of baseline level, 3
rd
 and 6
th 
month 
level of the mean & S.D of QOL score in both groups of the HIV infected 
adolescents. In baseline assessment, all the QOL domains in both groups had more or 
less equal mean value. i.e., the total mean value was 163.7 and 162.9 respectively and 
the mean difference score was 0.73. It was tested with Student Independent test and 
proved that all variables are not significant. But in 3
rd  
and 6
th 
 month in the 
experimental group there was slight improvement in all QOL domains i.e., the total 
mean value was increased from 163.6 to 187.8 and 215.6. In control group, it 
increased from  162.9 to 164.3and 166.02 and the total mean difference score was 
23.43 and 49.61.  The t-test proved that the significant improvement in all QOL 
domains at p ≤ 0.001***.  
The similar findings also supported by the low cost approach of yoga 
improved psychosomatic state of PLHIV and regular practice of MBSR is essential to 
enhance the QOL of adolescents.
230,231
 The another similar study  also found the HIV 
infection was associated with a negative impact on QOL among children with lower 
scores of physical, school, and emotional functioning and health symptoms. The 
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results suggested that, ARV treatment to be associated with improved QOL among 
HIV-infected children.
232 
  Table 5.3.4 (d) showed effectiveness of HIV interventional package on QOL 
score in both groups of the HIV infected adolescents.  In experimental group, the 
mean QOL score in pretest was 163.66 and post test score was 215.64. The mean 
difference in QOL score with 95% CI was 51.97 and percentage of QOL gain score 
was 15.1%. However, in control group, the mean QOL score in pretest was 162.93 
and post test score was 166.02. The mean difference in QOL score with 95% CI was 
3.09 and percentage of QOL gain score was only 0.9%. It’s denoted that, there was 
marked improvement in QOL of HIV infected adolescents in experimental group than 
the control group.   
It was supported by Andrinopoulos K et al (2012) suggested that patients 
with low CD4+ T-cell counts showed the higher use of health care utilization, 
demonstrating how early HIV diagnosis can helps to reduce health care costs.
59  
The 
other review article also supported that patients with elevated CD4 count had 
improved  QOL than those with low CD4 count.
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  Table 5.3.5 showed overall effectiveness of HIP components in both groups of 
the HIV infected adolescents. In adherence rate, the experimental group has gained 
13.4% and control group 4.9%. The difference was 8.5%. Considering with nutritional 
status, the gain score was 9.3% in experimental group and 1.5% in control group. The 
difference was 7.8%. In regard to QOL the gain score was 15.1% in experimental 
group and 0.9% in control group. The difference was 14.2%. It’s revealed that, the 
experimental group has gained more score than the control group. It was supported by 
Pathak RS et al 2010 evaluated that the effect of pranayama and yogasana program 
on immunity of hundred HIV infected individuals in west Bengal, India. At the 6
th
 
month results showed that, the significant increase in CD4 count (P<0.05) in 
experimental group. The study concluded that the practice of yogasana and 
pranayama by HIV infected individuals would increase their longevity.
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  In addition the other review articles also suggested that health promotion by 
nurses can lead many positive health outcomes including adherence, quality of life, 
patients’ knowledge of their illness and self-management.234,235 The above findings of 
the present study  suggested that there is significant improvement in post test score on 
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adherence rate, nutritional status and QOL of HIV infected adolescents in the 
experimental group alone. Since the second hypothesis of H 1 is rejected here. 
  The correlation of ART adherence level with nutritional status and quality 
of life on HIV infected adolescents in experimental and control group are discussed 
in section 5.4. The correlation co-efficient was calculated by Karl Pearson correlation 
coefficient method in both groups. 
 Table 5.4.1 showed correlation of ART adherence and nutritional status of 
HIV infected adolescents in both groups. In experimental group, the baseline value 
showed that poor correlation between ART and nutritional score. But in the 3
rd  
 and 
the 6
th
 month there was fair and moderate correlation between ART and nutritional 
score since r =0.31, 0.42 was significant at p=0.01** and at p=0.001*** respectively. 
Whereas in control group, throughout the assessment period showed that there was a 
poor correlation between ART with nutritional score because of ‘r’ value was lesser 
than 0.2. It’s depicted that the adherence and nutrition are directly propositional. The 
finding revealed that there is a positive correlation between the adherence and 
nutritional level of the HIV infected adolescents in experimental group.  
The similar findings was supported  by Kabue MM et al (2008) evidenced in 
their study, after beginning of ART resulted in significant improvement in mean 
standardized weight for-age Z-score (P < 0.001), and the height – for - age and  
Z-score (P < 0.05). The study findings found that, weight gain was more rapid than 
height after initiation of ART.
236
 Eby J et al (2015) identified that association 
between the adherence and VL relationship among adolescents with Medication Event 
Monitoring System (MEMS) with diaries. The 273 HIV infected adolescents on ARV 
treatment were monitored with MEMS for 30 days preceding a VL measurement. The 
handwritten diaries were used to comprehensively record deviations from 
recommended use (bottle opened but does not taken or bottle not opened and dose 
taken).The adherence was highly associated with VL and improved nutritional status 
(OR 1.05, p < 0.001).237  
The study conducted in Chennai and Madurai revealed that, among 231 HIV 
infected  children the prevalence of underweight was 63%, stunting with anemia 58%,  
wasting 16%  and overall 33–45% were moderately or severely malnourished even at 
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CD4 >25%.The height & weight for age Z scores , and weight for height were highly 
associated with CD4 cell counts. The results found that, under nutrition and stunting 
are common among HIV-infected children at all stages of the disease in India. The 
early and aggressive nutritional intervention along with optimal adhernce is required, 
if long-term outcomes are to be improved.
238
 
 Table 5.4.2 showed correlation of ART adherence with QOL of HIV infected 
adolescents in both groups.  In experimental group, the baseline value showed that 
poor correlation between ART adherence and QOL score. But in the 3
rd  
 and the 6
th
 
month there was fair and moderate correlation between ART adherence and QOL 
score since r=0.31, 0.43 was significant at p=0.05** and p=0.001*** 
correspondingly. Whereas in control group, throughout the assessment period showed 
that, there was a poor correlation between ART adherence and QOL score because ‘r’ 
value was lesser than 0.2. It’s depicted that the adherence and QOL are directly 
propositional. The finding revealed that there is a positive correlation between the  
ART adherence and QOL of the HIV infected adolescents in experimental group.  
  The similar findings was supported by Mannheimer et al (2005) reported that 
participants had 100% ART adherence attained significantly good QOL scores when 
compared to those with poorer ART adherence.
239 
The other study conducted in South 
Africa also found, the optimal adherence improved the overall QOL and observed it 
was persistent along with > 95 % adherence over the 12 month of study period.
240
  
The above findings suggested that, there is significant correlation between 
ART adherence with, nutritional status and QOL of HIV infected adolescents in 
experimental group alone. Since the third hypothesis of H2 is rejected here. 
 The association of the gain score findings of HIP in both groups of HIV 
infected adolescents with demographic variables of HIV infected adolescents / 
caregivers are discussed in section 5.5.  
  Table 5.5.1(a) and 5.5.3 (a) showed association between the ART adherence 
and QOL gain score with demographic variables of HIV infected adolescents with 
their caregivers in experimental group. In that the age and sex of adolescents, 
caregiver’s age, sex, relationship with adolescents and residence variables were 
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shown significant association with adherence and QOL gain score. Regarding age and 
sex of adolescents, the younger age of 10-12 years and males were gained high gain 
score of 15.89, 54.96  and 14.71, 54.35 respectively  was significant at the p ≤ 0.05*. 
Because the younger ages of 10-12 years were under the supervision of caregivers and 
especially more attention is given to males since the LFTU rates was slightly higher 
makes to gain more benefits when compared to the age group and the female 
adolescents. 
In consideration with caregivers age and sex, the younger of 20-35 years and 
females gained high gain score of 15.99, 57.80 and 14.83, 53.98 respectively was 
significant at p=0.05*.  Since the younger ages of female caregivers were played a 
major role to attain the high gain scores when compared to other age categories and 
males. In regard to relationship with adolescents and residential area, the high gain 
score of 17.48, 58.25 and 14.99, 56.19 was seen with mothers and adolescents 
residing in rural areas. It was significant at p ≤ 0.04* and 0.05* respectively.  Because 
the primary caregivers of mothers showed a great attention towards the adolescents 
health and the  adolescents residing  in the rural  areas  followed the interventions in 
disciplined manner,  adopted the diet modifications  makes easy to gained more score 
than the other type of caregivers and residing in urban areas. The rest of other 
demographic variables were not associated with adherence gain score.  
  Table 5.6.1 (a & b) & 5.6.3 (a & b) showed the influencing factors for ART 
adherence and QOL gain score by using Uni and Multivariate logistic regression 
analysis in experimental group. In Univariate analysis, the influencing factors of 
adolescents age and sex, age and  sex of caregivers , relationship with adolescents and 
residence were significant with unadjusted OR  with 95 % CI . While in multivariate 
analysis, the sex of caregiver and residence were not significant at p= 0.60 and 0.18, 
with adjusted OR 1.3 & 1.5 respectively. The rest of other variables were more 
significant with adjusted OR with 95 % CI. 
  The similar findings were supported by the following studies , Kuntawee C  
et al (2010) revealed, the HIV infected children's (78.7%) were in  need of 
improvement in QOL. The factors associated with poor QOL includes, having others 
as main caretakers OR 4.64, parental death OR 4.19, age of caregivers above 45 years 
OR 9.52, and family income > 5,000/- month OR 5.25 with 95 % CI. However, on 
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multivariate analysis, only age of caregiver was a significant predictor for QOL of the 
child. The other controversial view of the study includes, children who were cared  by 
caregivers  and aged 45 years or above had a better quality QOL than those whose 
caregivers were 20-45 years old (OR 6.32, 95% CI 1.12-35.62). Therefore, to improve 
QOL among HIV infected children, age of caregiver is an important factor to be 
considered.
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In the other articles also indentified the caregiver’s age of 25–34 years (AOR 
= 22.27) and 35–44 years (AOR = 7.14) were most probable to adhere than other age 
groups .
202 
The other study  also found that, children living with caregivers were more 
likely to have poor adherence compared to biological parents with OR = 2.84, 95% 
CI: 1.04-7.77. The children of primary school age were less significant compared to 
who never went to school i.e., preschool age children with OR = 2.39, 95% CI: 0.69-
8.28.
224
 The  another study from Lowenthal ED et al (2015) revealed that absence of 
a primary caregiver an adolescent’s clinic visit was significantly associated with 
virologic failure (OR  4.1 95% CI, 1.5–4.3).242  
The other similar studies reported that, 90.4 % study population had ≥ 95% 
adherence maintained on their ART cards in rural health facilities (P< 0.05) was 
significantly associated with optimal adherence to ART.
243- 44
 The controversial view 
from Ench AU (2013)
 
 stated that,  predictors of poor adherence includes mother as 
the primary caregiver (OR 3.32; 95%  CI, 1.33-8.67), It may be due to mother illness 
because of  majority of Pediatric HIV is acquired through vertically by MTCT.
121
 The 
another view from Ndiaye M et al (2013) identified that, male adolescents up to 65%  
are in non-adherent group (P = 0.02). In the multivariate logistic regression model in 
gender wise only the male sex (OR3.29, 95% CI, 1.13–9.54; P = 0.03) was 
independently associated with suboptimal ART adherence than the females due to 
failure to get the medicines from the pharmacy (9.7% vs. 30% P = 0.03).
245
 
     Hansana V et al (2013) through multivariate analysis revealed that, secondary 
school of education, dislike exercise and forgot to take ART drugs were mainly 
related with non-adherence with 95% CI.
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 The other study revealed that the mothers 
had completed tertiary education (OR: 0.10; 95%CI: 0.03-0.37) or other forms of 
education such as vocational trainings etc (OR: 0.16; 95%CI: 0.04-0.63) were likely 
to have good QOL than those whose mothers had no formal level of education.
246 
The 
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other article revealed that boys scored slightly higher than girls in each domain. But, 
significant gender differences were only found in relation to physical well-being, 
peers and the overall HRQOL score.
58  
The other similar study also identified that, the 
psychosomatic and environmental factors should be integrated in the physical and 
clinical assessment may be associated with strong association with QOL domains.
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Table 5.5.2(a) showed association between the nutritional status with 
demographic variables of HIV infected adolescents/caregivers in experimental group. 
In that, the age and education of adolescents, caregiver’s age, sex, relationship with 
adolescents and residence variables were shown significant association with 
improvement in nutritional status. Regarding adolescents age ,the majority of 92% 
were normal in the younger age of 10-12 years  and  only 8 % were in malnourished 
when compare to other age categories and it was significant at p=0.001***.In 
consideration with education, the highest  93% and 87 % were normal in primary and 
middle level educated adolescents and it was significant at p=0.001***. Because the 
higher education makes to misinterpret the correct information and perceive in wrong 
way to adopt the worst lifestyle changes made the adolescents to get less  score.  
In regard to caregiver’s age, the majority of 94 % were normal in younger age 
of 20-35 years and it was significant at p=0.03*.In relationship with adolescents, the 
highest percentage of 92 % were associated with mothers when compare to the other 
categories and it was significant at 0.04*.In regard to residence, the majority of 88% 
were associated with rural and it its significant at p=0.05%. The remaining other 
demographic variables were not associated with nutritional status of HIV infected 
adolescents. It depicted that there was a significant association between the nutritional 
statuses of HIV infected adolescents with specific demographic variables. 
 Table 5.6.2 (a & b) shows the influencing factors for nutrition gain score by 
using uni and multivariate logistic regression analysis in experimental group. In 
univariate analysis, the influencing factors of adolescents age & sex, age & sex of 
caregiver, relationship with adolescents and residence were significant with 
unadjusted OR  with 95 % CI. Whereas in multivariate analysis, the sex of caregiver 
and residence were not significant at p= 0.14 and 0.33 with adjusted OR 1.5 & 0.5 
respectively. The rest of other variables were more significant with adjusted OR with 
95 % CI. Another study revealed that HIV/AIDS orphan children living with their 
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elderly relatives (59%) and no formal education were associated with poor nutritional 
status.
248
  
 This findings are supported by the following review articles  Lwanga F et al 
(2015) identified the risk factors for stunting in male (AOR: 4.0; 95% CI: 1.81- 7.02) 
and residence in rural settings (AOR: 6.0; 95% CI 2.70-12.16).
94
 Imam MH  
et al (2011) through bivariate analysis revealed that the overall perception of QOL 
was better in the respondents living in urban area, higher in females and all caregivers 
in less than 35 years of age.
159
  
Thapa R (2015) identified the association between literacy status of 
caregivers with poor nutrition was found significant. i.e., caregivers who were not 
educated through formal education 2-3 times got undernourished with AOR 
=2.31with 95% CI 1.10-4.82.
249
 The other cross-sectional study from West Bengal, 
India identified the correlation of height and QOL indicates that enduring 
undernourishment consequentially at the end in stunting may correlate with lower 
levels of QOL.
250
 In both the studies, the positive correlation was seen between 
weight and BMI with all four domains. Notably, height is also found to be 
significantly correlated with three domains (psychological, level of independence and 
environment) of QOL.  
These result findings highlights the need for enhanced socio-psychosocial 
support, better environment and educational strategies for improving the health 
related QOL among people living with HIV.  
The above findings suggested that, there is an association between the gain 
score findings of ART adherence, nutritional status and QOL of HIV infected 
adolescents with demographic variables in experimental group alone. Since the final 
hypothesis of H4 is rejected here. 
 
Chapter - VII
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CHAPTER – VII  
   SUMMARY, RECOMMENDATIONS, IMPLICATIONS AND 
CONCLUSION 
 “If a society is to preserve stability and a degree of continuity it must 
learn how to keep its adolescents from imposing their tastes, values 
and fantasies on everyday life”.            - Eric Hoffer 
 The randomized controlled trial was used to evaluate the effectiveness of HIP 
on HIV infected adolescents attending ART clinic. The total of 388 HIV infected 
adolescents was divided in to experimental (195) and control group (193) by simple 
random technique. The data was collected through structured interview schedule by 
modified adolescent adherence questionnaire, modified QOL questionnaire (ACTG), 
nutritional assessment questionnaire and anthropometric variables. The data were 
collected from HIV infected adolescents / caregivers from four ART centres namely, 
Institute of Child Health and Hospital For Children (ICH) Egmore, Rajiv Gandhi 
Government General Hospital (RGGGH), Kilpauk Medical College and Hospital, 
(KMCH) and Government Hospital of Thoracic Medicine (GHTM). 
The HIV interventional package (HIP) is given to experimental group alone 
and the selected asanas (Padmasana, Vajrasana, Pranayama Trikonsana, 
Ardhamatsyendrasana or Ushtrasana, Bhujangasana & Shavasana) were demonstrated 
by the researcher.  But the conservative care was given to control group. At end of the 
6
th
 month the cursory instructions regarding HIP and practice of asana were also given 
to control group.  Simultaneously the data were collected from both groups at 
‘0’month, the 3rd and the 6th month intervals. The collected data were analyzed by 
using of both descriptive and inferential statistics. Here the investigator found the 
major findings of the study were listed below: 
7.1 MAJOR FINDINGS OF THE STUDY 
Regarding the CD4 count 
 In experimental group, the CD4 count were 40% in 601-900 cells/mm3, 10% 
in   901-1200 cells/mm
3
 and only 4 % in>1200 cells/mm
3 
of baseline assessment. But 
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at the 6
th
 month evaluation it was increased to 61 % , 24 % and  6% in  respective of 
the CD4 counts and only  9% were the CD4 count of 301-600 cells/mm
3
. The chi 
square value of 71.47 was significant at P=0.001***. Whereas in control group there 
was no marked improvement in CD4 count from baseline to the 6
th
 month evaluation. 
The chi square value of 3.89 was not significant at P=0.14. It denoted that there is a 
marked improvement in CD4 count of the HIV infected adolescents in experimental 
group. 
 In baseline assessment, the mean score was 664.86 in experimental group and 
669.72 in control group. The mean difference was 4.86. Where as in the 6
th
 month 
assessment of mean score in the experimental and control group was 840.30 and 
703.35 respectively. The mean difference was 136.96. The paired t-test value of 7.21 
was significant at p=0.001*** in experimental group. It depicted that, there is 
statistically significant improvement in CD4 count in experimental group than the 
control group. 
Regarding the level of adherence rate 
 However there are various methods was used in this study for to assess the 
ART adherence level, since the pill count was highly correlated with missed dose 
history in both groups. In baseline assessment, 44% had optimal level adherence but it 
increased to 93% at 6
th
 month in the experimental group. The chi square value of 
149.14 was significant at p=0.001***. Whereas in the control group, 38% had optimal 
level adherence in baseline, but it slightly increased to 48% at the 6
th
 month.  The chi 
square value of 4.29 was not significant at p=0.11. It revealed that there is statistically 
a significant improvement in  the experimental group than the control group. 
 In experimental group, the mean ART adherence score in pretest was 85.36 
and the post test score 98.74. The mean difference in ART score with 95% confidence 
interval was 13.38 and percentage of adherence gain score was 13.4%. However, in 
the  control group, the mean ART adherence score in pretest was 85.60 and the post 
test score was 90.54. The mean difference in ART score with 95% confidence interval 
was 4.94 and percentage of adherence gain score was only 4.9%. It denoted that there 
is marked improvement in adherence level of HIV infected adolescents in 
experimental group than the control group. 
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 Regarding the reasons for the non-adherence of ART for HIV infected 
adolescents in baseline assessment showed that, there were 41% and 36% of 
adolescents only in the not applicable category in experimental and control groups. 
The remaining adolescents had many reasons for the non adherence includes, forgot 
(33% vs. 40%)) boring (6% vs. 5%), busy scheduled (10% vs. 7%) travelling  
(7% vs. 9%) and not having finance to come and collect the drugs (2% vs. 1%) and 
adverse effects of drugs (1% vs. 0.5%) respectively in both groups.  But after HIP, in 
experimental group not applicable category was increased to 89 % and 94% 
respectively in subsequent evaluation but still 6% of adolescents had non adherence 
problems because of forgot. Whereas in control group, the not applicable category  
increased up to 46% and 62% only in further evaluation period. The chi square value 
of 88.98 and 60.69 was significant in p=0.001***.  
 In consideration of aids for improving adherence to ART in both groups of  
HIV infected adolescents in baseline assessment, the half of percentage (47% and 
50%) of adolescents were using pillboxes and nearly 44% and 46% of adolescents 
were not using any aids to improve the adherence. Whereas in the experimental group 
got investigator reinforcement counseling and also the diary used as a remainder cue 
along with previous aids. But in the control group there was no special aids used to 
improve the adherence and no marked changes in the aids from the baseline to  the 6
th
 
month evaluation. The chi square value of 189.50 and 182.45 were significant at 
p=0.001***. It depicted that the reminder cue of diary has effectiveness to improve 
the adherence among HIV infected adolescents in experimental group. 
 These findings depicted that the motivational counseling and interventional 
diary has effectiveness to increase the adherence to ART among HIV infected 
adolescents in experimental group (13.4%) than the control group (4.9%). The gain 
score differences of 8.5% showed the effectiveness of HIP in the improvement of 
adherence level in experimental group of HIV infected adolescents. 
Regarding Nutritional status 
 Regarding the anthropometric variables of weight, BMI, Mid arm 
Circumference, Skin fold thickness (Triceps) and waist circumference of HIV 
infected adolescents in experimental  group showed a significant improvement from 
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baseline to the 6
th
 month evaluation at the p=0.05* except the height. Where as in 
control group there was no significant changes in the anthropometric variables of HIV 
infected adolescents. 
  In experimental group, the repeated measures of ANOVA F’ test showed the 
statistically significant improvement in all the anthropometric variables except height 
at p=0.001***.  It showed that, except height there wass a marked improvement in all 
other nutritional variables of HIV infected adolescents. But the Bonferroni t–test 
revealed that, all the variables had significance from baseline to the 6
th
  month 
evaluation at p<0.01* and  the 3
rd
 to 6
th  
 month evaluation also had significance at 
P<0.05* except the height. It denoted that, there is also a minimal improvement in 
height of the HIV infected adolescents. Whereas in control group, all nutritional 
variables of HIV infected adolescents had no significance in ANOVA F-test and 
Bonferroni t–test. It revealed that there is no marked improvement in the all 
nutritional variables of HIV infected adolescents in the control group. 
  Regarding the interpretation of ‘Z’ score on HIV infected adolescents, in 
experimental group, 7% were severely malnourished and 22% were moderately 
malnourished in baseline assessment whereas in  the 6
th 
month evaluation it reduced 
to 1% and 18% respectively. The chi square value of 9.48 was significant at 
p=0.05*.However in control group, there was no significant improvement from 
baseline to 6
th
month evaluation. The chi square value of 0.10 was not significant at 
p=0.99. 
  In consideration with nutritional gain score in experimental group, the 
baseline assessment showed that  28% of participants were  malnourished where as in 
6
th
 month evaluation it reduced to 19%. However in control group the baseline 
assessment showed that, 29% of participants were malnourished where as in the 6
th
 
month evaluation it reduced to 28% only. It depicted that, the experimental group has 
gained more (9.3%) score when compare to the control group. (1.5%).  
 These findings revealed that the reinforcement of nutritional counseling have 
effectiveness to increase the nutritional level of HIV infected adolescents in the 
experimental group than the control group. The gain score difference of 7.8% showed 
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the effectiveness of HIP in the improvement of nutritional status of HIV infected 
adolescents in experimental group. 
  Regarding  clinical signs and symptoms, the dry skin, skin rashes, oral 
problems, loss of appetite, nausea, vomiting and  diarrhea  were  reduced from 
baseline to 6
th
 month evaluation in experimental group and it was significant at 
p=0.01*.But Seborric dermatitis, texture and color of hair, eye problems no marked 
improvement  in  the study period.  Where as in the control group there was no 
significant changes seen in the HIV infected adolescents. 
Regarding Quality of Life 
  In regard to QOL on HIV infected adolescents, in experimental group, 81%  
had poor QOL, none of them had good QOL in baseline assessment whereas in 6
th
 
month 14% had good QOL and subsequently reduced the poor QOL to 23%). The chi 
square value of 174.19 was significant at p=0.001*.However in control group, there 
was no significant improvement from baseline to 6
th  
month evaluation. The chi square 
value of 0.10 was not significant at p=0.99. 
  In experimental group, the mean QOL score in baseline was 163.66 and 6th 
month  was 215.64. The mean difference in ART score with 95% confidence interval 
was 51.97 and percentage of adherence gain score was 15.1%. However, in control 
group, the mean QOL score in baseline was 162.93 and 6
th 
month was 166.02. The 
mean difference in ART score with 95% confidence interval was 3.09 and percentage 
of adherence gain score was only 0.9%. It denoted  that, there is a marked 
improvement in QOL of HIV infected adolescents in experimental group than the 
control group. 
 This finding depicted that, the strategies of QOL counseling and yoga has 
effectiveness to increase the QOL of HIV infected adolescents in experimental group 
than the control group. The gain score difference of 14.2 % showed the effectiveness 
of HIP in the improvement of QOL of HIV infected adolescents in experimental 
group. 
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 The above findings suggests that there is significant improvement in post test 
score on adherence rate, nutritional status and QOL of HIV infected adolescents in  
the experimental group alone. Since the hypothesis of H0 and H1 is rejected here. 
Regarding correlation of ART adherence with Nutritional status and QOL 
 In considering with nutritional status, in experimental group the baseline 
assessment showed that poor correlation between ART  adherence and nutritional 
score. But in,  the 3
rd 
and 6
th
 month evaluation there is fair and moderate correlation 
between ART adherence and  nutritional score since r=0.31, 0.42 was significant at 
p=0.01** Whereas in control group, throughout the assessment period showed that, 
there is a poor correlation between ART adherence and  nutritional score because of 
‘r’ value was lesser than 0.2. It showed that adherence rate and nutrition is directly 
propositional. It revealed that there is a positive correlation between the  ART 
adherence with nutritional status of the HIV infected adolescents in experimental 
group. 
  In regard to ART  adherence and  QOL score, in baseline assessment showed 
that poor correlation between ART adherence with QOL score. But in the 3
rd
 and 
6
th
month  evaluation there is fair and moderate correlation between ART with QOL 
score since r=0.31, 0.43 was significant at p=0.05**. Whereas in the control group, 
throughout the assessment period showed that there is a poor correlation between 
ART  adherence and  QOL  score because  of ‘r’ value was lesser than 0.2. It denoted 
that, adherence rate and QOL are directly propositional. It depicted that there is a 
positive correlation between the adherence with QOL of the HIV infected adolescents 
in  the experimental group. 
  The above findings revealed that there is significant correlation between ART 
adherence with nutritional status and QOL of HIV infected adolescents in 
experimental group alone. Since the research hypothesis of H2 is rejected here 
Regarding association of ART, Nutritional status and QOL of HIV infected 
adolescents in experimental group with demographic variables 
 Regarding ART adherence gain score, In  the univariate analysis, the 
influencing factors of adolescents age & sex, age & sex of caregivers, relationship 
with adolescents and residence were significant with unadjusted OR with 95% CI. 
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Whereas in  the multivariate analysis, the sex of caregiver and residence were not 
significant at p=0.60 and 0.18 with adjusted OR 1.3 & 1.5 respectively. The rest of 
other variables were more significant with adjusted OR with 95 % CI. It depicted that 
adolescent’s age of less than 15 years and male, caregiver’s age of less than 35 years, 
parents especially mothers  and adolescence residing in rural areas were highly 
associated with adherence improvement. 
 Considering with nutritional gain score, in the univariate analysis, the 
influencing factors of adolescents age & education, age & sex of caregivers, 
relationship with adolescents and residence were significant with unadjusted OR with 
95% CI. Whereas in the multivariate analysis, the sex of caregivers and residence 
were not significant at p=0.14 and 0.33 with adjusted OR 1.5 & 0.5 respectively. The 
rest of other variables were more significant with adjusted OR with 95 % CI. It 
revealed  that adolescent’s age of 10-12 years and who were in primary level 
education, caregivers age of 20-35 years and mothers are highly associated with 
nutritional improvement of HIV infected adolescents.    
 In regard to QOL gain score, in the univariate analysis, the influencing 
factors of adolescents age and sex, age and sex of caregivers, relationship with 
adolescent and residence were significant with unadjusted OR  with 95% CI. Whereas 
in multivariate analysis, the sex of caregivers and residence were not significant at p= 
0.60 and 0.3 with adjusted OR 1.3 & 1.5 respectively. The rest of other variables were 
more significant with adjusted OR with 95 % CI. It depicted that adolescent’s age of 
less than 15 years  and male, caregiver’s age of less than 35 years, parents especially 
mothers and the adolescents residing rural areas are highly associated with  QOL 
improvement of HIV infected adolescents. 
 The  above findings of the study depicted that, there is significant association 
between the gain score findings of ART adherence, nutritional status and QOL of HIV 
infected adolescents with demographic variables of HIV infected adolescents / 
caregivers in experimental group alone. Since the hypothesis of H4 rejected here. 
7.2 RECOMMENDATIONS 
Evidence suggests that, adolescents continue to have a variety of unmet needs. 
The evidence from adolescent’s agency and autonomy is limited to studies with young 
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men and women aged 15-24 years. Further research is needed to examine factors 
under lying adolescent’s adherence problems, nutritional impact, QOL and the 
expression of unequal gender role attitudes for adolescents 10-19 years of age. 
 A similar study can be conducted on high risk groups and young women with 
HIV.  
 A comparative study can be undertaken on gender influences, urban vs. rural 
and orphan vs. non orphan  of HIV infected children / adolescents. 
  A comparative study can be undertaken to infected adolescents with healthy 
controls in terms of QOL improvements. 
 A longitudinal study is needed to identify long term effects of yoga and to be 
evaluate with biological markers. 
 A Mind -fullness based relaxation techniques (meditation) are needed in HIV 
infected adolescents still they need relaxation techniques and psychological 
support to improve over all well being. 
 A study can be undertaken in various clinical settings and in various ethics 
groups. 
 A mixed method study can be undertaken to identify the psychological 
barriers of adolescents living with HIV / AIDS. 
 The unmet needs of adolescent’s areas should be focused separately and 
address the needs with appropriate intervention based study in order to make 
safe transition to adulthood. 
 A need based intervention studies can be undertaken to improve adherence 
level, nutritional concern and QOL of adolescents with biological markers. 
  A similar study can be conducted with nutritional supplementations. 
 The computer based reminders cues can be studied in the adolescent groups in 
order to improve the adherence level. 
 More research is required to examine adolescent-specific treatment concerns, 
including  drug resistance, treatment failure and loss to program rates among 
ALHIV since many adolescents are requiring the second and the third-line 
regimens. 
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 Operations research should be undertaken to assess the impact of ‘life skills 
building’ programs to identify effective interventions suitable for scale-up. 
The impact of limited autonomy and decision making on the age at marriage 
and long term reproductive health outcomes, educational attainment, and 
access to employment among adolescents needs to be studied. 
7.3 NURSING IMPLICATIONS 
 The nurses are the center part of the multi disciplinary team in hospital, other 
health and ART care centres for assessing, planning and evaluating the outcome of 
any kind of treatment and management of PLHIV. The paradigm of HIV prevention 
has shifted to treatment as prevention strategies, it is essential to recognize factors like 
adherence promotion and retention in care to ARV regimens among HIV-positive 
adolescents and youth. This study findings further contribute to the evidence based 
clinical research for the future researchers.  This study reports stimulate creative and 
innovative thoughts among the health professionals to evolve better strategies for 
further research and improve the QOL of ALHIV. 
7.3.1 Nursing Education 
 One of the most challenges facing student nurses is that recognizing and using 
appropriate strategies to meet the health education needs of ALHIV in regard 
to commitment to life saving drugs, nutrition and prevention of HIV/AIDS. A 
training / Continuing Nursing Education (CNE) can be conducted on this 
topic/issues.  
 In the nursing curriculum, the importance should focus to the Pediatric 
HIV/AIDS especially on adolescent age groups. The student nurse educators 
should need a adequate knowledge and necessary training  is essential to 
impart optimal adherence to ART and managing the ALHIV in ART centres. 
 The HIV interventional package (HIP) module developed for this study can be 
used in all ART centres and College of Nursing as health education material 
for students. 
 The curriculum plan to be extended to alternative medicine of yoga and 
pranayama helps to improve the overall well being of nursing students. 
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 The nurse educators should arrange for periodical educational camps for 
student nurses regarding reproductive health of adolescents, prevention 
strategies of HIV/ AIDS and especially reinforce safer sexual practices among 
high risk groups in the community. 
 The Indian Nursing Council (INC) / Tamilnadu Nurses and Midwives Council 
(TNMC) should take up this type of interventions as educational program for 
student nurses includes symposium/workshop/seminars /conferences on the 
rules and regulations of nurses involved in adolescent HIV care. 
 Periodical in service education for Nurses and Nursing students can be 
conducted on adolescents HIV care with regard to national guidelines. 
7.3.2 Nursing practice  
 The nursing fraternity should co-ordinates with nongovernmental organization  
in regard to implementation and scaling up of HIV control and prevention 
programs and safer sex practices among youths in the community and as well 
as the hospital periodically. 
 The community health nurse should plan and conduct periodical training 
programs for school teachers, parents and village health workers on adolescent 
reproductive health, importance of nutrition in the puberty and HIV 
prevention. 
 The study findings should develop  positive attitudes to  the  ART staff nurses 
to  provide appropriate counseling  in regard to adherence improvement, 
importance of anti oxidants in the  diet  and  strategies to enhance the  QOL of  
all  PLHA. 
 The knowledge obtained from this research has to be translated into nursing 
service both in hospital and community settings. In hospitals, 
 Every hospital should have special training to HIV nurse who can 
look after HIV infected people including adolescent HIV clients.  
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 The nurse specialist can do the following duties, 
 Chronic diseases management including health monitoring 
and symptomatic management. 
 Acute care 
 Health promotion and disease prevention 
 Palliative care      
 Mental health monitoring 
 Positive living support and advocacy 
 Referral management 
 Adherence  and nutritional care   
 Strategies that enhance QOL. 
 In community, the public health nurse can make necessary arrangements for 
youth clubs and health camps especially counseling program on prevention of 
HIV and premarital counseling. 
7.3.3 Nursing Research 
 More of the qualitative and quantitative research studies can be undertaken in 
the area of adolescent health. 
 The research and practice should consider intervention approaches that 
address the “live experience” of individuals in HIV care, which includes 
adherence challenges for those on ART, impact of nutrition and also other life 
priorities that influence treatment-related decisions to enhance the QOL. 
 Disseminate the findings through conferences, seminars, publications in 
professional, national and international journals and worldwide websites helps 
to find  the thirst areas of research in HIV/AIDS.    
 Government should allot more funds for the nursing research in regard to 
HIV/AIDS. 
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7.3.4 Nursing Administration 
 Nurse administrators have the responsibility to increase knowledge and 
awareness about ART and prevention of HIV/AIDS to community. The 
refresher courses for all health care professionals to be conducted periodically. 
 The health professionals at all levels should be given exclusive training like in 
service education and continuing education for handling ALHIV.  The health 
professionals of same gender should focus the problem of boys and girls 
individually. 
 The nurse administrators should consult with positive networks for to promote 
community participation for ALHIV in order to create life skills and to be 
dynamic part in community programs. 
 The administrators motivate the health care professionals to focus on 
adolescent friendly clinics. Through that, periodical screening of adolescent 
health problems, HIV testing and counseling, ART initiation and voluntary 
medical male circumcision (VMMC) are ready to implement the need based 
service. 
 The nursing fraternity allots appropriate funds for care, monitoring and other 
interventions for PLWA. 
 Through this study findings nurse administrators help the policy makers to 
frame appropriate plan for the welfare of the HIV positive adolescents. 
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CONCLUSION 
We cannot always build the future for our youth, 
   But we can build our youth for the future. 
        Franklin D. Roosevelt 
 The young people are our future as well as the world’s greatest resource. But 
the HIV epidemic brought a terrible toll on adolescents and youth have become 
increasingly vulnerable to transmit and acquire HIV infection. The paradigm of HIV 
prevention has moved to treatment as prevention strategies, it is essential to identify 
factors like adherence promotion and retention in care to antiretroviral regimens, 
promoting nutritional status among HIV-positive adolescents and youth. The 
successful transition of HIV infected children through adolescence into adulthood 
requires the multi disciplinary team approach including sexual and reproductive 
health, psycho social support and vocational training in order hopefully build up for 
their future.  
 The study reports revealed that, in the experimental group pretest mean score 
was 85.36 in adherence and 163.66 in QOL. But in the 6
th
 month evaluation, it was 
increased to 98.74 and 215.64 respectively. In corresponding to the improvement of 
HIP components, the mean difference score with 95 % confidence interval was 13.38 
& 51.97 and percentage of gain score was 13.4% in adherence and 15.1% in QOL. 
But in the control group, there was no significant change in mean difference score and 
the percentage of gain score increased to 4.9% in adherence and 0.9% in QOL. In 
regard to nutritional status, the both groups   baseline assessment showed 28% and 
29% of HIV infected adolescents had malnourished. But in the 6
th
 month evaluation, 
It reduced to 19% and 28% respectively. In percentage wise nutritional gain score was 
increased to 9.3 % in experimental and 1.5% in control group.   
This study finding suggests that adolescent focused interventions including behavior 
modifications are essential to improve the CD4 count, adherence rate, nutritional 
status and enhance quality of life. The global targets of zero infections, zero 
discrimination and zero deaths in the adolescent population  for HIV is within our 
reach  but  adolescents centered interventions are needed as in tailored approach  in 
order to improve the overall wellbeing of adolescents. This study finding revealed that 
the motivational counseling with interventional aids of diary and yoga practice makes 
the adolescents to build a chance for a safe, happy, healthy and productive nation in 
the future. 
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Annexure-i (a) 
ASSESSMENT TOOLS 
SECTION A 
PART I – DEMOGRAPHIC DATA OF ADOLESCENTS 
1. Name of the subject:                                      ART no:                        Place: 
2. Age (years)  
1.10-12      
 2.13-15 
 3.16-18          
3. Sex 
 1. Male 
 2. Female         
4. Educational status 
1. Primary level                           
 2. Middle level         
 3. Secondary 
4. Higher secondary                   
5. Religion  
1. Hindu  
2. Muslim 
3. Christian 
4. Others              
 
PART II - DEMOGRAPHIC DATA OF CAREGIVERS 
 
6. Name of the Care giver 
7. Age (years) 
1.20-35                   
2.36-50                               
3.>50             
8. Sex  
 1. Male  
 2. Female.                        
9. The caregiver’s relationship with the subject is, 
    1.Father 
    2.Mother 
    3.Others (Grandmother/ Grandfather/ Uncle/ Aunty/Guardian)           
10. Educational status   
   1. No formal education      
    2. Up to school level 
     3. Up to college level              
11. Occupational status            
    1. Employed 
2. Unemployed 
3. Not Applicable          
12. Annual income of care giver’s for, 
 1. Up to 12,000 Rs/- 
 2. Up to 24,000 Rs/- 
 3. >24,000 Rs/- 
 4. Not applicable.            
13. Residence  
1. Rural 
            2. Urban                                   
 
PART III - CLINICAL INFORMATION RELATED TO ADOLESCENTS 
 
14. The adolescent diagnosed as HIV positive is , 
   1. Less than 5 yrs  
   2. 5 - 10yrs 
   3. >10 yrs.                      
15. The probable route of  HIV transmission is, 
   1. Mother to  child transmission  
  2. Blood transfusion 
   3. Sexual transmission              
  4. Unknown                                                                                      
16. The HIV stage of the subject  includes, 
   1. Stage I  
     2. Stage II 
   3. Stage III                 
17. The subject has been on ART for 
   1. 3months -1 year 
    2. 1- 5 years 
  3.  >5 years.                                                                 
18.  The subject had previous history of the tuberculosis?          Yes /No  
18. a. If  yes, the history of ATT drugs for subject is, 
   1. Completed. 
   2. On ATT 
  3.  Discontinued   
19.  The caregiver disclosed the HIV information to the adolescent: Yes /No       
20.  The level of CD4 count before initiating   ART was   …………. 
21.  The latest CD4 count,  
   1.  ‘0’ month                          2. 6th month   
PART IV - BACK GROUND INFORMATION OF ADOLESCENTS/ 
CAREGIVERS (Includes the family and social history) 
22. The parental living status of subject is,    
   1.Father    - Alive /Dead /Unknown 
            2.Mother  - Alive /Dead /Unknown 
3. Siblings - Alive /Dead /Unknown                
23. The parental /siblings HIV status of subject is,      
    1. Father        -     Positive /Negative /Unknown    
    2. Mother       -    Positive /Negative /Unknown 
            3. Siblings      -    Positive /Negative /Unknown    
24. The subject is residing with biological parents   :    Yes / No         
24a. If,  No the subject is living with,   
   1.Family members 
   2.NGO 
  3.Non biological parents                                     
25. The healthcare facilities are accessible for other      :    Yes / No        
      health related problems  
26. The caregiver has adequate financial support        :    Yes / No   
27. The caregiver has adequate social support    :    Yes / No             
       if yes,          
a) You have received any help pertaining to your adolescent  
        health condition from  relatives & neighbor ?      :   Yes / No 
b)   You have received any Governmental support like         :  Yes / No 
       financial / health related/others?  
c)   You have any NGO support for adolescent’s survival?    :  Yes / No 
d)   You have find discrimination of adolescent in society?    :   Yes /No  
        if yes, 
1. Family Members    
2. Relatives 
3. Neighbors.    
4. Schools 
5. Others. 
e)   Do you satisfied with available social support?       Yes / No          
28. The caregiver’s came to know about the basic information on HIV/ART through,  
1. Newspaper    
  2. TV / Cinema    
3. Health Care Professionals   
  4. Others   (specify)                 
29.  The most of the ART information and benefits are informed by, 
1. Doctors   
  2. Nurse  
  3. Counselors  
  4. Others (specify)          
  30.   Do  you know the basic information on HIV/ART?    Yes / No  
    If Yes,  
    a) AIDS is caused by                 
    1. Micro bacteria   
    2. Fungus 
      3. HIV  virus 
               4. Low immunity                                                        
  b) AIDS/ HIV transmitted through is  
        1. Touching the HIV infected People with bare hand.     
2. Hugging the adolescents   living with HIV 
 3. Sexual intercourse 
 4. Sharing plates of the HIV infected people with others.         
        c) Transmission can be prevented by using the, 
   1. Condoms      
             2. Hot water   
             3. Clean clothes                                               
4. Alcohol              
        d) The HIV/AIDS can be diagnosed by   
    1. Urine 
  2. Blood 
  3. Sputum 
  4. All the above       
     e)  The AIDS/HIV can be cured by using ART?         Yes / No                    
SECTION-B 
 
MODIFIED ADOLESCENT ADHERENCE  ASSESSMENT QUESTIONNAIRE  
(AIDS  Clinical Trial Group- ACTG)) 
1. The subject is consuming ART in,   
     1. I line drugs  
        2. Alternative I   line   drugss 
       3. II line drugs                       
1a.  Name of the drug is, 
      1. ZLN  2.SLN     3. ZLE    4.SLE     5. ALN   6. ALE   7.TLE 8.AL/LR        
2. The ART medications can be administered by 
   1.  Self  
   2.  Care givers                    
3. Is there any previous exposure to adherent assessment tool?   Yes / No                                                                
4. Is there any previous hospitalization of the subject for the past 3 months? Yes / No   
4a. If yes, because of    
  1. OI   
  2. Side effects of ART 
 3. Others         
5. Do you know the exact dose of the ART medications?        Yes / No      
6. Do you know the exact dosage frequency of ART medications?      Yes / No       
7. Is there any change in ART therapy for the past 3 months?              Yes / No        
                      If yes, reason    ………………………… 
8. Do you feel, the subject has medication burden         Yes / No 
                      If yes, reason    …………………………. 
9. Do you feel difficulty in giving drugs to the subject        Yes / No           
                      If yes, reason  ………………………… 
10. Do you feel, whether the subject is depressed while giving the medicines? Yes / No  
        If yes, reason …………………………….       
11. Table to Assess Adherence to HIV Medications: 5 - POINT RESPONSE SCALE 
"Thinking of the medications PRESCRIBED to subject by the doctor(s), please answer 
the following questions." 
Response options: Never = 0; Rarely = 1; Sometimes = 2; Often = 3; Always = 4 
 0 1 2 3 4 
Do you ever forget to give medications? 
Are you careless at times about giving medications? 
When subject feel better, do you sometimes stop giving medications? 
Sometimes, if subject feel worse when you give medications,  
do you stop giving them? 
 
12. VISUAL ANALOG METHOD : List codes for all antiretroviral drugs that 
subject was prescribed to take in last 30 days. Identify up to 3 drugs. 
DRUG A:             DRUG B :          DRUG C : 
DRUG A:  
DRUG B:  
DRUG C:  
 
Interpretations: 
        0% means  not given / taken any drugs 
        50% means taken/given in half level of drugs 
        100% means taken /given the medicine daily as prescribed by the doctors 
 
13. The ‘3’ days recall method of Adherence can be calculated by ,   
 
% Adherence= Number of doses expected to be taken – Number of doses missed x100                                                                                                                                                                             
                        Number of doses expected to be taken for the past 3 days      
  
14. The percentage of adherence by pill count method can be calculated by , 
      (Missed dose correlates with pill count mentioned in ART medical record book) 
 
% Adherence = Number of pills  expected to be taken - Number of pills missed  x 100  
                                        Number of pills expected to be taken for 1 month 
 
15. The reason for non-adherence includes, 
 1. Not   applicable. 
2. Forgot. 
3. Boring/fatigue 
4. Got in the way of daily schedule (school work) too busy/busy schedule 
5. Travelling 
6. Not having finance to come and collect the drug. 
7. Not available in pharmacy 
8. Medicines caused me to have other physical symptoms/side effects 
9. Others  (specify)                  
 
16. The subject can utilize any of the following aids for improving adherence, 
1. Pill boxes 
            2. Calendars 
 3. Reminders in the mobile 
            4. Buddy system 
 5. Diary 
            6. Nil 
SECTION-C 
PART I - NUTRITIONAL ASSESSMENT 
 
I. ANTHROPOMETRIC ASSESSMENT 
1. Height      :         cms      
2. Weight      :         Kgs          
3. BMI       :         Kg/m
2
 
        4. Waist circumference     :         cms 
        5. Mid upper arm circumference :         cms.  
        6. Skin fold thickness (Triceps)  :          mm 
        7. “Z” Score      : 
PART II  
II.CLINICAL HISTORY/ASSESSMENT FOR THE SUBJECT 
8. Have you been given treatment  for any nutritional deficiency?   Yes / No  
     If yes, a. name of the deficiency disorder …………….. 
       b. Treatment ………………………… 
9. Are you dewormed  of your subject regularly?    Yes / No  
10. Do you have iron deficiency anemia at present?   Yes / No  
11. Have you lost your weight for the last 3 months?  Yes / No 
11a. If yes,   
        a. 0-5%      b.5-10 %              c.  >10%  of present body weight.          
12. At present, do you have any of the following signs and symptoms? 
      a. Skin           
          Dry skin    : Yes / No 
          Nails  : Yes / No    if yes, 
   Koilonchia / Ridged nails/Discoloration 
      b. Head/ Hair  
          Color      :  Pigmented/ depigmented  
          Texture  :  Shiny /Dull / Thin/ Pluck ability     
           Infections/injuries:  Yes/No ,  If yes,  …………..  
      c. Eyes            : Yes/No,   If yes, 
             Xeropthalmia / Bitot’s  spot / Paleness in conjunctiva 
      d. Oral       : Yes/ No,   if yes, 
  Stomatitis / Glossitis / Bleeding gums / Dryness of lips 
      e. Gastro Intestinal  
          System      :  Yes/ No,  if yes 
Appetite / Nausea / Vomiting/ Streotorrhoea / Diarrhea      
      f. Extremities  :   Muscle wasting  :   Yes / No 
    Oedema               :  Yes / No 
    Lipo dystrophy    :   Yes / No                   
 
   
  
 SECTION -D 
MODIFIED QUALITY OF LIFE ASSESSMENT QUESTIONNAIRE 
(For Ages 5   -   11 Years) 
 
1. General Health Ratings:  These statements ask about the health and behavior of 
    adolescents. 
  A. On the scale from 1 to 10 (1 being very worst, and 10 being the very best) 
       How has adolescent feeling, on the average, of the past 3 months?                                                                   
The Very Worst     The Very Best 
He /She Ever Felt    He /She Ever Felt 
 
 
1. Overall, in general ?     1    2 3       4        5      6      7     8    9 10 
 
2. Physically ?       1    2 3       4        5      6      7     8    9 10 
 
3. Emotionally?       1    2 3       4        5      6      7     8    9 10 
 
4. About their  
    School work?       1    2 3       4        5      6      7     8    9 10 
 
B.  For  the following statements, decide which phrase best describes   adolescent’s 
health over the past 3 months, and then answer your choice. 
      During the past 3 months,     
 
Never or 
Rarely 
Some of 
the Time 
Almost 
Always 
 
1.  My Adolescent’s health is excellent…………………     1   2       3 
2.  My Adolescent seems to resist illness very well ……      1   2       3  
3.  My Adolescent seems less healthy than other  
     adolescent I know ………………..   1   2       3 
4.  When there is something going around, my adolescent  
     usually catches it………………………………………   1   2       3 
5.  My adolescent is somewhat confused…………………   1   2       3 
6.  My adolescent seems accident-prone ………………… 1   2       3 
7.  When my adolescent is sick or injured, he / she usually    
      recovers quickly  ……………………………………    1            2       3  
II. Physical Functioning 
 
How much if at all, has adolescent’s health interfered with his / her activities 
during the past 4 weeks? 
             How much has adolescent’s health interfered with?   
 
            
                   Not          A Little         Moderately     Quite a        Extremely       
    at all         bit        bit 
 
1. The kinds or amount of vigorous 
 activities your adolescent can do,  
 like lifting heavy objects, running,  
 or participating in strenuous sports?   1       2         3        4              5 
 
2. The kinds or amount of moderate         
activities your adolescent can do, like 
bowling?  1       2         3        4               5 
 
3. Walking uphill or climbing a few  1          2             3        4       5 
 flights or stairs? 
 
4. Walking one block?        1        2              3        4  5
      
5. Bending, lifting or stooping?       1        2              3        4      5 
 
6. Eating, dressing, bathing or       1        2              3         4  5 
 using the toilet? 
 
III.  Psychological Well-Being 
 
These statements are about behavior problems of adolescents. You decide 
which phrase describes adolescent’s behavior over the past 3 months, and then answer 
your choice. 
 
Thinking about your adolescent, during the past 3 months…. 
                    Often    Some   Not true 
  true times   
 true            
 
1. My adolescent has sudden changes in mood or feelings …     1         2           3  
 
2. My adolescent feels or complains that no one loves him / her 1         2           3 
 
3. My adolescent is rather high strung, tense, and nervous         1         2           3 
 
4. My adolescent cheats or tells lies……………………………  1         2           3 
 
5. My adolescent is too fearful or anxious………………….…   1         2           3 
 
6. My adolescent argues too much……………………………    1         2           3 
 
7. My adolescent has difficulty in concentrating, cannot pay  
    attention for long.              1         2           3 
 
8. My adolescent is easily confused, seems to be in a fog……    1         2           3 
 
9. My adolescent bullies or is cruel or mean to others   ………   1          2           3 
 
10. My adolescent is disobedient at home………………..……  1          2            3 
 
11. My adolescent is disobedient at school……….…………      1          2            3 
 
12. My adolescent does not seem to feel sorry after his/ her  
      misbehavior………………………….          1          2            3 
 
13. My adolescent has trouble getting along with other  
      adolescents………………………..…             1          2            3 
III. Psychological Well-Being (continued) 
 
Thinking about your adolescent, during the past 3 months…… 
Often  Some Not 
true  times true 
true  
 
14. My adolescent has trouble getting along with teachers ………      1    2    3
  
15. My adolescent is impulsive, or acts without thinking……………1    2    3 
 
16. My adolescent feels worthless or inferior………………………   1     2    3 
 
17. My adolescent is not liked by other adolescent…………………   1     2    3 
 
18. My adolescent has a lot of difficulty getting his / her.……………1     2    3 
       mind off certain thoughts. 
 
19. My adolescent is restless or over active, cannot sit still…………  1     2    3 
 
20. My adolescent is stubborn sullen or irritable……………………   1     2    3 
 
21. My adolescent has a very strong temper and loses it easily………1     2    3 
 
22. My adolescent is unhappy, sad or depressed………….…………  1     2    3 
 
23. My adolescent is withdrawn and does not involve with others…   1     2    3 
 
24. My adolescent breaks things on purpose and deliberately destroys 
       his / her own or other’s things……………………………………1     2    3 
        
25. My adolescent clings to adults…………………………………… 1     2    3 
 
26. My adolescent cries too much…………………………………… 1     2    3 
 
27. My adolescent demands a lot attention……………………………1     2    3 
 
28. My adolescent is too dependent on others……………………….. 1     2    3 
 
     0   1-2         3-5   6-10    11-15   > 16  
    (1)    (2)         (3)    (4)                (5)    (6) 
 
IV. Social and Role Functioning      
A.   1. How many days adolescent was bedridden due to any illness or injury? 
 0   1-2         3-5   6-10    11-15   > 16  
 (1)    (2)         (3)    (4)                (5)   (6) 
 
2. Did illness or injury keep your adolescent away from school? (if during a 
vacation period, refer to the last month school was open) 
 
 
 
B.  Please select only one answer for each question: 
 
 3. What grade is your adolescent now? (or will be in, if between grades?) 
3
rd
  Std…..…………[   ]  4th  Std….………………[   ] 
5
th 
 Std...…………    [   ] 6th  Std………………… [   ] 
7
th
 Std......……….…[   ]  Not in school..………… [   ]      
Others (specify)…   [   ]      
   Correct to age/delay  
  4. Has your adolescent ever repeated a grade for any reason?....……      Yes / No 
5. In general, is your adolescent limited in school attendance because of his /her     
    health ?                      Yes / No 
 6. In general, is your adolescent limited in the kind or amount of other activities    
because of his / her health?............................................       Yes / No 
7. In general, has your adolescent participated in school sports?……       Yes / No 
8. Does your adolescent go to a special class or get special help in school  
    because of a disability or health problems? ………………………..    Yes / No         
      8.a .What type of special help does your adolescent receive?      
Reading  ………………………………..….. [   ] 
Learning disability…………………………. [   ] 
Speech or Language………………………... [   ] 
Physical Therapy / Occupational Therapy ... [   ] 
More than one of above…………………….[   ] 
Others………………………..…………….. [   ] 
 
V.  Health Care Services 
 
A.   During the past 4 weeks . . . . 
1. How many times did illness or injury make it necessary for your adolescent to 
use any medicines other than ART and vitamins that a doctor prescribed? 
 
      0          1-2         3-4       5-6         7-9      > 10  
     (1)          (2)          (3)       (4)          (5)        (6) 
 
2. How many times, you brought medications for adolescent from pharmacy 
without a prescription from a doctor? 
      0          1-2         3-4       5-6         7-9      > 10  
     (1)          (2)          (3)        (4)         (5)        (6) 
 
 
3. How many visits did your adolescent make to a clinic, hospital or emergency 
room to see a doctor, nurse or other specialist?  
 
      0          1-2         3-4       5-6          7-9      > 10  
          (1)          (2)          (3)        (4)         (5)        (6) 
 
4.   How many times, did your adolescent sickness need to use medical help 
including from medical practicenaires functioning his/her in daily life? 
      0          1-2         3-4       5-6          7-9       >10  
     (1)          (2)          (3)        (4)         (5)        (6) 
 
B. 5.  Does the adolescent has undergoing any alternative treatment for improve 
his/her health? 
 
1. Herbal supplements 
2. Massage therapy 
3. Yoga 
4. Acupuncture 
5. Nil 
VI. Symptoms 
The following questions ask about symptoms or feelings of adolescent might 
had during the past 4 weeks. Please answer how distressing the following symptoms 
have been for adolescent, during the past 4 weeks. How much was adolescent 
distressed by this symptom or feeling? 
 
Not at   Very                      Very 
All   Mildly   Mildly  Moderately    Much    Extremely 
 
1. Physical or bodily pain   1   2      3         4         5      6 
 
2. Coughing, wheezing  1   2      3         4         5      6 
 
3. Nausea, vomiting,  
abdominal / stomach pain  1   2      3         4         5      6 
 
4. Diarrhea   1   2      3         4         5      6 
 
5. Rash, itching, or other skin  
problems   1   2      3         4         5      6 
 
6. Fatigue, weakness  1   2      3         4         5      6 
 
7. Feeling dizzy or lightheaded 1   2      3         4         5      6 
 
8. Fever, night sweats, shaking,  
chills    1   2      3         4         5      6 
 
9. Loss of appetite   1   2      3         4         5      6 
 
10. Trouble in sleeping  1   2      3         4         5      6 
 
11. Eye trouble, problem with vision1   2      3         4         5      6 
 
12. Headache   1   2      3         4         5      6 
 
13. Dry or painful mouth, trouble in  
swallowing     1   2      3         4         5      6 
 
14. Chest pain or tightness  1   2      3         4         5      6 
 
15. Difficulty breathing or  
Catching breath   1   2      3         4         5      6 
 
16. Runny nose, sinus trouble 1   2      3         4         5      6 
 
17. Muscle aches, joint bone pain 1   2      3         4         5      6 
 
18. Pain, numbness, or tingling  
in hands or feet    1   2      3         4         5      6 
 
19. Ear aches   1   2      3         4         5      6 
 
20. Overall discomfort  1   2      3         4         5      6 
MODIFIED QUALITY OF LIFE ASSESSMENT QUESTIONNAIRE 
(For Ages 12 - 20 Years) 
 
1. General Health Ratings:  These statements ask about the health and behavior of 
    adolescents. 
  A. On the scale from 1 to 10 (1 being very worst, and 10 being the very best) 
       How has adolescent feeling, on the average, of the past 3 months?                                                                   
The Very Worst     The Very Best 
He /She Ever Felt    He /She Ever Felt 
 
 
1. Overall, in general ?     1    2 3       4        5      6      7     8    9 10 
 
2. Physically ?       1    2 3       4        5      6      7     8    9 10 
 
3. Emotionally?       1    2 3       4        5      6      7     8    9 10 
 
4. About their  
    School work?       1    2 3       4        5      6      7     8    9 10 
 
B.  For the following statements, decide which phrase best describes   adolescent’s 
health over the past 3 months, and then answer your choice 
      During the past 3 months,     
 
Never or 
Rarely 
Some of 
the Time 
Almost 
Always 
 
1.  My Adolescent’s health is excellent…………………     1   2       3 
2.  My Adolescent seems to resist illness very well ……     1   2       3  
3.  My Adolescent seems less healthy than other  
     adolescent I know ………………..   1   2       3 
4.  When there is something going around, my adolescent  
     usually catches it………………………………………   1   2       3 
5.  My adolescent is somewhat confused…………………   1   2       3 
6.  My adolescent seems accident-prone ………………… 1   2       3 
7.  When my adolescent is sick or injured, he / she usually    
      recovers quickly  ……………………………………    1            2       3  
II. Physical Functioning 
 
 How much if at all, has adolescent’s health interfered with his / her activities 
during the past 4 weeks? 
             How much has adolescent’s health interfered with?   
 
            
                      Not          A Little         Moderately        Quite a    Extremely       
    at all        bit           bit 
 
1. The kinds or amount of vigorous 
 activities your adolescent can do,  
 like lifting heavy objects, running,  
 or participating in strenuous sports?   1         2          3        4              5 
 
2. The kinds or amount of moderate         
activities your adolescent can do, like 
bowling?  1         2           3        4               5 
 
3. Walking uphill or climbing a few  1             2                3        4       5 
 flights or stairs? 
 
4. Walking one block?        1          2                3        4  5
      
5. Bending, lifting or stooping?       1          2                3         4      5 
 
6. Eating, dressing, bathing or       1          2                 3         4  5 
 using the toilet? 
 
III.  Psychological Well-Being 
 
These statements are about behavior problems of adolescents. You decide 
which phrase describes adolescent’s behavior over the past 3 months, and then answer 
your choice. 
 
Thinking about your adolescent, during the past 3 months…. 
                    Often    Some   Not true 
  true times   
 true            
 
1. My adolescent has sudden changes in mood or feelings …     1         2           3  
 
2. My adolescent feels or complains that no one loves him / her 1         2           3 
 
3. My adolescent is rather high strung, tense, and nervous         1         2           3 
 
4. My adolescent cheats or tells lies…………………………… 1         2           3 
 
5. My adolescent is too fearful or anxious………………….…   1         2           3 
 
6. My adolescent argues too much……………………………     1         2           3 
 
7. My adolescent has difficulty in concentrating, cannot pay  
    attention for long.                1         2           3 
 
8. My adolescent is easily confused, seems to be in a fog……      1         2           3 
 
9. My adolescent bullies or is cruel or mean to others   ………     1          2           3 
 
10. My adolescent is disobedient at home………………..……    1          2            3 
 
11. My adolescent is disobedient at school……….…………        1          2            3 
 
12. My adolescent does not seem to feel sorry after his/ her  
      misbehavior………………………….            1          2            3 
 
13. My adolescent has trouble getting along with other  
      adolescents………………………..…               1          2            3 
III. Psychological Well-Being (continued) 
 
Thinking about your adolescent, during the past 3 months…… 
Often  Some Not 
true  times true 
true  
 
14. My adolescent has trouble getting along with teachers ………     1    2    3
  
15. My adolescent is impulsive, or acts without thinking……………1    2    3 
 
16. My adolescent feels worthless or inferior………………………  1     2    3 
 
17. My adolescent is not liked by other adolescent…………………  1     2    3 
 
18. My adolescent has a lot of difficulty getting his / her.……………1     2    3 
       mind off certain thoughts. 
 
19. My adolescent is restless or over active, cannot sit still………… 1     2    3 
 
20. My adolescent is stubborn sullen or irritable……………………   1     2    3 
 
21. My adolescent has a very strong temper and loses it easily………1     2    3 
 
22. My adolescent is unhappy, sad or depressed………….…………  1     2    3 
 
23. My adolescent is withdrawn and does not involve with others…   1     2    3 
 
24. My adolescent breaks feels others are out to get him/her………    1     2    3 
        
25. My adolescent hangs around with kids who get into trouble …… 1     2    3 
 
26. My adolescent is secretive, keeps things to himself/herself……   1     2    3 
 
27. My adolescent worries too much    ………………………………1     2    3 
 
28. My adolescent is too dependent on others………………………..1     2    3 
 
 
     0   1-2         3-5   6-10    11-15   > 16  
    (1)    (2)         (3)    (4)                (5)    (6) 
 
IV. Social and Role Functioning      
A.   1. How many days adolescent was bedridden due to any illness or injury? 
 0   1-2         3-5   6-10    11-15   > 16  
 (1)    (2)         (3)    (4)                (5)   (6) 
 
2. Did illness or injury keep your adolescent away from school? (if during a 
vacation period, refer to the last month school was open) 
 
 
 
B.  Please select only one answer for each question: 
 
 3. What grade is your adolescent now? (or will be in, if between grades?) 
 
 4
th
   Std…..…….……[   ]  5th Std…………………..[   ] 
 6
th  
 Std…...………… [   ]  7th  Std….………………[   ] 
 8
th 
  Std...…………… [   ]  9th  Std…….……………[   ] 
10
th
 Std.......……..….   [   ]   11th Std……………….. .[   ] 
    12
th
 Std.......……..…..  [   ]                       Correct to age/delay
  
  4. Has your adolescent ever repeated a grade for any reason?                Yes / No 
5. In general, is your adolescent limited in school attendance because of his /her     
    health ?                       Yes / No 
 6.  In general, is your adolescent limited in the kind or amount of other activities     
because of his / her health?                        Yes / No 
7. In general, has your adolescent participated in school sports?                 Yes / No 
8. Does your adolescent go to a special class or get special help in school  
     because of a disability or health problems?         Yes / No         
      8.a.What type of special help does your adolescent receive?     
  
Reading  ………………………………..….. [   ] 
Learning disability…………………………. [   ] 
Speech or Language………………………... [   ] 
Physical Therapy / Occupational Therapy ... [   ] 
More than one of above…………………….[   ] 
Others………………………..…………….. [   ] 
 
V.  Health Care Services 
 
A.   During the past 4 weeks . . . . 
1. How many times did illness or injury make it necessary for your adolescent to 
use any   medicines other than ART and vitamins that a doctor prescribed? 
 
      0          1-2         3-4       5-6         7-9      > 10  
     (1)          (2)          (3)       (4)          (5)        (6) 
 
3. How many times, you brought medications for adolescent from pharmacy 
without a prescription from a doctor? 
      0          1-2         3-4       5-6         7-9      > 10  
     (1)          (2)          (3)        (4)         (5)        (6) 
 
 
3. How many visits did your adolescent make to a clinic, hospital or emergency 
room to see a doctor, nurse or other specialist?  
 
      0          1-2         3-4       5-6          7-9      > 10  
          (1)          (2)          (3)        (4)         (5)        (6) 
 
4.   How many times, did your adolescent sickness need to use medical help 
including from medical practicenaires functioning his/her in daily life? 
      0          1-2         3-4       5-6         7-9      >10  
     (1)          (2)          (3)        (4)         (5)        (6) 
 
B. 5.  Does the adolescent has undergoing any alternative treatment for improve 
his/her health? 
 
1. Herbal supplements 
2. Massage therapy 
3. Yoga 
4. Acupuncture 
5. Nil 
VI. Symptoms 
The following questions ask about symptoms or feelings of adolescent might 
had during the past 4 weeks. Please answer how distressing the following symptoms 
have been for adolescent, during the past 4 weeks. How much was adolescent 
distressed by this symptom or feeling? 
 
Not at   Very                      Very 
All   Mildly   Mildly   Moderately    Much    Extremely 
 
21. Physical or bodily pain   1   2      3         4         5      6 
 
22. Coughing, wheezing  1   2      3         4         5      6 
 
23. Nausea, vomiting,  
abdominal / stomach pain  1   2      3         4         5      6 
 
24. Diarrhea   1   2      3         4         5      6 
 
25. Rash, itching, or other skin  
problems   1   2      3         4         5      6 
 
26. Fatigue, weakness  1   2      3         4         5      6 
 
27. Feeling dizzy or lightheaded 1   2      3         4         5      6 
 
28. Fever, night sweats, shaking,  
chills    1   2      3         4         5      6 
 
29. Loss of appetite   1   2      3         4         5      6 
 
30. Trouble in sleeping  1   2      3         4         5      6 
 
31. Eye trouble, problem with vision1   2      3         4         5      6 
 
32. Headache   1   2      3         4         5      6 
 
33. Dry or painful mouth, trouble in  
swallowing     1   2      3         4         5      6 
 
34. Chest pain or tightness  1   2      3         4         5      6 
 
35. Difficulty breathing or  
Catching breath   1   2      3         4         5      6 
 
36. Runny nose, sinus trouble 1   2      3         4         5      6 
 
37. Muscle aches, joint bone pain 1   2      3         4         5      6 
 
38. Pain, numbness, or tingling  
in hands or feet    1   2      3         4         5      6 
 
39. Ear aches   1   2      3         4         5      6 
 
40. Overall discomfort  1   2      3         4         5      6 
 
 
Annexure-i (b) 
gFjp - m 
Muha;r;rp njhlh;Gila mbg;gilj; jfty;fs; 
gphpT - I 
tsh; ,sk; gUtf; Foe;ijf;fSf;fhd rKjhaf; fhuzpfs; 
1. ngah;    V.Mh;.b. vz; :  ,lk; : 
2. taJ (tUlq;fspy;) 
1) 10-12  
2) 13-15  
3) 16-18  
3. ghypdk;  
1. Mz; 
2. ngz; 
4. fy;tpj; jFjp  
1. njhlf;ff; fy;tp  
2. eLepiyf; fy;tp 
3. cah;epiyf; fy;tp 
4. Nky; epiyf; fy;tp 
5. kjk; / rkak; 
1. ,e;J 
2. K];yPk; 
3. fpwp];Jth; 
4. gpw kjj;jpdh;  
gphpT - II 
guhkhpg;ghsh; gw;wpa rKjhaf; fhuzpfs; 
6. ngah; 
7. taJ (tUlq;fspy;) 
1. 20-35  
2. 36-50  
3. > 50  
8. ghypdk;  
1. Mz; 
2. ngz; 
9. guhkhpg;ghshpd; cwT Kiw 
1. jha; 
2. je;ij 
3. gpw cwTKiw (jhj;jh / ghl;b / mj;ij / khkh /  
                        ghJfhg;ghsh;) 
 
 
10. fy;tpj; jFjp  
1. Kiwahdg; gbg;G ,y;iy 
2. gs;spg; gbg;G tiu 
3. fy;Y}hpg; gbg;G tiu 
11. gzpj; jFjp  
1. gzpapy; cs;sth;  
2. gzpapy; ,y;yhjth; 
3. nghUe;jhJ 
12. Mz;L tUkhdk; 
1. Rs. 12>000/- tiu 
2. Rs. 24>000/- tiu 
3. Rs. >24>000/- tiu 
4. nghUe;jhJ 
13. thoplk;  
1. fpuhkk;  
2. efuk; 
 
gphpT -  III         
tsh; ,sk;gUtf;Foe;ijapd; Neha; njhlh;ghd Nfs;tpfs; 
14. vg;nghOJ vr;.I.tp. Neha; cs;sJ vd;W fz;lwpag;gl;lJ? 
1. Fiwe;jJ 5 tUlj;jpw;F Kd; 
2. 5-10 tUlj;jpw;F Kd;  
3. 10 tUlj;jpw;F Kd; 
15. Neha;j;njhw;W Vw;gl;ljw;fhd fhuzpfs;? 
1. jhaplkpUe;J Foe;ijf;F 
2. ,uj;jk; Vw;wpajhy;  
3. clYwtpd; %ykhf 
4. kw;wit 
16. tsh; ,sk;gUtf; Foe;ijapd; vr;.I. tpapd;  epiy  
1. epiy I 
2. epiy II 
3. epiy III 
17. vt;tsT fhykhf tsh; ,sk;gUtf; Foe;ij $l;L kUe;J 
rpfpr;irapy; cs;sJ? 
1. 3 khjk; - 1 tUlk; tiu 
2. 1-5 tUlq;fs; 
3. 5 tUlj;jpw;F Nkyhf 
 
 
 
18. ,jw;F Kd; tsh; ,sk;gUtf; Foe;ijf;Ff; fhrNeha; ,Ue;jjh?  
1. Mk;  
2. ,y;iy.  
18.1 Mk;> Vdpy;> V.b.b kUe;ij vLj;Jf; nfhz;lhuh? 
     1. KOikahf vLj;Jf; nfhz;lhh; 
     2. vLj;Jf; nfhz;bUf;fpwhh; 
     3. ghjpapy; epWj;jp tpl;lhh;.  
19. Neha;  ,Uf;Fk;  epiyiag;  gw;wp   tsh;  ,sk;gUt   Foe;ijf;F 
njhpag;gLj;jp ,Uf;fpwPh;fsh? 
1. Mk;  
2. ,y;iy 
20. $l;L kUe;J vLf;f njhlq;Ftjw;F Kd;G> rp.b 4 vz;zpf;ifapd;; 
msT__________________ 
21. jw;nghOija rp.b. 4 vz;zpf;ifapd; msT>  
1. ‘0’ khjk;   2. ‘6’ tJ khjk; 
gphpT - IV 
tsh; ,sk;gUtf; Foe;ij / guhkhpg;ghshpd; FLk;g kw;Wk;  
r%fk; njhlh;ghd jfty;fs;  
22. ngw;Nwhh; / cld;gpwe;jth;fspd; caph; epiyik> 
1. je;ij  - capUld; cs;shh;  / ,we;J tpl;lhh;  
              / njhpatpy;iy  
2. jha;  -  capUld; cs;shh;  / ,we;J tpl;lhh;  
             / njhpatpy;iy 
3. cld;gpwe;jth;fs;- capUld; cs;shh; / ,we;J tpl;lhh;  
       / njhpatpy;iy. 
23.  ngw;Nwhh; / cld;gpwe;jth;fspd; vr;.I.tp epiyik  
 1. je;ij - cz;L / ,y;iy / njhpatpy;iy 
 2. jha;  -  cz;L / ,y;iy / njhpatpy;iy 
 3. cld;gpwe;jth;fs; - cz;L / ,y;iy / njhpatpy;iy 
24.  tsh; ,sk; gUtf; Foe;ij jdJ ngw;NwhUld; trpf;fpwjh? 
 1. Mk; 
 2. ,y;iy 
24.1. ,y;iynadpy;> trpg;gJ 
      1. FLk;g cwtpdUld; 
      2. jdpahh; njhz;L epWtdq;fspy;; 
      3. jj;njLj;j ngw;NwhUld; 
 
 
25. MNuhf;fpak; njhlh;ghd gpur;ridfSf;F Rfhjhu trjp 
fpilf;fpwjh?     Mk; / ,y;iy. 
26. guhkhpg;ghshplk; NghJkhd msT gz trjp cs;sjh? 
      Mk; / ,y;iy. 
27. guhkhpg;ghsUf;F NghJkhd msT rKjha MjuT cs;sjh? 
       Mk; / ,y;iy. 
27. Mk;> vdpy; 
27.1 tsh;    ,sk;gUtf;    Foe;ijapd;     cly;epiy    njhlh;ghf  
    cq;fs;   cwtpdh;   my;yJ   mayhhplk;    VNjDk;      cjtp  
    ngWfpwPh;fsh?                
       Mk; / ,y;iy 
27.2. ePq;fs; VNjDk; murhq;f cjtp ngWfpwPh;fsh?  
       Mk; / ,y;iy 
27.2. (i) Mk ;vdpy;  
   gzcjtp /  rpfpr;ir cjtp / kw;wit     
27.3. tsh; ,sk;gUtf;Foe;ijf;F muR jdpahh; njhz;L 
       epWtdq;fs; %ykhf VNjDk; cjtp ngWfpwPh;fsh?    
Mk; / ,y;iy 
27.4. Neha;   jd;ikapdhy;  tsh;   ,sk;  gUtf;Foe;ij r%fj;jpy; 
    Vw;wj;jho;it  re;jpf;fpwjh?  
     Mk; / ,y;iy 
27.4. i) tsh;,sk;gUtf; Foe;ij Vw;wj;jhoit re;jpf;fpwJ vdpy; 
       gpd;tUdtw;wpy; ahh; %ykhf> 
        1. FLk;g cWg;gpdh;   
  2. cwtpdh;    
  3. mayhhplk;  
  4. gs;spapy; 
  5. kw;wth;fs; 
 27.5. jw;nghOJ fpilf;Fk; rKjha MjuT cq;fSf;F 
  epiwthf   cs;sjh?  
       Mk; / ,y;iy. 
28. vr;.I.tp / $l;L kUe;J  rpfpr;ir  gw;wpa  Kjd;ik  jfty;fisg; 
guhkhpg;ghsh;>  vtw;wpd;  %yk; mwpthh;? 
1. nra;jpj;jhs;      
2. njhiyf;fhl;rp / rpdpkh    
3. cly; ey ty;Yeh;fs; 
4. kw;witfs; 
 
 
 
29.  $l;L   kUe;J    gw;wpa     ed;ikfisAk;  /   tpsf;fq;fisAk; 
 cq;fsplk;   NghjpasT   ahh;   vLj;Jiug;ghh;? 
1. kUj;Jth; 
2. nrtpypah; 
3. cld; Mw;Wg;gLj;Jeh; 
4. kw;wth;fs; (ez;gh;fs;) 
30.  vr;.I.tp. / $l;L  kUe;J   rpfpr;irapd;  Kjd;ik  jfty;fisg; 
 guhkhpg;ghsh;  mwpthuh?  
     Mk; / ,y;iy.  Mk; Vdpy; 
 30.1. va;l]; Nehapd; fhuzp 
1. ikf;Nuhghf;Bhpah 
2. G+Q;ir   
3. vr;.I.tp fpUkp 
4. Fiwe;j vjph;g;G rf;jp. 
 30.2. vr;.I.tp / va;l;]; guTtJ>  
      1. vr;.I.tp     Neha;      njhw;Ws;stiu   ntWk;   ifAld;  
      njhLtJ   %ykhf 
     2. vr;.I.tp    Neha;   njhw;Ws;s   Foe;ijia   mizg;gJ 
      %ykhf 
       3. ghJfhg;gw;w clYwT nfhs;Stjhy; 
       4. vr;.I.tp      Neha;     ghjpf;fg;gl;lthpd;    jl;L     kw;Wk; 
      cilikfis  gfph;e;Jf;  nfhs;tjd;   %ykhf  
 30.3. vr;.I.tp. Neha; njhw;W guTtijj; jLf;f gad;gLtJ 
     1. MZiw 
      2. RL;jz;zPh;  
      3. J}a;ikahd cil    
      4. kJ mUe;JtJ  
 30.4. vr;.I.tp Neha; cs;sij vjd; %yk; mwpayhk;? 
      1. rPWePh; 
       2. ,uj;jk; 
       3. rsp 
      4. vy;yhtw;wpd; %ykhfTk; 
 30.5. vr;.I.tp. Nehia $l;L kUe;jpd; %ykhf Fzg;gLj;j 
  ,aYkh? 
         Mk; / ,y;iy. 
 
 
 
gFjp - M 
khw;wpaikf;fg;gl;l tsh; ,sk;gUtf; Foe;ijfSf;fhd 
epiwikr; rjtPjj;ij fz;lwptjw;fhd jfty;fs; 
1. tsh; ,sk;gUtf; Foe;ij vLj;Jf; nfhs;tJ>  
    1. Kjy; epiy kUe;J 
    2. Kjy;epiy - khWgl;l kUe;J 
    3. ,uz;lhk; epiy kUe;J 
 
  1. 1. kUe;Jfspd; ngah;  
2. $l;L kUe;ij ahh; %ykhf vLj;Jf; nfhs;fpwPh;fs;? 
1. jhdhf 
2. guhkhpg;ghsh; %ykhf 
3. ,jw;F  Kd;G  kUe;Jfspd; msit fz;lwpAk; Ma;tpy; VNjDk; 
<Lgl;L ,Uf;fpwPh;fsh?        
        Mk; / ,y;iy 
4. %d;W khjj;jpw;F Kd;ghf  kUj;Jtkidapy;   Nrh;e;J  rpfpr;ir 
 ngWfpwPh;fsh?       Mk; / ,y;iy 
           4.1 Mk; vdpy;>    
     1. Neha; njhlh;ghd gpur;ridfs; 
     2. kUe;Jfspd; gf;ftpisTfs;   
     3. kw;wit 
5. cq;fSf;F> kUe;J vLj;Jf;nfhs;Sk; msitg; gw;wp njhpAkh?  
        Mk; / ,y;iy 
6. cq;fSf;F>  kUe;J   vLj;Jf;   nfhs;Sk;   fhy  msitg;  gw;wp 
njhpAkh? 
        Mk; / ,y;iy 
7. %d;W   khjj;jpw;F  Kd;G  $l;L  kUe;Jfspy;  VNjDk;   khw;wk; 
    nra;jhh;fsh?       Mk; / ,y;iy  
    7.1 Mk; vdpy;>  fhuzk; .................................. 
 
8. cq;fs;  tsh;  ,sk;  gUtf;  Foe;ijf;F> kUe;J cl;nfhs;StJ 
    fbdkhf ,Uf;fpwjh?  
                Mk; / ,y;iy 
   8.1 Mk; vdpy;> fhuzk; .................................. 
 
9. cq;fs;  tsh;  ,sk;gUtf;  Foe;ijf;F  kUe;Jfis  nfhL;g;gJ 
f\;lkhf  ,Uf;fpwjh?   
       Mk; / ,y;iy 
    9.1. Mk; vdpy;> fhuzk; .................................. 
 
10.  tsh; ,sk;;gUtf; Foe;ijf;F> kUe;ij nfhLf;Fk; nghOJ 
 kdcisr;ry;> Vw;gL;fpwjh?   
Mk; / ,y;iy 
 
 
11.  vr;.I.tp.  kUe;Jfspd;  epiwikia   fzf;fpl cjTk; `5’ kjpg;G 
     msT   Nfhy; /  ml;ltiz   gq;Nfw;ghshplk;  Nfl;fg;gl;lJ. 
 ‘kUj;Jtuhy;    Foe;ijf;F        $wg;gl;l     kUj;JtKiwfis 
    epidtpy;  nfhz;L  fPo;tUtdtw;wpw;F  tpilaspf;fTk;”  gjpy;;  
  Njh;T: 
  vg;nghOJk;  ,y;iy = 0,      mhpjhf = 1     rpy Ntisfspy; = 2  
  mbf;fb = 3,    vg;nghOJk; = 4,  
 
ePq;fs; vg;nghOjhtJ Foe;ijf;F kUe;Jfs; nfhLf;f 
kwe;Js;sPh;fsh? 
0 1 2 3 4 
     
Foe;ijf;F kUe;;J nfhLg;gjpy; ftdf;Fiwthf 
,Ue;jpUf;fpwPh;fsh? 
     
Foe;ij xusT ed;whf ,Uf;Fk;NghJ> vg;nghOjhtJ 
kUe;Jfis epWj;jp ,Uf;fpwPh;fsh? 
     
Foe;ij cly;epiy rhpepiyapy;yhj epiyapy;> 
vg;nghOjhtJ kUe;Jfis epWj;;jp ,Uf;fpwPh;fsh? 
     
 
 12. kUe;Jfspd;   tz;zj;ijf;  nfhz;L>  epiwik  Ra   kjpg;Giu 
      %yk; fhZk; Kiw :  
 fle;j 30 ehl;fspy; ePq;fs; nfhLj;j $l;L kUe;Jfspd; msit 
fzpj;J> cq;fs; gjpiy $wTk;.  
 V.Mh;.b. kUe;Jfs;         
kUe;J A :     0%  10%    20%  30%   40%  50%  60%  70%   80%    90%   100% 
 
kUe;J B :     0%  10%   20%  30%  40%   50%   60%  70%   80%    90%   100% 
 
kUe;J C :        0%  10%   20%  30%  40%   50%   60%  70%   80%    90%   100% 
 
fzf;fpLk; Kiw 
   0%    vd;why; ePq;fs; ve;j kUe;Jk; nfhLf;ftpy;iy  
   50%  vd;why; cq;fsplk; cs;stw;wpy; ghjp kUe;ij nfhLj;Js;sPh;fs;  
   100% vd;why; jpdKk; xUKiw vd midj;J kUe;JfisAk;  
    nfhLj;Js;sPh;fs;  
 
 
13. fle;j    3    ehl;fspy;    vLj;jpUf;f   Ntz;ba   khj;jpiufspd; 
 epiwik rjtPjj;ij fzf;fpLk; Kiw>  
 
                 fle;j 3 ehl;fspy; vLj;jpUf;f Ntz;ba khj;jpiufspd; msit  
- fle;j 3 ehl;fspy; tpL;gl;l khj;jpiufspd; msT  
                     fle;j 3 ehl;fspy; vLj;jpUf;f Ntz;ba khj;jpiufspd; msT 
 
14.  khj;jpiuapd;  vz;zpf;ifiaf;   nfhz;L  epiwik  rjtPjj;ij 
 fzf;fpLk; Kiw> 
 
                          vLj;jpUf;f Ntz;ba khj;jpiufspd; vz;zpf;if    
epiwik rjtPjk; =        - vLj;Jf; nfhz;l khj;jpiufspd; vz;zpf;if    
                    vLj;jpUf;f Ntz;ba khj;jpiufspd; vz;zpf;if 
 
15. khj;jpiuia vLf;fhky; ,Ue;jjw;;fhd fhuzq;fs;> 
     1. nghUe;jhJ 
 2. kwe;J tpl;lJ 
     3. rypj;J tpl;lJ / Nrhh;T mile;J tpl;lJ 
     4. Neukpd;ikahy; (gs;sp kw;Wk; ,ju Ntiy gStpdhy;) 
     5. gazk; fhuzkhf 
     6. gz trjpapd;ik fhuzkhf 
     7. kUe;jfj;jpy; kUe;J ,y;yhikahy;  
     8. kUe;Jfspd; gf;f tpisTfs; fhuzkhf 
     9. kw;wit (VNjDk;) 
16. tsh;   ,sk;   gUtf;Foe;ij    gpd;tUk;     cjtp     nghUl;fisg; 
     gad;gLj;jp   kUe;Jfis  cl;nfhs;fpwjh? 
   1. khj;jpiu ngl;b 
       2. ehs; fhl;b 
       3. ifNgrp epidT+l;ly;fs; 
       4. ez;gh;fs; %ykhf 
   5. ifNaL 
       6. VJkpy;iy 
  
epiwik  
rjtPjk;  = 
x 100 
x 100 
 
 
gFjp - , 
gphpT - I 
Cl;lr;rj;J epiyikia fz;lwptjw;fhd jfty;fs; 
I. cly; FwpaPL msT Nfhy;fs; 
1. cauk;     :  nr.kP  
2. vil      :  fp.fp 
3. clypd; nkhj;j FwpaPL  :  fp.fp / kP2 
(Body Mass Index)  :   
4. ,Lg;G Rw;wsT   :  nr.kP  
(Waist Circumference)  
5. Nky;if kj;jpa gFjpapd;  
Rw;wsT (Mid Upper Arm 
Circumference)   :  nr.kP  
6. jir gpbapd; msT  
 (biurg;];)    :  kp.kP. 
(skin Fold Thickness –Triceps) 
7. `Z’ kjpg;G  
                                   
gphpT - II 
II. tsh; ,sk;gUtf; Foe;ijapd; Neha; njhlh;ghd jfty;fs; 
 
 8.  ,jw;F   Kd;ghf   tsh;   ,sk;   gUtf;  Foe;ijf;F   czT+l;l 
       FiwghL  Neha;  njhlh;ghf    rpfpr;ir   mspj;jpUf;fpwhh;fsh?   
         Mk; / ,y;iy 
 8.1 Mk; vdpy;> Nehapd; ngah; ................................................. 
                rpfpr;ir jfty;fs; ................................................. 
 
 9.  tsh;     ,sk;gUt     Foe;ijf;F    Kiwahf     G+r;rp     kUe;J  
   nfhLg;gPh;fsh?  
          Mk; / ,y;iy 
 10. ,g;nghOJ     tsh;  ,sk;gUtf;   Foe;ijf;F   ,uj;j    Nrhif 
         Neha;   cs;sjh?  
         Mk; / ,y;iy  
 11. fle;j 3 khjj;jpy;  tsh; ,sk;gUtf;  Foe;ijapd; vil Fiwe;J 
       cs;sjh?  
          Mk; / ,y;iy  
 11.1 Mk; vdpy;  
      1) 0-5%  2) 5-10%   3) >10% clypd; vilapypUe;J   
  
 
 
 12. gpd; tUtdtw;wpy; VNjDk; mwpFwpfs; Vw;gl;L cs;sjh? 
       1.  Njhy; - twl;rp    Mk; / ,y;iy 
            efk; -     Mk; / ,y;iy 
     1.1 Mk; vdpy>;  
    Fopefk; / jplkhd efk; / epwk; khwpa efk;  
  2.   jiy / Nuhkk; (Kb)     
    epwk; - tof;fkhd epwk; / epwk; khwpaJ  
             mikg;G - gsgsg;ghd/ke;jkhd/nky;ypa/gwpj;J jpwd; 
         Neha; njhw;Wk; jd;ik   Mk; / ,y;iy 
        2.1  Mk; vdpy;_________________  
      3.  fz;       Mk; / ,y;iy   
       3.1 Mk; vdpy;> twl;rpahd fz; / iglhl; ];ghl; / ntspwpa  
    jd;ik nfhz;l ntz;glyk;  
       4. tha;     Mk; / ,y;iy          
  4.1 Mk; vdpy;>  tha;g;Gz; /  ehf;Fg;Gz;  / <Wfspy; ,uj;jk; /  
            twz;l cjL  
       5. nrhpj;jy; kz;lyk;     Mk; / ,y;iy 
       5.1Mk; vdpy;>   grp   jd;ik   / Fkl;ly; /  the;jp  /  nfhOg;G  
   fye;j fopr;ry; / tapw;W Nghf;F 
     6. if kw;Wk; fhy;fs;  
      jir Fiwg;G Mk; / ,y;iy  
  jputf;Nfhh;it   Mk; / ,y;iy  
  nfhOg;gZ rpijT Mk; / ,y;iy   
 
  
 
 
gphpT < 
khw;wpaikf;fg;gl;l tho;f;ifj;ju kjpg;gPL 
(5 Kjy; 11 taJ tiu) 
I)m. nghJthd MNuhf;fpa juk;: gpd;tUk; Nfs;tpfs; midj;Jk; tsh; 
          ,sk; gUtf; Foe;ijapd; MNuhf;fpak; kw;Wk; gof;ftof;fk; gw;wpajhFk;. 
 fle;j 3 khjq;fspy; nghJthf cq;fs; Foe;ij vt;thW ,Ue;jJ? 
             kpf Nkhrkhf     kpf ed;whf 
      czh;fpwhd;/czh;fpwhs;  czh;fpwhd;/czh;fpwhs; 
1) nghJthf> nkhj;jj;jpy;? 1    2     3     4     5     6     7     8     9     10 
2) cly; hPjpahf?   1    2     3     4     5     6     7     8     9     10 
3) kd hPjpahf?   1    2     3     4     5     6     7     8     9     10 
4) mth;fs; gs;sp Ntiyfs; gw;wp? 1    2     3     4     5     6     7     8     9     10 
(M) fPNo cs;s thf;fpaq;fis gbf;Fk;NghJ. fle;j 3 khjq;fspy; cq;fs; 
Foe;ijapd; MNuhf;fpaj;ij tpsf;Fk; thf;fpaj;ij Njh;T nra;J> cq;fs; 
tpilAld; xj;Jg;NghFk; gjpiyf; $wTk;. 
   
  vgNghJk; 
,y;iy (m) 
mhpjhf 
VNjDk; rpy 
rkaq;fspy; 
mNefkhf 
vg;NghJk; 
1) vd; Foe;ijapd; MNuhf;fpak; 
rpwg;ghf cs;sJ. 
 
1 2 3 
2) vdJ Foe;ij Nehia ed;whf 
vjph; nfhs;tjhf njhpfpwJ 
 
1 2 3 
3) vdf;F njhpe;j kw;w 
Foe;ijfis tpl vd; Foe;ij 
MNuhf;fpaj;jpy; Fiwthf  
cs;sjhfj; Njhd;WfpwJ 
 
1 2 3 
4) vd; Foe;ij nghJthf jd;id 
Rw;wp VNjDk; ele;jhy; gpbj;Jf; 
nfhs;fpwJ. 
 
1 2 3 
5) vd; Foe;ij Fog;gkhd 
kdepiyapy; cs;sJ 
 
1 2 3 
6) vd; Foe;ijaplk; FWk;G jdk; 
kpf cs;sJ. 
 
1 2 3 
7) vd; Foe;ij Neha; tag;gl;lhNyh 
my;yJ fhakile;jhNyh> 
nghJthf tpiutpy; 
Fzkile;J tpLfpwJ. 
1 2 3 
 
 
II.  cly;hPjpahd nray;ghL 
A.  fle;j 4 thuq;fspy;> cq;fs; tsh;  ,sk; gUtf;Foe;ijapd; MNuhf;fpak; ve;j 
msT mtd; / mtsJ nray;ghl;il ,ilkwpf;fpwJ. 
ve;j msT cq;fs; Foe;ijapd; MNuhf;fpak; ,ilkwpf;fg;gLfpwJ? 
     xUNghJk;  kpjkhf VNjDk;    mjpfkhf  kpf mjpfkhf
                 ,y;iy         rpy rkaq;fspy;  
1) cq;fs; Foe;ij nra;Ak; typikahd  
  nray;fs; mjhtJ gSthd  
  nghUs;fis J}f;Fjy;> XLjy;  1 2 3  4 5 
  kw;Wk; fLikahd clw;gapw;rp   
  Nghd;wit my;yJ 
 mtw;wpd; msT? 
2) cq;fs; Foe;ij nra;Ak; kpjkhd  
  nray;fs;> mjhtJ ge;J tPRjy;  
  Nghd;wit my;yJ mtw;wpd; 1 2 3  4 5 
 msT? 
3) caukhd ,lq;fSf;F VWjy;  
  my;yJ gbfl;by; VWjy;? 1 2 3  4 5 
 
4) xU fl;lj;jpy; elf;Fk;NghJ? 1 2 3  4 5  
5) rha;;jy;> J}f;Fjy;> ftpo;jy;? 1 2 3  4 5 
6) cz;gJ> cLg;gJ. Fwpg;gJ  
  my;yJ fopTePf;fk;? 1 2 3  4 5 
III.  kdhPjpahd ghq;F 
,e;j thf;fpaq;fs; midj;Jk; tsh; ,sk; gUtf;Foe;ijfSf;F Vw;gLk; 
nray;ghl;L gpur;ridfis gw;wpaJ.  fle;j 3 khjq;fspy; cq;fs; Foe;ijapd; 
eltbf;ifia tpthpf;Fk; ,e;j thf;fpaq;fis KbT nra;J> cq;fspd; gjpiy 
$wTk;.   
  
vg;nghOJk; 
cz;ik 
rpy 
Neuq;fspy; 
cz;ik 
cz;ik 
,y;iy 
1 vd; Foe;ijapd; czh;T kw;Wk; 
vz;zq;fspy; jpBh; khWjy;fs; cz;L. 
1 2 3 
2 vd; Foe;ij mtis / mtid ahUk; 
Nerpf;ftpy;iy vd;W vz;ZfpwJ. 
1 2 3 
3 vd; Foe;ij vg;NghJk; ,Wf;fj;JlDk;> 
gjw;wj;JlDk; ,Uf;fpwJ. 
1 2 3 
4 vd; Foe;ij ngha; NgRfpwJ (my;yJ 
Vkhw;WfpwJ.  
1 2 3 
5 vd; Foe;ij mjpf gaj;Jld;> ftiyAld; 
,Uf;fpwJ. 
1 2 3 
6 vd; Foe;ij mjpfkhf tpthjpf;fpwJ. 1 2 3 
 
 
7 vd; Foe;ijf;F ftdf;FiwT cs;sJ. 
mjpf ftdk; nrYj;j Kbatpy;iy. 
1 2 3 
8 vd; Foe;ij vspjpy; Fog;gkhfp tpLfpwJ / 
kdf;Fog;gj;jpy; ,Ug;gJNghy; Njhd;WfpwJ. 
1 2 3 
9 vd; Foe;ij kw;wth;fsplk; Nfhgkhf 
,Uf;fpwJ. 
1 2 3 
10 vd; Foe;ij tPl;by; fPog;gbahky; cs;sJ. 1 2 3 
11 vd; Foe;ij gs;spapy; fPog;gbahky; cs;sJ. 1 2 3 
12 vd; Foe;ij jtwpioj;j gpd;Gk; mjw;fhf 
tUe;Jtjpy;iy. 
1 2 3 
13 vd; Foe;ij kw;w Foe;ijfSld; Nrh;tjpy; 
gpur;rid nfhs;fpwJ. 
1 2 3 
14 vd; Foe;ij Mrphpah;fSld; goFtjpy; 
gpur;rid nfhs;fpwJ. 
1 2 3 
15 vd; Foe;ij mtru Gj;jpAld; cs;sJ kw;Wk; 
vijak; rpe;jpf;fhky; nray;gLfpwJ. 
1 2 3 
16 vd; Foe;ij jho;T kdg;ghd;ikAld; 
cs;sJ. 
1 2 3 
17 vd; Foe;ij kw;w Foe;ijfshy; 
tpUk;gg;gltpy;iy. 
1 2 3 
18 vd; Foe;ij jd; rpe;jidapy; ,Ue;J 
ntsptu f\;lg;gLfpwJ (kd fyf;fk; 
cs;sJ) 
1 2 3 
19 vd; Foe;ij kpfTk; glglg;Gld; cs;sJ 
my;yJ JWJWntd;W cs;sJ. 
1 2 3 
20 vd; Foe;ij gpbthj Fzj;JlDk;> 
Nfhgj;JlDk; kw;Wk; vhpr;rY}l;Lk; 
Fzj;Jld; cs;sJ. 
1 2 3 
21 vd; Foe;ij mjpf Nfhgk; nfhzL kw;Wk; 
mij tpiutpy; ,oe;Jk; tpLfpwJ. 
1 2 3 
22 vd; Foe;ij Jauj;Jld;> Nrhfkhd 
kdf;ftiyAld; cs;sJ. 
1 2 3 
23 vd; Foe;ij kw;wth;fSld; Nrh;tjpy;iy. 1 2 3 
24 vd; Foe;ij mtDila / mtSila 
nghUl;fisAk;> my;yJ kw;wth;fSila 
nghUl;fisAk; Ntz;Lnkd;Nw 
cilf;fpd;whd; / cilf;fpwhs;. 
1 2 3 
25 vd; Foe;ij Kjpath;fsplk; ed;whf 
goFfpwJ. 
1 2 3 
26 vd; Foe;ij mjpfkhf mOfpwJ. 1 2 3 
27 vd; Foe;ijf;F mjpf ftdk; 
Njitg;gLfpwJ. 
1 2 3 
28 vd; Foe;ij mjpfk; kw;wtiu rhh;e;J 
cs;sJ. 
1 2 3 
 
  
 
 
IV. r%f kw;Wk; Ra nray;ghLfs;  
m)  fle;j 4 thuq;fspy;> vj;jid ehl;fs;... 
     1) Neha; (m) fhaj;jpdhy; cq;fs; Foe;ij gLf;ifapy; ,Ue;jJ? (mNefkhf 
(m) ehs;   KOtJk;) 
  0   1-2    3-5   6-10      11-15 >16 
--------  ---------  ---------  ---------      --------- ------- 
    (1)      (2)        (3)     (4)         (5)   (6) 
 2) Neha; (m) fhaj;jpdhy; cq;fs; Foe;ij gs;spf;Fr; nry;tJ jilgl;ljh? 
          (tpLKiw  ehl;fshf ,Ue;jhy> gs;sp ,Ue;j filrp khjj;ij Fwpg;gplTk;)
   0   1-2    3-5   6-10      11-15 >16 
--------  ---------  ---------  ---------      --------- ------- 
    (1)      (2)        (3)     (4)         (5)   (6) 
M)   xt;nthU Nfs;tpf;Fk; xU tpilia kl;Lk; Njh;T nra;aTk;.  
 3) cq;fs; Foe;ij jw;nghOJ ve;j thpirapy; cs;sJ (my;yJ ,Uf;f 
 Ntz;Lk;) 
   rpWth; gs;sp [  ]   Foe;ijfs; gs;sp [  ] 
  Kjy; tFg;G [  ]   2-k; tFg;G  [  ] 
  3-k; tFg;G [  ]   4-k; tFg;G  [  ] 
  5-k; tFg;G [  ]   6-k; tFg;G  [  ] 
  7-k; tFg;G [  ]   gs;spapy; ,y;iy [  ] 
  kw;wit [  ] 
 4) cq;fs; Foe;ij VjhtJ fhuzj;jpw;fhf mNj tFg;gpy; jpUk;gTk;            
 ,Ue;jjh? …………………………………………………..   
         Mk;/ ,y;iy 
 5) nghJthf mtdpd; / mtspd; MNuhf;fpaj;jhy; gs;spapd;    
 tUifg;gjptpy; VNjDk; ghjpg;G vw;gl;ljh?     
         Mk;/ ,y;iy 
 6) cq;fs; Foe;ijapd; MNuhf;fpak; mtspd; / mtdpd; nghJthd   
 nray;ghl;il Fiwj;jjh?        
         Mk;/ ,y;iy 
 7) gs;sp tpisahl;Lfspy; cq;fs; Foe;ij gq;Nfw;wjh?   
         Mk;/ ,y;iy 
 8) cq;fs; tsh; ,sk; gUtf;Foe;ijapd; ,ayhik (m) MNuhf;fpa 
 gpur;ridahy; mts; / mtd; rpwg;G tFg;Gfs; (m) rpwg;G cjtpfs; 
 Mfpatw;iw gs;spapy; ,Uf;fpwjh?    
   Mk;/ ,y;iy 
 Mk;nadpy;> gpd;tUthd tw;wpy; ve;j tifahd rpwg;G cjtpia cq;fs; 
Foe;ij ngWfpwJ. 
 thrpg;gjpy;   ..... [  ] 
 gbg;gjpy;   ..... [  ] 
 Ngr;R (m) nkhop  ..... [  ] 
 cly; gapw;rp / njhopy; gapw;rp ..... [  ]  
   Xd;Wf;F Nky;   ..... [  ]  
   kw;w tiffs;    
 
 
V) Rfhjhu Nritg; gad;ghL  
 
m.  fle;j 4 thuq;fspy;> 
 1) vj;jid Kiw cq;fsJ Foe;ijapd; cly; epiy ghjpf;fg;gl;lNghJ my;yJ 
 fhak; Md nghOJ> kUj;Jth; ghpe;Jiuj;j $l;L kUe;J kw;Wk; rj;J 
 khj;jpiufis jtpu> kw;w khj;jpiufis cgNahfpf;Fk; epiyia 
Vw;gLj;jpaJ?  
   0 1-2  3-4  5-6  7-9  >10 
   1  2   3   4   5   6 
 2) vj;jid Kiw> cq;fSila Foe;ijapd; cly; epiy ghjpf;fg;gl;l NghJ 
    kUj;Jthpd; MNyhridapd;wp kUe;jfj;jpw;F nrd;W kUe;J thq;fpdPh;fs;? 
   0 1-2  3-4  5-6  7-9  >10 
   1  2   3   4   5   6 
3) vj;jid Kiw kUj;Jth;> nrtpypah; my;yJ rpwg;G kUj;Jtiu re;jpf;f 
cq;fs; Foe;ij kUj;Jtkid my;yJ mtru rpfpr;irf;F nrd;wPh;fs;? 
   0 1-2  3-4  5-6  7-9  >10 
   1  2   3   4   5   6 
4) vj;jidKiw> cq;fSila Foe;ij cly; eyf; Fiwtpdhy; kUj;Jtk; rhh;e;j 
cjtpia ,q;fpUf;Fk; kUj;Jth; jtpu> jdpahh; kUj;Jthplk;> cjtp ngw;W 
,Uf;fpwPh;fs;? 
   0 1-2  3-4  5-6  7-9  >10 
   1  2   3   4   5   6 
M)5) cq;fs;  Foe;ij  cly;  eyj;ij  Nkk;gLj;Jk;  gpd;tUk;   epiwT 
          cz;lhf;Ffpw NtW top Kiw rprpr;iria Nkw;nfhs;fpwjh? 
 
   m) %ypif kUe;Jfs; 
   M) krh[; rpfpr;ir 
   ,) Nahfh 
   <) mf;Fgr;rh; 
      c) kw;wit. 
 
  
 
 
VI. mwpFwpfs; 
fle;j 4 thuq;fspy; cq;fs; Foe;ijf;F ,Ue;j mwpFwpfs; gw;wpa Nfs;tpfs; fPNo 
nfhLf;fg;gl;Ls;sd.,e;j mwpFwpfs; cq;fs; Foe;ijia ve;j msT 
Jaug;gLj;jpapUf;fpwJ vd;gij $wTk;. 
  vg;NghJk;    kpf      Fiwthf  kpjkhf  mjpfkhf  kpf mjpfkhf                    
    ,y;iy   Fiwthf  
1) cly; typ  1 2 3  4 5   6 
2) ,Uky;> %r;Rj;jpzwy;  1 2 3   4 5   6 
3) Fkl;ly;> the;jp> tapw;Wtyp 1 2 3   4 5   6 
4) tapw;Wg;Nghf;F  1 2 3   4 5   6 
5) rpuha;g;G> mhpg;G kw;Wk; gpw  1 2 3   4 5   6
 Njhy; gpur;ridfs; 
6) Nrhh;T> gytPdk;  1 2 3   4 5  6 
7) jiyr;Rw;W> kaf;fk; ,Ug;gJ 1 2 3   4 5  6 
 Nghy; Njhd;Wfpwjh 
8) fha;r;ry;> ,utpy; tpah;j;jy;>  1 2 3   4 5  6         
      eLf;fk; kw;Wk; Fsph; 
9) grpapd;ik  1 2 3   4 5  6 
10) cwf;fkpd;ik  1 2 3   4 5  6 
11) fz; kw;Wk; ghh;it  
       gpur;ridfs;  1 2 3   4 5  6 
12)   jiytyp  1 2 3   4 5  6 
13)   tha;typ my;yJ twl;rp>  
  tpOq;Ftjpy; gpur;rid  1 2 3   4 5  6 
14) neQ;R typ my;yJ milg;G  1 2 3   4 5  6 
15) %r;RtpLjypy; gpur;rid 1 2 3   4 5  6 
16) [yNjhrk;> ird]; gpur;rid 1 2 3   4 5  6 
17) jiy typ> %l;Ltyp         1 2 3   4 5  6 
18)  if> fhy;fspy; typ>  
 kwj;Jg;Nghjy;> eikr;ry; 1 2 3   4 5  6 
19) fhJ typfs;  1 2 3   4 5  6 
20) nghJthd gpw gpur;ridfs; 1 2 3   4 5  6 
 
  
 
 
khw;wpaikf;fg;gl;l tho;f;ifj;ju kjpg;gPL 
(12 Kjy; 20 taJ tiu) 
I)m. nghJthd MNuhf;fpa juk;: gpd;tUk; Nfs;tpfs; midj;Jk; tsh; 
          ,sk; gUtf; Foe;ijapd; MNuhf;fpak; kw;Wk; gof;ftof;fk; gw;wpajhFk;. 
 fle;j 3 khjq;fspy; nghJthf cq;fs; Foe;ij vt;thW ,Ue;jJ? 
             kpf Nkhrkhf     kpf ed;whf 
      czh;fpwhd;/czh;fpwhs;  czh;fpwhd;/czh;fpwhs; 
1) nghJthf> nkhj;jj;jpy;? 1    2     3     4     5     6     7     8     9     10 
2) cly; hPjpahf?   1    2     3     4     5     6     7     8     9     10 
3) kd hPjpahf?   1    2     3     4     5     6     7     8     9     10 
4) mth;fs; gs;sp Ntiyfs; gw;wp? 1    2     3     4     5     6     7     8     9     10 
(M) fPNo cs;s thf;fpaq;fis gbf;Fk;NghJ. fle;j 3 khjq;fspy; cq;fs; 
Foe;ijapd; MNuhf;fpaj;ij tpsf;Fk; thf;fpaj;ij Njh;T nra;J> cq;fs; 
tpilAld; xj;Jg;NghFk; gjpiyf; $wTk;. 
   
  vg;NghJk; 
,y;iy (m) 
mhpjhf 
VNjDk; rpy 
rkaq;fspy; 
mNefkhf 
vg;NghJk; 
1) vd; Foe;ijapd; MNuhf;fpak; 
rpwg;ghf cs;sJ. 
 
1 2 3 
2) vdJ Foe;ij Nehia ed;whf 
vjph; nfhs;tjhf njhpfpwJ 
 
1 2 3 
3) vdf;F njhpe;j kw;w 
Foe;ijfis tpl vd; Foe;ij 
MNuhf;fpaj;jpy; Fiwthf  
cs;sjhfj; Njhd;WfpwJ 
 
1 2 3 
4) vd; Foe;ij nghJthf jd;id 
Rw;wp VNjDk; ele;jhy; gpbj;Jf; 
nfhs;fpwJ. 
 
1 2 3 
5) vd; Foe;ij Fog;gkhd 
kdepiyapy; cs;sJ 
 
1 2 3 
6) vd; Foe;ijaplk; FWk;G jdk; 
kpf cs;sJ. 
 
1 2 3 
7) vd; Foe;ij Neha; tag;gl;lhNyh 
my;yJ fhakile;jhNyh> 
nghJthf tpiutpy; 
Fzkile;J tpLfpwJ. 
1 2 3 
 
 
 
II.  cly;hPjpahd nray;ghL 
A.  fle;j 4 thuq;fspy;> cq;fs; tsh;  ,sk; gUtf;Foe;ijapd; MNuhf;fpak; ve;j 
msT mtd; / mtsJ nray;ghl;il ,ilkwpf;fpwJ. 
ve;j msT cq;fs; Foe;ijapd; MNuhf;fpak; ,ilkwpf;fg;gLfpwJ? 
     xUNghJk;  kpjkhf VNjDk;    mjpfkhf  kpf mjpfkhf
                 ,y;iy         rpy rkaq;fspy;  
1) cq;fs; Foe;ij nra;Ak; typikahd  
  nray;fs; mjhtJ gSthd  
  nghUs;fis J}f;Fjy;> XLjy;  1 2 3  4 5 
  kw;Wk; fLikahd clw;gapw;rp   
  Nghd;wit my;yJ 
 mtw;wpd; msT? 
2) cq;fs; Foe;ij nra;Ak; kpjkhd  
  nray;fs;> mjhtJ ge;J tPRjy;  
  Nghd;wit my;yJ mtw;wpd; 1 2 3  4 5 
 msT? 
3) caukhd ,lq;fSf;F VWjy;  
  my;yJ gbfl;by; VWjy;? 1 2 3  4 5 
 
4) xU fl;lj;jpy; elf;Fk;NghJ? 1 2 3  4 5  
5) rha;jy;> J}f;Fjy;> ftpo;jy;? 1 2 3  4 5 
6) cz;gJ> cLg;gJ. Fwpg;gJ  
  my;yJ fopTePf;fk;? 1 2 3  4 5 
III.  kdhPjpahd ghq;F 
,e;j thf;fpaq;fs; midj;Jk; tsh; ,sk; gUtf;Foe;ijfSf;F Vw;gLk; 
nray;ghl;L gpur;ridfis gw;wpaJ.  fle;j 3 khjq;fspy; cq;fs; Foe;ijapd; 
eltbf;ifia tpthpf;Fk; ,e;j thf;fpaq;fis KbT nra;J> cq;fspd; gjpiy 
$wTk;.   
  
vg;nghOJk; 
cz;ik 
rpy 
Neuq;fspy; 
cz;ik 
cz;ik 
,y;iy 
1 vd; Foe;ijapd; czh;T kw;Wk; 
vz;zq;fspy; jpBh; khWjy;fs; cz;L. 
1 2 3 
2 vd; Foe;ij mtis / mtid ahUk; 
Nerpf;ftpy;iy vd;W vz;ZfpwJ. 
1 2 3 
3 vd; Foe;ij vg;NghJk; ,Wf;fj;JlDk;> 
gjw;wj;JlDk; ,Uf;fpwJ. 
1 2 3 
4 vd; Foe;ij ngha; NgRfpwJ (my;yJ 
Vkhw;WfpwJ.  
1 2 3 
5 vd; Foe;ij mjpf gaj;Jld;> ftiyAld; 
,Uf;fpwJ. 
1 2 3 
6 vd; Foe;ij mjpfkhf tpthjpf;fpwJ. 1 2 3 
 
 
7 vd; Foe;ijf;F ftdf;FiwT cs;sJ. 
mjpf ftdk; nrYj;j Kbatpy;iy. 
1 2 3 
8 vd; Foe;ij vspjpy; Fog;gkhfp tpLfpwJ / 
kdf;Fog;gj;jpy; ,Ug;gJNghy; Njhd;WfpwJ. 
1 2 3 
9 vd; Foe;ij kw;wth;fsplk; Nfhgkhf 
,Uf;fpwJ. 
1 2 3 
10 vd; Foe;ij tPl;by; fPog;;gbahky; cs;sJ. 1 2 3 
11 vd; Foe;ij gs;spapy; fPog;;gbahky; cs;sJ. 1 2 3 
12 vd; Foe;ij jtwpioj;j gpd;Gk; mjw;fhf 
tUe;Jtjpy;iy. 
1 2 3 
13 vd; Foe;ij kw;w Foe;ijfSld; Nrh;tjpy; 
gpur;rid nfhs;fpwJ. 
1 2 3 
14 vd; Foe;ij Mrphpah;fSld; goFtjpy; 
gpur;rid nfhs;fpwJ. 
1 2 3 
15 vd; Foe;ij mtru Gj;jpAld; cs;sJ kw;Wk; 
vijak; rpe;jpf;fhky; nray;gLfpwJ. 
1 2 3 
16 vd; Foe;ij jho;T kdg;ghd;ikAld; 
cs;sJ. 
1 2 3 
17 vd; Foe;ij kw;w Foe;ijfshy; 
tpUk;gg;gltpy;iy. 
1 2 3 
18 vd; Foe;ij jd; rpe;jidapy; ,Ue;J 
ntsptu f\;lg;gLfpwJ (kd fyf;fk; 
cs;sJ) 
1 2 3 
19 vd; Foe;ij kpfTk; glglg;Gld; cs;sJ 
my;yJ JWJWntd;W cs;sJ. 
1 2 3 
20 vd; Foe;ij gpbthj Fzj;JlDk;> 
Nfhgj;JlDk; kw;Wk; vhpr;rY}l;Lk; 
Fzj;Jld; cs;sJ. 
1 2 3 
21 vd; Foe;ij mjpf Nfhgk; nfhzL kw;Wk; 
mij tpiutpy; ,oe;Jk; tpLfpwJ. 
1 2 3 
22 vd; Foe;ij Jauj;Jld;> Nrhfkhd 
kdf;ftiyAld; cs;sJ. 
1 2 3 
23 vd; Foe;ij kw;wth;fSld; Nrh;tjpy;iy. 1 2 3 
24 vd; Foe;ij mLj;jth;fs; jd;dplk; rhh;e;J  
,y;iy vd;gJ Nghy; czh;f;fpwJ. 
1 2 3 
25 vd; Foe;ij gpwh;f;F gpur;ridfs; J}z;Lk; 
ez;gh;fis rhh;e;J ,Uf;fpwhd; 
1 2 3 
26 vd; Foe;ij ufrpak; kw;Wk; jdJ 
clikfis ghJfhf;fpwJ. 
1 2 3 
27 vd; Foe;ij mjpfkhd ftiyAld; cs;sJ. 1 2 3 
28 vd; Foe;ij mjpfk; kw;wtiu rhh;e;J 
cs;sJ. 
1 2 3 
 
  
 
 
IV. r%f kw;Wk; Ra nray;ghLfs;  
m)  fle;j 4 thuq;fspy;> vj;jid ehl;fs;... 
     1) Neha; (m) fhaj;jpdhy; cq;fs; Foe;ij gLf;ifapy; ,Ue;jJ? (mNefkhf 
(m) ehs;   KOtJk;) 
  0   1-2    3-5    6-10      11-15 >16 
--------  ---------  ---------  ---------      --------- ------- 
    (1)      (2)        (3)     (4)         (5)   (6) 
 2) Neha; (m) fhaj;jpdhy; cq;fs; Foe;ij gs;spf;Fr; nry;tJ jilgl;ljh? 
          (tpLKiw  ehl;fshf ,Ue;jhy> gs;sp ,Ue;j filrp khjj;ij Fwpg;gplTk;)
   0   1-2    3-5   6-10      11-15 >16 
--------  ---------  ---------  ---------      --------- ------- 
    (1)      (2)        (3)     (4)         (5)   (6) 
M)   xt;nthU Nfs;tpf;Fk; xU tpilia kl;Lk; Njh;T nra;aTk;.  
 3) cq;fs; Foe;ij jw;nghOJ ve;j thpirapy; cs;sJ (my;yJ ,Uf;f 
 Ntz;Lk;) 
   4-k; tFg;G  [  ] 5-k; tFg;G  [  ] 
  6-k; tFg;G  [  ] 7-k; tFg;G  [  ] 
  8-k; tFg;G  [  ] 9-k; tFg;G  [  ] 
  12-k; tFg;G  [  ]   
 4) cq;fs; Foe;ij VjhtJ fhuzj;jpw;fhf mNj tFg;gpy; jpUk;gTk;            
 ,Ue;jjh? …………………………………………………..   
         Mk;/ ,y;iy 
 5) nghJthf mtdpd; / mtspd; MNuhf;fpaj;jhy; gs;spapd;    
 tUifg;gjptpy; VNjDk; ghjpg;G vw;gl;ljh?     
         Mk;/ ,y;iy 
 6) cq;fs; Foe;ijapd; MNuhf;fpak; mtspd; / mtdpd; nghJthd   
 nray;ghl;il Fiwj;jjh?        
         Mk;/ ,y;iy 
 7) gs;sp tpisahl;Lfspy; cq;fs; Foe;ij gq;Nfw;wjh?   
         Mk;/ ,y;iy 
 8) cq;fs; tsh; ,sk; gUtf;Foe;ijapd; ,ayhik (m) MNuhf;fpa 
 gpur;ridahy; mts; / mtd; rpwg;G tFg;Gfs; (m) rpwg;G cjtpfs; 
 Mfpatw;iw gs;spapy; ,Uf;fpwjh?    
   Mk;/ ,y;iy 
 Mk;nadpy;> gpd;tUthd tw;wpy; ve;j tifahd rpwg;G cjtpia cq;fs; 
Foe;ij ngWfpwJ. 
 thrpg;gjpy;   ..... [  ] 
 gbg;gjpy;   ..... [  ] 
 Ngr;R (m) nkhop  ..... [  ] 
 cly; gapw;rp / njhopy; gapw;rp ..... [  ]  
   Xd;Wf;F Nky;   ..... [  ]  
   kw;w tiffs;   
  
 
 
V) Rfhjhu Nritg; gad;ghL  
m.  fle;j 4 thuq;fspy;> 
 1) vj;jid Kiw cq;fsJ Foe;ijapd; cly; epiy ghjpf;fg;gl;lNghJ my;yJ 
 fhak; Md nghOJ> kUj;Jth; ghpe;Jiuj;j $l;L kUe;J kw;Wk; rj;J 
 khj;jpiufis jtpu> kw;w khj;jpiufis cgNahfpf;Fk; epiyia 
 Vw;gLj;jpaJ?  
   0 1-2  3-4  5-6  7-9  >10 
   1  2   3   4   5   6 
 2) vj;jid Kiw> cq;fSila Foe;ijapd; cly; epiy ghjpf;fg;gl;l NghJ 
    kUj;Jthpd; MNyhridapd;wp kUe;jfj;jpw;F nrd;W kUe;J thq;fpdPh;fs;? 
   0 1-2  3-4  5-6  7-9  >10 
   1  2   3   4   5   6 
3)  vj;jid Kiw kUj;Jth;> nrtpypah; my;yJ rpwg;G kUj;Jtiu re;jpf;f 
 cq;fs; Foe;ij kUj;Jtkid my;yJ mtru rpfpr;irf;F nrd;wPh;fs;? 
   0 1-2  3-4  5-6  7-9  >10 
   1  2   3   4   5   6 
4)  vj;jidKiw> cq;fSila Foe;ij cly; eyf; Fiwtpdhy; kUj;Jtk; 
rhh;e;j cjtpia ,q;fpUf;Fk; kUj;Jth; jtpu> jdpahh; kUj;Jthplk;> cjtp 
ngw;W ,Uf;fpwPh;fs;? 
   0 1-2  3-4  5-6  7-9  >10 
   1  2   3   4   5   6 
M) 5) cq;fs;  Foe;ij  cly;  eyj;ij  Nkk;gLj;Jk;  gpd;tUk;   epiwT 
          cz;lhf;Ffpw NtW top Kiw rprpr;iria Nkw;nfhs;fpwjh? 
 
    m) %ypif kUe;Jfs; 
    M) krh[; rpfpr;ir 
    ,) Nahfh 
    <) mf;Fgr;rh; 
       c) kw;wit. 
 
  
 
 
VI. mwpFwpfs; 
fle;j 4 thuq;fspy; cq;fs; Foe;ijf;F ,Ue;j mwpFwpfs; gw;wpa Nfs;tpfs; fPNo 
nfhLf;fg;gl;Ls;sd.,e;j mwpFwpfs; cq;fs; Foe;ijia ve;j msT 
Jaug;gLj;jpapUf;fpwJ vd;gij $wTk;. 
  vg;NghJk;    kpf      Fiwthf  kpjkhf  mjpfkhf  kpf mjpfkhf                    
    ,y;iy   Fiwthf  
1) cly; typ  1 2 3  4 5   6 
2) ,Uky;> %r;Rj;jpzwy;  1 2 3   4 5   6 
3) Fkl;ly;> the;jp> tapw;Wtyp 1 2 3   4 5   6 
4) tapw;Wg;Nghf;F  1 2 3   4 5   6 
5) rpuha;g;G> mhpg;G kw;Wk; gpw  1 2 3   4 5   6
 Njhy; gpur;ridfs; 
6) Nrhh;T> gytPdk;  1 2 3   4 5  6 
7) jiyr;Rw;W> kaf;fk; ,Ug;gJ 1 2 3   4 5  6 
 Nghy; Njhd;Wfpwjh 
8) fha;r;ry;> ,utpy; tpah;j;jy;>  1 2 3   4 5  6         
      eLf;fk; kw;Wk; Fsph; 
9) grpapd;ik  1 2 3   4 5  6 
10) cwf;fkpd;ik  1 2 3   4 5  6 
11) fz; kw;Wk; ghh;it  
       gpur;ridfs;  1 2 3   4 5  6 
12)   jiytyp  1 2 3   4 5  6 
13)   tha;typ my;yJ twl;rp>  
  tpOq;Ftjpy; gpur;rid  1 2 3   4 5  6 
14) neQ;R typ my;yJ milg;G  1 2 3   4 5  6 
15) %r;RtpLjypy; gpur;rid 1 2 3   4 5  6 
16)  [yNjhrk;> ird]; gpur;rid 1 2 3   4 5  6 
17) jiy typ> %l;Ltyp         1 2 3   4 5  6 
18)  if> fhy;fspy; typ>  
 kwj;Jg;Nghjy;> eikr;ry; 1 2 3   4 5  6 
19) fhJ typfs;  1 2 3   4 5  6 
20) nghJthd gpw gpur;ridfs; 1 2 3   4 5  6 
 
Annexure- ii 
ASSESSMENT OF COUNSELING SCHEDULES 
 The HIP interventional package (HIP) includes the following components of 
Adherence counseling, Nutritional counseling, strategies to enhance the quality of life 
of HIV infected adolescents includes demonstration of selected asana and 
maintenance of diary every day.Here, the investigator planned to give HIP to 
experimental group of HIV infected adolescents in order to increase immune power, 
improve nutritional status, and enhance the quality of life of ALHIV.  
PART – I 
ART ADHERENCE COUNSELING SCHEDULE 
 First, the investigator has planned to implement the adherence counseling to 
the care givers and HIV infected adolescents in ART clinic together.As per inclusion 
criteria, adolescents on ART management for a period of minimum 3 months were 
only enrolled in the study. So they might have undergone pre ART adherence 
counseling during initiation of ART. Our intervention is to focus more on to achieve 
100% adherence and follow up ART counseling. The steps are as follows,  
Baseline ART adherence counseling 
Step 1: Assess the knowledge regarding disease and health status 
 Review and assess care giver understands about subject’s HIV disease and 
health status. 
 Explain overall treatment and follow-up plan 
 Importance of counseling sessions on ART. 
 Monthly follow-up with physician. 
 Monthly pharmacy refill and laboratory investigations as required 
 Make the subject feel comfortable. 
Step 2:  Assess the knowledge regarding treatment and follow-ups 
 Review and assess care giver’s understanding and recall of treatment and 
follow-up plan 
 Overall health and physical condition 
 Disease stage and past OIs 
 CD4 counts and viral load 
 Expected changes in health and CD4 counts with regular ART 
 Importance of  more than 95% adherence 
 Consequences of non-adherence. 
 Past use of ARVs/Other medications 
 Protective and preventive behaviors. 
During the session assess, 
 Care giver’s beliefs and attitudes about HIV infection and treatment 
  Care giver’s and subjects mental health. 
Step 3: Discuss subject ’sliving conditions and social support 
 Employment and income of the care giver 
 Living condition and housing 
 Disclosure of HIV status 
 Social support 
 Dependants, other HIV infected persons 
 Migrant status and travel 
 Daily routine. 
Step 4: Discuss treatment plan. 
 Treatment regimen 
 Name and the dose of drugs 
 Instructions about  food and fluid intake/restrictions if any, 
 Storage of medications 
 Take all the doses of all medications and do not share 
 Discuss the side effects- briefly, do not overwhelm the subjects 
 Follow-up plan 
 Next counseling sessions 
 Physician check up and investigations 
 Contact information-Health professionals and subjects. 
Step 5: Discuss the proposed adherence strategy 
 HAART  and its importance 
 Treatment Buddy 
 Family involvement 
 Tools: Pillbox, diary, treatment reminder cues etc. 
Step 6: Identify barriers to adherence 
 Identify potential barriers from earlier discussion 
 Discuss ways to address barriers. 
Step 7: Fix a date for the next appointment 
3
rd
 AND 6
th 
MONTH ART ADHERENCE COUNSELING 
 Use an approach of continuing discussion on every month and evaluation 
at 3
rd
 and 6
th
 month. 
 Repeat information whenever necessary 
 Re-emphasize important issues 
 Use dummy pills to repeat the instructions. 
Step 1:Assess the knowledge regarding disease and health status 
 Review and assess care giver understands of his/her HIV disease and 
health status 
Step 2: Assess the knowledge regarding treatment and follow-ups 
 Review and assess care giver understands and recall of treatment and 
follow-up plan. 
Step 3:  Provide information on side effects 
 Expected side effects 
 How to manage them 
 When to seek care 
 How to contact  the health care providers. 
Step 4: 
  Proposed adherence strategy. 
Step 5: 
 Review barriers and how to address them. 
Step 6: 
 Fix a date for the next appointment. 
 
 
 
 
NURSE ADHERENCE COUNSELOR CHECKLISTS FOR  
COUNSELING SESSIONS 
ADHERENCE COUNSELING CHECKLIST 
 
BASELINE COUNSELING SESSION  
 
Subject’s Name ................................................................................ 
 
Date of Counseling session................................................................ 
 
S.No. ADHERENCE COUNSELING CONTENT REMARKS 
1. Subject’s assessment  
 Medical history  
 Knowledge of HIV/AIDS  
 Prior use of ART  
 Determine social support  
 Disclosure—have they disclosed to anyone?  
 Alcohol/drug use  
 Mental status  
2. Review health status  
 Opportunistic infections  
 CD4/viral load  
 Review living conditions and  the Employment  
 Housing  
 Employment/income  
3. Describe the treatment program and importance of 
adherence 
 
 Drug regimen- Name/frequency/storage/dietary 
instructions/not to share pills 
 
 What ART does- suppresses virus/improves 
immunity/less OIs/not a cure 
 
 Cost  
 Side effects and what to do  
 Follow-up  
 Importance of adherence and consequences of non 
adherence 
 
  
4. Discuss adherence promotion strategies  
 Buddy reminder—discuss role of support person  
 Pill box, diary  
 Other reminder cues  
5. Identify barriers to adherence                                                Yes No 
 Poor communication   
 Low literacy   
 Inadequate understanding about HIV/AIDS   
 Lack of social support   
 Failure to disclose status   
 Mental  health status   
6. Schedule next counseling session and complete 
appointment card 
 
  
NURSE ADHERENCE COUNSELOR CHECKLISTS FOR  
COUNSELING SESSIONS 
ADHERENCE COUNSELINGCHECKLIST 
 
3
rd
 AND 6
th
MONTH COUNSELING SESSION 
 
Subject’s Name .................................................................................. 
 
Date of counseling session.................................................................. 
 
S.No. ADHERENCE COUNSELING CONTENT REMARKS 
1. Review client’s understanding of HIV/AIDS  
 What is HIV and AIDS?  
 Opportunistic infections  
 CD4/viral load  
 Effect of treatment  
2. Review the treatment program and importance of 
adherence 
 
 Drug regimen  
 Dummy pill demonstration  
 What ART does—improves immunity/less OIs/ART 
not a cure 
 
 Need for continued prevention  
 Side effects and what to do?  
 Follow-up  
 Importance of adherence and consequences of non-
adherence 
 
3. Review proposed adherence promotion strategies  
 Buddy reminder—discuss role of support person  
 Pill box , diary  
 Other reminder cues  
4. Review barriers to adherence and progress made  
 Poor communication  
 Low literacy  
 Inadequate understanding about HIV/AIDS  
 Lack of social support  
 Lack of self confidence  
 Mental  health status  
5. Take/ Record  subject’s address and establish contact 
system with treatment centre 
 
6 Schedule next counseling session and complete 
appointment card 
 
 
PART - II 
NUTRITIONAL COUNSELLING SCHEDULE 
Steps 1: Assessing dietary habits 
 The investigator should ask questions about a subject's typical food intake. 
 The 24-hour food recall and food frequency questionnaire can be used to 
estimates more accurate picture of a subject’s typical eating patterns. 
 The investigator can  ask the client how often he or she consumes certain 
food groups or the consumed servings of dairy products, fruits, vegetables, 
grains and cereals, meats, or fats he or she consumes in a typical day, 
week, or month 
 The investigator can assess the socioeconomic background of  subjects in 
order to make modifications if needed in diet 
 The investigator emphasize the importance of diet in health status of the 
subjects and the caregivers 
Step 2: Identifying changes needed 
 The initial dietary assessment and interview provide the basis for 
identifying behaviors that need to be changed. 
 Identify any allergic to specific foods. 
 The investigator can help to educate a person regarding the health effects 
of different dietary choices. 
 The investigator and caregiver work together to identify areas where 
change is needed to prioritize changes and problem-solve related to health 
status. 
Step 3: Setting goals 
 Theinvestigator and subject set behavior-oriented goals together.  
 Goals should focus on the behaviors needed to achieve the desired dietary 
change, not on an absolute value, such as achieving a certain body weight 
and improvement in health status. 
Step4:Making dietary change 
 In making dietary changes, each subject’s situation, background and the 
factors that affect food decisions must be carefully considered. 
 In subject, adding new foods should be a gradual process, may start with 
one or two easier dietary changes the first few weeks and gradually make 
additional or more difficult changes over several weeks or months. 
Step 5:Identifying barriers to change 
 Once the needed changes have been identified, the investigator should 
think through potential problems that may arise. 
 Some common barriers are changing the eating habits includes: 
inconvenience, social gatherings, food preferences, lack of knowledge or 
time, cost etc. 
Step 6:Finding support 
 Care givers &family members are encouraged to attend nutrition 
counseling sessions with the subject’s, especially if they share 
responsibility for food selection and preparation.  
 Although the care giver / subject must make food choices and take 
responsibility for dietary changes, having the support and understanding of 
family and friends makes success more likely. 
General Advice 
 Encourage to take high calories, high proteins and vitamins& minerals-rich 
diet. 
  Instructed to eat the rainbow colored foods (choose foods from variety of 
colors to get most nutrients). 
 Eat daily from the five food groups: staple foods, fats and oils, legumes, 
fruits and vegetables, and food from animals 
 Drink plenty of clean water and fluids (real fruit juices and herbal green 
teas can be beneficial).   
 Drink clean boiled water for at least 3-4 lt/day or 8-12 templar/day. 
 Avoid food that may contain unboiled water like refridged drinks & butter 
milk. 
 Avoid too much of spicy foods – chilies and masala.  
 Avoid excess oil while cooking in the home and oily food like fried foods 
in outsides. 
 Include pulses and sprouted, steamed legumes daily. 
 Include at least two vegetables and one seasonal fruit daily. 
 Include daily  one egg and have a warm  milk 2 glasses/day (after 
waking up and before going to bed) 
 Fish is the best flesh food. Mutton & chicken can also be included. 
 Try to eat regular meals even if not hungry. 
 Chew food well and move around the mouth to stimulate taste 
receptors. 
 Encourage small frequent meals of 5-6 times /day when unable to 
eat wholesome meals. 
 Soft, mashed and moist foods are easier to eat when compare to the 
fried items. 
 Discuss methods of food preparation which maintain hygiene and 
maximize nutrient retention. 
 Encourage general personal hygiene like maintaining, trimmed 
nails and washing hands before & after eating.   
  
PART - III 
STRATEGIES / PRACTICES THAT ENHANCES QUALITY OF LIFE 
 
 The investigator should educate the care givers and subjects in ART clinic 
together, about the strategies and practices that could enhance quality of life .Our 
intervention is more focus on enhance quality of life and increase the life span of HIV 
infected adolescents. They are as follows, 
 Instruct the care giver to provide as adequate and balanced diet for the 
subject. 
 Keep the environment in hygiene and free from infections. 
 Avoid allergic foods. 
 Encourage the subject do physical work and state its importance. 
 Insist to do moderate physical activity without any interference to subject’s 
health. 
 Maintain subject’s personal hygiene, especially hand and oral hygiene so 
neatly. 
  Keep the subject’s emotionally stable. Entertain the subject’s regularly. 
 Provide opportunities for the subject to socialize with peer group. 
 Keep the subject psychologically stable and sustain without any damage. 
 Encourage the subject get along with friends and elders respectively. 
 Encourage the care giver to concentrate on subject psychological aspect. 
 Encourage care givers to provide ART medications to the subject regularly 
and ask them to maintain ART adherence level > 95 %. 
 Encourage the subject to study the school subjects and attend the school 
regularly. 
 Seek for medical help whenever necessary. 
 Treat the subjects when she/he is sick at nearby hospital without fail. 
 Encourage the spiritual aspect among the subjects. 
 Provide hope and confidence among the care giver and subjects. 
 Maintain good rapport with community health workers. 
 Encourage adequate rest and sleep. Increase the food quantity in phased 
manner. 
 Utilize the locally available cost effective, nutritional food. 
 Provide information to the care giver regarding the Government schemes 
for the welfare of the HIV infected child. 
 Take bath daily with soap. 
 Use mosquito net when sleeping. 
 Avoid scratches or injury over the skin. 
 Avoid skin drying by applying coconut oil on the skin. 
 Seekmedical advice for any allergy and take medication as advised without 
any skip. 
 Keep the subjects happy and focused on care. 
 Encourage the subjects do exercises regularly. 
 Making these changes in your life will help you stay healthier longer, even 
with HIV. 
 The investigator plan to discuss regarding the symptomatic management to the 
caregivers/ subjects whenever necessary care is needed, if problem persists or not 
cured immediately consult with medical advice or nearer to the health centre. 
  
PART - IV 
YOGA - SELECTED ASANA AND PRANAYAMA 
 The investigator planned to demonstrate the asana and pranayama as a part of 
HIV interventional package. The first three components of HIP can be enhanced by 
the fourth components of yoga. Our intervention is more focus on to increase 
immunity, improve nutritional status and enhance quality of life of HIV infected 
adolescents. 
General Instructions 
1. Do asana in clean and well ventilated rooms.  
2. Use yoga mat or 6 feet length of bed spread on the floor. 
3. Do asana in empty stomach, or after empty the bowel and bladder.  
4. Wait for 3 hours after a heavy meal, or two hours after a light meal. 
5. Wear non-restrictive cotton clothing while practicing yoga and do 
not wear shoes or socks. 
6. Do yoga in a relaxed manner with maximum capacity.  
Asana Demonstration 
  The principle investigator teaches and demonstrates the selected asana during 
the HIV interventional package as a part of intervention. As per instruction, the HIV 
infected adolescent has to re demonstrate the asanas in presence of investigator on the 
same time. They were also given brochures for practicing the selected asanas every 
day for minimum10 to 15 minutes on their own at home. The selected asanas are,  
1. Padmasana (1-2 min) 
2. Vajrasana (1-2min) 
3. Pranayama (3 min). 
4. Trikonsana (2-3 min) 
5. Ardhamatsyendrasana (1 minutes on each side) 
or  Ushtrasana (1 min) 
6. Bhujangasana (1-2  min) & 
7. Shavasana(3-5min) 
 Once completed the asana, drink water or any liquids after 5-10 minutes. At 
every month visit, the investigator should assess and reinforce the HIV infected 
adolescents to practice the asana regularly in their life and maintain the dairy after the 
practice of yoga and drug intake of every day. 
Benefits of asana 
 Regulate blood circulation all over the body especially in thymus gland. 
 Improve the digestion power and reduce the gastrointestinal problems related 
to OIinfections. 
 Decrease the lung problems and clear the sputum from lungs. 
 Enhance all the organs in our body to function normally.   
 Relieve the stress, increase the immunity and enhance the overall quality of 
life. 
 
 
Annexure-iii 
HIV INTERVENTIONAL PACKAGE (HIP) MODULE 
 
In this present study, the investigator plan to implement the following 
components of the HIV interventional package (HIP) to the HIV infected adolescents/ 
caregivers. It comprises of, 
1. Adherence Counseling.  
2. Nutritional Counseling. 
3. Provision of educational strategies to improve the quality of life of HIV 
infected adolescents. 
4. Yoga includes selected asanas and pranayama and 
5. Maintenance of diary as remainder cue for every day after the intake of 
drugs and yoga practice. 
 The investigator implemented the following counseling sections as part of 
interventions in the present study. 
PART – I 
ADHERENCE COUNSELING 
 The investigator assesses ART adherence level by using Modified Adolescent 
Adherence Questionnaire from Pediatric AIDS clinical Trial group (PACTG). Based 
on ART adherence level of HIV infected adolescents, the investigator will plan for 
counseling section. The main goal of adherence counseling is to improve the 
adherence level and maintain 100 % adherence to ART. 
Adherence counseling  
 The Nurse has a very important and unique opportunity with regard to the 
promotion of successful adherence. Many health care systems identified that 
adherence as the nurse’s first responsibility when treating a client who is receiving 
ARV treatment. So, the professional experience of researcher has taken an initiation 
to improve the ART adherence to HIV infected adolescents. 
  
 
 
Meaning of Adherence 
Adherence describes how faithfully a person sticks to and participates in his or 
her HIV prevention, care, and treatment plan. Adherence means “the patient’s 
behavior of taking drugs correctly - the right drug, right dose, right route, right 
frequency and right time”. It also includes the clients attend all scheduled 
visits/procedures/prescription refills. 
Concept of adherence 
It includes the active participation of the adolescents in his or her care plan 
(and, if applicable, the active participation of caregivers in the client’s care plan) 
 It includes the adherence to both medicines and  care/management 
 It depends on a shared decision-making process between the subject 
and care givers. It determines the success of HIV prevention, care, and 
treatment programs 
 Adherence not static , in other words, it changes over time and all 
ALHIV depends on  their age go through different developmental 
stages and life changes  
 A need to achieve 100 % adherence to ART to keep the correct amount 
of drugs in their body to fight the virus. 
Adherence to care includes 
 Continuing as a lifelong commitment to the care and treatment plan 
 Attending appointments and tests, such as regular CD4 tests and other 
blood investigations as schedule. 
 Taking (or giving) medicines to prevent and treat opportunistic 
infections. 
 Participating in ongoing health education and counseling. 
 Picking up medicines when scheduled and before running out. 
 Recognizing when there is a problem or a change in health and coming 
to the clinic for care. 
 Adopting a healthy lifestyle and trying to avoid risky behaviors (as 
much as is possible given to the client’s life situation) 
 
 
 
Adherence to treatment includes, 
 Taking  ART correctly, as prescribed, for a person’s whole life even if 
he or she feels healthy (“every pill, every day”) 
 Taking (or giving) other medicines, such as multivitamins, as 
prescribed. 
 Not taking any “treatment breaks” 
Non Adherence 
 Non adherence means the subject’s inability take his/her drugs or attend 
scheduled clinical visits (including laboratory) in the prescribed manner. The poor 
adherence leads to drug resistance, increased viral load and increased possibility of 
mortality and morbidity. 
Non-adherence includes 
 Missing one or many appointments at the hospital or health centre, lab, or 
pharmacy 
 Not following the care plan 
 Missing a dose or doses of medicine 
 Sharing medicines with other people 
 Stopping medicine for a day or many days (taking a “treatment break” or 
“holiday”) 
 Taking medicines at the wrong times 
 Taking medicines without following instructions about timing or food 
intake 
Factors affecting Adherence 
 The following are the lists of some common factors that can affect adolescents 
ART adherence. 
 Lack of family support structure or help from the caregivers with 
decision making.(Particularly in case younger adolescents and single 
orphans.) 
 Lack of transportation of health facility. 
 Lack of financial resources. 
 Lack of understanding and the need to adhere to ART 
 
 
 Adolescent  not believing that ART works 
 Adolescent has the difficulty with medication times.(School) 
 Taste and side effects from the ART.(Nausea, vomiting) 
 Underlying depression. 
 Stigma  and discrimination 
 Lack of social support at home and in the community including at 
school 
 Lack of self confidence 
 Unavailability of reminder cues- Pill boxes, diary, calendar, alarms, 
SMS 
Importance of Optimal Adherence 
 To ensure the 100% ART adherence will increase the adolescent CD4  
count and to decrease the amount of viral load in the blood. 
 To help ALHIV   grow and develop in to healthy adult by reducing OI 
infections. 
 To make sure adolescents get all the benefits that ART has to offer, 
such as feeling better, not getting sick as often or as badly, living a 
longer life, etc. 
 To reduce the risk of spreading the virus to others. 
 To keep adolescent looking and feeling good so they can get back to 
“normal” life, including going to school, working, socializing, and 
being an active family and community member .It shows the overall 
improvement in QOL 
Suggestions to improve the adherence level 
1. Ensure the services are provided on days and times that are convenient 
for adolescents. 
2. The motivational counseling and education approach that corresponds 
to adolescent’s maturational stage. 
3. Build a relationship of trust, respect with client and ensure 
confidentiality. 
4. Ensure that all adolescents are given reminders cues of diary to help 
them remember upcoming appointments. 
 
 
5. Make sure to review each client’s drug regimen to assess whether 
changes can be made to facilitate adherence (for example, changing the 
client to a once-daily regimen.) 
6. Use fixed dose combinations of ARV when possible to reduce 
subject’s pill burden. 
Strategies to improve ART Adherence level 
 The investigator conducted the counseling session in groups or individual 
session or as a combination of two. For initial stage, individual sessions are used to 
find out the reason for adherence and to identify the areas in which they need extra 
support, and to develop an individual adherence plan. The individual counseling 
session should include talking with the client (and caregiver or treatment buddy) 
about any adherence challenges he or she may face and rule out the side effects. The 
group and peer support counseling   conducted   for mainly in orphanage adolescents 
those who known  their  status. 
 A treatment buddy or treatment supporter is someone who is chosen by a 
client to provide him or her with ongoing support for adherence to care and treatment. 
 A treatment buddy is usually a subject’s caregiver, friend, family members, or 
another ALHIV who is also enrolled in care and who is a trusted person to whom the 
subject can disclose his or her status. Younger adolescents may have one of their 
primary caregivers as a treatment buddy, while older adolescents may prefer to have a 
friend or peer as their treatment buddy. Counsel the adolescents to utilize the 
following aids for improve the adherence level. 
 Labels in the medicine box 
 Calendar / diary 
 Pill boxes 
 Reminders in the mobile and cards 
 Programmable wrist watches 
 SMS through Mobile 
 Treatment buddy. 
 Among the following aids, the investigator implemented the diary for 
improving the adherence level of HIV infected adolescents in experimental group 
throughout the study period. If treatment buddies or pill boxes available the 
investigator continued the aids along with diary in experimental group. 
 
 
PART – II  
NUTRITIONAL COUNSELING 
 Adolescents are not homogeneous. The adolescents of the same age can differ 
in their physical, psychological or the social development. There are many 
developmental differences between a young 10-year-old adolescent and a 18-year-
old.These differences makes  adolescents’ counseling needs to be prioritized  and 
their capacity to care for them. In nutritional counseling, the investigator helps the 
subjects to develop strategies to address their nutrition goals and overcome their 
personal barriers. The goals of the nutritional counseling and support for adolescents 
with HIV are listed below, 
• Provide adequate nutrition in order to promote normal growth and 
development during puberty.  
• Maintain adequate nutritional status to promote health and prevent 
opportunistic infections. 
•  Promote optimal nutrition and prevent malnutrition.  
• Manage or reduce symptoms of HIV disease. 
•  Enhance drug compliance and efficacy through diet counseling. 
•  Prevent food-borne illness. 
•  Manage complications associated with HIV and antiretroviral therapy 
(ART).  
 The counseling strategies are based on the results of the nutritional assessment 
by anthropometric measurements and as well as clinical findings. The side effects 
experienced are targeted to address the individual needs are identified in the 
nutritional assessment. The nutrition counseling process involves, developing a 
specific management plan that takes an account of the broad range of factors that 
influence food intake. The consideration should be given to cultural and family 
background, food preferences, available budget and dietary practices. Apart from their 
regular diet, the investigator is given special attention to antioxidants in their diet 
along with major nutrients. The investigator first start the section regarding, physical 
access to, and availability of the food products as well as in  having the financial 
resources to purchase them on a regular basis. Ensuring access to an adequate quantity 
and quality of food can contribute to improve the treatment outcomes and a better 
quality of life.  
 
 
 The investigator should help the adolescents / caregivers to understand the 
need to maintain an adequate diet and ways to manage common gastrointestinal 
problems related to HIV that may have a negative impact on diet. The nutritional 
status of the HIV-infected adolescents has a great impact on overall health, growth, 
and development. The investigator should start the counseling session with what is the 
purpose of taking nutritious diet and nutritional consequence of HIV for the 
adolescents. It also deals with the caregivers and as well as the adolescents regarding 
the need to take of healthy and nutritious diet in their life. 
Need for healthy and nutritious diet in HIV and AIDS 
 HIV and AIDS increase the body’s need for food. 
 People living with HIV and AIDS are more at risk for malnutrition 
 When sick, more nutrients help to fight illness and need to recover faster. 
 Healthy eating helps to maintain weight and increase the strength and 
reduce the weight loss. 
 Good health delays the onset of AIDS and reduces the time and money 
spent on health care. 
 Good nutrition helps to make pills work better and easier to take. 
Nutritional consequences of HIV 
 Decreased food intake may result from, 
 Loss of appetite 
 Pain when eating 
 Mechanical difficulties: chewing, swallowing, digesting, delayed in empty 
of the stomach. 
 Mal absorption of nutrients and micro nutrients  
 Small intestine alterations ,causing diarrhea 
 Constipation due to inadequate intake and inactivity. 
The nutritional counseling focuses on 
 Educating the caregivers regarding the water and food safety with regard 
to purchasing, handling, preparing and storing foods 
 Food budgeting and cooking 
 Healthy and nutritious diet to increase weight and maintain normal growth 
and development and meets additional need during puberty.  
 Achieving optimal intake of macro- and micro nutrients   
 
 
1. Carbohydrates and fats produce energy and insulation. 
 2. Protein builds and repairs tissues and improves the immune system. 
 3. Vitamins and minerals maintain healthy lining of skin, lungs, GI 
tract; aid in production of bloods; vital elements for functioning of 
the immune system, thereby helping to protect against OIs and 
additional attention to specific nutrients (e.g. vitamin A, C, E and D, 
iron and Calcium), 
4. The micro nutrients supplementation of zinc and selenium could 
improve immune function and delay the onset AIDS. 
 Address any nutrition related complications and management, such as 
diarrhea, weight loss, loss of appetite, problems in chewing and 
swallowing, and nausea and vomiting. 
 Preventing weight loss and potential wasting 
 Providing nutritional counseling on simple dietary changes to increase the 
absorption of anti-retroviral drugs 
 Drink porridge with soya flour or pounded groundnuts for increased 
strength 
 Eat favorite and tasty foods with spices (garlic, ginger, curry), onions or 
tomatoes for flavor (unless you have oral thrush, diarrhea or another 
condition that spicy food can aggravate) 
 Grind meat and chicken or cut into smaller pieces for easier eating 
 Promote physical activity and exercise 
Boosting antioxidants 
 Eat lots of colorful fruits and vegetables to get the antioxidants found in the 
pigments and the phytochemicals contained in the whole food. Try to include blue, 
purple, green, orange, red and yellow foods to get the full complement of beneficial 
substances. Black and green tea, mushrooms, and dark chocolate are also good 
sources of antioxidants.  The antioxidant supplements include vitamins A, C and E, 
the minerals like zinc, selenium and magnesium decrease the oxidative damage and 
tend to decrease the severity of HIV/AIDS. The various sources of antioxidants and 
minerals which are easily available, affordable and accessible are listed below. 
 
 
 
S.No. Nutrients Sources 
1. Vitamin A Pumpkin, Carrots, Tomatoes,  Sweet potatoes,   and 
dark green leafy vegetables (especially in  Spinach) 
Papaya, Mangoes, oranges, grapes, egg, fish and liver 
2.  Vitamin C Citrus foods containing of orange, Amla and Lime, 
Guava, strawberry, cabbage, potatoes, including sweet 
potatoes, dark green leaves and plantains. (Vitamin C 
lost when food is cut up , heated or left standing after 
cooking) 
3. Vitamin E Wheat germ, Whole grains, nuts and seeds includes 
vegetable oil, butter, milk fat, egg yolk and dark green 
leafy vegetables. 
4
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          Zinc Fish, meat, fortified beans, soya beans, peanuts, 
legumes, wheat gram, milk, and cheese. 
5. Selenium Fish , meat, chicken, egg, milk, nuts and whole grains 
6. Magnesium Nuts and beans, legumes and whole grains, cereals, 
pineapple, sweet potatoes, wheat germ, and dark leafy 
vegetables.     
7. Iron  Red meat, liver, fish, poultry, eggs, legumes, pea nuts, 
cereals, and dried fruits. 
8. Calcium  Milk, Cheese, butter, legumes, peas and green leafy 
vegetables. 
 
 The investigator instructed the participants to take at least 3-5 items of the 
antioxidants rich foods that are suggested in the diary which is easily available, 
affordable and accessible in the community helps to improve the nutritional status and 
increase the immunity. 
Education on management of nutritional issues 
General tips 
 Encourage to take high calorie, high protein and vitamin & minerals-rich diet or 
eat the colors of rainbow (choose foods that are a variety of colors to get more 
nutrients). 
 
 
 Eat daily from the five food groups: staple foods, fats and oils, legumes, fruits and 
vegetables, and food from animals 
 Drink plenty of clean water and fluids (real fruit juices and herbal green teas can 
be beneficial)   
 Drink only clean boiled water at least for 3-4 lt/day or 8-12 templar/ day. 
 Avoid the food that may contain unboiled water like refridged drinks & butter 
milk. 
 Avoid spicy food – chilies, pepper and too much masala.  
 Avoid excess oil while cooking in the home and oily food like fried foods in 
outsides. 
 Include pulses & sprouted, steamed legumes daily. 
 Include at least two vegetables & one seasonal fruit daily. 
 Include daily one egg and have a warm milk 2 glasses /day. (after waking up and 
before going to bed) 
 Fish is the best flesh food. Mutton & chicken can also be included. 
 Try to eat regular meals even if not hungry. 
 Chew food well and move around the mouth to stimulate taste receptors. 
 Encourage small frequent meals of 5-6 times per day when unable to eat 
wholesome meals. 
 Soft, mashed and moist foods are easier to eat when compare to the fried items. 
 Discuss methods of food preparation which maintain hygiene and maximize 
nutrient retention. 
 Encourage general personal hygiene like maintaining, trimmed nails and washing 
hands before & after eating. 
Poor appetite 
 Eat small and frequent meals and nourishing snacks. 
 Eat favorite foods  and avoid strong smelling foods 
 Select recipes that combine foods to give a more nutrient dense 
composition(high in protein, vitamins, and  minerals) 
Change or loss of taste 
 Use flavor enhancers such as lemon, salt, or spices 
 Chew food well and move around in the mouth to stimulate taste receptors. 
Nausea/Vomiting 
 Eat small ,frequent meals 
 
 
 Avoid having an empty stomach. 
 Drink after meals and the intake of fluids with meals. 
 Avoid lying down directly after eating 
 Eat lightly salty and dry foods to calm the stomach. 
Diarrhea   
 Provide more water/Oral Rehydration Solution (ORS) / Tea / Lassie in more 
amounts.  
 Provide Rice porridge in large amounts. 
 Provide any fresh fruit juices. 
 After every visit to toilet, wash the child’s anal area with clean water. 
 After every visit to toilet, wash child’s hands with soap & water. 
  If persist more than 3-5 times consult with medical advice. 
 Maintain follow up care 
Early fullness 
 Eat small, frequent meals. 
Abdominal Pain 
 Get medical evaluation. 
 The researcher emphasizes the subjects to essentials of taking the major and 
minors nutrients in their diet and also educate about the various sources of vitamins 
and minerals and the importance of taking the nutrients in illness state. The good 
nutrition can help to maintain and improve the nutritional status of adolescents living 
with HIV/AIDS.  The nutritional counseling may improve health outcomes in 
adolescents with HIV by reducing the incidence of HIV-associated complications and 
delaying the progression of HIV infection, thereby improving quality of life and 
ultimately reducing disease-related mortality. 
PART –III 
STRATEGIES TO ENHANCE THE QOL 
 Having HIV doesn’t have to stop living a complete and healthy life. With the 
right treatment and care the subjects can lead their life fitter, healthier and happier. 
The investigator counsel the HIV infected adolescents regarding positive living and to 
enhance the QOL. The investigator counsel the subject’s regarding the current 
treatment for HIV is not a cure  the disease but it can keep HIV under control and this 
keeps your immune system strong. Once, start of ARV drug, taking it every day is 
 
 
very important to keep yourself well. The major side effect of drugs includes skin 
rashes, persistent cough with sputum, anemia makes need to be consulting with the 
medical officers. The minor side effects of the drugs can be managed by home itself 
with following the symptomatic management tips. 
S. 
No. 
Problems Suggestions When  seek medical help 
1. 
 
 
 
 
 
Head ache   Rest in a quiet and dark 
place     
 Rub the base of your head 
with fingers. 
 Take a warm bath 
 Avoid coffee ,tea , soft 
drinks and foods with 
caffeine 
 Use mild pain palms 
 Vision becomes blurry 
or unfocused. 
 Vomiting, fever with 
continuous head ache 
 A headache is 
frequent or very 
painful. 
2.  Fatigue  Get up and go to bed at the 
same time on all days 
 Sleep at least 8 hours/day 
 Do simple and regular 
exercises 
 Take balanced and 
nutritious diet at regular 
intervals. 
 Too tried to eat or 
move 
 Cannot swallow or eat 
enough to feel strong 
3. Dry Mouth 
 
 Rinse   mouth with clean 
water and salt. 
 Suck on crushed ice or sip 
clean water 
 Avoid sweets , soft drinks 
and coffees 
 The problem persists 
with red and white 
spots need medical 
advice 
4. Usual bad 
dreams  
 Do something happy and 
calm right before going to 
sleep 
 Avoid food with lot of fat 
 Avoid alcohol and 
unnecessary drug intake. 
 Cannot sleep for three 
or more nights 
5.  Anemia  Increase the foods rich in 
iron like spinach, dark leafy 
greens, and dried fruits. 
 Encourage to take egg, red 
meat, liver, fish and poultry. 
 Feeling tried for three 
to four weeks and its 
worsening. 
 Subject feet’s are 
swelling 
 
 
6. Dry Skin 
and Skin 
rashes  
 Use  soft soap for bathing 
 Use water and soap to clean 
the skin. 
 Apply coconut oil 
 Keep the nail trimmed and 
clean 
 All the clothes used by the 
subject should be washed 
with soap and dried in sun 
light. 
 Take fruits and vegetables 
adequately with food. 
 If problem persist  
with pus or blood 
 Not healed and have 
inching 
7.  Cough   Provide luke warm water 
for cough in children. 
 Mild lemon juice with salt 
or sugar in luke warm may 
also be provided to subject. 
 Mild lemon juice with 
honey &sugar in luke warm 
can also be provided. 
 Instruct the subject’s to 
keep a cloth or hand on the 
mouth when coughs. 
 Instruct the subject’s to 
avoid spitting the sputum 
on the floor. 
 When all the measures 
fail, seek medical 
advice and follow up 
care. 
 Persistent cough with 
sputum more than 3 
days.  
8.   Fever   Provide adequate water and 
fluids 
 Provide tepid sponging 
 If need use blanket for 
shivering  
 Continuous increase 
of running tempera-
ture. 
 Have shivering and 
vomiting  
9. Dizziness   Take adequate rest and 
sleep 
 Avoid lifting anything 
heavy or moving quickly. 
 Avoid driving a bicycle and 
bike 
 The dizziness lasts 
more than two days 
10. Tingling or 
pain in feet 
and hands 
 Wear loose –lifting shoes 
and socks. 
 Keep feet uncovered in 
bed. 
 Soak feet in cold water for 
some time. 
 Rub feet and hands 
 Tingling does not 
reduce and gets worse. 
 Pain so intense and 
cannot walk. 
11.   Hair loss  Protect hair from damage 
 Don’t dye, straighten or 
plait 
 Don’t buy products that 
promise to grow hair back. 
 Take balanced and 
nutritious diet 
 If more obvious consult 
with medical advice. 
 Don’t take self 
medications for hair 
growth. 
 
 
Strategies to enhance the QOL 
 More than 95 % of adherent to the ARV drugs are essential and to be considered 
as a long life commitment. 
 To eat a balanced and nutritious   diet, without too much fat, sugar or salt. 
 Plenty of fruit and vegetables to provide fibers, vitamins and minerals. 
  Avoidance of high risky behaviors includes smoking, alcohol, drug use and 
unsafe sex practice. 
 If sexually active advice for condom use and male circumcision for safer sex 
practice. 
 Getting tested and treated for sexually transmitted diseases, even if they are 
asymptomatic. 
 Avoid stressful life and do activities of   dancing, playing, walking and gardening 
can all help to get relieve from stress.  
 Try to get  adequate of rest and sleep 
 Instruct to maintain personal hygiene especially oral and hand hygiene. 
 Advice to prevent infections includes the avoidance of risky behaviors, washing 
hands well and often, and practicing good food safety to avoid food borne illness, 
and staying current on recommended vaccines. 
 Have a Little Faith - spirituality can help people better cope with their health 
problems. Religion can also help to build their social circle and feel generally 
more positive. 
 Exercise can help to build the muscles, makes bones strong, and promote us 
healthy. Some people who are living with HIV experience a loss of muscle mass 
and strength, so exercise can helps to prevent this. The practices of moderate 
exercise regularly or three to six times a week can help to improve the mood and 
as well as to improve the overall quality of life. 
  Provide hope and confidence among the caregivers and subjects 
 Provide opportunities for the subjects to socialize with peer group. 
 Provide information to the caregivers regarding the Government schemes for the 
welfare of HIV infected child. 
 Maintain good rapport with community health workers. 
 Seek medical   advice for any allergy and take medication as advised without any 
skip. 
 Treat the subjects when he/she is sick without fail. 
 Encourage the subjects get along with friends and elders respectively. 
 Encourage to maintain good psychological health  and happiness 
 Making these changes in the life will help to stay healthier longer, even with HIV. 
 
 
PART- IV 
YOGA 
 The investigator planned to demonstrate the asana and pranayama as a part of 
HIV interventional package. The first three components of HIP can be enhanced by 
the fourth components of yoga. Our intervention is more focus on to increase 
immunity, improve nutritional status and enhance quality of life of HIV infected 
adolescents. 
General Instructions 
1. Do asana in clean and well ventilated rooms.  
2. Use yoga mat or 6 feet length of bed spread on the floor. 
3. Do asana in empty stomach, or after empty the bowel and bladder.  
4. Wait for 3 hours after a heavy meal, or two hours after a light meal. 
5. Wear non-restrictive cotton clothing while practicing yoga and do not wear 
shoes or socks. 
6. Do yoga in a relaxed manner with maximum capacity.  
Asana Demonstration 
  The principle investigator teaches and demonstrates the selected asana during 
the HIV interventional package as a part of intervention. As per instruction, the HIV 
infected adolescent has to re demonstrate the asanas in presence of investigator on the 
same time. They were also given brochures for practicing the selected asanas every 
day for minimum10 to 15 minutes on their own at home. The selected asanas are,  
1. Padmasana (1-2 min) 
2. Vajrasana (1-2min) 
3. Pranayama (3 min). 
4. Trikonsana (2 -3 min) 
5. Ardhamatsyendrasana (1 minutes on each side) 
 Or  Ushtrasana (1 min) 
6. Bhujangasana (1-2  min)& 
7. Shavasana(3 -5min) 
 The procedure of doing the selected asanas and their benefits are listed in the 
following tables, 
 
 
S. 
No. 
Name of asana Procedure Benefits 
1. Padmasana  
(Lotus pose) 
 
1. First sit on the floor, with 
the legs stretched out in 
front of you and keep 
the legs together. 
2. Next, fold the right 
ankle with the right hand 
and right big toe with 
the left hand and 
followed by keep on to 
the left thigh. 
3. Similarly, fold left leg 
and place the foot firmly 
at the right upper thigh.   
4. The both heels to touch 
the lower abdomen with 
the sole turned upwards. 
5. Now interlocked with 
both legs, keep the 
spine, neck and the head 
straight. 
6. Place the hands in the 
chin mudra (i.e., thumb 
finger, and index finger 
should have to touch and 
other remaining fingers 
should be straight) over 
the thighs. 
7. Now, close the eyes and 
maintain silent for 1-2 
minutes or the vision to 
be pointed to the nose. 
8. Once completed slowly 
open the eyes and 
release the legs one by 
one come to normal 
position. If possible 
practice in alternating 
the legs. 
 
 
 
1. It relieves the 
stress, relaxes our 
mind and increases 
the concentration 
power. 
2. It improves the 
general well being 
and enhances the 
appetite. 
 
 
 
 
 
 
 
 
 
2. Vajrasana 
(Thunderbolt or Adamant 
Pose) 
 
 
 
 
 
 
Back View 1 
1. Sit with legs extended 
together the hands by 
the side of the body, 
palm resting on the 
ground, finger of the 
hands together pointing 
forward.  
2.  Fold the right leg at the 
knee level and place the 
foot under the right 
buttock and sole remain 
inside. 
3.  Similarly folding the 
left foot, places it under 
the left buttock and 
keep hands on the 
respective thighs. 
4.  Now sit straight, gaze 
in front or close the 
eyes and remain in this 
posture for 30 sec to 
1min. 
5. While returning to the 
original position bends 
little towards right side 
take out the left leg and 
extend out. 
6. Similarly extend the 
right leg and return to 
the original position. 
1. It enhances the 
blood circulation 
in the lower 
abdomen, improves 
digestion and 
relieves 
constipation. 
 
2. It relaxes the thigh 
muscles, ankles, hip 
muscles and 
strengthens the 
spine.     
 
 
Side View 1
 
 
3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pranayama  
Nadi Shodha 
Pranayama 
 (Alternative Nostril  
Breathing) 
 
1. Sit on the floor in 
Vajarana or Padmasana 
posture with spine 
straight 
2. Keep the left hand on the 
left thigh in chin mudra 
(palm up, connecting the 
thumb and index finger) 
3. In the right hand tuck the 
index finger and middle 
finger towards close the 
palm, keep the right 
thumb on right nose, ring 
finger on left nose with 
extended little finger. 
4. Breath in through the left 
nostril by closing the 
right nostril with thumb 
and followed by closing 
the left nostril, with ring 
finger breath out through 
the right nostril.  
5. Now breath in through 
right nostril, keeping the 
left nostril closed with 
the ring finger and 
followed by close the 
right nostril breathe out 
through the left nostril, It 
completes one round. 
6. Continue the pranayama 
1:2:2 ratio for 5-7 times 
in 1 minute. 
7. Repeat the pranayama for 
at least for 2-3 minutes 
8. Once it’s completed, rub 
the palms together till it 
warm, and place it on the 
face. At last slowly open 
the eyes with smile. 
1. It improves the 
lung function and 
reduces the lung 
diseases. 
 
2. It increases the 
blood circulation to 
the brain, relieves 
the stress and 
relaxes the mind. 
 
 
 
4. Trikonasana 
(Triangle Pose) 
 
1. Stand straight and keep the 
feet apart about for 3 to 4 
feet 
2. Stretch out the arms 
sideways at shoulder level 
and take normal breath for 
2-3 times 
3. Now, take a deep breath, 
then exhale slowly 
followed by, rotate the 
trunk and head together 
around to the left side 
without moving the feet. 
4. Simultaneously, bend the 
right hand and touch at the 
back of the heel; At the 
same time left arm should 
be straight; eyes to focus 
on the left hand fingers and 
ensure that, both knees to 
be straight.  
5. Hold this position as per 
the comfort or 5-10 
seconds then completes the 
exhalation and come to 
starting point. 
6.  Do the same procedure 
with the left hand. 
7. Perform this asana four to 
six times on both sides for 
2-3 minutes. 
1. It is recommended for 
the growing children   
to increase their 
height. 
 
2. It helps to expand the 
chest and efficiency 
of thymus gland, 
increase the general 
immunity. 
 
3. It improves the 
mobility of hip joint 
and neck. 
 
4. It gives proper stretch 
to spine. 
 
5. It provides energy 
and increase the 
concentration. 
 
6. It improves appetite, 
relieves constipation 
and also helps for 
digestion.  
5. Ustrasana  
(Camel pose) 
 
 
1. First sit in vajrasana and 
slowly to kneel on the floor 
and toes pointing back. 
2. Next, stretch the arms in 
straight and slightly bend 
back ward. 
3. Now, further bend 
backwards and slowly keep 
one by one of both hands 
to catch the heels and 
continue with inhalation, 
allowing rib cage to 
expand.  
 
1. It strengthens the 
back; expands the 
chest muscles and 
reduces respiratory 
problems. 
 
2. It strengthens the 
stomach muscles, 
relieves constipation 
and increases the 
appetite. 
 
 
 
 
 
4. Then press the palm of 
hands into the heels while 
draping the fingers over the 
soles and simultaneously 
contract the buttocks; 
stretch the spine still 
further keeping the neck 
forward. 
5. Remain in this posture as 
per comfort or 5-10 
seconds.  
6. While exhaling, slowly 
release the hands one by 
one and bring back to 
starting posture. 
7. Repeat this asana 2-4times 
for 1-2 minutes. 
3. It also strengthens the 
pelvic muscles and 
organs. 
6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ardha 
Matsyendrasana 
(The Half Spinal Twist). 
 
 
 
 
 
 
 
 
 
 
 
1. First sit on the floor with 
both legs extended and 
heels together. 
2. Bring the left leg under the 
right bottom and sit on a 
left heel. 
3. Next, cross the right foot 
over the left knee nearly 
close to the chest place it 
firmly on the floor; sit 
comfortably as in the 
picture. 
4. Now, Inhale and bring the 
left hand behind right knee 
and catch the left knee or if 
possible great toe  
5. While exhaling slowly, start 
to turn the head, then 
shoulders and back to the 
right side and right hand to 
catch the left lower part of 
hip. 
6. Keep spine straight and be 
sure to keep the weight of 
the body mainly on the 
spine and not on the left 
arm. 
 
1. It reduces the gastro 
intestinal and genito    
urinary problems. 
 
2. It increases appetite 
and enhances the 
digestion. 
 
3. It also strengthens the 
pelvic muscles and 
organs. 
 
4. It helps to increases 
general wellbeing of   
the individual. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. 
 
 
 
 
 
 
 
Bhujangasana 
(Cobra Pose) 
 
 
 
7. Hold this posture as per 
comfort or 5-10 seconds; 
then slowly release the legs 
to come starting posture and 
same to be done on other 
side. 
8. Do this asana 2-4times on 
both sides, for 2-3 minutes 
9. Once completed release 
your legs slowly and come 
to normal position 
 
1. First, turnover on the 
stomach, place chin on the 
floor; keeping the legs 
together and soles facing 
up. 
2. Place the hands with palms 
down, at chest level. 
3. While inhale, raise the head 
& the upper portion of the 
trunk slowly, till the navel 
portion to leave the ground.  
4. Bring the arms back to the 
last rib bone, keep it 
straight, and also close to 
the body 
5. Now, obtain as complete 
arch as possible and remain 
this position as per comfort 
or 5-10 seconds. 
6. Once completed, start to 
exhale slowly, at the same 
time lower the body to the 
floor.  
7. Relax the body and rest 
with right or left cheek on 
the floor for about 2-3 
seconds. Repeat this asana 
3- 4 times per one minute. 
 
 
 
 
 
 
 
 
 
 
 
 
1. This asana brings a 
rich blood supply to 
the spinal region, 
clears the chest and 
cures respiratory 
diseases. 
2. Energizes and 
activates the upper 
areas of the body like 
head, face, neck,  
shoulders and chest, 
and gives the youthful 
appearance. 
3. Good for troubles like 
constipation, 
indigestion and it 
increases the appetite 
and strengthens the 
hands. 
 
 
8. Shanthi asana  
(Quick relaxation 
technique) 
 
1. Lie down flat on back, i.e., 
the position of shavasana or 
the corpse pose (see the 
picture.) 
2. Keep the legs apart, heels 
facing outside, hands by the 
side of the body slightly 
away, palms facing 
upwards, eyes closed 
gently and relax the whole 
body including facial 
muscles.  
3. First, focus the mind to the 
abdominal region and feel 
the mutual expansion and 
contractions of abdomen. 
4. Now, synchronize the 
breath along with the 
abdomen movements. i.e., 
While inhaling the 
abdomen should come out, 
while exhaling abdomen go 
inside and do this practice 
for minimum of 5 rounds. 
5. By doing regular practice, 
the inhalation makes whole 
body to get energized with 
positive energies where as 
exhalation, feel the toxins 
and negative energies go 
out of the body. 
6. After completion of above 
steps, slowly move the toes 
and bring the legs together 
followed by move the 
fingers and bring the hands 
close to the body. Now 
move the head to left and 
right slowly.  
1. It helps to maintain 
the blood 
circulation 
throughout the 
body. 
2. It relieves the 
stress and relaxes 
our mind 
especially 
abdominal 
muscles. 
 
 
 
7. Next fold the leg, turn to 
right and with the support 
of the left hand, and slowly 
get up and sit in 
comfortable position. 
8. Rub the palms briskly to 
generate enough heat, make 
a cup shape and transfer the 
heat to the eye balls and 
massage the whole face 
gently. 
9. Now open the eyes and 
complete this cycle within 
3-5 minutes. 
 
Once completed the asana, drink water or any liquids after 5-10 minutes. At 
every month visit, the investigator should assess and reinforce the HIV infected 
adolescents to practice the asana regularly in their life and maintain the dairy after the 
practice of yoga and after the intake of drug every day. 
             Annexure – iv (a) 
INFORMATION SHEET 
 I Mrs.S.Rajathi Ph.D Scholar, The Tamilnadu Dr.M.G.R Medical University, 
conducting a study on “Impact of Nurse Initiated HIV Interventional Package 
(HIP) on HIV Infected Adolescents Attending ART clinic: A Randomized 
Controlled Trial” for that your participation may be valuable to me.  
The purpose of the study is to assess effectiveness of HIV interventional 
package; it includes the adherence level, nutritional status, educational strategies to 
improve the quality of life and yoga. The planned duration of participation 
involvement is up to 6 months. 
I am selecting the adolescents for my study from this ART centre and if you 
are found eligible can agree to participate in this study. The investigator plan to 
implement the nursing interventions like ART adherence counseling, Nutritional 
counseling, educational strategies to improve the quality of life and as well as the 
demonstration of  the selected asana to the HIV infected adolescents in order to 
improve their overall health and it will not affect your regular ART treatment.  The 
expected benefits from the interventions are to increase the immune power, to build 
the muscle strength, improve energy, and reduce stress and to promote the quality of 
life of HIV/AIDS infected adolescents. There is no risk associated with this study. 
The privacy of the adolescent in the research will be maintained throughout 
the study. In the event of any publication or presentation resulting from the research, 
no personally identifiable information will be shared and prior permission will be 
getting from TANSAC. 
Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will not result in 
any loss of benefits to which you are otherwise entitled.  
The results of the study may be intimated to you at the end of the study period 
and during the study if anything is found abnormal which may aid in the management. 
Caregiver’s Name:   Signature:    Date: 
Investigator’s Name:  Signature:    Date: 
Phone No: 91766 42487 
Annexure iv(a)
Ma;T gq;Nfw;ghsh;fSf;fhd jfty; jhs;
R. uh[hj;jp Mfpa ehd;> lhf;lh; vk;.[p. Mh; kUj;Jt gy;fiyf;foj;jpy;
vr;.[.tp  Nehapdhy; ghjpf;fg;gl;Ls;s tsh; ,sk; gUtf; Foe;ijapd; Mz;b
nul;Nuhituy; rpfpr;irapy; epiyj;jpUj;jy;> czT+l;lj;jpd; epiyik>
tho;f;if juk; kw;Wk; Nahfhtpd; ed;ik gw;wpa Ma;it Nkw;nfhs;fpNwd;.
,jw;F cq;fSila gq;Nfw;ghdJ kpf Kf;fpakhdjhFk;.
,e;j Muha;r;rpapy; gq;Nfw;gjd; %yk; cq;fs; tsh; ,sk; gUtf;
Foe;ijapd; Neha; njhw;W FiwAk; jd;ik> czT+l;lj;jpd; epiyik kw;Wk;
tho;f;ifj; juj;ij cah;j;j KbAk;. Nahfh ,k;%d;W epiyfisr;
rPh;g;gLj;Jtjw;F cjTk; kpf Kf;fpakhd clw;gapw;rpahFk;. ,t;thuha;r;rpapd;
gq;Nfw;G fhyk; 6 khjkhFk;.
ePq;fs; jUk; midj;J jfty;fSk; ufrpakhf ghJfhf;fg;gLk;.
,j;jfty;fs; midj;Jk; ,e;j Muha;r;rpf;Fj; jtpu NtW vjw;Fk; gad;gLj;j
Nghtjpy;iy. ,t;thua;r;rpapy; ePq;fs; gq;Nfw;gjpy; kpFe;j kfpo;r;rp. ePq;fs;
vg;NghJ Ntz;LkhdhYk; ,e;j Muha;r;rpapy; ,Ue;J tpyfpf; nfhs;syhk;.
,jdhy; ,e;j kUj;JkidapypUe;J ePq;fs; ngwg;gLk; kUe;Jfs; / kUj;Jt
guhkhpg;GfspYk; ve;j FiwAk; Vw;glhJ. ,e;j Muha;r;rp Kbe;jTld; ePq;fs;
tpUk;gpdhy;> ,e;j KbTfs; cq;fSld; gfph;e;J nfhs;sg;gLk;. ,j;jfty;
,jOld; ,izj;Js;s xg;Gjy; gbtj;jpid ifnaOj;jpl;L ,e;j
Muha;r;rpapy; ePq;fs; gq;Nfw;fyhk;.
xg;Gjy; toq;Fgthpd; ngah;:  ifnahg;gk;   Njjp
Ma;thshpd; ngah; :    ifnahg;gk;   Njjp
njhiyNgrp vz;. 9176642487.
         Annexure – iv (b) 
INFORMED CONSENT FORM 
 I __________________ have read / heard the information in this form I was free to 
ask any questions and they have been answered. I am Father/Mother/Caregiver, hereby give 
my consent to be including my daughter/son___________________as a participant in 
“Impact of Nurse Initiated HIV Interventional Package (HIP) on HIV Infected 
Adolescents Attending ART Clinic: A Randomized Controlled Trial” 
1. I have read and understood this consent form and the information provided to me.  
2. I have been explained about the nature of the study. 
3. I have been informed about all the interventions pertaining to the study. 
4. I have been advised about the benefits / risks associated with participation in this 
study 
5. I agree to cooperate with the investigator and I will inform him/her immediately if 
my daughter/son suffers unusual symptoms. 
6. I am aware of the fact that I can opt out of the study at any time without  giving any 
reason and this will not affect my daughter/son future treatment. 
7. I am also aware that the investigator may terminate my daughter/son participation in 
the study at any time, for any reason, without my consent. 
8. I hereby give permission to the investigators to release the information obtained from 
my daughter/son as the result of the participation in this study to the regulatory 
authorities and Government agencies. 
9. I have understood that my daughter/son identity will be kept confidential if data are 
publicly presented. 
10. I have got satisfied answers for all my questions. 
11. I have decided that I will permit my daughter/son to be a participant in the research 
study. 
 I am aware that if my daughter/son may have any question during this study, I can 
contact the investigator. By signing this consent form I attest that the information given in this 
document has been clearly explained to me and understood by me, I will be given a copy of 
this consent document.  
Caregiver’s Name:   Signature:    Date: 
Investigator’s Name:   Signature:    Date: 
Phone No: 91766 42487. 
Annexure iv (b)
Ra xg;Gjy; gbTk;
ehd;    Ma;Tj; jfty; jhspYs;s Ma;T Fwpj;J
nfhLf;fg;gl;l jftiyg; gbj;J / Nfl;Lj; njhpe;J nfhz;Nld;. vdf;F Nfs;tp Nfl;gjw;F
KO Rje;jpuKk; mspf;fg;gl;lJ. ehd; je;ij / jha; / ghJfhtyh; Mfpa vdJ kfd; / kfs;
    vr;.[.tp Nehapdhy; ghjpf;fg;gl;Ls;s tsh; ,sk; gUtf; Foe;ijapd;
$l;L kUe;J rpfpr;irapy; epiyj;jpUj;jy;> czT+l;lj;jpd; epiyik> tho;f;if juk; kw;Wk;
Nahfhtpd; ed;ik gw;wpa  ,e;j Ma;tpy; gq;Nfw;ghsuhf gq;Fngw KO kdJld; rk;kjk;
mspf;fpNwd;.
1. ehd; Ma;Tj;jfty; jhs; kw;Wk; Ra xg;Gjy; gbtj;jpy; cs;s Ma;T Fwpj;j
jfty;fisg; gbj;Njd;.
2. vdf;F Ma;T Fwpj;J KO tpsf;fKk; mspf;fg;gl;lJ.
3. vdJ chpikfSk; nghWg;GfSk; Fwpj;J Muha;r;rpahsh; tpsf;fpdhh;.
4. vdf;F mspf;fg;gLk; rpfpr;ir Kiw Fwpj;Jk; mjd; tpisTfs; Fwpj;Jk; KO
tpsf;fKk; mspf;fg;gl;lJ.
5. ehd; kfd;/ kfSf;F VNjDk; Ntz;lhj mwpFwpfs; njhpe;jhy; clNd
Muha;r;rpahsUf;Fj; njhptpg;Ngd;.
6. ehd; ,e;j Ma;tpy; vd; kfis / kfid gpwh; eph;ge;jkpd;wp vd; nrhe;j tpUg;gj;jpd;
Nghpy; jhd; gq;Fg; ngwr; rk;kjk; mspf;fpNwd;.
7. vd; kfd; / kfis ,e;j Ma;tpypUe;J ve;NeuKk; gpd;thq;fyhk; vd;gijAk; mjdhy;
ve;j ghjpg;Gk; Vw;glhJ vd;gijAk; ehd; Ghpe;J nfhz;Nld;.
8. ,e;j Ma;tpypUe;J vd; kfs; / kfd; ve;j NeuKk; Muha;r;rpahsh; vd;Dila rk;kjk;
,y;yhkNyNa tpyf;fyhk; vd;gijAk; njhpe;Jf; nfhz;Nld;.
9. ehd; ,e;j Ma;tpd; KbTfis ntspapl rk;kjpf;fpNwd;. Mdhy; vd;Dila
milashk; ,ufrpakhf ghJfhf;fg;gLk; vd;gijAk; njhpe;Jf; nfhz;Nld;.
10. vdJ midj;J Nfs;tpfSf;Fk; jpUg;jpfukhd gjpy;fSk; mspf;fg;gl;lJ.
11. vd; kfd; / kfs; ,e;j Ma;tpy; fye;Jf; nfhs;s rk;kjk; njhptpf;fpNwd;. vdf;F
Ma;T  elf;Fk; NghJ Nfs;tp Nfl;Fk; chpik cs;sJ vd;gijAk; njhpe;J
nfhz;Nld;.
 ehd; RaepidNthL ,e;j Ma;tpy; vd; kfd; / kfs; gq;F ngw rk;kjk; njhptpj;J
,e;j Ra xg;Gjy; gbtj;jpy; ifnahg;gkpLfpNwd; kw;Wk; Ra xg;Gjy; gbtk; kw;Wk; Ma;Tj;jfty;
jhspd; efiyAk; ngw;Wf; nfhz;Nld;.
xg;Gjy; toq;Fgthpd; ngah;:   ifnahg;gk;   Njjp
Ma;thshpd;  ngah;  :     ifnahg;gk;    Njjp
njhiyNgrp vz;. 9176642487.
                               Annexure – iv (c) 
ASSENT FORM 
 You are invited to be part of the research study titled as, “Evaluate the 
adherence level of ART and its barriers, CD4 count, nutrition and quality of life 
(QOL) of the HIV infected adolescents”. Adolescence is viewed as a transitional 
period between the childhoods to the adulthood. It is a period of multiple transitions 
involving education, training and employment makes to be increase their QOL. But 
the chronic disease of HIV makes the HIV infected adolescents to shunt the growth 
and frequent to get the infections lead to worsen their QOL. Because of this reason, 
the investigator decided to give counseling regarding benefits of the optimal 
adherence to ART medications and how to overcome barriers, importance of nutrition 
and inclusion of food items, as well as how to reduce the infections and its 
management. 
 Apart from this, the investigator plans to teach and demonstrate our traditional 
practice of selected asanas (yoga) and instructed to follow a diary as remainder cue 
for after the intake the drug and yoga practice to the HIV infected adolescents. These 
asanas are very helpful to improve the immunity, physical growth and enhance the 
QOL of the HIV infected adolescents. The counseling components of adherence 
improvement, nutrition and QOL can be enhanced by the fourth component of this 
yoga. So, in order to evaluate the effectiveness the investigator divide the adolescents 
into two (experimental and control) groups.  
The experimental group will receive the counseling from hospitals and as well 
as the investigator counseling and yoga practice where as the control group only will 
receive the hospital management. The planned duration of participation involvement 
is up to 6 months.  During this period, the investigator used to identify the nutritional 
status through anthropometric measurements and collect the information regarding 
adherence level &QOL through standardized questionnaire from both the groups. The 
investigator explained to me regarding of the benefits of the research can be evaluated 
at the 3
rd
 and 6
th
 month intervals.  So, the control group also will receive the cursory 
instructions of investigator counseling and demonstration of asana at the end of the 
research period.     
 In regard to this research, your answers will be kept confidential and identity 
will not be revealed. I would be happy if you could take part in this research. I assure 
you that you will not be harmed in any way throughout the research. There is no 
compulsion. You can withdraw from the research at anytime. You will continue to 
receive the routine care and medication will be given as per the hospital protocol. You 
have the rights to ask any questions and will get the answers from investigators 
regarding study at any time. Here with I am signing this form and give consent to 
participate in the study as in ………………. group. 
 
Adolescent’s Name:    Signature:  Date: 
 
Caregiver’s Name:    Signature:  Date: 
 
Investigator’s Name:   Signature:  Date: 
Phone no: 91766 42487 
Annexure iv(c)
xg;Gjy; gbtk;
vr;.I.tp. Nehapdhy; ghjpf;fg;gl;Ls;s tsh; ,sk; ;gUtf; Foe;ijfSf;fhd
$l;L kUe;J rpfpr;irapy; epiyj;jpUf;Fk; nghOJ Vw;gLk; khw;wk; kw;Wk; mij
njhlu Kbahky; Vw;gLk; gpur;rpidfs;> rpb4 mZf;fspd; vz;zpf;if>
czT+l;lj;jpd; epiyik kw;Wk; tho;f;if juk; gw;wpa Ma;tpy; ePq;fs; xU mq;fkhf
,Uf;Fk;gb cq;fisf; Nfl;Lf; nfhs;fpNwd;.
 tsh; ,sk; gUtk; vd;gJ Foe;ij gUtj;jpw;Fk; kw;Wk; ,sik gUtj;jpw;Fk;
,ilapyhdJ. ,e;j gUtj;jpy; fw;Fk; fy;tp> jpwikfs; kw;Wk; Ntiy nra;Ak; jpwd;
Mfpaitfs; jhd; ,th;fspd; tho;f;ifj; juj;ij cah;j;JfpwJ. Mdhy; ,e;j
vr;.I.tp. Nehapdhy; ghjpf;fg;gl;Ls;s ,f;Foe;ijfs; cly; tsh;r;rpapy; gpd; jq;fpAk;
mbf;fb re;jh;g;gthj NehapfspdhYk; ghjpf;fg;gl;Ls;sdh;. ,jdhy; ,th;fspd;
tho;f;ifj; juk; KOtJkhf ghjpf;fg;gLfpwJ. ,jdhy; ePq;fs; $l;L kUe;Jfisr;
rhpahd Neuj;jpy; vLj;J nfhs;Stjpd; ed;ikfisAk;> mjw;Nfw;wthW czTfis
cl;nfhs;StJ gw;wpAk;> vr;.I.tp. Neha; rhh;e;j gpw gpur;rpidfis vt;thW jtph;g;gJ
vd;gijAk;> kUe;Jfis cl;nfhz;l gpwF ifNaL gad;gLj;Jk; Kiwfisg; gw;wpa
MNyhridfis cq;fSf;F ju ,Uf;fpNwd;.
 ,J kl;Lkpd;wp ,d;W rh;tNjr mstpy; nfhz;lhlg;gLk; ekJ ghuk;ghpa
fiyahd rpy Mrdq;fisAk; (Nahfh) cq;fSf;F fw;Wj;ju ,Uf;fpNwd;. ,e;j
Mrdq;fs; midj;Jk; cq;fs; clypd; Neha; vjph;g;Grf;jp> cly; tsh;r;rp kw;Wk;
tho;f;if juj;ij cah;j;Jk;. ,e;j Muha;r;rpapy; gq;Nfw;gjpd; %yk; cq;fspd; Neha;
njhw;W FiwAk; jd;ik> czT+l;lj;jpd; epiyik kw;Wk; tho;f;ifjuj;ij cah;j;j
KbAk;. Nahfh ,k;%d;W epiyfisr; rPh;g;gLj;Jtjw;F cjTk; kpf Kf;fpakhd
clw;gapw;rpahFk;. ,e;j Ma;tpd; gyd;fis fz;lwptjw;fhf Ma;thsh; Mfpa ehd;
tsh; ,sk;; gUtf; Foe;ijfis ,U FOf;fshf (Nrhjid FO kw;Wk; fl;Lg;ghl;L
FO) gphpj;J fl;Lg;ghl;L FOtpw;F kUj;JkidapypUe;J ngwg;gLk; MNyhridfis
kl;Lk; ikakhf itj;Jk; kw;Wk; Nrhjid FOtpw;F kUj;JtkidapypUe;J
ngwg;gLk; MNyhridfSld; Ma;thshpd; MNyhridAk; kw;Wk; Nahfh gapw;rpAk;
fw;Wj; jutpUf;fpNwd;. ,e;j Muha;r;rpapd; gq;Nfw;g;G fhyk; 6 khjkhFk;.
,f;fhyfl;lj;jpy; Ma;thsh; cq;fSila $l;L kUe;Jfspd; epiwik rjtPjk;>
cly;tsh;r;rp kw;Wk; tho;f;if juj;ij fzf;fpl cjTk; Fwpg;gpl;l Nfs;tpfis
Ma;tpy; 3 kw;Wk; 6tJ khjj;jpy; cq;fsplk; Nfl;ghh;. mjw;F ePq;fs; jUk; gjpy;fs;
kw;Wk; cq;fSila milahsKk;  ufrpakhf ghJfhf;fg;gLk;.
 NkYk; ,e;j Ma;tpd; KbTfis itj;J jhd; Muha;r;rpfspd; gyd;fis
Ma;thsh; cWjp nra;a KbAk; vd;gijAk; njhpe;Jf; nfhz;Nld;. ,jdhy; fl;Lghl;L
FOtpw;F Ma;tpd; Kbtpy; Ma;thsh; Nahfh gapw;rpAld; MNyhridfis nrhy;yp
jUthh; vd;gijAk; njhpe;Jf;nfhz;Nld;. ePq;fs; tpUk;ghtpl;lhy;> ,e;j Ma;tpypUe;J
vg;nghOJ Ntz;LkhdhYk; tpyfpf; nfhs;syhk;. ,jdhy; ,e;j
kUj;JtkidapypUe;J ePq;fs; ngwg;gLk; kUe;Jfs; kw;Wk; kUj;Jt guhkhpg;GfspYk;
ve;j FiwAk; Vw;glhJ. ePq;fs; Nfl;Fk; Ma;T njhlh;Gila midj;J Nfs;tpfSf;Fk;
jFe;j tpsf;fk; mspf;fg;gLk; vd;gijAk; njhpe;J nfhz;Nld;. ,jdhy; tsh;,sk;
Foe;ijahfpa ehd; ,e;j Ma;tpy;                                          FOtpy;   ,Uf;f
rk;kjk;   njhptpj;J Muha;r;rpapy; gq;Nfw;gjw;F xg;Gf; nfhs;fpNwd;.
Foe;ijapd; ngah; :     ifnahg;gk;   Njjp
xg;Gjy; toq;Fgthpd; ngah;:   ifnahg;gk;   Njjp
Ma;thshpd;  ngah;  :     ifnahg;gk;    Njjp
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ABSTRACT 
The Acquired Immuno Deficiency Syndrome (AIDS) considered to be great deal 
of courage to face the disease that seems to have no cure as yet. Many of the 
people living with HIV (PLHIV), have the intense feelings of hopelessness, 
loneliness, fear, anxiety and depression. The Highly Active Anti Retroviral 
Therapy (HAART) has effectively reduced HIV related morbidity and mortality 
for PLHIV. Even they are living longer with ART, but significant side-effects like 
anorexia, nausea, vomiting, fatigue and stress related problems are 
unavoidable. The National Institute of Health and World Health Organization 
recommends that, yoga makes to minimize the side effects of ART and stress 
related problems of PLHIV. Among many branches of yoga, Hatha yoga 
enhances the capacity of the physical body through the use of series body 
postures, movements (Asanas) and breathing techniques (Pranayama). It’s a 
form of mind-body fitness that involves the combination of muscular activity 
and an internally focus on the mind for awareness of the self, breath and energy 
aids to boost immunity and relax the mind. Many research studies supported 
that, this behavior modification of yoga is potentially safe, effective and this 
low-cost management help to ‘detoxify’ the body, mitigate chronic fatigue, 
enhance endurance, improve organ and immune functions makes to enhance 
overall well being and quality of life of PLHIV. 
INTRODUCTION 
 Globally, an estimated 35 million people are 
living with Human Immunodeficiency Virus (HIV) is a 
hazardous entity to human beings. In the account of 2.5 
million people living with HIV and AIDS (PLHIV) in India. 
Only Anti-retro viral therapies have brought renewed 
hope for many of the people living with HIV.[1] But the 
ART adherence rate and the life expectancy or quality of 
life improvement in PLHIV is affected due to the negative 
lifestyle such as addictions, intake of unhealthy foods and 
sedentary lifestyle such as behavioral problems like 
anxiety, phobia etc., By altering the lifestyle and 
behavioral changes, the life expectancy of PLHIV can be 
improved.[2] In western world, now yoga regarded as a 
holistic approach for health. The National Institute of 
Health is classified Yoga as a form of Complementary and 
Alternative Medicine (CAM) for HIV/AIDS. Recent 
surveys estimate that 47–74% of HIV infected 
individuals in the United States have used some form of 
alternative/complementary therapy to improve general 
health and well being[3]. Yoga has a important role to play 
in the rehabilitative efforts for many people living with 
HIV/AIDS[4] 
WHAT IS YOGA? 
The yoga, is derived from Sanskrit word “yuj” 
means “to control” or “to yoke” and is often termed as 
“uniting” or a method of discipline. The Indian sage 
Patanjali have ellaborated the practice of yoga into the 
Yoga Sutra an estimated 2,000 years ago. He outlines the 
eight limbs of yoga (Ashtanga Yoga). They are Yama 
(universal ethics), Niyama (individual ethics), Asana 
(physical postures), Pranayama (breath control), 
Pratyahara (strengthening senses), Dharana 
(concentration), Dyana (meditation), and Samadhi (self 
realization). 
  Among these eight limbs, today many people 
practicing third and fourth limb of Ashtanga yoga. The 
word “asana” refers to pose or posture, its helps to 
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increase stamina, physical power and as well as designed 
to purify the body. The Asanas are aids to open the many 
channels of the body especially the spine, so that energy 
flow in our body to go freely. Its increase concentration 
of our breath (Prana), which helps us to connect the 
body-mind.[5] 
THE MIND - BODY CONNECTION 
  Asana and Prana are important concepts in the 
Hatha Yoga. The word Hatha means wilful or forceful. 
Hatha yoga is a kind of physical exercises, and series of 
asana, aids to align our skin, muscles, and bones. The 
word Hatha is derived from two roots - ha means ‘sun’ – 
has masculine aspects of hot, active and tha means 
“moon” – has feminine aspects of cool and receptive. The 
two energies of ‘Ha’ and ‘Tha’ make us to get powerful 
tool for self-transformation. The thoughtful feature of 
yoga is regularly achieved through an individual's 
intellectual focus of the asana and Prana.[6] 
Yoga is unique because it connect the movement 
of the body and the fluctuations of the mind to the 
rhythm of our breath. The relation between mind, body, 
and breath helps us to sharp our concentration inward. 
Through this process of hidden attention, learn to be 
aware of our habitual thought patterns without tagging 
them, judging them, or annoying to change them. The 
aware of experiences from moment to moment cultivate 
through a daily practice of yoga, makes a task or a goal to 
be completed.[7] 
HIV AND YOGA 
  Yoga is an ideal exercise for people with HIV. 
Yoga consists of three parts: exercise, breathing, and 
meditation. The yoga exercises are easy movements that 
extend and toughen the nervous system, main muscle 
groups, compress on glands and organs to motivate the 
hormonal system, to progress circulation in body. It’s 
makes our brain and all vital organs receive oxygenated 
blood and nutrients. A habitual perform of a yoga 
exercises will increase our energy levels and feelings of 
happiness. The breathing exercises are most excellent 
tool for handle with stress and anxiety. By concentrating 
simply on the movements of the breath, build 
concentration, willpower, and the ability to reduce the 
hurtful possessions of a stress reaction. The different 
methods of breathing exercises increase the system to all 
the respiratory muscles and improve vital capacity. 
There's been ample research showing that both yoga and 
meditation elicit the relaxation response, regulates 
breath, heart rate and improves immunity power.[8] 
   Jon Kaiser (1998) said that, “Healing comes 
from inside”. He strongly recommends that PLHIV take 
time to practice deep relaxation daily. Yoga makes to 
relieves stress, peace the mind, and regulates breathing 
and circulation. A regular practice can aid to sustain the 
immune system in concurrence with a comprehensive 
HIV management program.[9] Chapel Hill (2008) reported 
that stress significantly increases the hazard of HIV will 
progress to AIDS.[10] Steve Cole (2010) said that HIV is an 
tremendously stressful disease equally during the period 
of adjusting as well as living with it and because of the 
medications side effects. HIV spread more rapidly in 
presence of nor-epinephrine (stress hormone) in the 
body, make ‘T’ cells more vulnerable to attack and can 
increase the HIV rate of the reproduction 10 fold. And 
also he found that, ARV medications are less effective in 
people with high levels of nor epinephrine and people 
with HIV face treatment options that can range from 
uncomfortable (including sleeplessness and nausea) to 
dangerous (for example, increased risk of heart attack). 
"That's why behavioral interventions, like yoga and 
meditation, are so important," for PLHIV.[11] 
   Misha Cohen (2010) reported that, Yoga is 
superb tool for the stress decline when done 
appropriately,” it can help to relieve various symptoms, 
as well as the ARV medications side effects, including the 
digestive problems and the joints pain. “A regular yoga 
practice is a simple way to achieve the good strength, 
boost the immune system and enhance circulation 
always”.[12] Joseph and Nair (2015) evaluated the effect 
of naturopathy and yoga intervention on CD4 counts of 
HIV/AIDS patients. He observed that, an increasing trend 
in the CD4 count was proportional to the participants 
following yoga intervention. This indicates the possibility 
of lifestyle changes can bring positive outcomes in people 
living with HIV/AIDS.[13]  
  Naoroibam and Metri (2016) identified through 
the randomized control trial, One month practice of 
Integrated Yoga practice (Asana, Pranyama and 
relaxation technique) may reduce depression and 
improve immunity in HIV-1 infected individuals in 
experimental group when compare to the control 
group.[14] 
  HIV/AIDS makes a grand deal to face a disease 
that seems to have no heal as yet. The most people with 
HIV experience extreme feelings of despair, loneliness, 
fear, anxiety, and depression. Yoga cannot replace the 
professional counselling in connection with major grief, 
but yoga techniques can help to ease extreme fear and 
anxiety, gain knowledge of stress-coping skills, and 
fabricate the internal strength through the relaxation and 
self-awareness exercise of the meditation. Yoga helps to 
train the most of the physical capabilities, a slow-paced 
version that can emphasis for extends of flexibility and 
breathing techniques that helps in relaxation.[15] 
The goal of yoga for HIV/AIDS is to 
 Strengthens the immune system. 
Diminish the Opportunistic infections 
 Improves nutritional status. 
 Provides relief from symptoms and drug side effects.  
 Improve quality of life and increase the life span.  
 Possibly reduces transmission of HIV to others in 
future. [16] 
RECOMMENAND ASANA AND ITS MECHANISM 
  Yoga has many amazing effects of PLHIV, leading 
to greater levels of physical fitness, improves immunity, 
lower levels of stress and a greater sense of inner peace. 
Worldwide, it is estimated that yoga is regularly 
practiced by about 30 million people. The Yoga vidya 
Gurukul University, Washington University and many 
research institutions recommends that these following 
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Asanas are beneficial for PLHIV. Depending upon the 
advice of a doctor, yoga techniques for HIV and AIDS are 
viable option. [17-22] 
1. Yoga keeps the body clean, flexible and well balanced 
by decreasing the catabolic process of cell 
deterioration. 
2. Asana Safely stretches the muscles, release the lactic 
acid that builds up the muscle use and increase the 
range of motion in the joints. Ex- Vriksasana (Tree 
Pose) and Sun Salutations. 
3. Forward pose: Associated with Chest compression, 
exhalation and induces relaxation. It redirects the 
blood, energy flow to thymus its helps to regulate, 
control the ‘T’ cells and produces the hormones 
thymosins. Thymosins regulate white blood cells, 
particularly T-cells, control other hormones. Ex- 
Trikonasana (Trianglepose), Vajrasana (Thunderbolt 
Pose), Yoga mudra, Paschimottasana (sitting 
forward), Uttanasana (Standing Forward Bend), 
Ardha Uttanasana (Standing Half Forward). 
4. Back Bend pose: It stretches abdominal muscles, 
tone and strengthen the muscles in Controlling 
spine, open up the chest, improve performance of the 
thymus gland and increase the immunity. e.g. 
Bhujansansa (Cobrapose), Ushtrasana (Camel pose) 
Matsyasana (Fish pose) Supta Baddha 
Konasana (Reclining Bound Angle Pose). Setu 
Bandha Sarvangasana (Supported Bridge Pose), 
Supta Virasana (Reclining Hero Pose) and Viparita 
Karani (Legs-up-the-Wall Pose). 
5. Spinal Twisting Asana: The twist stimulates the 
spinal nerves and makes the spinal column more 
flexible. The whole trunk exercises enhance 
circulation in spine and strongly influence the 
abdominal muscles. e.g. Vakrasana, Ardha 
matyendrasana (Half spinal twist pose). 
6. Inverted Asana: Encourage the rich supply of blood 
to flow to the brain, nourishing the neurons and rush 
out toxins. The accumulated blood and lymph, in 
lower limbs and abdomen are again go back to the 
heart and then purified by the lungs and re-
circulated to whole parts of the body. E.g. Sirsasana 
(Headstand), Sarvangasana (Shoulder stand) 
Halasana (Plow Pose) and Pincha mayurasana 
(Feathered Peacock Pose). 
7. Relaxation pose: Stress suppress levels of the 
infection fighting cells and immunity boosting 
gamma interferon in the blood. The yoga inhibits the 
release of stress hormone (nor-epinephrine, 
cortisol) and increase the relaxation efforts by 
stimulation of good chemicals such as serotonin and 
cytokines. e.g. Sukhasana (Simple cross leg pose), 
Padmasana (lotus pose), Tadagasana (pond pose), 
Makrasana (Corcodile pose) Shanthiasana (corpose 
pose) includes Instant relaxation technique (IRT), 
Quick relaxation technique (QRT), and Deep 
relaxation Technique (DRT).  
8. Pranayama: Prana begins to store the energy, 
allowing toxins to be released and removed. It 
directs the movements of inspiration, expiration and 
the retention of vital energy. Yogic breathing of 
Pranayama, is a unique method for balancing the 
autonomic nervous system and influencing 
psychological and stress-related disorders. 
Sudarshan kriya yoga (SKY) is a type of cyclical 
controlled breathing practice that provides relief for 
depression and favourable effects on the mind-body 
system. The Nadi sodhana pranayama (Alternate 
nostril breathing) reduces the stress level has 
soothing result on the nervous system. The absolute 
yogic respiration of abdominal, thoracic, and 
clavicular methods, increase the vital capacity of 
lungs. Fluctuations of mind can be minimized 
by practices like Trataka (concentration on a point 
or object) When practice Pranayama sit in 
Sukhasana, Padmasana, or Vajrasana posture and 
better to close the eyes, helps to increase the 
concentration and relax the mind. 
  The goals of yoga will be achieved more in 
adolescent age when compare to other age groups living 
with HIV/AIDS. Anitha Menon et al., (2013) and many 
research studies are found that adolescents are the most 
vulnerable group to get and spread HIV/AIDS in the 
community. About 31% of HIV prevalence in India is 
among the adolescent between age group of 10- 24years. 
The regular practice of yoga will promote the health, to 
develop positive attitudes and health practices, improve 
self confidence of adolescents living with HIV /AIDS 
which prevents HIV transmission in future. [23] 
BENEFITS OF ASANAS [24,25] 
 Physical 
 Improves body flexibility and balance 
 Increase the cardiovascular endurance (stronger 
heart) 
 Ease the digestion power 
 Enhance the overall muscular strength 
 Relaxation of the muscular strains 
 Progress the respiratory functions  
 Increase the energy levels 
 To develop good sleep patterns 
 To boost immune system 
 Mental 
 Relieves the stress resulting from the control of 
emotions 
 Prevents and relieves from stress-related 
disorders 
 Intellectual enhancement, leading to improved 
decision-making skills 
 Spiritual 
 Life with meaning, purpose, and direction 
 Inner peace and tranquillity 
 Contentment 
CONCLUSION 
  Anti-retro viral therapies have brought 
rehabilitated trust for many of the people living with HIV. 
However, they do not offer cure, and they can cause 
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many side effects and other non adherence reasons, 
more than 70% of HIV-positive people have turned 
to alternative medicine for help along with HARRT 
regimen. Now Over all yoga, acts both as curative and 
preventive therapy for the minor ailments in PLHIV. In 
fact many researchers have reported that, reducing 
stress appears to be a key asset for supporting people 
with HIV virus. Today yoga has become popularity in 
therapeutic practice; nearly stress reduction in people 
with HIV can contributes longevity and improves health. 
Regular yoga practices along with adherence to HARRT 
regimen leads to enhance overall well being with less 
burden to the society for PLHIV. 
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A R T I C L E  I N F O            A B S T R A C T
HIV infection presents one of the most laborious complications to humans
worldwide. The one of the co-factors involved in development of AIDS is
prominent levels of reactive oxygen species (ROS), as the deferred reaction
by the immune system may be due to a primary reduction of antioxidants.
The antioxidants are substances that restrain oxidation and sentinel the body
from the detrimental effects of free radicals which play a vital role in scavenging
excess ROS to sustain normal physiological conditions. The optimization of
anti oxidants in diet, including nutrients and other bio-active food components,
are needed to contribute to strengthen immune system. The success of
antiretroviral therapy has forced reconsideration of alternative therapies, such
as antioxidants in diet. People with HIV+/AIDS are needed a nutritional
counseling for  including antioxidants in their diet, and education about life
style changes should be beneficial to the quality and extension of life in AIDS.
Introduction
 According to National AIDS Control Organization (2014),
India has the third largest HIV epidemic in the world. The
prevalence of HIV in India is an estimated 0.31% its equals
to 2.1million. The most four high prevalence states of
South India account for 57% of all HIV infections, includes
Andhra Pradesh, Maharashtra, Karnataka & Tamil Nadu.
The estimated age distribution of HIV infection is 4.4%
among the children below 15 years, 82.4% among adults
aged 15 to 49 years & the remaining 13.2% over 50 years
and also by sex approximately 61% for male and 39% in
female. After the arrival of HARRT, now India’s overall
HIV epidemic is slowing down between 2000 to 2013, the
57% decline in new HIV infections, and 29 % in AIDS-
related deaths [1].
Antioxidants and Free Radicals
Anti oxidants are the vitamins, minerals and enzymes
which protect and repair our cells from damage made by
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free radicals. Free Radicals are unstable molecules that
respond with vital molecules of our body, including DNA,
fat and proteins. The electron deficient of free radicals
(oxidants) are formed by result of all metabolic activity
and by environmental stressors, such as pollution,
smoking, pesticides and radiation. Generally, free radical
production is counter balanced by our own defense
mechanism that includes both enzymatic and non-
enzymatic antioxidants. When the natural stability
between oxidants and antioxidants inside the body is
distressed via antioxidant deficit or increased ROS
(Reactive Oxygen Spices) production result in Oxidative
Stress (OS)[2].
HIV: An Oxidative Role
HIV associated with substantial oxidative stress and
reactive oxygen species participate in the progression of
HIV to AIDS.  Oxidative Stress following HIV- infection
depletes CD4+ T-cell count through apoptosis, and also
enhancing HIV replication and transcription. At earlier
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Sl. 
No 
Name of 
Antioxidants 
Action Sources Benefits 
1. Gluthathione It interfere’s with HIV’s 
entry into CD4 cells. 
Asparagus, avocado, grapefruit, 
squash, potato, cantaloupe, peach, 
zucchini, spinach, broccoli, 
watermelon, strawberries,       
whey proteins Fish, meat, 
Compromise T-cell 
function and decrease 
the survival of Virus. 
2. N-Acetyl 
Cysteine 
Reinstates gluthathione  
levels  
Animal proteins have higher in 
sulfur amino acids of cysteine 
than vegetable proteins.( beans 
and grains) 
Improve T-cell counts, 
and reduce  the viral 
load 
3. Vitamin C Increase the production of 
infection fighting white 
blood cells,    antibodies, 
and interferon , 
 Citrus fruits, green peppers, 
broccoli, green leafy vegetables, 
strawberries, raw cabbage, 
tomatoes and  sweet potatoes 
 
Helps the body to use 
calcium and other 
nutrients to strengthen 
bones, blood vessel 
walls and reduce the risk 
of cardio vascular 
diseases. 
4. 
 
 
 
 
 
 
 
 
 
Vitamin E Protects vitamin A and 
other fats from oxidation. 
Facilitates the resistance of 
against the diseases 
especially lungs problems.  
Wheat germ, whole grains, nuts, 
seeds, green leafy vegetables, 
vegetable oil, and fish-liver oil. 
Some foods that are rich in 
vitamin C also supply at least 10 
% daily intake of vitamin E, 
including raspberries, 
blackberries, sweet peppers, 
broccoli and tomatoes. 
Protects cell membranes, 
metabolism especially 
red and white blood 
cells. 
 
 
 
 
 
5. Phytochemicals 
a. Carotenoids 
 
 
 
 
 
 
 
Reduce oxidative stress in   
the cells prevents atrophy 
of thymus gland, other 
lymphoid tissues, 
maintaining of the 
epithelial cells in the 
mucous membranes and 
skin.  
Plant pigment found in colorful 
fruits and vegetables and is 
converted into vitamin A in the 
body. Pumpkin, carrots, tomatoes, 
sweet potatoes, red peppers  
oranges, and dark  green leafy 
vegetables.(spinach) 
Essential for the immune 
system function and     
increase the resistance to 
infections. Ensures good 
vision. 
 
 b. Flavonoids 
 
Promotes cellular health 
and normal tissue growth. 
Cranberries, kale, beets, berries, 
red and black grapes, oranges, 
lemons, grapefruits,  green tea 
and  Dark chocolates 
Renewal of Cells 
throughout the body. 
c. Resveratrol Helps for the free radical 
scavenging, anti-tumor, 
enhance antiviral activity. 
Dark blue and purple fruits, 
including grapes, blackberries and 
blueberries. 
Limit HIV replications 
and reduce 
inflammations. 
Table - 1: Role of antioxidants in HIV and its sources [5-8]
Table - 1 continued...
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Sl. 
No 
Name of 
Antioxidants 
Action Sources Benefits 
6. Selenium Decreases the effect of 
inflammatory cytokines, 
which may reduce the risk 
of developing neurological 
damage, Kaposi's sarcoma 
and wasting syndrome. 
Fish, shellfish, red meat, chicken, 
egg, pork, beef and milk. Nuts 
(Brazil nuts), grains, garlic can 
also be a good source if grown in 
selenium-rich soils 
 
Stabilize viral loads and 
moderate the CD4 
levels. 
7 Zinc Acts as immune 
modulator, anti-viral 
agent. It  helps to inhibit  
the cell death and cellular 
apoptosis and wasting 
syndrome 
Oysters, meats, shellfish, 
fortified beans, soya beans, pea 
nuts, wheat gram, squash seeds, 
spinach and mushroom 
The risk of CD4 cell 
counts falling below the 
critical to 200 cells/mm3 
and  reduce the diarrhea 
8. Magnesium Important role in 
enzymatic reactions, 
muscle relaxation. and 
aids in the absorption 
of calcium  
 
 
Nuts, beans, pineapple, brown 
rice and sweet potatoes.  nuts 
(especially almonds), whole 
grains, wheat germ, fish, and 
green leafy vegetable 
Helps to reduce lipo 
dystrophy symptoms in 
HIV 
 
 
9. Iron  Requires to make 
hemoglobin for red blood 
cells and to transport 
oxygen from lungs to cells 
throughout the body. 
Red meat, liver, fish, poultry, 
shellfish ,eggs, legumes, peanuts, 
cereals, and dried fruits 
Helps for the utilization 
of the energy and the 
metabolism of cells. 
10. Green Tea Act as immune modulator. 
Green tea leaves contain 
compounds called 
catechins, its helps to 
block HIV virus to T cells.   
 It’s coupled with other 
nutrients like vitamin C 
or lysine, inhibits the 
replication of HIV 
virus. 
 
stage, Cellular CD4 immunodeficiency is the hallmark of
HIV infection. Yet, as soon as T-lymphocytes become
infected, the body is faced with the dilemma of promoting
apoptosis to abolish HIV, however consequently
decreasing the body’s battle to HIV results in decline of
antioxidants [3].
HIV, the Body and Antioxidants
The HIV infection increases the free radicals production
inside our body. To counteract this, our body increases
production of own antioxidants. A number of events work
towards hindering this defense, which includes the
following:
1. HIV virus harms the intestinal wall, results in decreased
power to break down and utilize nutrients from food.
2. The overall   nutrients  of  high-quality protein, vitamins
and minerals increases as HIV infection takes hold, and
the immune system needs to respond for continuous
attack from the virus. It makes many numbers of the
immune system’s cells to be   disabled or destroyed.
3. HIV-infected cells steal vital nutrients from the body
that those cells need in order to make many viruses every
day. In PHAs, antioxidant production may not get first
priority [4]. Moreover, the nutrients may simply is not
available because of the following factors
Ø It reduced absorption from the intestine
Ø The poor eating habits
Ø Loss of appetite (sometimes a side effect of
     medications) and diarrhea
Cells   of the immune system need antioxidants to work
properly. Anthony  et al., (2011) revealed, that  PHAs
levels of antioxidants  inside CD4 and CD8 cells are low
because of this deficit the  immune cells may impair the
ability to fight HIV virus [3,4].
Types of Antioxidants
Antioxidants come in a variety of the forms; it is generated
endogenously by the body and exogenously as dietary
supplements. It protects the body from the destructive
effects of free radicals. The two type’s antioxi­dants are:
1. Anti oxidant enzymes  and
2. Non enzymatic dietary antioxidants.[2]
Antioxidant Enzymes:
Superoxide dismutase (SOD) is an enzyme used to modify
superoxide radicals into the less toxic hydrogen peroxide.
s
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But SOD needs mineral cofactors of either manganese or
copper and zinc to function actively. The Other enzymes
of catalase and glutathione peroxidase help to convert
the hydrogen peroxide into oxygen and water.  The heme
requiring enzyme of catalase, and selenium-containing
enzyme of glutathione peroxidase needs glutamine or
glutamate to makes glutathione.
The cofactors of minerals like manganese, selenium, zinc,
copper and iron are needed to enhance these enzyme
activities. Moreover, the dual role in production and
destruction of ROS needs iron and copper.
Non enzymatic antioxidants
Non enzymatic antioxidants are vitamins C and E,
caro­tenes, glutathione, and phyto chemicals. All these
antioxidants are available in food and activate the
intercepting and stabilizing  of the ROS. This is called as
scavenging. Elevated levels of reactive oxygen species
(ROS) is the onset of infection. To protect from excessive
exposure to free radicals, the body can make its own
antioxidants by using some of the following nutrients
that are found in the food or supplements:
1. The amino acid cysteine
2. Minerals such as copper, manganese, zinc and
magnesium
3. B complex vitamins
The body also depends on ready-made antioxidants
found in food. For e.g., vitamin C, vitamin E and mixed
carotenoids such as alpha-carotene, beta-carotene,
lycopene and zinc [2]
Available forms of antioxidants
Many of those defensive free radical scavenging
enzymes are based on micronutrients such as Selenium,
Zinc and Vitamins C and E, and Beta-Carotene. Those
nutrients are not produced by the body, so they must be
included by food and/or supplements. Many of the
antioxidant supplements are available in pill, powder or
liquid form, primarily from health food stores [4]. Here’s a
list of antioxidants or the compounds used to make them
which are taken by some PHAs:
Vitamin C 1000 mg once daily
Vitamin E -100 – 400 IU alpha tocopherol and 200 mg
     gamma tocopherol daily
R-lipoic acid 210 mg twice daily
Mixed Carotenoids especially Beta-carotene: 5000 IU
    daily
Selenium 200 – 400 mcg daily
Zinc 30 mg daily
NAC (N-acetyl-cysteine) : 600 mg twice daily
Co-enzyme Q10: (as Ubiquinol): 200 mg daily.
Green tea, standardized extract: 725 – 1450 mg daily.
Even many antioxidant supplements are available, the
nurses should note that rich source of antioxidants are
in foods. Because it helps for the nutritional counseling
of PLHIV and life threatening illness patients in order to
improve the immunity, increase nutritional status and
enhance the quality of life. The role of Anti-oxidants in
HIV and its sources are illustrated in Table 1
Conclusion
The WHO recommends that the antioxidant nutrients as
a key part in slowing the progression of HIV infection to
the AIDS stage.  The combination of antioxidants and
HAART lower the viral loads and the generation of ROS
from antiretroviral treatment. A rule of thumb when it
comes to antioxidants thinks “ACE.” Vitamins A, C, and
E are best sources of antioxidants and   “eat the rainbow”
color foods. Moreover, nutritional management,
counseling and education should be beneficial for the
quality and extension of life in PLHIV. Hence on a global
scale, it is presumed that antioxidant management may
offer a cost effective therapeutic approach for individuals
living with HIV/AIDS.
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ABSTRACT 
 
Antiretroviral therapy (ART) is a life-long commitment for all the clients living with HIV/AIDS and 
especially for the perinatally infected adolescents. The optimal adherence to ART is the most 
significant factor to suppress HIV replication and to shun the emergence of the drug resistance. 
Globally, all over the two million adolescents aged 10–19 yrs, and the five million young people aged 
15–24 yrs are living with HIV. ART adherence in adolescents contributes significantly to shape the 
future of the HIV epidemic and face different challenges and needs than children and adults. The 
optimal level of drug adherence (>95%) are associated with improved virological, immunological and 
clinical outcomes. Adherence rates exceeding 95% are essential to maximize the benefits of ARV 
medications. The non-adherence (<95%) are finally associated with ART failure includes the 
development of viral resistance, treatment failure and increased the risk of disease progression. The 
many factors like pill burden, forgetfulness, regimen fatigue, busy schedule, depression, stigma and 
disclosure contributes to the poor retention in the care, sub optimal and non adherence to antiretroviral 
therapy in this population. Hence, a multi disciplinary approach towards ALHIV is an essential and 
specially needs to focus the optimal adherence to ART helps to achieve the global targets. 
 
Keywords: Adolescents, Anti retro viral therapy, adherence, Non adherence and ART failure.  
 
INTRODUCTION 
[1-11]
 
 The term "Adolescence" literally 
means "to emerge" or "to attain identity". 
It‟s characterized by myriad of physical, 
psychological, neurobehavioral, hormonal 
and socio developmental changes start from 
the onset of puberty to transiting phase of 
adult. 
[1]
 Adolescents (10-19 yrs) are 
„Fulcrum‟ of key population and centre of 
the epidemic for HIV/AIDS. Globally 62% 
of adolescents and young adults only were 
the adherent to ART and comparable to 
adults ,there were discrepancy between 
regions like lower adherence in Europe , 
South America and North America (50-
60%) and higher levels in Africa and Asia 
(>70%). 
[2]
 The distinct group of adolescents 
in the context of HIV is Perinatally Infected 
Adolescents (PIA) and Behaviorally 
Infected Adolescents (BIA).
 [3] 
Adherence to 
the antiretroviral therapy is poorer in both 
categories of adolescents.
 
The other 
controversial view of PIA were started on 
ART early in life with mono or dual therapy 
regimens resulting in partial viral 
suppression and an emergence of resistance, 
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end in ART failure when compare to the 
adolescents infected in second decade. The 
infected adolescents adhere to ART 
treatment and support has misfired 
throughout to the epidemic results in many 
non adherence problems.
 [4] 
 According to „WHO‟, Adherence is 
defined as “the extent to which a person‟s 
behavior of taking medicine, following a 
diet and /or executing lifestyle changes, 
corresponds with agreed recommendations/ 
prescriptions from a health care provider.” 
[5] 
The adherence measurement is usually 
based on Paterson‟s pioneer study; found 
that up to 95% adherence is mandatorily 
needed for an effective HIV viral 
suppression. 
[6]
 The ALHIVs are 
experiencing many hurdles and challenges 
for optimal adherence when compare to the 
children and adults due to dependency on 
caregivers, need of autonomy, attitudes of 
defiance/ denial, history of loss (parents and 
home) and delay in the disclosure status. 
[7] 
The co-existing group of these adolescents 
faces many concerns related to the 
disclosure, treatment fatigue or stigma 
within their schools, homes and 
communities /self stigma, loss of 
parents/caregivers support and financial 
burden.
 
The adolescents above age of 15yrs 
have greater risk of non adherence 
compared to younger adolescents. It is also 
important to note adolescents can act as a 
transitional phase towards adulthood in 
which drug use and sexual experimentation 
are initiated, thus increasing the risk of 
invite and as well as transmit HIV. 
[3,8]
 
Current Scenario of Adolescents Living 
with HIV/AIDS (ALHIV) 
Global scenario 
  At 2014, globally an estimated 36.9 
million people were living with HIV; of 
these 2.1 million adolescents aged 10–19 
yrs it‟s comprise almost one fifth of the 
world‟s population. The majority of 80% 
adolescent HIV infections are in sub-
Saharan Africa. The new HIV infections 
among adolescents in this region 440 per 
day, nearly one sixth in this age group and 
especially 64% were girls (15-19 yrs). AIDS 
remains the number one killer of 
adolescents in Africa and the second most 
common cause of death among adolescents 
globally.
 
The ART coverage at the end of 
2013 was 37 % for adults but only 23% in 
children/adolescents. Even with the dawn of 
HARRT, globally 13.3 million children (0–
17 years) have lost one or both parents due 
to AIDS. 
[9]
 
Indian scenario  
  In 2014, India had the third largest 
number of persons living with HIV in the 
world around 2.3 million, almost one in 
seven new infections occurred in 15-19 year 
olds. In Asia, AIDS-related deaths were 
increased; nearly 110 % in 10-19 yrs in 
contrast it‟s reduced to 28% in adults. 
Almost in South Asia, death among 
adolescents was quadrupled, around 1,500 
in 2001 to 5,300 in 2014.
 [10] 
The second 
largest number of people (> 700,000) in 
India was on anti retroviral therapy and also 
its home to the second largest numbers of 
HIV/AIDS orphans in the world after South 
Africa. It is also estimated that 13% of HIV 
infection through sexual contact and 20-
30% of female sex workers are less than 
18yrs. 
[11]
 
Rationale to hub on Adolescent Living 
with HIV/AIDS (ALHIV) 
[3, 8, 10, 12,13]
 
 In the modern era, with the 
introduction of HAART and the evolution in 
the diagnosis and treatment of AIDS, many 
of the children are infected through the 
vertical transmission of HIV survive, 
crossed the stage of childhood and entering 
"Adolescence with AIDS”. [3,8] 
Adolescence is a typical period of 
experimentation, vulnerability makes 
usually attempt to break parental bonds 
increase the high risk behaviors.  
Worldwide, adolescents HIV related 
deaths were increased up to 50%. (71,000 in 
2005,110, 00 in 2012) whereas in contrast 
32% decrease among all the other age 
groups during the same period. 
[10,12]
 
ALHIV are very likely to face many 
challenges to lead a big question mark in 
their future and the successful treatment for 
PIA is complex, since they face additional 
                   International Journal of Health Sciences & Research (www.ijhsr.org)  355 
Vol.6; Issue: 5; May 2016 
physical challenges makes difficult to reach 
the transition phase of adult. 
Adolescents have a life time 
potential of transmitting HIV as risk 
behavior. So the hidden epidemic of ALHIV 
needs more attention and a tailored 
approach in order to reduce the risk of 
spreading the virus to others. 
[13]
  
  To address this serious gaps, the 
UNAIDS and UNICEF launched „All In‟ 
movement in 2015. The objectives are, to 
reduce new HIV infections among 
adolescents by at least 75 %, to reducing the 
AIDS-related deaths by at least 65%, and 
eliminating stigma and discrimination by 
2020. Overall, the goal of optimal adherence 
to ART is reduced HIV/AIDS morbidity and 
mortality to 60%-90% and to prolong the 
quality and the survival life of all ALHIV. 
[10]
 
Anti retroviral therapy and its 
Significance 
 
  Antiretroviral therapy means not 
only for the adherence to ARV medications 
(right drug, dose, route, frequency and time) 
and also it includes in the complete 
treatment and care. The optimal level of (95 
%) adherence to ART inhibits the HIV 
replication which has resulted in the steady 
decline in AIDS related to morbidity and 
mortality. ART adherence below 95% 
associated with the treatment failure and 
even 80-90 % have the risk of resistance to 
ARV medications. Non-adherence to ART 
results in inadequate suppression of viral 
replication in the body and allows the 
disease to progress at a faster rate and it‟s 
one of the main reasons for the failure of 
first line ART .The poor adherence to ART 
showed that patient‟s adherence levels were 
below 75% were three times more likely to 
die compared to those adherence levels were 
above 75%. 
[14] 
Specific Adherence Barriers of ALHIV  
[4, 5, 8, 14, 18,19] 
  Adolescents often have less 
disciplined or structured lives than adults. 
Outreach is more intricate with adolescents 
because they are scattered and it is harder to 
bring them into care. As the scenario of HIV 
prevention has shifted to the treatment as 
prevention strategies, it is necessary to 
identify barriers and promote adherence to 
ART among adolescents are essential.
 [4] 
The specific adherence barriers are listed 
below, 
1. Physical barriers 
  The behavioral and cognitive issues 
may directly influence on adherence related 
to lifestyle. Feeling well or worsening of 
diseases, high risk behaviors, less 
knowledge regarding treatment benefits 
leads to ignore the ARV medications. 
[8]
 
2. Medication related barriers 
  The PIA usually have treatment 
fatigue ,complexity of regimens including 
pill burden , palatability of ARV 
medications particularly drugs such as 
nelfinavir and ritonavir, adverse the drug 
effects and long-term toxicities like 
lipodystrophy may also cause non-
adherence. 
[8,14]
 
 
 
Fig-1: shows the specific adherence barriers of ALHIV 
 
3. Psychological barriers 
  The many PIAs have an experienced 
history of depression and psychological 
distress. The disclosure usually associated 
with denial, anger, anxiety and end in 
depressions are directly influence their 
adherence. The disclosure stressors ranked 
second to medication stressors for the 
adolescents and disclosing to more than one 
friend makes hidden of medications. 
[8] 
The 
psychiatric illness which includes the mood 
disorders, Attention Deficit Hyperactivity 
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Disorder (ADHD) and disruptive behavior 
disorders were significantly associated with 
suboptimal adherence. 
[15]
 
 4. Social/Environmental barriers 
  The stigma and discrimination 
usually associated with abandonment from 
the peer group, societal issues and coping 
strategies. The high levels of HIV stigma 
are three times as likely to be non adherent 
with their medications compared to those 
with low stigma. The common structural 
barriers includes, lack of medical insurance, 
stigma in work or school, housing 
instability, unemployment, financial burden, 
lack of transportation to the clinic visits or 
to obtain medication are also influence on 
adherence to ART.
 
5. Lifestyle barriers  
  The above mentioned all the 
barriers are influencing with lifestyle of 
ALHIV. Along with, the forgetfulness, 
falling asleep, busy work schedule, and 
being away from home and frequent 
travelling makes to get precise non 
adherence to this group. 
[8] 
The forgetting, 
changes in daily routine and being away 
from home were the most common causes 
of missing pills. 
[5] 
While another study 
reports that, financial constraints and 
forgetting as the most common reason for 
omitted drugs. 
[16]
 
Monitoring and Assessing Antiretroviral 
Therapy Adherence 
[4,5,14,15,17-22]
 
  There is no „gold standard‟ for the 
assessing and monitoring the adherence 
therefore, multiple approaches are often 
used. A routine adherence assessment 
should be included into every clinic visit by 
the all health professionals in the ART 
centre.
 
They are,  
A. Indirect / Subjective methods: 
1. Self / Care giver’s Report of Adherence 
(Behavior assessment questionnaire) 
 Globally, self/caregiver‟s report is a 
main indicator of adherence, usually 
monitored by the standardized questionnaire 
developed from Adult AIDS clinical trial 
Group (ACTG) and adapted by pediatric 
AIDS clinical trial group. The another 
method of visual analogue scale (VAS) 
indicates, how many of each drug they have 
taken in the past 3or 4 weeks in the range 0-
100.This method was highly correlated, and 
to be equivalent to 3 day recall or self 
report. 
[4] 
The major snag is over estimation 
of adherence due to the desirability bias. 
The self-report of any missed dose history 
have a strong association with development 
of viral failure. 
[17] 
2. Pill Count Method 
Pill count to be calculated as, dividing 
number of pills actually taken by the 
number of pills prescribed in one month 
multiplied by 100. 
[5]
 But its major 
drawback is manipulation of pills or pill 
dumping prior to the hospital visits will 
result in overestimation of adherence. 
[14]
 
This method is economical and correlates 
well with viral load. 
[18]
  
3. Pharmacy Based-Records 
  Pharmacy record is a simple and 
valuable tool for measuring adherence; 
correlated with CD4 count and weight gain. 
The necessary record keeping is essential 
for pharmacy refill tracking. The major 
setback is, believe of that adherence based 
on their empty pill boxes and the regular 
collection of their medication, it does not 
measure the actual medication intake. 
[14]
 
The number of adolescents achieving 100% 
estimated by pharmacy refills, was lower 
than the adults. 
[15] 
B. Direct/objective methods. 
4. Electronic Monitoring Devices (EMD) 
The Micro electronic monitoring systems 
(MEMS) on bottle caps use to calculate by 
dividing the number of time of appropriate 
bottle openings by the number of expected 
dose over the period. This technique 
assumes that opening of the bottle by the 
patient coincides with actual intake of the 
drug. The major hitch is quiet expensive and 
non-reliable device because it 
underestimates or over estimate the 
adherence. 
[14] 
The compared methods of 
adherence monitoring is found that no 
correlation between electronic device 
monitor, pill count and self-report methods. 
[19]
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5. Biological Markers Monitoring 
   Low viral loads and improved CD4 
counts are indication of good adherence. 
Although some clients may have a high 
viral load in spite of taking the ART 
regularly, suggests alternative or second line 
regimens. The major hurdle in this method 
is cost and unavailability in all the health 
care settings. 
[14]
 The viral load and CD4 is a 
good measure of adherence when correlated 
with weight gain compared to self-report 
and pharmacy records. 
[20]
 
6. Therapeutic Drug Monitoring (TDM)  
   It involves measuring the drug 
levels in the blood. This process is not used 
regularly, as most ARV medications have 
less circulating times in the body. 
[14] 
A 
comparative study depicts that, nevirapine 
plasma concentration monitoring provides 
an accurate measurement of adherence 
compared to self-report, 
[21]
 but it is very 
expensive and not feasible to do in all health 
care settings. Drug concentrations in the 
hair are being studied as another method to 
measure adherence. 
[5,22]
 
Strategies and Tools for Enhancing 
Adherence to ART 
[4,14,23-28]
 
  Adherence to ART is central to 
therapeutic success, since it is very complex 
and unpredictable among adolescents. The 
several methods of enhancing adherence, to 
be tailored according to the individual needs 
or depends on barriers to adherence. 
[4]
 They 
are, 
 1. Antiretroviral Therapy Strategies 
   It involves the simplification of 
regimen characteristics, reduction of pill 
burden, management of side effects, and 
adjusting dietary restrictions if needed in 
daily activities. The research studies have 
demonstrated that, enhanced adherence with 
once or twice dose of ART. The fixed-dose 
combinations (FDC) of ARVs are currently 
available and have been revealed to improve 
adherence in adolescents. 
[14] 
2. Information, Education, Counseling 
(IEC) and collaborative planning 
  This is the core of ART program in 
any settings; IEC enrich the adolescent‟s 
knowledge but still regarding the 
reproductive health, high level education 
and career training is needed in this 
population. 
[23] 
During the counseling, 
potential barriers to adherence are 
addressed. The peer group and safe sex 
counseling regarding „ABC‟ approach are 
necessarily to be insisted according to their 
age limit of adolescents.
 [4] 
The motivational 
counseling greatly assists the adolescents in 
developing positive beliefs, and helps to 
increases the self-efficacy and adherence 
level. 
[14] 
Collaborative planning with multi 
disciplinary team is essential to meet their 
needs, emphasize the benefits of optimal 
adherence in the follow up session. 
[24]
 
3. Adherence Tools  
  The „Reminder tools‟ are, one of the 
facilitators for adherence enhancement of 
people living with HIV/AIDS. The research 
has shown that the tools are more benefit 
when it‟s combined with education or 
counseling to clients. In USA, a randomized 
controlled trial reported that reminder tools 
alone do not improve adherence and 
recommends that it should be pooled with 
counseling as the part of comprehensive 
support for clients on ART. They are 
1. Pill boxes are the containers use to store 
the ARV for regular use and facilitate to 
take their medications correctly. The 
Electronic version of pill boxes with 
reminders are also available but major 
problem is the lack of confidentiality, 
privacy associated with it. The drawback is 
the unskilled adolescents may not be able to 
fill the boxes properly. 
2. Pill charts involve visual display of the 
pills in expressions of their shape, color, 
dosage and name of the medications during 
counseling. This is very useful primarily for 
non formal trained adolescents. 
[4,14] 
3. Medication diaries are used to document 
the date, time of taking the medications, 
missed doses and the reasons for it. Mainly 
it is used to identify side effects or other 
problems may encounter in the course of 
taking ART. The home based nursing 
program and medication diaries had a 
positive effect on knowledge, medication 
refills (p=0.002) and no missed dose in 
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intervention group but in control group no 
change and viral load increased from 30-
80%. 
[25]
 
4. Buddy system has been widely used 
where relatives or friends agree to assist the 
clients to remind and encourage to taking 
their medications, adhering to the hospital 
visits, medical care and social support. The 
psycho-social support is not only that assists 
the patient in adhering to ART but also 
provides moral support to cope with the 
disease and enhance the quality of life. 
[4]
 
5. Electronic devices such as beepers, 
alarms and watches, remind patients to 
take their medication as prescribed in 
schedule. In addition, telephonic calls and 
mobile phone text messages have shown to 
improve medication adherence in HIV 
infected individuals. Electronic pagers 
connected to the internet may be used to 
send reminders to the patients to take their 
drugs. The major snag is the lack of privacy, 
cost required to set up this kind of services. 
[4, 14,26]
 
  The other strategies includes, Direct 
Observed Therapy (DOT) and positive 
reinforcement techniques like incentives 
(financial) and rewards (meal tickets, 
grocery bags, lotto ticket) can also 
facilitates adherence. 
[27] 
A meta-analysis 
report was found that, participants receiving 
adherence interventions were 1.5 times as 
likely to report 95% adherence and 1.25 
times more likely to achieve undetectable 
VL than controls. 
[28]  
 
CONCLUSION  
  The Optimal adherence to 
antiretroviral therapy (ART) is essential to 
maintain HIV suppression, lower the risk of 
drug resistance, and improves overall 
health, quality of life and survival.. A multi 
disciplinary team should be able to address 
the barriers, reinforce importance of ARV 
medications, information, education and 
communication (IEC) towards the 
HIV/AIDS in each counseling section will 
facilitates adherence and prevention of HIV 
in future. Moreover, the fixed dose 
combinations (FDCs), reminders, peer 
group counseling, adolescent centered 
service are essential to achieve the optimal 
adherence to ART in adolescents and 
transition to adult care. The Recent 
Millennium Development Goals (MDGs) 
for 2015 'Getting to Zero' and UNAIDS goal 
of “AIDS free generation - within reach by 
2030” can‟t be achieved without imparting 
the significance of adherence to ART to the 
HIV infected adolescents in order to 
develop healthy adults in future forever. 
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